"dataset_id","analysis_id","issue"
"CD000143_pub2_data","1::3::Bronchopulmonary dysplasia ","No usable data for effect sizes"
"CD000143_pub2_data","1::5::Combined outcome of bronchopulmonary dysplasia and mortality","No usable data for effect sizes"
"CD000143_pub2_data","1::6::Mortality at any time up to 28 days or discharge from hospital","No usable data for effect sizes"
"CD000143_pub2_data","1::7::Intraventricular haemorrhage","No usable data for effect sizes"
"CD000143_pub2_data","1::8::Retinopathy of prematurity","No usable data for effect sizes"
"CD000219_pub5_data","2::3::Abnormal tympanometry at 4 weeks","No usable data for effect sizes"
"CD000478_pub5_data","2::1::Failure to maintain remission","No usable data for effect sizes"
"CD000478_pub5_data","4::1::Failure to maintain remission","No usable data for effect sizes"
"CD000478_pub5_data","5::1::Failure to maintain remission","No usable data for effect sizes"
"CD000547_pub3_data","3::6::Proportion with vertical incision","No usable data for effect sizes"
"CD000547_pub3_data","3::9::Postoperative haemoglobin","No usable data for effect sizes"
"CD000547_pub3_data","4::2::Postoperative morbidity (complications)","No usable data for effect sizes"
"CD000547_pub3_data","4::3::Difficulty of surgery (visual analogue scale)","No usable data for effect sizes"
"CD000547_pub3_data","4::4::Fibroid recurrence","No usable data for effect sizes"
"CD000547_pub3_data","5::8::Intraoperative blood loss > 1000 ml","No usable data for effect sizes"
"CD000547_pub3_data","5::13::Postoperative haemoglobin","No usable data for effect sizes"
"CD000547_pub3_data","6::5::Change in menstrual blood loss from baseline to treatment end","No usable data for effect sizes"
"CD001072_pub2_data","1::1::Failure of treatment","No usable data for effect sizes"
"CD001072_pub2_data","1::2::Death in the first year","No usable data for effect sizes"
"CD001072_pub2_data","1::3::Tachycardia","No usable data for effect sizes"
"CD001155_pub3_data","1::10::Osteonecrosis of the Jaw","No usable data for effect sizes"
"CD001155_pub3_data","3::1::Clinical vertebral fractures","No usable data for effect sizes"
"CD001155_pub3_data","5::1::Non-vertebral fractures","No usable data for effect sizes"
"CD001155_pub3_data","5::2::Hip fractures","No usable data for effect sizes"
"CD001155_pub3_data","5::3::Wrist fractures","No usable data for effect sizes"
"CD001155_pub3_data","5::4::Radiographic vertebral fractures","No usable data for effect sizes"
"CD001155_pub3_data","6::1::Clinical vertebral fractures","No usable data for effect sizes"
"CD001155_pub3_data","6::2::Non-vertebral fractures","No usable data for effect sizes"
"CD001155_pub3_data","6::3::Hip fractures","No usable data for effect sizes"
"CD001155_pub3_data","6::4::Radiographic vertebral fractures","No usable data for effect sizes"
"CD001155_pub3_data","8::1::Clinical vertebral fractures","No usable data for effect sizes"
"CD001155_pub3_data","8::3::Hip fractures","No usable data for effect sizes"
"CD001155_pub3_data","8::4::Radiographic vertebral fractures","No usable data for effect sizes"
"CD001155_pub3_data","11::1::Clinical vertebral fractures","No usable data for effect sizes"
"CD001155_pub3_data","14::1::Clinical vertebral fractures","No usable data for effect sizes"
"CD001155_pub3_data","14::3::Hip fractures","No usable data for effect sizes"
"CD001155_pub3_data","14::8::Atypical femoral fracture","No usable data for effect sizes"
"CD001155_pub3_data","15::1::Clinical vertebral fractures","No usable data for effect sizes"
"CD001155_pub3_data","15::2::Non-vertebral fractures","No usable data for effect sizes"
"CD001155_pub3_data","15::3::Hip fractures","No usable data for effect sizes"
"CD001155_pub3_data","15::4::Radiographic vertebral fractures","No usable data for effect sizes"
"CD001155_pub3_data","16::1::Clinical vertebral fractures","No usable data for effect sizes"
"CD001155_pub3_data","16::3::Hip fractures","No usable data for effect sizes"
"CD001155_pub3_data","17::1::Non-vertebral fractures","No usable data for effect sizes"
"CD001155_pub3_data","17::2::Radiographic vertebral fractures","No usable data for effect sizes"
"CD001155_pub3_data","18::1::Clinical vertebral fractures","No usable data for effect sizes"
"CD001155_pub3_data","18::3::Radiographic vertebral fractures","No usable data for effect sizes"
"CD001155_pub3_data","19::1::Clinical vertebral fractures","No usable data for effect sizes"
"CD001155_pub3_data","19::3::Hip fractures","No usable data for effect sizes"
"CD001155_pub3_data","20::2::Hip fractures","No usable data for effect sizes"
"CD001155_pub3_data","21::1::Clinical vertebral fractures","No usable data for effect sizes"
"CD001155_pub3_data","21::2::Non-vertebral fractures","No usable data for effect sizes"
"CD001155_pub3_data","22::2::Hip fractures","No usable data for effect sizes"
"CD001155_pub3_data","23::1::Clinical vertebral fractures","No usable data for effect sizes"
"CD001155_pub3_data","23::2::Non-vertebral fractures","No usable data for effect sizes"
"CD001155_pub3_data","23::3::Wrist fractures","No usable data for effect sizes"
"CD001155_pub3_data","23::8::Atypical femoral fracture","No usable data for effect sizes"
"CD001155_pub3_data","31::1::Alendronate 70 mg/week vs Zolendronic acid 5 mg/year, Secondary","No usable data for effect sizes"
"CD001321_pub7_data","2::2::Clinical UTI: symptoms, no culture","No usable data for effect sizes"
"CD001321_pub7_data","4::1::Symptomatic UTI: culture-verified UTI","No usable data for effect sizes"
"CD001321_pub7_data","5::2::Microbiological UTI: positive culture without known symptoms","No usable data for effect sizes"
"CD001321_pub7_data","5::3::Clinical UTI without culture verification","No usable data for effect sizes"
"CD001321_pub7_data","8::1::Symptomatic UTI: culture-verified UTI","No usable data for effect sizes"
"CD001533_pub7_data","3::1::Number relapsing by 6 to 12 months","No usable data for effect sizes"
"CD001533_pub7_data","3::2::Number relapsing by 12 to 24 months","No usable data for effect sizes"
"CD001533_pub7_data","3::3::Number with frequent relapses","No usable data for effect sizes"
"CD001533_pub7_data","4::1::Number with relapse","No usable data for effect sizes"
"CD001533_pub7_data","5::1::Relapse at 12 months","No usable data for effect sizes"
"CD001533_pub7_data","5::2::Number with FRNS","No usable data for effect sizes"
"CD001533_pub7_data","6::2::Number with relapse","No usable data for effect sizes"
"CD001533_pub7_data","7::3::Number of relapses/patient at 2 years","No usable data for effect sizes"
"CD001533_pub7_data","9::3::Mean relapse rate/patient/year","No usable data for effect sizes"
"CD001533_pub7_data","10::1::Relapse by 6 months","No usable data for effect sizes"
"CD001533_pub7_data","11::2::Mean relapse rate","No usable data for effect sizes"
"CD001533_pub7_data","11::6::Cumulative steroid dose [mg/kg]","No usable data for effect sizes"
"CD001533_pub7_data","11::7::Number with HPA suppression","No usable data for effect sizes"
"CD001533_pub7_data","12::3::Number with FRNS or SDNS at 12 months","No usable data for effect sizes"
"CD001533_pub7_data","12::4::Cumulative prednisone dose to achieve remission [mg/kg]","No usable data for effect sizes"
"CD001533_pub7_data","13::1::Number of relapses in 12 months [number/year]","No usable data for effect sizes"
"CD001533_pub7_data","14::1::Number with relapse during treatment","No usable data for effect sizes"
"CD001533_pub7_data","14::2::Number with relapse by 6 months","No usable data for effect sizes"
"CD001533_pub7_data","16::3::Number with FRNS or SDNS","No usable data for effect sizes"
"CD001552_pub3_data","1::7::Health-related quality of life at long-term follow-up: over 3 months","No usable data for effect sizes"
"CD001552_pub3_data","1::9::Need for surgery or secondary surgery at short-term follow-up: 3 months or less","No usable data for effect sizes"
"CD001552_pub3_data","2::5::Function at short-term follow-up: 3 months or less","No usable data for effect sizes"
"CD001552_pub3_data","2::7::Pain at short-term follow-up: 3 months or less","No usable data for effect sizes"
"CD001552_pub3_data","2::8::Pain at long-term follow-up: over 3 months","No usable data for effect sizes"
"CD001552_pub3_data","2::10::Need for surgery or secondary surgery at short-term follow-up: 3 months or less","No usable data for effect sizes"
"CD001552_pub3_data","2::11::Need for surgery or secondary surgery at long-term follow-up: over 3 months","No usable data for effect sizes"
"CD001552_pub3_data","3::1::Clinical improvement at short-term follow-up: 3 months or less","No usable data for effect sizes"
"CD001552_pub3_data","3::2::Clinical improvement at long-term follow-up: over 3 months","No usable data for effect sizes"
"CD001552_pub3_data","3::3::Symptoms at short-term follow-up: 3 months or less","No usable data for effect sizes"
"CD001552_pub3_data","3::4::Symptoms at long-term follow-up: over 3 months","No usable data for effect sizes"
"CD001552_pub3_data","3::5::Function at short-term follow-up: 3 months or less","No usable data for effect sizes"
"CD001552_pub3_data","3::6::Function at long-term follow-up: over 3 months","No usable data for effect sizes"
"CD001552_pub3_data","3::7::Adverse effects","No usable data for effect sizes"
"CD001552_pub3_data","4::1::Symptoms at long-term follow-up: over 3 months","No usable data for effect sizes"
"CD001552_pub3_data","4::2::Function at long-term follow-up: over 3 months","No usable data for effect sizes"
"CD001552_pub3_data","4::3::Pain at long-term follow-up: over 3 months","No usable data for effect sizes"
"CD001552_pub3_data","5::1::Clinical improvement at long-term follow-up: over 3 months","No usable data for effect sizes"
"CD001552_pub3_data","5::8::Health-related quality of life at short-term follow-up: 3 months or less","No usable data for effect sizes"
"CD001552_pub3_data","5::9::Health-related quality of life at long-term follow-up: over 3 months","No usable data for effect sizes"
"CD001552_pub3_data","6::1::Clinical improvement at long-term follow-up: over 3 months","No usable data for effect sizes"
"CD001552_pub3_data","6::2::Symptoms at long-term follow-up: over 3 months","No usable data for effect sizes"
"CD001552_pub3_data","6::3::Function at long-term follow-up: over 3 months","No usable data for effect sizes"
"CD001552_pub3_data","6::4::Pain at long-term follow-up: over 3 months","No usable data for effect sizes"
"CD001552_pub3_data","6::6::Need for surgery or secondary surgery at long-term follow-up: over 3 months","No usable data for effect sizes"
"CD001552_pub3_data","7::1::Symptoms at long-term follow-up: over 3 months","No usable data for effect sizes"
"CD001552_pub3_data","7::2::Function at long-term follow-up: over 3 months","No usable data for effect sizes"
"CD001552_pub3_data","7::3::Pain at long-term follow-up: over 3 months","No usable data for effect sizes"
"CD001552_pub3_data","8::1::Symptoms at short-term follow-up: 3 months or less","No usable data for effect sizes"
"CD001552_pub3_data","8::2::Function at short-term follow-up: 3 months or less","No usable data for effect sizes"
"CD001552_pub3_data","8::3::Need for surgery or secondary surgery at short-term follow-up: 3 months or less","No usable data for effect sizes"
"CD001703_pub4_data","1::3::Non-specific low back pain: pain intensity (0 to 100) at mid-term follow-up (> 16 to 52 weeks)","No usable data for effect sizes"
"CD001703_pub4_data","1::5::Non-specific low back pain: disability (ODI, 0 to 100) at short-term follow-up (> 4 to 16 weeks): SSRI","No usable data for effect sizes"
"CD001703_pub4_data","1::7::Non-specific low back pain: disability (RMDQ, 0 to 24) at mid-term follow-up (> 16 to 52 weeks): TCA","No usable data for effect sizes"
"CD001703_pub4_data","1::9::Non-specific low back pain: depressive symptoms (MADRS, 0 to 60) at short-term follow-up (> 4 to 16 weeks): SSRI","No usable data for effect sizes"
"CD001703_pub4_data","1::11::Non-specific low back pain: depressive symptoms (BDI, 0 to 63) at mid-term follow-up (> 16 to 52 weeks): TCA","No usable data for effect sizes"
"CD001703_pub4_data","1::12::Non-specific low back pain: depressive symptoms (BDI, 0 to 63) at short-term follow-up (> 4 to 16 weeks): other antidepressants","No usable data for effect sizes"
"CD001703_pub4_data","1::15::Non-specific low back pain: HRQoL (EQ-5D, 0 to 100 VAS) at mid-term follow-up (> 16 to 52 weeks): TCA","No usable data for effect sizes"
"CD001703_pub4_data","1::18::Spine-related leg pain: pain intensity (0 to 100) at mid-term follow-up (> 16 to 52 weeks)","No usable data for effect sizes"
"CD001703_pub4_data","1::21::Spine-related leg pain: disability (ODI, 0 to 100) at mid-term follow-up (> 16 to 52 weeks)","No usable data for effect sizes"
"CD001703_pub4_data","1::22::Spine-related leg pain: depressive symptoms (HADS-D, 0 to 21) at immediate-term follow-up (≤ 4 weeks)","No usable data for effect sizes"
"CD001703_pub4_data","1::23::Spine-related leg pain: depressive symptoms (BDI, 0 to 63) at short-term follow-up (> 4 to 16 weeks)","No usable data for effect sizes"
"CD001703_pub4_data","1::24::Spine-related leg pain: HRQoL (SF-36, 0 to 100) at short-term follow-up (> 4 to 16 weeks)","No usable data for effect sizes"
"CD001797_pub4_data","1::5::Change in mean disability score within 6 weeks; generic inverse variance approach","No usable data for effect sizes"
"CD001797_pub4_data","1::8::Change in mean disability score at 24 weeks or later","No usable data for effect sizes"
"CD001797_pub4_data","2::1::Change in mean disability score within 6 weeks","No usable data for effect sizes"
"CD001797_pub4_data","3::1::Significant improvement in disability within 6 weeks","No usable data for effect sizes"
"CD001797_pub4_data","3::2::Improvement of ≥ 1 point on Rankin scale","No usable data for effect sizes"
"CD001797_pub4_data","3::3::Change in mean disability score within 6 weeks","No usable data for effect sizes"
"CD001797_pub4_data","3::4::Change in mean disability score on Rankin scale within 6 weeks","No usable data for effect sizes"
"CD001797_pub4_data","3::5::Change in muscle strength (mean Medical Research Council sum score) within 6 weeks","No usable data for effect sizes"
"CD001797_pub4_data","3::6::Frequency of serious side effects","No usable data for effect sizes"
"CD001797_pub4_data","3::7::Frequency of any side effects","No usable data for effect sizes"
"CD001797_pub4_data","4::1::Significant improvement in disability within 6 weeks","No usable data for effect sizes"
"CD001797_pub4_data","4::2::Improvement of ≥ 1 point on Rankin scale","No usable data for effect sizes"
"CD001797_pub4_data","4::3::Change in mean disability score within 6 weeks","No usable data for effect sizes"
"CD001797_pub4_data","4::4::Change in mean disability score on Rankin scale within 6 weeks","No usable data for effect sizes"
"CD001797_pub4_data","4::5::Change in muscle strength (Medical Research Council sum score) within 6 weeks","No usable data for effect sizes"
"CD001797_pub4_data","4::6::Change in mean disability score at 24 weeks or later","No usable data for effect sizes"
"CD001797_pub4_data","4::7::Frequency of serious side effects","No usable data for effect sizes"
"CD001797_pub4_data","4::8::Frequency of any side effects","No usable data for effect sizes"
"CD001920_pub4_data","1::5::Length of stay","No usable data for effect sizes"
"CD001920_pub4_data","2::5::Adverse eventsa","No usable data for effect sizes"
"CD001920_pub4_data","3::5::Length of stay","No usable data for effect sizes"
"CD001920_pub4_data","7::5::Functional task training compared to other: Length of hospital stay","No usable data for effect sizes"
"CD001920_pub4_data","7::11::Neurophysiological approach compared to other: Adverse events","No usable data for effect sizes"
"CD001920_pub4_data","8::5::Functional task training compared to other approaches: Adverse events","No usable data for effect sizes"
"CD001920_pub4_data","8::8::Neurophysiological approaches compared to other approaches: Balance (Berg Balance Scale)","No usable data for effect sizes"
"CD002042_pub6_data","2::13::Morbidity: pulmonary oedema","No usable data for effect sizes"
"CD002042_pub6_data","2::14::Morbidity: (N)MODS","No usable data for effect sizes"
"CD002042_pub6_data","2::21::Morbidity: acute kidney injury (AKI)","No usable data for effect sizes"
"CD002042_pub6_data","2::22::Morbidity: renal failure","No usable data for effect sizes"
"CD002052_pub4_data","1::1::Hypotension","No usable data for effect sizes"
"CD002052_pub4_data","1::2::Apnoea","No usable data for effect sizes"
"CD002052_pub4_data","2::1::Hypotension","No usable data for effect sizes"
"CD002052_pub4_data","2::2::Apnea","No usable data for effect sizes"
"CD002052_pub4_data","2::3::All‐cause mortality until hospital discharge ","No usable data for effect sizes"
"CD002052_pub4_data","2::5::Days of supplemental oxygen use","No usable data for effect sizes"
"CD002052_pub4_data","2::6::Intraventricular haemorrhage (any grade)","No usable data for effect sizes"
"CD002052_pub4_data","2::8::Length of NICU stay (days)","No usable data for effect sizes"
"CD002052_pub4_data","2::9::Number of infants requiring additional medications for sedation or analgesia or both","No usable data for effect sizes"
"CD002052_pub4_data","2::10::Seizures","No usable data for effect sizes"
"CD002052_pub4_data","2::11::Irritability","No usable data for effect sizes"
"CD002052_pub4_data","2::12::Drowsiness","No usable data for effect sizes"
"CD002052_pub4_data","3::1::Apnoea","No usable data for effect sizes"
"CD002052_pub4_data","3::2::Number of infants requiring additional medications for sedation or analgesia or both","No usable data for effect sizes"
"CD002052_pub4_data","3::3::Successful sedation","No usable data for effect sizes"
"CD002052_pub4_data","4::1::Sedation 30 minutes post administration","No usable data for effect sizes"
"CD002052_pub4_data","4::2::Apnoea","No usable data for effect sizes"
"CD002052_pub4_data","4::3::Successful completion of the procedure","No usable data for effect sizes"
"CD002112_pub2_data","2::3::Mean number of wet nights at follow-up","No usable data for effect sizes"
"CD002112_pub2_data","2::5::Adverse events","No usable data for effect sizes"
"CD002112_pub2_data","5::3::Mean number of wet nights at follow-up","No usable data for effect sizes"
"CD002112_pub2_data","5::5::Adverse events","No usable data for effect sizes"
"CD002112_pub2_data","6::5::Adverse events","No usable data for effect sizes"
"CD002115_pub6_data","1::3::Number of participants with self-reported improvement in constipation (continuous)","No usable data for effect sizes"
"CD002122_pub3_data","1::4::Assessment of implant (continuous scale)","No usable data for effect sizes"
"CD002122_pub3_data","1::5::Assessment of implant (dichotomous)","No usable data for effect sizes"
"CD002122_pub3_data","4::5::Patient satisfaction","No usable data for effect sizes"
"CD002122_pub3_data","5::4::Assessment of implant (dichotomous)","No usable data for effect sizes"
"CD002122_pub3_data","5::6::Patient satisfaction","No usable data for effect sizes"
"CD002122_pub3_data","7::2::Assessment of implant","No usable data for effect sizes"
"CD002122_pub3_data","9::2::Assessment of implant","No usable data for effect sizes"
"CD002122_pub3_data","12::2::Adverse effects","No usable data for effect sizes"
"CD002122_pub3_data","13::2::Patient satisfaction (dichotomous)","No usable data for effect sizes"
"CD002122_pub3_data","14::1::Adverse effects","No usable data for effect sizes"
"CD002203_pub5_data","1::8::Number of days in hospital","No usable data for effect sizes"
"CD002203_pub5_data","1::12::Acquisition of macrolide-resistant Staphylococcal aureus","No usable data for effect sizes"
"CD002203_pub5_data","1::15::Acquisition of macrolide-resistant Haemophilus influenzae","No usable data for effect sizes"
"CD002203_pub5_data","1::18::Number of courses of oral antibiotics","No usable data for effect sizes"
"CD002203_pub5_data","1::19::Number of days of additional oral antibiotics","No usable data for effect sizes"
"CD002203_pub5_data","1::21::Number of courses of intravenous antibiotics","No usable data for effect sizes"
"CD002203_pub5_data","1::22::Number of days of intravenous antibiotics","No usable data for effect sizes"
"CD002203_pub5_data","1::23::Development of allergic bronchopulmonary aspergillosis","No usable data for effect sizes"
"CD002203_pub5_data","1::24::Change in BMI z score","No usable data for effect sizes"
"CD002203_pub5_data","1::25::Mean BMI score at 3 years of age","No usable data for effect sizes"
"CD002203_pub5_data","1::27::Change in total quality of life score (CFQ-R)","No usable data for effect sizes"
"CD002203_pub5_data","1::29::Change in respiratory symptom domain of CFQ-R QoL score","No usable data for effect sizes"
"CD002203_pub5_data","1::32::Change in eating disorder domain of CFQ-R QoL score","No usable data for effect sizes"
"CD002203_pub5_data","1::33::Change in problems with body weight domain of the CFQ-R QoL score","No usable data for effect sizes"
"CD002203_pub5_data","1::34::Change in inflammatory markers: IL-8 pg/mL","No usable data for effect sizes"
"CD002203_pub5_data","1::35::Change in inflammatory markers: neutrophil elastase µg/mL","No usable data for effect sizes"
"CD002203_pub5_data","1::36::Change in CRP","No usable data for effect sizes"
"CD002203_pub5_data","2::1::Pulmonary exacerbation rate (per child, per month)","No usable data for effect sizes"
"CD002203_pub5_data","3::2::Days to first pulmonary exacerbation","No usable data for effect sizes"
"CD002203_pub5_data","3::4::Days in hospital","No usable data for effect sizes"
"CD002203_pub5_data","3::5::Number of hospital admissions","No usable data for effect sizes"
"CD002203_pub5_data","3::6::Acquisition of azithromycin-resistant Staphylococcal aureus","No usable data for effect sizes"
"CD002243_pub5_data","2::2::Long-term mortality","No usable data for effect sizes"
"CD002243_pub5_data","2::4::90-day all-cause mortality","No usable data for effect sizes"
"CD002243_pub5_data","2::9::Number of participants with shock reversal at day 28","No usable data for effect sizes"
"CD002290_pub6_data","2::1::Relapse at 12 months","No usable data for effect sizes"
"CD002290_pub6_data","3::3::Relapse rate","No usable data for effect sizes"
"CD002290_pub6_data","3::4::Infection rate","No usable data for effect sizes"
"CD002290_pub6_data","4::1::Relapse/treatment failure during MMF therapy (to 505 days)","No usable data for effect sizes"
"CD002290_pub6_data","4::2::Relapse rate with RTX during MMF therapy (to 505 days)","No usable data for effect sizes"
"CD002290_pub6_data","4::3::Steroid dose during MMF therapy (to 505 days) [mg/m2/day]","No usable data for effect sizes"
"CD002290_pub6_data","4::4::Relapse/treatment failure during entire study","No usable data for effect sizes"
"CD002290_pub6_data","7::4::GFR at 12 months [mL/min]","No usable data for effect sizes"
"CD002290_pub6_data","8::1::Relapse at 12 months","No usable data for effect sizes"
"CD002290_pub6_data","8::2::Alopecia","No usable data for effect sizes"
"CD002290_pub6_data","10::1::Relapse by 12 months","No usable data for effect sizes"
"CD002290_pub6_data","11::1::Number with FRNS or SDNS","No usable data for effect sizes"
"CD002290_pub6_data","11::3::Sustained remission","No usable data for effect sizes"
"CD002290_pub6_data","11::4::Treatment failure","No usable data for effect sizes"
"CD002290_pub6_data","11::5::Serious adverse events","No usable data for effect sizes"
"CD002290_pub6_data","12::1::Infrequent or no relapses at 12 months","No usable data for effect sizes"
"CD002290_pub6_data","12::2::Relapse by 12 months","No usable data for effect sizes"
"CD002290_pub6_data","14::2::Number needing cytotoxic agents","No usable data for effect sizes"
"CD002290_pub6_data","14::3::Creatinine at end of study [µmol/L]","No usable data for effect sizes"
"CD002290_pub6_data","15::1::Remission","No usable data for effect sizes"
"CD002290_pub6_data","15::2::Overall reduction in prednisone dose","No usable data for effect sizes"
"CD002290_pub6_data","15::3::Adverse events","No usable data for effect sizes"
"CD002290_pub6_data","17::2::Relapse rate ","No usable data for effect sizes"
"CD002290_pub6_data","17::4::Infection rate","No usable data for effect sizes"
"CD002290_pub6_data","17::5::Cumulative prednisone dose [mg]","No usable data for effect sizes"
"CD002290_pub6_data","19::2::Relapse at 24 months","No usable data for effect sizes"
"CD002290_pub6_data","19::3::Leucopenia","No usable data for effect sizes"
"CD002290_pub6_data","20::1::Relapse at 12 months","No usable data for effect sizes"
"CD002290_pub6_data","21::2::Continuing frequently relapsing or steroid dependent SSNS at 6 months","No usable data for effect sizes"
"CD002290_pub6_data","22::1::Relapse at 12 months","No usable data for effect sizes"
"CD002290_pub6_data","28::1::Relapse at 6 months","No usable data for effect sizes"
"CD002303_pub4_data","1::1::Reulceration at 6 months","No usable data for effect sizes"
"CD002303_pub4_data","2::1::Reulceration","No usable data for effect sizes"
"CD002303_pub4_data","2::2::Noncompliance ","No usable data for effect sizes"
"CD002303_pub4_data","4::1::Reulceration at 18 months","No usable data for effect sizes"
"CD002303_pub4_data","4::2::Noncompliance  at 18 months","No usable data for effect sizes"
"CD002971_pub6_data","1::12::Hearing impairment","No usable data for effect sizes"
"CD002971_pub6_data","1::13::Visual impairment","No usable data for effect sizes"
"CD003129_pub2_data","1::4::Pain (visual analogue scale) ","No usable data for effect sizes"
"CD003129_pub2_data","1::5::Participant global assessment of well-being","No usable data for effect sizes"
"CD003129_pub2_data","2::2::Sustained clinically inactive disease (Wallace criteria or as defined by study authors)","No usable data for effect sizes"
"CD003129_pub2_data","2::6::Serious adverse events","No usable data for effect sizes"
"CD003129_pub2_data","2::7::Withdrawals due to adverse events","No usable data for effect sizes"
"CD003129_pub2_data","3::1::Treatment response (American College of Rheumatology criteria or as defined by study authors)","No usable data for effect sizes"
"CD003129_pub2_data","3::3::Function (Childhood Health Assessment Questionnaire or equivalent)","No usable data for effect sizes"
"CD003129_pub2_data","3::5::Participant global assessment of well-being","No usable data for effect sizes"
"CD003129_pub2_data","3::6::Serious adverse events","No usable data for effect sizes"
"CD003129_pub2_data","3::7::Withdrawals due to adverse events","No usable data for effect sizes"
"CD003214_pub4_data","1::1::Mortality","No usable data for effect sizes"
"CD003214_pub4_data","1::2::Chronic lung disease at 28 days","No usable data for effect sizes"
"CD003214_pub4_data","1::3::Duration of oxygen supplementation (days)","No usable data for effect sizes"
"CD003214_pub4_data","1::4::Duration of assisted ventilation (days)","No usable data for effect sizes"
"CD003214_pub4_data","1::5::Age of weaning from ventilatory support (days)","No usable data for effect sizes"
"CD003214_pub4_data","1::6::Need for intravenous dexamethasone","No usable data for effect sizes"
"CD003214_pub4_data","1::7::Infants with one or more episodes of respiratory infection","No usable data for effect sizes"
"CD003214_pub4_data","1::8::Infants with one or more episodes of sepsis (positive blood culture)","No usable data for effect sizes"
"CD003216_pub3_data","2::1::Incidence of pressure ulcers","No usable data for effect sizes"
"CD003216_pub3_data","3::1::Incidence of pressure ulcers","No usable data for effect sizes"
"CD003216_pub3_data","4::1::Incidence of pressure ulcers","No usable data for effect sizes"
"CD003216_pub3_data","6::1::Incidence of pressure ulcers","No usable data for effect sizes"
"CD003216_pub3_data","7::2::At least one adverse gastrointestinal effect","No usable data for effect sizes"
"CD003216_pub3_data","8::4::At least one adverse gastrointestinal effect","No usable data for effect sizes"
"CD003216_pub3_data","9::1::Pressure ulcers healed","No usable data for effect sizes"
"CD003216_pub3_data","9::2::Change in pressure ulcer area (cm²)","No usable data for effect sizes"
"CD003216_pub3_data","9::4::Change in PUSH score","No usable data for effect sizes"
"CD003216_pub3_data","9::5::DESIGN-R score","No usable data for effect sizes"
"CD003216_pub3_data","9::7::Costs (EUR)","No usable data for effect sizes"
"CD003216_pub3_data","9::8::Acceptability: non adherence","No usable data for effect sizes"
"CD003216_pub3_data","10::1::PUSH score","No usable data for effect sizes"
"CD003216_pub3_data","10::2::At least one side effect","No usable data for effect sizes"
"CD003216_pub3_data","10::3::Acceptability: non adherence","No usable data for effect sizes"
"CD003216_pub3_data","11::1::Pressure ulcers healed","No usable data for effect sizes"
"CD003216_pub3_data","11::2::PUSH score","No usable data for effect sizes"
"CD003216_pub3_data","12::1::Pressure ulcers healed","No usable data for effect sizes"
"CD003216_pub3_data","12::2::Pressure ulcer episodes","No usable data for effect sizes"
"CD003216_pub3_data","12::3::PUSH score","No usable data for effect sizes"
"CD003216_pub3_data","12::4::Diarrhoea episodes","No usable data for effect sizes"
"CD003216_pub3_data","12::5::Costs (EUR)","No usable data for effect sizes"
"CD003216_pub3_data","13::1::Change in pressure ulcer area (cm²)","No usable data for effect sizes"
"CD003216_pub3_data","13::3::DESIGN-R score","No usable data for effect sizes"
"CD003216_pub3_data","14::1::PUSH score","No usable data for effect sizes"
"CD003216_pub3_data","14::2::At least one adverse gastrointestinal effect","No usable data for effect sizes"
"CD003216_pub3_data","15::1::Change in pressure ulcer area (cm²)","No usable data for effect sizes"
"CD003216_pub3_data","15::2::Change in pressure ulcer area (percentage)","No usable data for effect sizes"
"CD003216_pub3_data","15::3::Side effects","No usable data for effect sizes"
"CD003216_pub3_data","16::2::Change in pressure ulcer area (percentage)","No usable data for effect sizes"
"CD003216_pub3_data","17::1::Pressure ulcers healed","No usable data for effect sizes"
"CD003216_pub3_data","17::2::Change in pressure ulcer volume (mL)","No usable data for effect sizes"
"CD003333_pub4_data","2::1::All-cause mortality","No usable data for effect sizes"
"CD003333_pub4_data","2::2::Non-fatal cardiovascular events (non-fatal stroke, myocardial infarction, pulmonary embolism, peripheral arterial embolism)","No usable data for effect sizes"
"CD003333_pub4_data","2::3::Major bleeding events","No usable data for effect sizes"
"CD003357_pub5_data","1::1::Live birth rate per woman","No usable data for effect sizes"
"CD003357_pub5_data","2::2::Clinical pregnancy rate per woman","No usable data for effect sizes"
"CD003357_pub5_data","2::3::Multiple pregnancy rate per woman","No usable data for effect sizes"
"CD003357_pub5_data","2::4::Miscarriage rate","No usable data for effect sizes"
"CD003376_pub4_data","1::8::Gastrointestinal adverse events","No usable data for effect sizes"
"CD003376_pub4_data","2::1::Radiographic vertebral fractures","No usable data for effect sizes"
"CD003376_pub4_data","4::1::Non-vertebral fractures","No usable data for effect sizes"
"CD003376_pub4_data","4::2::Hip fractures","No usable data for effect sizes"
"CD003376_pub4_data","4::3::Wrist fractures","No usable data for effect sizes"
"CD003376_pub4_data","5::2::Hip fractures","No usable data for effect sizes"
"CD003376_pub4_data","5::3::Wrist fractures","No usable data for effect sizes"
"CD003376_pub4_data","6::1::Clinical vertebral fractures","No usable data for effect sizes"
"CD003376_pub4_data","6::3::Hip fractures","No usable data for effect sizes"
"CD003376_pub4_data","6::4::Wrist fractures","No usable data for effect sizes"
"CD003376_pub4_data","9::1::Clinical vertebral fractures","No usable data for effect sizes"
"CD003376_pub4_data","10::4::Wrist fractures","No usable data for effect sizes"
"CD003376_pub4_data","11::4::Withdrawals due to adverse events","No usable data for effect sizes"
"CD003376_pub4_data","11::5::Serious adverse events","No usable data for effect sizes"
"CD003376_pub4_data","11::6::Gastrointestinal adverse events","No usable data for effect sizes"
"CD003376_pub4_data","12::1::Radiographic vertebral fractures","No usable data for effect sizes"
"CD003376_pub4_data","14::1::Hip fractures","No usable data for effect sizes"
"CD003376_pub4_data","14::2::Wrist fractures","No usable data for effect sizes"
"CD003376_pub4_data","14::3::Radiographic vertebral fractures","No usable data for effect sizes"
"CD003414_pub4_data","1::5::Ectopic pregnancy rate per woman","No usable data for effect sizes"
"CD003414_pub4_data","4::1::Live birth rate per woman","No usable data for effect sizes"
"CD003414_pub4_data","4::2::Miscarriage rate per woman","No usable data for effect sizes"
"CD003414_pub4_data","4::3::Endometrial thickness","No usable data for effect sizes"
"CD003414_pub4_data","5::1::Live birth rate per woman","No usable data for effect sizes"
"CD003414_pub4_data","5::2::Miscarriage rate per woman","No usable data for effect sizes"
"CD003414_pub4_data","5::3::Multiple pregnancy rate per woman","No usable data for effect sizes"
"CD003451_pub3_data","1::4::Piers-Harris self-concept scale","No usable data for effect sizes"
"CD003451_pub3_data","2::5::Need for surgery in adulthood (6-year follow-up)","No usable data for effect sizes"
"CD003451_pub3_data","5::1::Overjet","No usable data for effect sizes"
"CD003451_pub3_data","5::3::Wits","No usable data for effect sizes"
"CD003451_pub3_data","6::1::Overjet","No usable data for effect sizes"
"CD003451_pub3_data","6::2::ANB","No usable data for effect sizes"
"CD003451_pub3_data","7::1::Overjet","No usable data for effect sizes"
"CD003451_pub3_data","8::3::A-NPerp","No usable data for effect sizes"
"CD003451_pub3_data","9::1::Overjet","No usable data for effect sizes"
"CD003451_pub3_data","9::2::ANB","No usable data for effect sizes"
"CD003451_pub3_data","9::3::Wits","No usable data for effect sizes"
"CD003451_pub3_data","10::1::ANB","No usable data for effect sizes"
"CD003451_pub3_data","11::1::ANB","No usable data for effect sizes"
"CD003451_pub3_data","11::2::Wits","No usable data for effect sizes"
"CD003451_pub3_data","12::1::Overjet","No usable data for effect sizes"
"CD003451_pub3_data","12::2::ANB","No usable data for effect sizes"
"CD003451_pub3_data","12::3::Wits","No usable data for effect sizes"
"CD003451_pub3_data","13::1::Overjet","No usable data for effect sizes"
"CD003451_pub3_data","13::2::ANB","No usable data for effect sizes"
"CD003477_pub5_data","4::7::Cognition","No usable data for effect sizes"
"CD003594_pub7_data","1::3::Kidney failure","No usable data for effect sizes"
"CD003594_pub7_data","2::2::Death","No usable data for effect sizes"
"CD003594_pub7_data","2::4::Mean time to remission","No usable data for effect sizes"
"CD003594_pub7_data","3::3::Relapse following complete or partial remission","No usable data for effect sizes"
"CD003594_pub7_data","3::4::Kidney function: change in eGFR over 12 months","No usable data for effect sizes"
"CD003594_pub7_data","4::3::Kidney failure by 78 weeks","No usable data for effect sizes"
"CD003594_pub7_data","4::4::Death by 52 weeks","No usable data for effect sizes"
"CD003594_pub7_data","4::5::Kidney function: 50% decline in GFR by 78 weeks","No usable data for effect sizes"
"CD003594_pub7_data","5::3::Relapses [number/year]","No usable data for effect sizes"
"CD003594_pub7_data","5::4::Prednisone dose [mg/kg/d]","No usable data for effect sizes"
"CD003594_pub7_data","5::5::Kidney function: change in GFR [mL/min]","No usable data for effect sizes"
"CD003594_pub7_data","6::1::Remission at 6 months","No usable data for effect sizes"
"CD003594_pub7_data","6::2::Relapse at 12 months","No usable data for effect sizes"
"CD003594_pub7_data","6::3::Urinary protein-creatinine ratio at 6 months","No usable data for effect sizes"
"CD003594_pub7_data","7::1::Relapse by one year","No usable data for effect sizes"
"CD003594_pub7_data","8::2::Complete or partial remission","No usable data for effect sizes"
"CD003594_pub7_data","8::3::Treatment failure","No usable data for effect sizes"
"CD003594_pub7_data","8::4::Death (any cause)","No usable data for effect sizes"
"CD003594_pub7_data","9::2::Partial remission","No usable data for effect sizes"
"CD003594_pub7_data","9::3::Continuing remission at one year","No usable data for effect sizes"
"CD003594_pub7_data","9::4::Kidney function: renal insufficiency","No usable data for effect sizes"
"CD003594_pub7_data","9::6::Time to remission [days]","No usable data for effect sizes"
"CD003594_pub7_data","9::7::Mean duration of remission [months]","No usable data for effect sizes"
"CD003594_pub7_data","12::1::Active disease at end of treatment (12 months)","No usable data for effect sizes"
"CD003594_pub7_data","12::2::Active disease one year after treatment","No usable data for effect sizes"
"CD003594_pub7_data","13::1::Complete remission","No usable data for effect sizes"
"CD003594_pub7_data","13::2::Kidney failure","No usable data for effect sizes"
"CD003594_pub7_data","15::1::Complete remission","No usable data for effect sizes"
"CD003594_pub7_data","15::2::Complete or partial remission","No usable data for effect sizes"
"CD003594_pub7_data","17::3::Serum albumin [g/L]","No usable data for effect sizes"
"CD003594_pub7_data","17::4::Systolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD003594_pub7_data","17::5::Serum potassium [mmol/L]","No usable data for effect sizes"
"CD003594_pub7_data","17::6::Kidney function: creatinine clearance [mL/min]","No usable data for effect sizes"
"CD003594_pub7_data","18::1::Partial remission (> 40% reduction in UPCR) at 8 weeks","No usable data for effect sizes"
"CD003594_pub7_data","19::1::Complete remission of proteinuria (any time during follow-up to week 108)","No usable data for effect sizes"
"CD003594_pub7_data","19::2::Partial remission at 36 weeks","No usable data for effect sizes"
"CD003594_pub7_data","19::3::Kidney failure","No usable data for effect sizes"
"CD003594_pub7_data","19::4::Composite outcome: 40% reduction in GFR/death/kidney failure","No usable data for effect sizes"
"CD003598_pub3_data","1::12::Rejection","No usable data for effect sizes"
"CD003598_pub3_data","1::14::Proteinuria [g/24 hours]","No usable data for effect sizes"
"CD003598_pub3_data","1::19::Hypotension","No usable data for effect sizes"
"CD003598_pub3_data","1::22::Hyperglycaemia","No usable data for effect sizes"
"CD003598_pub3_data","1::23::Oedema of legs","No usable data for effect sizes"
"CD003598_pub3_data","1::25::Withdrawal due to rejection","No usable data for effect sizes"
"CD003598_pub3_data","1::26::Withdrawal due to congestive heart failure","No usable data for effect sizes"
"CD003598_pub3_data","1::27::Withdrawal due to heart block","No usable data for effect sizes"
"CD003598_pub3_data","1::29::Withdrawal due to fatigue","No usable data for effect sizes"
"CD003598_pub3_data","2::1::Graft loss","No usable data for effect sizes"
"CD003598_pub3_data","2::2::Serum creatinine [µmol/L]","No usable data for effect sizes"
"CD003598_pub3_data","2::3::Acute rejection","No usable data for effect sizes"
"CD003598_pub3_data","3::12::Controlled blood pressure","No usable data for effect sizes"
"CD003598_pub3_data","3::15::Proteinuria at end of treatment","No usable data for effect sizes"
"CD003598_pub3_data","3::17::Urinary albumin/creatinine ratio [mg/mg]","No usable data for effect sizes"
"CD003598_pub3_data","3::18::Nonfatal myocardial infarction","No usable data for effect sizes"
"CD003598_pub3_data","3::19::Myocardial infarction","No usable data for effect sizes"
"CD003598_pub3_data","3::20::Fatal stroke","No usable data for effect sizes"
"CD003598_pub3_data","3::23::Angina pectoris","No usable data for effect sizes"
"CD003598_pub3_data","3::24::Thromboembolic episodes","No usable data for effect sizes"
"CD003598_pub3_data","3::29::Any adverse event","No usable data for effect sizes"
"CD003598_pub3_data","3::31::Peripheral oedema","No usable data for effect sizes"
"CD003598_pub3_data","3::32::Infection","No usable data for effect sizes"
"CD003598_pub3_data","3::34::Withdrawal due to acute kidney injury","No usable data for effect sizes"
"CD003598_pub3_data","3::36::Withdrawal due to cough","No usable data for effect sizes"
"CD003598_pub3_data","4::2::Sudden death","No usable data for effect sizes"
"CD003598_pub3_data","4::4::Creatinine clearance [mL/min]","No usable data for effect sizes"
"CD003598_pub3_data","4::8::Acute kidney injury","No usable data for effect sizes"
"CD003598_pub3_data","4::12::Mean arterial pressure [mm Hg]","No usable data for effect sizes"
"CD003598_pub3_data","4::13::Any rejection","No usable data for effect sizes"
"CD003598_pub3_data","4::16::Nonfatal stroke","No usable data for effect sizes"
"CD003598_pub3_data","4::18::Urinary albumin/creatinine ratio [mg/g]","No usable data for effect sizes"
"CD003598_pub3_data","4::20::Haematocrit [%]","No usable data for effect sizes"
"CD003598_pub3_data","4::23::Any adverse event","No usable data for effect sizes"
"CD003598_pub3_data","4::26::Withdrawal due to acute kidney injury","No usable data for effect sizes"
"CD003598_pub3_data","4::28::Withdrawal due to hyperkalaemia","No usable data for effect sizes"
"CD003598_pub3_data","5::1::All-cause death","No usable data for effect sizes"
"CD003598_pub3_data","5::2::Cardiovascular death","No usable data for effect sizes"
"CD003598_pub3_data","5::3::Withdrawal due to adverse events","No usable data for effect sizes"
"CD003598_pub3_data","6::1::All-cause death","No usable data for effect sizes"
"CD003598_pub3_data","6::2::Graft loss","No usable data for effect sizes"
"CD003598_pub3_data","6::3::Acute kidney injury","No usable data for effect sizes"
"CD003598_pub3_data","6::4::Cardiovascular death","No usable data for effect sizes"
"CD003598_pub3_data","6::5::Any rejection","No usable data for effect sizes"
"CD003598_pub3_data","6::6::Acute rejection","No usable data for effect sizes"
"CD003598_pub3_data","6::7::Hyperkalaemia","No usable data for effect sizes"
"CD003598_pub3_data","6::8::Hypotension","No usable data for effect sizes"
"CD003598_pub3_data","6::9::Cough","No usable data for effect sizes"
"CD003598_pub3_data","6::10::Peripheral oedema","No usable data for effect sizes"
"CD003598_pub3_data","6::11::Fatigue","No usable data for effect sizes"
"CD003598_pub3_data","7::1::All-cause death","No usable data for effect sizes"
"CD003598_pub3_data","7::2::Graft loss","No usable data for effect sizes"
"CD003598_pub3_data","7::3::Systolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD003598_pub3_data","7::4::Rejection rate","No usable data for effect sizes"
"CD003598_pub3_data","8::1::All-cause death","No usable data for effect sizes"
"CD003598_pub3_data","8::2::Graft loss","No usable data for effect sizes"
"CD003598_pub3_data","8::3::eGFR [mL/min/1.73 m²]","No usable data for effect sizes"
"CD003598_pub3_data","8::4::Serum creatinine [µmol/L]","No usable data for effect sizes"
"CD003598_pub3_data","8::5::Cardiovascular death","No usable data for effect sizes"
"CD003598_pub3_data","8::6::Systolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD003598_pub3_data","8::7::Diastolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD003598_pub3_data","8::8::Mean arterial pressure [mm Hg]","No usable data for effect sizes"
"CD003598_pub3_data","8::9::Any rejection","No usable data for effect sizes"
"CD003598_pub3_data","8::10::Acute rejection","No usable data for effect sizes"
"CD003598_pub3_data","8::11::Urinary albumin/creatinine ratio [mg/g]","No usable data for effect sizes"
"CD003598_pub3_data","8::12::Cardiovascular events","No usable data for effect sizes"
"CD003598_pub3_data","8::13::Hyperkalaemia","No usable data for effect sizes"
"CD003598_pub3_data","8::14::New-onset hypertension","No usable data for effect sizes"
"CD003598_pub3_data","8::15::Withdrawal due to adverse events","No usable data for effect sizes"
"CD003598_pub3_data","9::11::Acute rejection","No usable data for effect sizes"
"CD003598_pub3_data","9::12::Rejection rate","No usable data for effect sizes"
"CD003598_pub3_data","9::14::Myocardial infarction","No usable data for effect sizes"
"CD003598_pub3_data","9::15::Fatal myocardial infarction","No usable data for effect sizes"
"CD003598_pub3_data","9::16::Cardiovascular events","No usable data for effect sizes"
"CD003598_pub3_data","9::24::Withdrawn due to graft loss","No usable data for effect sizes"
"CD003598_pub3_data","9::25::Withdrawn due to heart failure","No usable data for effect sizes"
"CD003598_pub3_data","9::27::Withdrawn due to kidney transplant artery stenoses","No usable data for effect sizes"
"CD003598_pub3_data","9::28::Withdrawn due to hyperkalaemia","No usable data for effect sizes"
"CD003598_pub3_data","9::29::Withdrawn due to cough","No usable data for effect sizes"
"CD003598_pub3_data","9::30::Withdrawn due to ankle oedema","No usable data for effect sizes"
"CD003598_pub3_data","9::31::Withdrawn due to fatigue","No usable data for effect sizes"
"CD003598_pub3_data","10::1::All-cause death","No usable data for effect sizes"
"CD003598_pub3_data","10::3::Cardiovascular death","No usable data for effect sizes"
"CD003598_pub3_data","10::4::Systolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD003598_pub3_data","10::5::Diastolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD003598_pub3_data","10::7::Controlled blood pressure","No usable data for effect sizes"
"CD003598_pub3_data","10::8::Any rejection","No usable data for effect sizes"
"CD003598_pub3_data","10::9::Rejection rate","No usable data for effect sizes"
"CD003598_pub3_data","10::10::Proteinuria [g/24 hours]","No usable data for effect sizes"
"CD003598_pub3_data","10::13::Hyperkalaemia","No usable data for effect sizes"
"CD003598_pub3_data","10::15::Withdrawal due to rejection","No usable data for effect sizes"
"CD003598_pub3_data","10::16::Withdrawal due to hyperkalaemia","No usable data for effect sizes"
"CD003598_pub3_data","10::17::Withdrawal due to hypotension","No usable data for effect sizes"
"CD003598_pub3_data","11::2::Doubling of serum creatinine","No usable data for effect sizes"
"CD003598_pub3_data","11::3::Systolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD003598_pub3_data","11::4::Mean arterial pressure [mm Hg]","No usable data for effect sizes"
"CD003598_pub3_data","11::5::Acute rejection","No usable data for effect sizes"
"CD003598_pub3_data","11::6::Rejection rate","No usable data for effect sizes"
"CD003598_pub3_data","11::7::Proteinuria [g/24 hours]","No usable data for effect sizes"
"CD003598_pub3_data","11::8::Proteinuria remission","No usable data for effect sizes"
"CD003598_pub3_data","11::10::Haematocrit [%]","No usable data for effect sizes"
"CD003598_pub3_data","11::12::Hyperkalaemia","No usable data for effect sizes"
"CD003598_pub3_data","12::1::All-cause death","No usable data for effect sizes"
"CD003598_pub3_data","12::2::Graft loss","No usable data for effect sizes"
"CD003598_pub3_data","12::3::Cardiovascular death","No usable data for effect sizes"
"CD003598_pub3_data","12::4::Systolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD003598_pub3_data","12::5::Diastolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD003598_pub3_data","12::6::Mean arterial pressure [mm Hg]","No usable data for effect sizes"
"CD003598_pub3_data","12::7::Fatal myocardial infarction","No usable data for effect sizes"
"CD003598_pub3_data","12::8::Cardiovascular events","No usable data for effect sizes"
"CD003598_pub3_data","12::9::Withdrawal due to adverse events","No usable data for effect sizes"
"CD003598_pub3_data","13::1::All-cause death","No usable data for effect sizes"
"CD003598_pub3_data","13::2::Graft loss","No usable data for effect sizes"
"CD003598_pub3_data","13::3::Cardiovascular death","No usable data for effect sizes"
"CD003598_pub3_data","13::4::Systolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD003598_pub3_data","13::5::Diastolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD003598_pub3_data","13::6::Mean arterial pressure [mm Hg]","No usable data for effect sizes"
"CD003598_pub3_data","13::7::Fatal myocardial infarction","No usable data for effect sizes"
"CD003598_pub3_data","13::8::Cardiovascular events","No usable data for effect sizes"
"CD003598_pub3_data","13::9::Withdrawal due to adverse events","No usable data for effect sizes"
"CD003598_pub3_data","14::1::eGFR [mL/min/1.73 m²]","No usable data for effect sizes"
"CD003598_pub3_data","14::2::Systolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD003598_pub3_data","14::3::Any adverse event","No usable data for effect sizes"
"CD003598_pub3_data","15::1::All-cause death","No usable data for effect sizes"
"CD003598_pub3_data","15::2::Creatinine clearance [mL/min]","No usable data for effect sizes"
"CD003598_pub3_data","15::3::Serum creatinine [µmol/L]","No usable data for effect sizes"
"CD003598_pub3_data","15::4::Systolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD003598_pub3_data","15::5::Diastolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD003598_pub3_data","15::6::Mean arterial pressure [mm Hg]","No usable data for effect sizes"
"CD003598_pub3_data","15::7::Myocardial infarction","No usable data for effect sizes"
"CD003598_pub3_data","15::8::Haemoglobin [g/dL]","No usable data for effect sizes"
"CD003598_pub3_data","16::1::All-cause death","No usable data for effect sizes"
"CD003598_pub3_data","16::2::Cardiovascular death","No usable data for effect sizes"
"CD003598_pub3_data","16::3::Any rejection","No usable data for effect sizes"
"CD003598_pub3_data","16::4::Acute rejection","No usable data for effect sizes"
"CD003598_pub3_data","16::5::Withdrawal due to adverse events","No usable data for effect sizes"
"CD003598_pub3_data","16::6::Withdrawal due to peripheral oedema","No usable data for effect sizes"
"CD003598_pub3_data","17::1::All-cause death","No usable data for effect sizes"
"CD003598_pub3_data","17::2::Creatinine clearance [mL/min]","No usable data for effect sizes"
"CD003598_pub3_data","17::3::Serum creatinine [µmol/L]","No usable data for effect sizes"
"CD003598_pub3_data","17::4::Cardiovascular death","No usable data for effect sizes"
"CD003598_pub3_data","17::5::Systolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD003598_pub3_data","17::6::Diastolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD003598_pub3_data","17::7::Mean arterial pressure [mm Hg]","No usable data for effect sizes"
"CD003598_pub3_data","17::8::Any rejection","No usable data for effect sizes"
"CD003598_pub3_data","17::9::Acute rejection","No usable data for effect sizes"
"CD003598_pub3_data","17::10::Haemoglobin [g/L]","No usable data for effect sizes"
"CD003598_pub3_data","17::11::Haematocrit [%]","No usable data for effect sizes"
"CD003598_pub3_data","17::12::Serum potassium [mmol/L]","No usable data for effect sizes"
"CD003598_pub3_data","17::13::Hyperkalaemia","No usable data for effect sizes"
"CD003598_pub3_data","17::14::Cough","No usable data for effect sizes"
"CD003598_pub3_data","17::15::Peripheral oedema","No usable data for effect sizes"
"CD003598_pub3_data","17::16::Withdrawal due to adverse events","No usable data for effect sizes"
"CD003598_pub3_data","18::1::All-cause death","No usable data for effect sizes"
"CD003598_pub3_data","18::2::Clearance creatinine [mL/min]","No usable data for effect sizes"
"CD003598_pub3_data","18::3::Serum creatinine [µmol/L]","No usable data for effect sizes"
"CD003598_pub3_data","18::4::Cardiovascular death","No usable data for effect sizes"
"CD003598_pub3_data","18::5::Systolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD003598_pub3_data","18::6::Diastolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD003598_pub3_data","18::7::Mean arterial pressure [mm Hg]","No usable data for effect sizes"
"CD003598_pub3_data","18::8::Any rejection","No usable data for effect sizes"
"CD003598_pub3_data","18::9::Acute rejection","No usable data for effect sizes"
"CD003598_pub3_data","18::10::Haemoglobin [g/L]","No usable data for effect sizes"
"CD003598_pub3_data","18::11::Haematocrit [%]","No usable data for effect sizes"
"CD003598_pub3_data","18::12::Serum potassium [mmol/L]","No usable data for effect sizes"
"CD003598_pub3_data","18::13::Hyperkalaemia","No usable data for effect sizes"
"CD003598_pub3_data","18::14::Cough","No usable data for effect sizes"
"CD003598_pub3_data","18::15::Peripheral oedema","No usable data for effect sizes"
"CD003598_pub3_data","18::16::Withdrawal due to adverse events","No usable data for effect sizes"
"CD003743_pub3_data","1::1::Weight gain (g/day)","No usable data for effect sizes"
"CD003743_pub3_data","1::2::Breastfeeding: stopped any breastfeeding on discharge from home support or hospital","No usable data for effect sizes"
"CD003743_pub3_data","1::3::Breastfeeding: stopped fully breastfeeding on discharge from home support or hospital","No usable data for effect sizes"
"CD003743_pub3_data","1::6::Breastfeeding: stopped any breastfeeding at 3 months' post discharge","No usable data for effect sizes"
"CD003743_pub3_data","1::7::Breastfeeding: stopped fully breastfeeding at 3 months' post discharge","No usable data for effect sizes"
"CD003743_pub3_data","1::8::Breastfeeding: stopped any breastfeeding at 6 months' post discharge","No usable data for effect sizes"
"CD003743_pub3_data","1::9::Breastfeeding: stopped fully breastfeeding at 6 months' post discharge","No usable data for effect sizes"
"CD003743_pub3_data","1::10::Rehospitalisation up to 12 months' post discharge from home support or hospital","No usable data for effect sizes"
"CD003743_pub3_data","1::11::Death up to 12 months' post discharge from home support or hospital","No usable data for effect sizes"
"CD003774_pub5_data","5::1::CMV disease in all treated patients","No usable data for effect sizes"
"CD003774_pub5_data","5::2::Death","No usable data for effect sizes"
"CD003774_pub5_data","5::3::CMV infection in all treated patients","No usable data for effect sizes"
"CD003774_pub5_data","5::4::Additional outcomes","No usable data for effect sizes"
"CD003774_pub5_data","10::1::All-cause death","No usable data for effect sizes"
"CD003774_pub5_data","10::3::Acute rejection","No usable data for effect sizes"
"CD003774_pub5_data","10::4::Graft loss","No usable data for effect sizes"
"CD003774_pub5_data","11::1::CMV disease","No usable data for effect sizes"
"CD003774_pub5_data","11::2::All-cause death","No usable data for effect sizes"
"CD003774_pub5_data","11::3::CMV infection","No usable data for effect sizes"
"CD003774_pub5_data","11::4::Acute rejection","No usable data for effect sizes"
"CD003774_pub5_data","11::5::Adverse events","No usable data for effect sizes"
"CD003962_pub3_data","1::3::Partial remission of proteinuria","No usable data for effect sizes"
"CD003962_pub3_data","1::9::Doubling of serum creatinine","No usable data for effect sizes"
"CD003962_pub3_data","1::10::> 50% increase in serum creatinine","No usable data for effect sizes"
"CD003962_pub3_data","1::11::Change in serum creatinine","No usable data for effect sizes"
"CD003962_pub3_data","1::15::Serious adverse events","No usable data for effect sizes"
"CD003962_pub3_data","2::1::Death","No usable data for effect sizes"
"CD003962_pub3_data","2::4::Complete remission","No usable data for effect sizes"
"CD003962_pub3_data","2::5::Partial remission","No usable data for effect sizes"
"CD003962_pub3_data","2::7::Haematuria","No usable data for effect sizes"
"CD003962_pub3_data","2::10::> 50% increase in serum creatinine","No usable data for effect sizes"
"CD003962_pub3_data","2::12::Change in creatinine clearance","No usable data for effect sizes"
"CD003962_pub3_data","2::14::Cardiovascular events","No usable data for effect sizes"
"CD003962_pub3_data","2::16::Serious adverse events","No usable data for effect sizes"
"CD003962_pub3_data","2::17::Gastrointestinal hemorrhage","No usable data for effect sizes"
"CD003962_pub3_data","2::18::Leukopenia","No usable data for effect sizes"
"CD003962_pub3_data","2::20::Nausea","No usable data for effect sizes"
"CD003962_pub3_data","2::22::Infection","No usable data for effect sizes"
"CD003962_pub3_data","2::23::Systolic blood pressure","No usable data for effect sizes"
"CD003962_pub3_data","3::1::Death","No usable data for effect sizes"
"CD003962_pub3_data","4::1::Proteinuria","No usable data for effect sizes"
"CD003962_pub3_data","4::3::Haematuria","No usable data for effect sizes"
"CD003962_pub3_data","4::4::Serum creatinine","No usable data for effect sizes"
"CD003962_pub3_data","4::6::Creatinine clearance","No usable data for effect sizes"
"CD003962_pub3_data","5::3::Relapse of proteinuria","No usable data for effect sizes"
"CD003962_pub3_data","5::5::Relapse of haematuria","No usable data for effect sizes"
"CD003962_pub3_data","5::6::Serum creatinine","No usable data for effect sizes"
"CD003962_pub3_data","5::8::Adverse events","No usable data for effect sizes"
"CD003962_pub3_data","6::1::Remission in proteinuria","No usable data for effect sizes"
"CD003962_pub3_data","6::6::Remission in haematuria","No usable data for effect sizes"
"CD003962_pub3_data","6::9::Creatinine clearance","No usable data for effect sizes"
"CD003962_pub3_data","6::10::Diarrhoea","No usable data for effect sizes"
"CD003962_pub3_data","6::12::Systolic blood pressure","No usable data for effect sizes"
"CD003962_pub3_data","6::13::Diastolic blood pressure","No usable data for effect sizes"
"CD003962_pub3_data","7::1::Kidney failure","No usable data for effect sizes"
"CD003962_pub3_data","7::5::Adverse events","No usable data for effect sizes"
"CD003962_pub3_data","7::6::Systolic blood pressure","No usable data for effect sizes"
"CD003962_pub3_data","7::7::Diastolic blood pressure","No usable data for effect sizes"
"CD003962_pub3_data","7::8::Body weight","No usable data for effect sizes"
"CD003962_pub3_data","7::9::BMI","No usable data for effect sizes"
"CD003962_pub3_data","7::10::Waist circumference","No usable data for effect sizes"
"CD003962_pub3_data","8::1::Kidney failure","No usable data for effect sizes"
"CD003962_pub3_data","8::6::Albuminuria","No usable data for effect sizes"
"CD003962_pub3_data","8::7::Remission of haematuria","No usable data for effect sizes"
"CD003962_pub3_data","8::9::> 50% increase in serum creatinine","No usable data for effect sizes"
"CD003962_pub3_data","8::11::Annual eGFR loss (mL/min/1.73 m2)","No usable data for effect sizes"
"CD003962_pub3_data","8::12::Change in eGFR (mL/min/1.73 m2)","No usable data for effect sizes"
"CD003962_pub3_data","8::14::Nausea","No usable data for effect sizes"
"CD003962_pub3_data","8::16::Dizziness","No usable data for effect sizes"
"CD003962_pub3_data","8::17::Hyperkalaemia","No usable data for effect sizes"
"CD003962_pub3_data","8::19::Systolic blood pressure","No usable data for effect sizes"
"CD003962_pub3_data","8::20::Diastolic blood pressure","No usable data for effect sizes"
"CD004184_pub3_data","1::1::All-cause mortality","No usable data for effect sizes"
"CD004184_pub3_data","2::1::All-cause mortality","No usable data for effect sizes"
"CD004406_pub6_data","1::3::Resolution of symptoms within 24 hours of treatment (ITT analysis)","No usable data for effect sizes"
"CD004406_pub6_data","1::5::Sore throat (ITT analysis)","No usable data for effect sizes"
"CD004406_pub6_data","1::6::Fever (ITT analysis)","No usable data for effect sizes"
"CD004406_pub6_data","1::8::Complications (ITT analysis)","No usable data for effect sizes"
"CD004406_pub6_data","3::1::Clinical cure at 24 to 28 days (ITT)","No usable data for effect sizes"
"CD004406_pub6_data","3::2::Clinical cure at 24 to 28 days (bacteriological per protocol population)","No usable data for effect sizes"
"CD004406_pub6_data","3::3::Relapse on day 38 to 45 (ITT)","No usable data for effect sizes"
"CD004406_pub6_data","3::4::Relapse on day 38 to 45 (bacteriological per protocol)","No usable data for effect sizes"
"CD004406_pub6_data","3::5::Adverse events (all participants)","No usable data for effect sizes"
"CD004406_pub6_data","5::1::Adverse events (ITT analysis)","No usable data for effect sizes"
"CD004406_pub6_data","6::1::Adverse events (ITT analysis)","No usable data for effect sizes"
"CD004417_pub6_data","6::2::Vomiting: delayed (prescription collection) versus no antibiotics","No usable data for effect sizes"
"CD004417_pub6_data","6::4::Diarrhoea: delayed (prescription collection) versus no antibiotics","No usable data for effect sizes"
"CD004417_pub6_data","6::6::Rash: delayed (prescription collection) versus no antibiotics","No usable data for effect sizes"
"CD004508_pub5_data","1::17::Satisfaction","No usable data for effect sizes"
"CD004661_pub4_data","1::4::Major neurodevelopmental disability (up to 2 years' corrected age)","No usable data for effect sizes"
"CD004661_pub4_data","1::8::Death or cerebral palsy (up to school age)","No usable data for effect sizes"
"CD004661_pub4_data","1::10::Death or major neurodevelopmental disability (up to school age)","No usable data for effect sizes"
"CD004661_pub4_data","2::12::Ventriculomegaly","No usable data for effect sizes"
"CD004661_pub4_data","2::13::Neonatal encephalopathy","No usable data for effect sizes"
"CD004661_pub4_data","2::15::Neonatal hypotonia","No usable data for effect sizes"
"CD004661_pub4_data","2::24::Air leak syndrome","No usable data for effect sizes"
"CD004661_pub4_data","3::3::Any neurodevelopmental disability (up to 2 years' corrected age)","No usable data for effect sizes"
"CD004661_pub4_data","4::4::Death or any neurodevelopmental disability (school age)","No usable data for effect sizes"
"CD004661_pub4_data","4::9::Death or substantial gross motor dysfunction (school age)","No usable data for effect sizes"
"CD004661_pub4_data","4::11::Respiratory function (school age)","No usable data for effect sizes"
"CD004661_pub4_data","5::7::Side effect: tachycardia","No usable data for effect sizes"
"CD004661_pub4_data","5::12::Side effect: sleepiness","No usable data for effect sizes"
"CD004661_pub4_data","5::16::Side effect: tendon reflex abolition","No usable data for effect sizes"
"CD004661_pub4_data","5::17::Side effect: ""curarisation""","No usable data for effect sizes"
"CD004661_pub4_data","5::18::Side effect: headache","No usable data for effect sizes"
"CD004661_pub4_data","5::20::Chorioamnionitis","No usable data for effect sizes"
"CD004661_pub4_data","6::1::Maternal admission to the intensive care unit","No usable data for effect sizes"
"CD004661_pub4_data","6::2::Length of postnatal hospitalisation for women (days)","No usable data for effect sizes"
"CD004661_pub4_data","6::3::Length of neonatal/infant hospitalisation (days)","No usable data for effect sizes"
"CD004661_pub4_data","6::4::Hospital admissions (up to 2 years' corrected age)","No usable data for effect sizes"
"CD004661_pub4_data","6::5::Postdischarge service (up to 2 years' corrected age)","No usable data for effect sizes"
"CD004661_pub4_data","6::6::Hospital admissions (school age)","No usable data for effect sizes"
"CD004667_pub6_data","1::16::Maternal readmission within 28 days","No usable data for effect sizes"
"CD004736_pub6_data","1::27::Maternal clinical malaria","No usable data for effect sizes"
"CD004736_pub6_data","1::64::Antepartum haemorrhage (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","1::66::Transfusion provided (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","1::72::Maternal wellbeing/satisfaction (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","1::73::Placental abruption (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","1::78::Infant serum ferritin concentration within first 6 months (in μg/L counting the last reported measure after birth within this period) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","1::79::Admission to special care unit (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","2::6::Maternal iron deficiency at term (as defined by trialists, based on any indicator of iron status at 37 weeks' gestation or more) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","2::7::Maternal iron-deficiency anaemia at term (Hb less than 110 g/L and at least one additional laboratory indicator at 37 weeks' gestation or more) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","2::8::Maternal death (death while pregnant or within 42 days of termination of pregnancy) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","2::9::Adverse effects (any reported throughout the intervention period) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","2::15::Infection during pregnancy (including urinary tract infections) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","2::28::Congenital anomalies (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","2::30::Maternal iron deficiency at or near term (as defined by trialists, based on any indicator of iron status at 34 weeks' gestation or more) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","2::31::Maternal iron-deficiency anaemia at or near term (Hb less than 110 g/L and at least one additional laboratory indicator at 34 weeks' gestation or more) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","2::39::Puerperal infection (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","2::41::Placental abruption (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","2::42::Pre-eclampsia (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","2::43::Very low birthweight (less than 1500 g) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","2::45::Admission to special care unit (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","3::27::Maternal clinical malaria","No usable data for effect sizes"
"CD004736_pub6_data","3::43::Neonatal death (within 28 days after delivery) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","3::56::Antepartum haemorrhage (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","3::58::Transfusion provided (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","3::59::Diarrhoea (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","3::62::Heartburn (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","3::64::Maternal wellbeing/satisfaction (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","3::65::Placental abruption (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","3::66::Pre-eclampsia (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","3::70::Infant serum ferritin concentration in the first 6 months (in μg/L, counting the last reported measure after birth within this period) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","3::71::Admission to special care unit (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","4::6::Maternal iron deficiency at term (as defined by trialists, based on any indicator of iron status at 37 weeks' gestation or more) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","4::7::Maternal iron-deficiency anaemia at term (Hb less than 110 g/L and at least one additional laboratory indicator at 37 weeks' gestation or more) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","4::8::Maternal death (death while pregnant or within 42 days of termination of pregnancy) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","4::9::Adverse effects (any reported throughout the intervention period) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","4::11::Infection during pregnancy (including urinary tract infections) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","4::24::Congenital anomalies (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","4::26::Maternal iron deficiency at or near term (as defined by trialists, based on any indicator of iron status at 34 weeks' gestation or more) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","4::27::Maternal iron-deficiency anaemia at or near term (Hb less than 110 g/L and at least one additional laboratory indicator at 34 weeks' gestation or more) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","4::35::Puerperal infection (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","4::37::Placental abruption (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","4::38::Pre-eclampsia (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","4::39::Very low birthweight (less than 1500 g) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","4::41::Admission to special care unit (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","5::6::Maternal iron deficiency at term (as defined by trialists, based on any indicator of iron status at 37 weeks' gestation or more) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","5::7::Maternal iron-deficiency anaemia at term (Hb less than 110 g/L and at least one additional laboratory indicator at 37 weeks' gestation or more) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","5::31::Maternal Hb concentration at or near term (in g/L at 34 weeks' gestation or more) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","5::32::Maternal Hb concentration within 6 weeks postpartum (in g/L) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","5::33::Maternal high haemoglobin concentrations during second or third trimester (Hb more than 130 g/L) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","5::34::Maternal high haemoglobin concentrations at or near term (Hb more than 130 g/L at 34 weeks' gestation or more) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","5::35::Moderate anaemia at postpartum (Hb more than 80 g/L and less than 110 g/L) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","5::36::Maternal severe anaemia at or near term (Hb less than 70 g/L at 34 weeks' gestation or more) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","5::38::Very low birthweight (less than 1500 g) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","5::39::Very premature birth (less than 34 weeks' gestation) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","5::40::Infant Hb concentration in the first 6 months (in g/L, counting the last reported measure after birth within this period) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","6::1::Adverse effects (any reported throughout the intervention period) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","6::4::Preterm birth (less than 37 weeks of gestation) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","6::5::Congenital anomalies (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","6::7::Maternal Hb concentration within 6 weeks postpartum (in g/L) (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","6::8::Constipation (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","6::9::Heartburn (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","6::10::Vomiting (ALL)","No usable data for effect sizes"
"CD004736_pub6_data","6::11::Diarrhoea (ALL)","No usable data for effect sizes"
"CD004762_pub3_data","1::1::Improvement of myotonia: visual analogue scale ","No usable data for effect sizes"
"CD004762_pub3_data","1::4::Quality of life: Individualized Neuromuscular Quality of Life","No usable data for effect sizes"
"CD004762_pub3_data","3::2::Quality of life: 36-item Short Form (overall health status)","No usable data for effect sizes"
"CD004762_pub3_data","4::1::Relaxation time","No usable data for effect sizes"
"CD004871_pub5_data","1::4::Participant-reported treatment success (short-term)","No usable data for effect sizes"
"CD004871_pub5_data","1::5::Participant-reported treatment success at short-term (dichotomous data)","No usable data for effect sizes"
"CD004871_pub5_data","1::6::Health-related quality of life (short-term)","No usable data for effect sizes"
"CD004871_pub5_data","2::4::Health-related quality of life (short-term)","No usable data for effect sizes"
"CD004871_pub5_data","3::2::Pain (long-term)","No usable data for effect sizes"
"CD004871_pub5_data","3::3::Pain (dichotomous data; short-term)","No usable data for effect sizes"
"CD004871_pub5_data","3::5::Function-disability (long-term)","No usable data for effect sizes"
"CD004871_pub5_data","3::8::Health-related quality of life (long-term)","No usable data for effect sizes"
"CD004904_pub4_data","1::2::Postpartum haemorrhage ","No usable data for effect sizes"
"CD004904_pub4_data","1::3::Newborn intensive care admission","No usable data for effect sizes"
"CD004953_pub5_data","2::2::Rate of mechanical ventilation","No usable data for effect sizes"
"CD004953_pub5_data","2::7::Surfactant administration in the delivery room","No usable data for effect sizes"
"CD004953_pub5_data","2::9::Patent ductus arteriosus (PDA)  - pharmacological treatment","No usable data for effect sizes"
"CD004992_pub4_data","1::9::Ovarian response (number of dominant follicles) after surgery","No usable data for effect sizes"
"CD005133_pub4_data","1::7::Graft loss","No usable data for effect sizes"
"CD005133_pub4_data","3::1::All symptomatic CMV disease","No usable data for effect sizes"
"CD005133_pub4_data","3::2::Death (any cause)","No usable data for effect sizes"
"CD005133_pub4_data","3::3::Other infections","No usable data for effect sizes"
"CD005133_pub4_data","4::1::Death (any cause)","No usable data for effect sizes"
"CD005133_pub4_data","5::1::CMV disease","No usable data for effect sizes"
"CD005133_pub4_data","5::2::Other infections","No usable data for effect sizes"
"CD005187_pub6_data","1::3::Admission to hospital for respiratory illness","No usable data for effect sizes"
"CD005187_pub6_data","2::3::Admission to hospital for respiratory illness","No usable data for effect sizes"
"CD005495_pub5_data","2::2::Rate of cerebral palsy","No usable data for effect sizes"
"CD005582_pub5_data","1::2::The main effect of prednisone compared with no prednisone on six months evaluation of pain (generic inverse variance)","No usable data for effect sizes"
"CD005595_pub4_data","3::11::Pain (numbers with pain; long-term/end of follow-up","No usable data for effect sizes"
"CD005595_pub4_data","4::3::Pain (interventions given during the initial fracture management period; VAS; short-term follow-up, ≤ 6 months)","No usable data for effect sizes"
"CD005595_pub4_data","4::4::Pain (numbers with pain; long-term follow-up, > 6 months)","No usable data for effect sizes"
"CD005951_pub5_data","2::6::Death by day 7","No usable data for effect sizes"
"CD005951_pub5_data","2::9::Cognitive function (Modified Telephone Interview for Cognitive Status (TICS-M))","No usable data for effect sizes"
"CD005951_pub5_data","2::10::Cognitive function (Mini-Mental State Examination (MMSE))","No usable data for effect sizes"
"CD005951_pub5_data","3::1::Death or dependence (mRS 4–6) at day 90","No usable data for effect sizes"
"CD005951_pub5_data","3::2::Intracerebral haemorrhage expansion by 24 hours","No usable data for effect sizes"
"CD005951_pub5_data","3::3::All serious adverse events","No usable data for effect sizes"
"CD005951_pub5_data","3::4::Thromboembolic adverse events","No usable data for effect sizes"
"CD005951_pub5_data","3::5::Death by day 90","No usable data for effect sizes"
"CD005951_pub5_data","4::1::Death or dependence (mRS 4–6) at 90 days","No usable data for effect sizes"
"CD005951_pub5_data","4::2::Intracerebral haemorrhage expansion by 24 hours","No usable data for effect sizes"
"CD005951_pub5_data","4::3::All serious adverse events","No usable data for effect sizes"
"CD006023_pub4_data","1::3::Hypercalcaemia","No usable data for effect sizes"
"CD006023_pub4_data","1::9::Stroke","No usable data for effect sizes"
"CD006023_pub4_data","1::10::Hospitalisation","No usable data for effect sizes"
"CD006023_pub4_data","1::12::Pruritus","No usable data for effect sizes"
"CD006023_pub4_data","1::18::Start dialysis","No usable data for effect sizes"
"CD006023_pub4_data","1::22::Serum alkaline phosphatase","No usable data for effect sizes"
"CD006023_pub4_data","1::25::Bone mineral density: lumbar spine","No usable data for effect sizes"
"CD006023_pub4_data","1::26::Bone mineral density: hip","No usable data for effect sizes"
"CD006023_pub4_data","1::27::Klotho","No usable data for effect sizes"
"CD006023_pub4_data","1::28::Arteriovenous fistula operation","No usable data for effect sizes"
"CD006023_pub4_data","2::3::Hypercalcaemia","No usable data for effect sizes"
"CD006023_pub4_data","2::7::Coronary artery calcification score","No usable data for effect sizes"
"CD006023_pub4_data","2::9::Stroke","No usable data for effect sizes"
"CD006023_pub4_data","2::11::Fracture","No usable data for effect sizes"
"CD006023_pub4_data","2::13::Pruritus","No usable data for effect sizes"
"CD006023_pub4_data","2::18::Start dialysis","No usable data for effect sizes"
"CD006023_pub4_data","2::19::Vascular calcification score","No usable data for effect sizes"
"CD006023_pub4_data","2::24::Bone mineral density: lumbar spine","No usable data for effect sizes"
"CD006023_pub4_data","3::11::Fracture","No usable data for effect sizes"
"CD006023_pub4_data","3::16::Start dialysis","No usable data for effect sizes"
"CD006023_pub4_data","3::17::Calciphylaxis","No usable data for effect sizes"
"CD006023_pub4_data","3::25::Soluble Klotho","No usable data for effect sizes"
"CD006023_pub4_data","3::26::Fatigue","No usable data for effect sizes"
"CD006023_pub4_data","4::7::Coronary artery calcium score","No usable data for effect sizes"
"CD006023_pub4_data","4::8::Nonfatal myocardial infarction","No usable data for effect sizes"
"CD006023_pub4_data","4::9::Nonfatal stroke","No usable data for effect sizes"
"CD006023_pub4_data","4::12::Pruritus","No usable data for effect sizes"
"CD006023_pub4_data","4::16::Abdominal bloating","No usable data for effect sizes"
"CD006023_pub4_data","4::21::eGFR","No usable data for effect sizes"
"CD006023_pub4_data","4::23::Serum fetuin-A","No usable data for effect sizes"
"CD006023_pub4_data","5::5::Fracture","No usable data for effect sizes"
"CD006023_pub4_data","5::9::Kidney failure","No usable data for effect sizes"
"CD006023_pub4_data","5::10::Commencing dialysis","No usable data for effect sizes"
"CD006023_pub4_data","5::12::Serum calcium-by-phosphate product","No usable data for effect sizes"
"CD006023_pub4_data","5::13::Serum iPTH","No usable data for effect sizes"
"CD006023_pub4_data","5::14::Serum alkaline phosphatase","No usable data for effect sizes"
"CD006023_pub4_data","5::17::Serum FGF23","No usable data for effect sizes"
"CD006023_pub4_data","5::18::α-Klotho","No usable data for effect sizes"
"CD006023_pub4_data","5::19::Shunt stenosis","No usable data for effect sizes"
"CD006023_pub4_data","5::20::Hyperkalaemia","No usable data for effect sizes"
"CD006023_pub4_data","5::21::Fatigue","No usable data for effect sizes"
"CD006023_pub4_data","6::6::Coronary artery calcification score","No usable data for effect sizes"
"CD006023_pub4_data","6::9::Fracture","No usable data for effect sizes"
"CD006023_pub4_data","6::11::Vomiting","No usable data for effect sizes"
"CD006023_pub4_data","6::15::Serum calcium-by-phosphate product","No usable data for effect sizes"
"CD006023_pub4_data","6::19::eGFR","No usable data for effect sizes"
"CD006023_pub4_data","6::20::Serum FGF23","No usable data for effect sizes"
"CD006023_pub4_data","7::1::Death (all causes)","No usable data for effect sizes"
"CD006023_pub4_data","7::2::Nausea","No usable data for effect sizes"
"CD006023_pub4_data","7::3::Constipation","No usable data for effect sizes"
"CD006023_pub4_data","7::4::Kidney failure","No usable data for effect sizes"
"CD006023_pub4_data","7::5::Abdominal pain","No usable data for effect sizes"
"CD006023_pub4_data","7::6::Diarrhoea","No usable data for effect sizes"
"CD006023_pub4_data","8::2::Hypercalcemia","No usable data for effect sizes"
"CD006023_pub4_data","8::6::Hospitalisation","No usable data for effect sizes"
"CD006023_pub4_data","8::7::Fracture","No usable data for effect sizes"
"CD006023_pub4_data","8::10::Vomiting","No usable data for effect sizes"
"CD006023_pub4_data","8::11::Abdominal pain","No usable data for effect sizes"
"CD006023_pub4_data","8::12::Start dialysis","No usable data for effect sizes"
"CD006023_pub4_data","8::16::eGFR","No usable data for effect sizes"
"CD006023_pub4_data","8::17::FGF23","No usable data for effect sizes"
"CD006023_pub4_data","8::18::Shunt occlusion","No usable data for effect sizes"
"CD006023_pub4_data","8::19::Arteriovenous fistula site complication","No usable data for effect sizes"
"CD006023_pub4_data","8::20::Shunt malfunction","No usable data for effect sizes"
"CD006023_pub4_data","8::21::Arteriovenous fistula site haemorrhage","No usable data for effect sizes"
"CD006023_pub4_data","8::22::Arteriovenous fistula thrombosis","No usable data for effect sizes"
"CD006023_pub4_data","8::23::Arteriovenous shunt operation","No usable data for effect sizes"
"CD006023_pub4_data","8::24::Hyperkalaemia","No usable data for effect sizes"
"CD006023_pub4_data","8::25::Fatigue","No usable data for effect sizes"
"CD006023_pub4_data","9::1::Death (all causes)","No usable data for effect sizes"
"CD006023_pub4_data","9::2::Nausea","No usable data for effect sizes"
"CD006023_pub4_data","9::3::Constipation","No usable data for effect sizes"
"CD006023_pub4_data","9::4::Abdominal pain","No usable data for effect sizes"
"CD006023_pub4_data","9::5::Diarrhoea","No usable data for effect sizes"
"CD006023_pub4_data","10::1::Death (all causes)","No usable data for effect sizes"
"CD006023_pub4_data","10::2::Nausea","No usable data for effect sizes"
"CD006023_pub4_data","10::3::Serum phosphate","No usable data for effect sizes"
"CD006023_pub4_data","10::4::Hospitalisation","No usable data for effect sizes"
"CD006023_pub4_data","10::5::Diarrhoea","No usable data for effect sizes"
"CD006023_pub4_data","10::6::Kidney failure","No usable data for effect sizes"
"CD006023_pub4_data","10::7::Start dialysis","No usable data for effect sizes"
"CD006023_pub4_data","10::8::Serum calcium","No usable data for effect sizes"
"CD006023_pub4_data","10::9::eGFR","No usable data for effect sizes"
"CD006023_pub4_data","11::1::Constipation","No usable data for effect sizes"
"CD006023_pub4_data","11::2::Hospitalisation","No usable data for effect sizes"
"CD006023_pub4_data","11::3::Diarrhoea","No usable data for effect sizes"
"CD006023_pub4_data","12::1::Serum alkaline phosphatase","No usable data for effect sizes"
"CD006023_pub4_data","13::1::Death (all causes)","No usable data for effect sizes"
"CD006023_pub4_data","13::4::Serum calcium-by-phosphate product","No usable data for effect sizes"
"CD006023_pub4_data","13::5::Serum iPTH","No usable data for effect sizes"
"CD006023_pub4_data","14::1::Serum phosphate","No usable data for effect sizes"
"CD006023_pub4_data","14::2::Serum calcium","No usable data for effect sizes"
"CD006023_pub4_data","14::3::Serum iPTH","No usable data for effect sizes"
"CD006023_pub4_data","14::4::Serum alkaline phosphatase","No usable data for effect sizes"
"CD006023_pub4_data","14::5::Serum bicarbonate","No usable data for effect sizes"
"CD006023_pub4_data","15::1::Hypercalcaemia","No usable data for effect sizes"
"CD006023_pub4_data","15::2::Serum calcium-by-phosphate product","No usable data for effect sizes"
"CD006023_pub4_data","16::1::Hypercalcaemia","No usable data for effect sizes"
"CD006023_pub4_data","16::2::Nausea","No usable data for effect sizes"
"CD006023_pub4_data","16::3::Constipation","No usable data for effect sizes"
"CD006023_pub4_data","16::4::Serum phosphate","No usable data for effect sizes"
"CD006023_pub4_data","16::5::Myocardial infarction","No usable data for effect sizes"
"CD006023_pub4_data","16::6::Stroke","No usable data for effect sizes"
"CD006023_pub4_data","16::7::Fracture","No usable data for effect sizes"
"CD006023_pub4_data","16::8::Pruritus","No usable data for effect sizes"
"CD006023_pub4_data","16::9::Vomiting","No usable data for effect sizes"
"CD006023_pub4_data","16::10::Abdominal pain","No usable data for effect sizes"
"CD006023_pub4_data","16::11::Diarrhoea","No usable data for effect sizes"
"CD006023_pub4_data","16::12::Abdominal bloating","No usable data for effect sizes"
"CD006023_pub4_data","16::13::Serum calcium","No usable data for effect sizes"
"CD006023_pub4_data","16::14::Serum iPTH","No usable data for effect sizes"
"CD006023_pub4_data","16::15::Serum alkaline phosphatase","No usable data for effect sizes"
"CD006023_pub4_data","17::6::Myocardial infarction","No usable data for effect sizes"
"CD006023_pub4_data","17::7::Fracture","No usable data for effect sizes"
"CD006023_pub4_data","17::11::Serum calcium-by-phosphate product","No usable data for effect sizes"
"CD006023_pub4_data","17::12::Serum PTH","No usable data for effect sizes"
"CD006023_pub4_data","17::13::Serum bicarbonate","No usable data for effect sizes"
"CD006023_pub4_data","18::1::Death (all causes)","No usable data for effect sizes"
"CD006023_pub4_data","18::2::Cardiovascular death","No usable data for effect sizes"
"CD006023_pub4_data","18::3::Nausea","No usable data for effect sizes"
"CD006023_pub4_data","18::4::Constipation","No usable data for effect sizes"
"CD006023_pub4_data","18::5::Serum phosphate","No usable data for effect sizes"
"CD006023_pub4_data","18::6::Fracture","No usable data for effect sizes"
"CD006023_pub4_data","18::7::Pruritus","No usable data for effect sizes"
"CD006023_pub4_data","18::8::Vomiting","No usable data for effect sizes"
"CD006023_pub4_data","18::9::Abdominal pain","No usable data for effect sizes"
"CD006023_pub4_data","18::10::Abdominal bloating","No usable data for effect sizes"
"CD006023_pub4_data","18::11::Serum calcium","No usable data for effect sizes"
"CD006023_pub4_data","18::12::Serum calcium-by-phosphate product","No usable data for effect sizes"
"CD006023_pub4_data","18::13::Serum iPTH","No usable data for effect sizes"
"CD006023_pub4_data","18::14::Serum bicarbonate","No usable data for effect sizes"
"CD006023_pub4_data","19::1::Death (all causes)","No usable data for effect sizes"
"CD006023_pub4_data","19::2::Stroke","No usable data for effect sizes"
"CD006023_pub4_data","19::3::Vomiting","No usable data for effect sizes"
"CD006023_pub4_data","19::4::Serum calcium","No usable data for effect sizes"
"CD006023_pub4_data","19::5::Serum iPTH","No usable data for effect sizes"
"CD006023_pub4_data","19::6::Serum alkaline phosphatase","No usable data for effect sizes"
"CD006023_pub4_data","20::2::Cardiovascular death","No usable data for effect sizes"
"CD006023_pub4_data","20::3::Nausea","No usable data for effect sizes"
"CD006023_pub4_data","20::4::Constipation","No usable data for effect sizes"
"CD006023_pub4_data","20::5::Serum phosphate","No usable data for effect sizes"
"CD006023_pub4_data","20::6::Myocardial infarction","No usable data for effect sizes"
"CD006023_pub4_data","20::7::Stroke","No usable data for effect sizes"
"CD006023_pub4_data","20::8::Pruritus","No usable data for effect sizes"
"CD006023_pub4_data","20::9::Vomiting","No usable data for effect sizes"
"CD006023_pub4_data","20::10::Abdominal pain","No usable data for effect sizes"
"CD006023_pub4_data","20::11::Diarrhoea","No usable data for effect sizes"
"CD006023_pub4_data","20::12::Serum calcium","No usable data for effect sizes"
"CD006023_pub4_data","20::13::Serum calcium-by-phosphate product","No usable data for effect sizes"
"CD006023_pub4_data","20::14::Serum iPTH","No usable data for effect sizes"
"CD006023_pub4_data","20::15::Serum alkaline phosphatase","No usable data for effect sizes"
"CD006023_pub4_data","21::1::Nausea","No usable data for effect sizes"
"CD006023_pub4_data","21::2::Constipation","No usable data for effect sizes"
"CD006023_pub4_data","21::3::Serum phosphate","No usable data for effect sizes"
"CD006023_pub4_data","21::4::Serum calcium","No usable data for effect sizes"
"CD006023_pub4_data","21::5::Serum iPTH","No usable data for effect sizes"
"CD006023_pub4_data","22::1::Serum phosphate","No usable data for effect sizes"
"CD006023_pub4_data","22::2::Serum calcium","No usable data for effect sizes"
"CD006023_pub4_data","22::3::Serum calcium-by-phosphate product","No usable data for effect sizes"
"CD006023_pub4_data","22::4::Serum iPTH","No usable data for effect sizes"
"CD006023_pub4_data","23::1::Death (all causes)","No usable data for effect sizes"
"CD006023_pub4_data","24::1::Death (all causes)","No usable data for effect sizes"
"CD006023_pub4_data","24::2::Cardiovascular death","No usable data for effect sizes"
"CD006023_pub4_data","24::3::Serum phosphate","No usable data for effect sizes"
"CD006023_pub4_data","24::4::Diarrhoea","No usable data for effect sizes"
"CD006023_pub4_data","24::5::Serum calcium","No usable data for effect sizes"
"CD006023_pub4_data","24::6::Serum iPTH","No usable data for effect sizes"
"CD006023_pub4_data","24::7::Serum alkaline phosphatase","No usable data for effect sizes"
"CD006023_pub4_data","25::1::Death (all causes)","No usable data for effect sizes"
"CD006023_pub4_data","25::2::Nausea","No usable data for effect sizes"
"CD006023_pub4_data","25::3::Serum phosphate","No usable data for effect sizes"
"CD006023_pub4_data","25::4::Hospitalisation","No usable data for effect sizes"
"CD006023_pub4_data","25::5::Diarrhoea","No usable data for effect sizes"
"CD006023_pub4_data","25::6::Kidney failure","No usable data for effect sizes"
"CD006023_pub4_data","25::7::Start dialysis","No usable data for effect sizes"
"CD006023_pub4_data","25::8::Serum calcium","No usable data for effect sizes"
"CD006023_pub4_data","25::9::eGFR","No usable data for effect sizes"
"CD006023_pub4_data","26::1::Death (all cause)","No usable data for effect sizes"
"CD006023_pub4_data","26::2::Hypercalcaemia","No usable data for effect sizes"
"CD006023_pub4_data","26::3::Nausea","No usable data for effect sizes"
"CD006023_pub4_data","26::4::Constipation","No usable data for effect sizes"
"CD006023_pub4_data","26::5::Serum phosphate","No usable data for effect sizes"
"CD006023_pub4_data","26::6::Pruritus","No usable data for effect sizes"
"CD006023_pub4_data","26::7::Vomiting","No usable data for effect sizes"
"CD006023_pub4_data","26::8::Abnominal pain","No usable data for effect sizes"
"CD006023_pub4_data","26::9::Diarrohea","No usable data for effect sizes"
"CD006023_pub4_data","26::10::Serum calcium","No usable data for effect sizes"
"CD006023_pub4_data","26::11::Serum PTH","No usable data for effect sizes"
"CD006023_pub4_data","27::1::Death (all causes)","No usable data for effect sizes"
"CD006023_pub4_data","27::2::Constipation","No usable data for effect sizes"
"CD006023_pub4_data","27::3::Serum phosphate","No usable data for effect sizes"
"CD006023_pub4_data","27::4::Fracture (femoral)","No usable data for effect sizes"
"CD006023_pub4_data","27::5::Vomiting","No usable data for effect sizes"
"CD006023_pub4_data","27::6::Diarrhoea","No usable data for effect sizes"
"CD006023_pub4_data","27::7::Serum calcium","No usable data for effect sizes"
"CD006023_pub4_data","27::8::Shunt disorder","No usable data for effect sizes"
"CD006023_pub4_data","28::1::Death (all causes)","No usable data for effect sizes"
"CD006023_pub4_data","28::2::Nausea","No usable data for effect sizes"
"CD006023_pub4_data","28::3::Serum phosphate","No usable data for effect sizes"
"CD006023_pub4_data","28::4::Hospitalisation","No usable data for effect sizes"
"CD006023_pub4_data","28::5::Diarrhoea","No usable data for effect sizes"
"CD006023_pub4_data","28::6::Kidney failure","No usable data for effect sizes"
"CD006023_pub4_data","28::7::Start dialysis","No usable data for effect sizes"
"CD006023_pub4_data","28::8::Serum calcium","No usable data for effect sizes"
"CD006023_pub4_data","28::9::eGFR","No usable data for effect sizes"
"CD006023_pub4_data","29::1::Death (all causes)","No usable data for effect sizes"
"CD006023_pub4_data","29::2::Nausea","No usable data for effect sizes"
"CD006023_pub4_data","29::3::Serum phosphate","No usable data for effect sizes"
"CD006023_pub4_data","29::4::Hospitalisation","No usable data for effect sizes"
"CD006023_pub4_data","29::5::Diarrhoea","No usable data for effect sizes"
"CD006023_pub4_data","29::6::Kidney failure","No usable data for effect sizes"
"CD006023_pub4_data","29::7::Start dialysis","No usable data for effect sizes"
"CD006023_pub4_data","29::8::Serum calcium","No usable data for effect sizes"
"CD006023_pub4_data","29::9::eGFR","No usable data for effect sizes"
"CD006023_pub4_data","30::1::Death (all causes)","No usable data for effect sizes"
"CD006023_pub4_data","30::2::Nausea","No usable data for effect sizes"
"CD006023_pub4_data","30::3::Constipation","No usable data for effect sizes"
"CD006023_pub4_data","30::4::Vomiting","No usable data for effect sizes"
"CD006023_pub4_data","30::5::Diarrhoea","No usable data for effect sizes"
"CD006023_pub4_data","31::2::Cardiovascular death","No usable data for effect sizes"
"CD006023_pub4_data","31::6::Serum calcium-by-phosphate product","No usable data for effect sizes"
"CD006023_pub4_data","31::7::Serum iPTH","No usable data for effect sizes"
"CD006027_pub3_data","2::3::Pain recurrence within 24 hours","No usable data for effect sizes"
"CD006027_pub3_data","3::1::Pain (change from baseline in pain score (VAS-10 cm) at 30 minutes)","No usable data for effect sizes"
"CD006027_pub3_data","3::2::Need for rescue medication","No usable data for effect sizes"
"CD006027_pub3_data","3::3::Serious adverse events","No usable data for effect sizes"
"CD006027_pub3_data","3::4::Minor adverse events","No usable data for effect sizes"
"CD006027_pub3_data","5::1::Pain (post-intervention pain score (VAS-10 cm) at 60 minutes)","No usable data for effect sizes"
"CD006027_pub3_data","5::3::Minor adverse events","No usable data for effect sizes"
"CD006027_pub3_data","6::2::Significant pain relief","No usable data for effect sizes"
"CD006027_pub3_data","6::3::Minor adverse events","No usable data for effect sizes"
"CD006027_pub3_data","7::1::Pain (post-Intervention pain score (VAS-10 cm) at 30 minutes)","No usable data for effect sizes"
"CD006027_pub3_data","8::1::Pain (change from baseline in pain score (VAS-10 cm) at 30 minutes)","No usable data for effect sizes"
"CD006027_pub3_data","8::3::Significant pain relief","No usable data for effect sizes"
"CD006027_pub3_data","9::2::Minor adverse events","No usable data for effect sizes"
"CD006027_pub3_data","10::1::Need for rescue medication","No usable data for effect sizes"
"CD006027_pub3_data","10::2::Minor adverse events","No usable data for effect sizes"
"CD006027_pub3_data","11::1::Need for rescue medication","No usable data for effect sizes"
"CD006027_pub3_data","11::2::Minor adverse events","No usable data for effect sizes"
"CD006027_pub3_data","14::3::Significant pain relief","No usable data for effect sizes"
"CD006027_pub3_data","15::1::Pain (post-intervention pain score (VAS-10 cm) at 30 minutes)","No usable data for effect sizes"
"CD006027_pub3_data","15::3::Pain recurrence","No usable data for effect sizes"
"CD006027_pub3_data","16::1::Need for rescue medication","No usable data for effect sizes"
"CD006027_pub3_data","16::2::Minor adverse events","No usable data for effect sizes"
"CD006027_pub3_data","17::1::Pain (change  from basline in pain score (VAS-10 cm) at 60 minutes)","No usable data for effect sizes"
"CD006027_pub3_data","17::2::Need for rescue medication","No usable data for effect sizes"
"CD006140_pub3_data","1::1::Any illicit opioid use (urine drug screen)","No usable data for effect sizes"
"CD006140_pub3_data","1::11::Opioid craving","No usable data for effect sizes"
"CD006140_pub3_data","1::12::Days of alcohol use","No usable data for effect sizes"
"CD006140_pub3_data","1::15::Days of cannabis use","No usable data for effect sizes"
"CD006140_pub3_data","1::17::Anxiety","No usable data for effect sizes"
"CD006140_pub3_data","1::18::Insomnia","No usable data for effect sizes"
"CD006140_pub3_data","1::19::Psychiatric disorder","No usable data for effect sizes"
"CD006140_pub3_data","1::20::Quality of life","No usable data for effect sizes"
"CD006140_pub3_data","1::21::Arrest or reincarceration","No usable data for effect sizes"
"CD006140_pub3_data","2::1::Any illicit opioid use (urine drug screen)","No usable data for effect sizes"
"CD006140_pub3_data","2::2::Any illicit opioid use (self report)","No usable data for effect sizes"
"CD006140_pub3_data","2::8::Overdose","No usable data for effect sizes"
"CD006140_pub3_data","2::9::Study treatment terminated due to adverse event","No usable data for effect sizes"
"CD006140_pub3_data","2::10::Insomnia","No usable data for effect sizes"
"CD006140_pub3_data","3::2::Opioid negative urine drug screens (count)","No usable data for effect sizes"
"CD006140_pub3_data","3::4::Time to dropout (days)","No usable data for effect sizes"
"CD006140_pub3_data","3::5::Acceptability","No usable data for effect sizes"
"CD006140_pub3_data","3::9::Overdose","No usable data for effect sizes"
"CD006140_pub3_data","3::11::Opioid craving","No usable data for effect sizes"
"CD006140_pub3_data","3::12::Quality of life","No usable data for effect sizes"
"CD006140_pub3_data","4::4::Opioid negative urine drug screens (count)","No usable data for effect sizes"
"CD006140_pub3_data","4::11::Days of alcohol use","No usable data for effect sizes"
"CD006140_pub3_data","4::12::Days of amphetamines or cocaine use","No usable data for effect sizes"
"CD006140_pub3_data","4::13::Days of cannabis use","No usable data for effect sizes"
"CD006140_pub3_data","4::14::Depression","No usable data for effect sizes"
"CD006140_pub3_data","4::15::Psychiatric disorder","No usable data for effect sizes"
"CD006140_pub3_data","5::1::Opioid negative urine drug screens (count)","No usable data for effect sizes"
"CD006140_pub3_data","5::2::Death","No usable data for effect sizes"
"CD006182_pub3_data","1::1::Mortality or NDI at 18-24 months","No usable data for effect sizes"
"CD006182_pub3_data","1::2::NDI at 18-24 months among surivors","No usable data for effect sizes"
"CD006182_pub3_data","1::3::Moderate to severe CP among surviving infants","No usable data for effect sizes"
"CD006182_pub3_data","1::5::Mortality before 18 to 24 months","No usable data for effect sizes"
"CD006182_pub3_data","5::1::Intraoperative Complications","No usable data for effect sizes"
"CD006182_pub3_data","5::5::Wound dehiscence","No usable data for effect sizes"
"CD006182_pub3_data","5::6::Severe intraventricular hemorrhage","No usable data for effect sizes"
"CD006182_pub3_data","5::7::Sepsis","No usable data for effect sizes"
"CD006182_pub3_data","5::8::PN-Associated Cholestasis","No usable data for effect sizes"
"CD006182_pub3_data","5::9::Recurrent NEC after primary procedure","No usable data for effect sizes"
"CD006182_pub3_data","6::2::Duration of parenteral nutrition (days)","No usable data for effect sizes"
"CD006182_pub3_data","7::1::Duration of mechanical ventilation (days)","No usable data for effect sizes"
"CD006182_pub3_data","9::1::Final bowel length (cm)","No usable data for effect sizes"
"CD006182_pub3_data","10::1::Survival with Neurodevelopmental Impairmentat 18-24 months","No usable data for effect sizes"
"CD006182_pub3_data","10::2::Mortality or Moderate to Severe CP at 18 to 24 months","No usable data for effect sizes"
"CD006182_pub3_data","10::3::Mortality or cognitive score worse than 1SD below the mean at 18-24 months","No usable data for effect sizes"
"CD006182_pub3_data","10::4::Cognitive score worse than 1SD below the mean at 18-24 months","No usable data for effect sizes"
"CD006182_pub3_data","10::5::Cognitive score worse than 2SD below the mean at 18-24 months","No usable data for effect sizes"
"CD006182_pub3_data","10::6::Mortality or cognitive score worse than 2SD below the mean at 18-24 months","No usable data for effect sizes"
"CD006182_pub3_data","10::7::Blindness","No usable data for effect sizes"
"CD006182_pub3_data","10::8::Hearing loss","No usable data for effect sizes"
"CD006214_pub5_data","1::1::Mean time to complete healing (days)","No usable data for effect sizes"
"CD006257_pub2_data","1::17::Dizziness","No usable data for effect sizes"
"CD006257_pub2_data","2::9::GFR (at end of treatment) [mL/min/1.73 m²]","No usable data for effect sizes"
"CD006257_pub2_data","2::14::Headache","No usable data for effect sizes"
"CD006257_pub2_data","2::15::Dizziness","No usable data for effect sizes"
"CD006257_pub2_data","3::8::Reduction in GFR","No usable data for effect sizes"
"CD006257_pub2_data","3::13::Headache","No usable data for effect sizes"
"CD006257_pub2_data","3::14::Impotence","No usable data for effect sizes"
"CD006257_pub2_data","4::1::Death: any cause","No usable data for effect sizes"
"CD006257_pub2_data","4::2::Cardiovascular death","No usable data for effect sizes"
"CD006257_pub2_data","4::3::Micro- to macroalbuminuria","No usable data for effect sizes"
"CD006257_pub2_data","4::4::Micro- to normoalbuminuria","No usable data for effect sizes"
"CD006257_pub2_data","5::8::Reduction in GFR","No usable data for effect sizes"
"CD006257_pub2_data","6::4::Hypekalaemia","No usable data for effect sizes"
"CD006257_pub2_data","6::5::Cough","No usable data for effect sizes"
"CD006257_pub2_data","6::6::Headache","No usable data for effect sizes"
"CD006257_pub2_data","7::3::Kidney failure","No usable data for effect sizes"
"CD006257_pub2_data","7::4::Fatal or nonfatal myocardial infarction","No usable data for effect sizes"
"CD006257_pub2_data","7::5::Fatal or nonfatal stroke","No usable data for effect sizes"
"CD006257_pub2_data","7::6::Doubling of serum creatinine","No usable data for effect sizes"
"CD006257_pub2_data","7::7::GFR (at end of treatment) [mL/min/1.7 3m²]","No usable data for effect sizes"
"CD006257_pub2_data","7::8::Macro-to microalbuminuria","No usable data for effect sizes"
"CD006257_pub2_data","7::9::Macro-to normoalbuminuria","No usable data for effect sizes"
"CD006257_pub2_data","7::11::Dizziness","No usable data for effect sizes"
"CD006257_pub2_data","8::2::Withdrawn: any cause","No usable data for effect sizes"
"CD006257_pub2_data","8::4::Change in GFR [mL/min/1.73 m²]","No usable data for effect sizes"
"CD006257_pub2_data","8::6::Headache","No usable data for effect sizes"
"CD006257_pub2_data","8::7::Dizziness","No usable data for effect sizes"
"CD006257_pub2_data","9::1::Change in GFR [mL/min/1.73 m²]","No usable data for effect sizes"
"CD006257_pub2_data","9::2::Hyperkalaemia","No usable data for effect sizes"
"CD006273_pub4_data","2::1::Quality of life from single-study data","No usable data for effect sizes"
"CD006273_pub4_data","3::1::Adverse events from single-study data: pain at injection site","No usable data for effect sizes"
"CD006273_pub4_data","3::2::Adverse events from single-study data: swelling at injection site","No usable data for effect sizes"
"CD006404_pub5_data","3::1::Total failure: day 28 (polymerase chain reaction-adjusted)","No usable data for effect sizes"
"CD006404_pub5_data","3::2::Total failure: day 42 (polymerase chain reaction-adjusted)","No usable data for effect sizes"
"CD006404_pub5_data","3::3::Total failure: day 28 (unadjusted)","No usable data for effect sizes"
"CD006404_pub5_data","3::4::Total failure: day 42 (unadjusted)","No usable data for effect sizes"
"CD006404_pub5_data","3::5::Serious adverse events","No usable data for effect sizes"
"CD006404_pub5_data","3::6::Adverse events leading to withdrawal","No usable data for effect sizes"
"CD006404_pub5_data","3::7::First treatment, alanine aminotransferase increase greater than five times the upper limit of normal","No usable data for effect sizes"
"CD006404_pub5_data","3::8::First treatment, aspartate aminotransferase increase greater than five times the upper limit of normal","No usable data for effect sizes"
"CD006404_pub5_data","3::9::First treatment, bilirubin increase greater than 2.5 times the upper limit of normal","No usable data for effect sizes"
"CD006404_pub5_data","4::11::Serious adverse events (pregnant women)","No usable data for effect sizes"
"CD006475_pub3_data","2::2::Food allergy by 2 years of age","No usable data for effect sizes"
"CD006475_pub3_data","3::5::Sensitivity analysis: asthma by 10 years of age by risk of bias","No usable data for effect sizes"
"CD006475_pub3_data","4::1::Asthma by 10 years of age","No usable data for effect sizes"
"CD006475_pub3_data","4::2::Eczema by 10 years of age","No usable data for effect sizes"
"CD006475_pub3_data","4::3::Allergic rhinitis by 10 years of age","No usable data for effect sizes"
"CD006515_pub2_data","1::6::Health-related quality of life (HRQoL)","No usable data for effect sizes"
"CD006515_pub2_data","1::7::Overhydration","No usable data for effect sizes"
"CD006536_pub5_data","1::24::LVEF measured by radionuclide ventriculography (≥ 12 months)","No usable data for effect sizes"
"CD006606_pub5_data","1::13::Congenital anomaly – low risk of bias (odds ratio, random-effects)","No usable data for effect sizes"
"CD006606_pub5_data","1::14::Congenital anomaly – low risk of bias (risk ratio, random-effects)","No usable data for effect sizes"
"CD006689_pub3_data","1::8::Maternal peripheral parasitaemia during pregnancy (any test)","No usable data for effect sizes"
"CD006689_pub3_data","1::15::Cord blood parasitaemia (loop-mediated isothermal amplification)","No usable data for effect sizes"
"CD006689_pub3_data","2::5::Clinical malaria episodes during pregnancy","No usable data for effect sizes"
"CD006689_pub3_data","3::6::Maternal peripheral parasitaemia during pregnancy (any test)","No usable data for effect sizes"
"CD006689_pub3_data","3::13::Cord blood parasitaemia (loop-mediated isothermal amplification)","No usable data for effect sizes"
"CD006689_pub3_data","3::24::Undetectable HIV viral load at delivery","No usable data for effect sizes"
"CD006689_pub3_data","4::4::Clinical malaria episodes during pregnancy","No usable data for effect sizes"
"CD006689_pub3_data","4::8::Cord blood parasitaemia","No usable data for effect sizes"
"CD006689_pub3_data","4::9::Prematurity","No usable data for effect sizes"
"CD006689_pub3_data","4::10::Severe adverse events during pregnancy","No usable data for effect sizes"
"CD006689_pub3_data","4::11::Spontaneous abortion","No usable data for effect sizes"
"CD006689_pub3_data","4::12::Stillbirth","No usable data for effect sizes"
"CD006689_pub3_data","4::13::Maternal mortality","No usable data for effect sizes"
"CD006689_pub3_data","5::1::Maternal peripheral parasitaemia during pregnancy","No usable data for effect sizes"
"CD006689_pub3_data","5::3::Placental malaria (histology)","No usable data for effect sizes"
"CD006689_pub3_data","5::4::Placental malaria (microscopy or polymerase chain reaction)","No usable data for effect sizes"
"CD006689_pub3_data","5::6::Maternal haemoglobin level at delivery (in g/dL)","No usable data for effect sizes"
"CD006689_pub3_data","5::9::Cord blood parasitaemia (rapid diagnostic test)","No usable data for effect sizes"
"CD006689_pub3_data","5::10::Congenital malaria","No usable data for effect sizes"
"CD006689_pub3_data","5::18::Infant mortality","No usable data for effect sizes"
"CD006689_pub3_data","5::19::Adverse events: rash","No usable data for effect sizes"
"CD006689_pub3_data","6::1::Maternal peripheral parasitemia at delivery (blood smear)","No usable data for effect sizes"
"CD006689_pub3_data","6::2::Placental malaria (blood smear)","No usable data for effect sizes"
"CD006689_pub3_data","6::3::Low birth weight (< 2500 g)","No usable data for effect sizes"
"CD006689_pub3_data","6::4::Prematurity","No usable data for effect sizes"
"CD006689_pub3_data","6::5::Adverse events: nausea ","No usable data for effect sizes"
"CD006689_pub3_data","6::6::Adverse events: headache","No usable data for effect sizes"
"CD006689_pub3_data","6::7::Adverse events: vomiting","No usable data for effect sizes"
"CD006689_pub3_data","6::8::Adverse events: dizziness ","No usable data for effect sizes"
"CD006689_pub3_data","6::9::Adverse events: gastric pain","No usable data for effect sizes"
"CD006689_pub3_data","7::1::Maternal peripheral parasitaemia at delivery (blood smear)","No usable data for effect sizes"
"CD006689_pub3_data","7::2::Maternal anaemia at delivery","No usable data for effect sizes"
"CD006689_pub3_data","7::3::Placental malaria (blood smear)","No usable data for effect sizes"
"CD006689_pub3_data","7::4::Clinical malaria episodes during pregnancy","No usable data for effect sizes"
"CD006689_pub3_data","7::5::Low birth weight (< 2.5 kg)","No usable data for effect sizes"
"CD006689_pub3_data","7::6::Mean birth weight (in kg)","No usable data for effect sizes"
"CD006689_pub3_data","7::7::Prematurity","No usable data for effect sizes"
"CD006689_pub3_data","7::8::SAEs during pregnancy","No usable data for effect sizes"
"CD006689_pub3_data","7::9::Spontaneous abortion","No usable data for effect sizes"
"CD006689_pub3_data","7::10::Stillbirth","No usable data for effect sizes"
"CD006689_pub3_data","7::11::Congenital malformations","No usable data for effect sizes"
"CD006689_pub3_data","7::12::Maternal mortality","No usable data for effect sizes"
"CD006689_pub3_data","7::13::Neonatal mortality","No usable data for effect sizes"
"CD006689_pub3_data","7::14::Adverse events: headache","No usable data for effect sizes"
"CD006689_pub3_data","7::15::Adverse events: nausea","No usable data for effect sizes"
"CD006689_pub3_data","7::16::Adverse events: vomiting","No usable data for effect sizes"
"CD006689_pub3_data","7::17::Adverse events: dizziness","No usable data for effect sizes"
"CD006689_pub3_data","7::18::Adverse events: abdominal pain","No usable data for effect sizes"
"CD006689_pub3_data","8::1::Maternal peripheral parasitaemia at delivery (polymerase chain reaction)","No usable data for effect sizes"
"CD006689_pub3_data","8::2::Maternal anaemia at delivery","No usable data for effect sizes"
"CD006689_pub3_data","8::3::Placental malaria (polymerase chain reaction)","No usable data for effect sizes"
"CD006689_pub3_data","8::4::Placental malaria (blood smear)","No usable data for effect sizes"
"CD006689_pub3_data","8::5::Maternal haemoglobin level at delivery (in g/dL)","No usable data for effect sizes"
"CD006689_pub3_data","8::6::Low birth weight (< 2500 g)","No usable data for effect sizes"
"CD006689_pub3_data","8::7::Mean birth weight (in grams)","No usable data for effect sizes"
"CD006689_pub3_data","8::8::Cord blood parasitaemia","No usable data for effect sizes"
"CD006689_pub3_data","8::9::Prematurity","No usable data for effect sizes"
"CD006689_pub3_data","8::10::SAEs during pregnancy","No usable data for effect sizes"
"CD006689_pub3_data","8::11::Spontaneous abortion","No usable data for effect sizes"
"CD006689_pub3_data","8::12::Stillbirth","No usable data for effect sizes"
"CD006689_pub3_data","8::13::Congenital malformations","No usable data for effect sizes"
"CD006689_pub3_data","8::14::Maternal mortality","No usable data for effect sizes"
"CD006689_pub3_data","8::15::Early neonatal mortality (< 7 days)","No usable data for effect sizes"
"CD006689_pub3_data","8::16::Infant mortality (≥ 7 days up to 6 weeks of age)","No usable data for effect sizes"
"CD006689_pub3_data","8::17::Adverse events: headache","No usable data for effect sizes"
"CD006689_pub3_data","8::18::Adverse events: vomiting","No usable data for effect sizes"
"CD006689_pub3_data","8::19::Adverse events: dizziness","No usable data for effect sizes"
"CD006689_pub3_data","8::20::Adverse events: fatigue/weakness","No usable data for effect sizes"
"CD006689_pub3_data","9::1::Maternal peripheral parasitaemia at delivery (blood smear)","No usable data for effect sizes"
"CD006689_pub3_data","9::2::Maternal anaemia at delivery (packed cell volume <33%)","No usable data for effect sizes"
"CD006689_pub3_data","9::3::Maternal anaemia at delivery (< 120 g/L)","No usable data for effect sizes"
"CD006689_pub3_data","9::4::Placental malaria: acute infection (histology)","No usable data for effect sizes"
"CD006689_pub3_data","9::5::Placental malaria: chronic infection (histology)","No usable data for effect sizes"
"CD006689_pub3_data","9::6::Mean haemoglobin at delivery (in g/L)","No usable data for effect sizes"
"CD006689_pub3_data","9::7::Low birth weight (< 2500 g)","No usable data for effect sizes"
"CD006689_pub3_data","9::8::Mean birth weight (in grams)","No usable data for effect sizes"
"CD006689_pub3_data","9::9::Prematurity","No usable data for effect sizes"
"CD006689_pub3_data","9::10::Mother-to-child transmission of HIV","No usable data for effect sizes"
"CD006689_pub3_data","9::11::Maternal viral load at delivery (≥ 10 000 copies/mL)","No usable data for effect sizes"
"CD006712_pub3_data","1::1::Pain with dilation","No usable data for effect sizes"
"CD006712_pub3_data","1::2::Pain with aspiration","No usable data for effect sizes"
"CD006712_pub3_data","2::1::Pain with dilation","No usable data for effect sizes"
"CD006712_pub3_data","2::2::Pain with aspiration","No usable data for effect sizes"
"CD006712_pub3_data","3::1::Pain during procedure","No usable data for effect sizes"
"CD006712_pub3_data","3::2::Pain during procedure in patients who all also received topical cervical lidocaine spray","No usable data for effect sizes"
"CD006712_pub3_data","4::1::Pain with aspiration","No usable data for effect sizes"
"CD006712_pub3_data","5::1::Pain during procedure","No usable data for effect sizes"
"CD006712_pub3_data","6::1::Pain during procedure","No usable data for effect sizes"
"CD006712_pub3_data","7::1::Pain during procedure","No usable data for effect sizes"
"CD006712_pub3_data","8::1::Pain with dilation (10 mL 2% lidocaine)","No usable data for effect sizes"
"CD006712_pub3_data","8::2::Pain with dilation (20 mL 1% lidocaine)","No usable data for effect sizes"
"CD006712_pub3_data","8::4::Pain with aspiration (20 mL 1% lidocaine)","No usable data for effect sizes"
"CD006712_pub3_data","9::1::Pain with aspiration","No usable data for effect sizes"
"CD006712_pub3_data","10::1::Pain with aspiration","No usable data for effect sizes"
"CD006712_pub3_data","11::1::Pain with aspiration","No usable data for effect sizes"
"CD006712_pub3_data","13::1::Pain with dilation","No usable data for effect sizes"
"CD006712_pub3_data","13::2::Pain with aspiration","No usable data for effect sizes"
"CD006712_pub3_data","14::1::Pain during procedure","No usable data for effect sizes"
"CD006712_pub3_data","15::1::Pain during procedure","No usable data for effect sizes"
"CD006712_pub3_data","17::1::Pain with dilation","No usable data for effect sizes"
"CD006712_pub3_data","18::1::Pain during procedure","No usable data for effect sizes"
"CD006714_pub3_data","1::4::Bleeding: mean estimated blood loss (mL)","No usable data for effect sizes"
"CD006714_pub3_data","1::5::Bleeding: post-abortion bleeding severity > menstrual period ","No usable data for effect sizes"
"CD006714_pub3_data","1::8::Patient experience of pain (mean pain score)","No usable data for effect sizes"
"CD006714_pub3_data","1::9::Patient satisfaction (overall satisfaction with assigned method)","No usable data for effect sizes"
"CD006714_pub3_data","1::10::Bleeding: hemorrhage not requiring transfusion","No usable data for effect sizes"
"CD006714_pub3_data","1::11::Nausea","No usable data for effect sizes"
"CD006714_pub3_data","1::12::Vomiting","No usable data for effect sizes"
"CD006714_pub3_data","1::13::Diarrhea","No usable data for effect sizes"
"CD006714_pub3_data","1::16::Psychological impact: General Health Questionnaire (GHQ-12)","No usable data for effect sizes"
"CD006714_pub3_data","1::17::Acceptability: would choose the same procedure again","No usable data for effect sizes"
"CD006714_pub3_data","1::18::Acceptability: rate experience worse than expected","No usable data for effect sizes"
"CD006742_pub3_data","1::5::Withdrawals due to adverse effects","No usable data for effect sizes"
"CD006839_pub5_data","3::1::Proportion of participants with clinical improvement in function at 3 months compared to baseline. Corticosteroid injection versus placebo","No usable data for effect sizes"
"CD006839_pub5_data","3::2::Proportion of patients with adverse events at the injection site. Corticosteroid injection versus placebo","No usable data for effect sizes"
"CD006839_pub5_data","4::1::Proportion of participants with clinical improvement in function at 12 months compared to baseline","No usable data for effect sizes"
"CD006839_pub5_data","4::2::Proportion of participants with wound infection/pain/sensory loss","No usable data for effect sizes"
"CD006913_pub3_data","4::11::Emergency visits per person (long-term)  - educational intervention vs care-as-usual","No usable data for effect sizes"
"CD006913_pub3_data","4::12::Days in hospital (short-term) - educational interventions vs care-as-usual","No usable data for effect sizes"
"CD006913_pub3_data","6::11::Days off work – change from pre-treatment  values (reference period: two years) - relaxation techniques vs care-as-usual","No usable data for effect sizes"
"CD006913_pub3_data","7::13::Failure to induce or maintain remission (short-term) (ITT) - educational intervention vs active control","No usable data for effect sizes"
"CD006913_pub3_data","7::14::Failure to induce or maintain remission (short-term) (PP, sensitivity analysis) - educational intervention vs active control","No usable data for effect sizes"
"CD006913_pub3_data","7::27::Failure to induce or maintain remission (short-term) (ITT) - relaxation techniques vs active control","No usable data for effect sizes"
"CD006913_pub3_data","8::2::Quality of life (long-term)  - psychotherapy vs care-as-usual","No usable data for effect sizes"
"CD006913_pub3_data","8::4::Depressive symptoms (long-term) - psychotherapy vs care-as-usual","No usable data for effect sizes"
"CD006913_pub3_data","8::6::Time off school - change from baseline (short-term) - psychotherapy vs care-as-usual","No usable data for effect sizes"
"CD006913_pub3_data","9::1::Quality of life (short-term) - educational intervention vs care-as-usual","No usable data for effect sizes"
"CD006913_pub3_data","9::2::Quality of life (long-term) - educational intervention vs care-as-usual","No usable data for effect sizes"
"CD006913_pub3_data","9::3::Depressive symptoms (short-term) - educational intervention vs care-as-usual","No usable data for effect sizes"
"CD006913_pub3_data","9::4::Depressive symptoms (long-term) - educational intervention vs care-as-usual","No usable data for effect sizes"
"CD006913_pub3_data","10::2::Quality of life (long-term) - relaxation technique vs care-as-usual","No usable data for effect sizes"
"CD006913_pub3_data","10::4::Depressive symptoms (long-term) - relaxation technique vs care-as-usual","No usable data for effect sizes"
"CD006913_pub3_data","10::5::Anxiety - change from baseline (short-term) - relaxation technique vs care-as-usual","No usable data for effect sizes"
"CD006913_pub3_data","10::6::Disease activity - change from baseline (short-term) - relaxation technique vs care-as-usual","No usable data for effect sizes"
"CD006913_pub3_data","10::7::Time off school - change from baseline (short-term) - relaxation technique vs care-as-usual","No usable data for effect sizes"
"CD006913_pub3_data","11::1::Disease activity (short-term)- psychotherapy vs active control","No usable data for effect sizes"
"CD006913_pub3_data","11::3::Quality of life - change from baseline (long-term) - educational intervention vs active control","No usable data for effect sizes"
"CD006913_pub3_data","11::4::Depressive symptoms - change from baseline (short-term) - educational intervention vs active control","No usable data for effect sizes"
"CD006913_pub3_data","11::5::Depressive symptoms - change from baseline (long-term) - educational intervention vs active control","No usable data for effect sizes"
"CD006913_pub3_data","11::6::Anxiety (short- term) - educational intervention vs active control","No usable data for effect sizes"
"CD006913_pub3_data","11::7::Anxiety - change from baseline (long-term) - educational intervention vs active control","No usable data for effect sizes"
"CD006913_pub3_data","11::8::Disease activity (short-term) - educational intervention vs active control","No usable data for effect sizes"
"CD006913_pub3_data","11::9::Quality of life - change from baseline (short-term) - relaxation technique vs active control","No usable data for effect sizes"
"CD006913_pub3_data","11::10::Quality of life - change from baseline (long-term) - relaxation technique vs active control","No usable data for effect sizes"
"CD006913_pub3_data","11::11::Depressive symptoms - change from baseline (long-term) - relaxation technique vs active control","No usable data for effect sizes"
"CD006913_pub3_data","11::12::Depressive symptoms - change from baseline (short-term)  - relaxation technique vs active control","No usable data for effect sizes"
"CD006913_pub3_data","11::14::Anxiety - change from baseline (long-term) - relaxation technique vs active control","No usable data for effect sizes"
"CD006913_pub3_data","11::15::Disease activity (short-term) - relaxation technique vs active control","No usable data for effect sizes"
"CD006919_pub5_data","2::1::Live birth and ongoing pregnancies","No usable data for effect sizes"
"CD006919_pub5_data","2::4::Amount of gonadotropins administered","No usable data for effect sizes"
"CD006919_pub5_data","2::5::Cycle cancellation","No usable data for effect sizes"
"CD006919_pub5_data","3::1::Clinical pregnancies","No usable data for effect sizes"
"CD006919_pub5_data","3::2::Number of oocytes","No usable data for effect sizes"
"CD006919_pub5_data","3::3::Amount of gonadotropins administered","No usable data for effect sizes"
"CD006919_pub5_data","3::4::Cycle cancellation","No usable data for effect sizes"
"CD006919_pub5_data","4::1::Live birth and ongoing pregnancies","No usable data for effect sizes"
"CD006919_pub5_data","5::1::Ongoing pregnancy rate primary analysis","No usable data for effect sizes"
"CD006919_pub5_data","6::1::Ongoing pregnancy rate","No usable data for effect sizes"
"CD006919_pub5_data","6::2::OHSS","No usable data for effect sizes"
"CD006919_pub5_data","7::1::Live birth and ongoing pregnancies","No usable data for effect sizes"
"CD006919_pub5_data","7::2::Clinical pregnancies","No usable data for effect sizes"
"CD006919_pub5_data","7::3::Number of oocytes","No usable data for effect sizes"
"CD006919_pub5_data","7::4::Amount of gonadotropins administered","No usable data for effect sizes"
"CD006919_pub5_data","7::5::Cycle cancellation","No usable data for effect sizes"
"CD006919_pub5_data","8::1::Live birth and ongoing pregnancies","No usable data for effect sizes"
"CD006919_pub5_data","8::2::Clinical pregnancies","No usable data for effect sizes"
"CD006919_pub5_data","8::3::Number of oocytes","No usable data for effect sizes"
"CD006919_pub5_data","8::4::Amount of gonadotropins administered","No usable data for effect sizes"
"CD006919_pub5_data","9::1::Clinical pregnancies","No usable data for effect sizes"
"CD006919_pub5_data","9::2::Number of oocytes","No usable data for effect sizes"
"CD006919_pub5_data","9::3::Amount of gonadotropins administered","No usable data for effect sizes"
"CD006919_pub5_data","9::4::Cycle cancellation","No usable data for effect sizes"
"CD006919_pub5_data","10::1::Live birth 500 µg versus 80 µg","No usable data for effect sizes"
"CD006919_pub5_data","10::2::Clinical pregnancy 500 µg vs 80 µg","No usable data for effect sizes"
"CD006919_pub5_data","10::3::Clinical pregnancy 100 µg vs 50 µg","No usable data for effect sizes"
"CD006919_pub5_data","10::5::Clinical pregnancy 50 µg vs 25 µg","No usable data for effect sizes"
"CD006919_pub5_data","10::6::Number of oocytes 500 µg vs 80 µg","No usable data for effect sizes"
"CD006919_pub5_data","10::7::Number of oocytes 100 µg vs 50 µg","No usable data for effect sizes"
"CD006919_pub5_data","10::9::Number of oocytes 50 µg vs 25 µg","No usable data for effect sizes"
"CD006919_pub5_data","10::12::Other outcomes: pregnancy loss","No usable data for effect sizes"
"CD006942_pub4_data","2::2::Clinical pregnancy per couple","No usable data for effect sizes"
"CD006942_pub4_data","2::3::Tubal pregnancy per couple","No usable data for effect sizes"
"CD006942_pub4_data","3::1::Live birth or ongoing pregnancy rate per couple","No usable data for effect sizes"
"CD006942_pub4_data","4::2::Clinical pregnancy per couple","No usable data for effect sizes"
"CD006942_pub4_data","4::3::Miscarriage per couple","No usable data for effect sizes"
"CD006942_pub4_data","6::1::Live birth or ongoing pregnancy rate per couple","No usable data for effect sizes"
"CD006942_pub4_data","6::2::Clinical pregnancy per couple","No usable data for effect sizes"
"CD006942_pub4_data","6::3::Miscarriage per couple","No usable data for effect sizes"
"CD006942_pub4_data","7::1::Clinical pregnancy per couple","No usable data for effect sizes"
"CD006982_pub5_data","2::2::Duration of oxygen treatment (days)","No usable data for effect sizes"
"CD007024_pub3_data","1::6::Dropout due to adverse events","No usable data for effect sizes"
"CD007024_pub3_data","1::7::Any adverse events","No usable data for effect sizes"
"CD007024_pub3_data","1::9::Craving (measured on a visual analogue scale of 0–100 points)","No usable data for effect sizes"
"CD007024_pub3_data","1::10::Depression (measured on a scale of 0–52 points)","No usable data for effect sizes"
"CD007024_pub3_data","1::11::Anxiety (measured on a scale of 0–56 points)","No usable data for effect sizes"
"CD007024_pub3_data","2::4::Dropout due to adverse events","No usable data for effect sizes"
"CD007024_pub3_data","2::6::Craving (measured on a visual analogue scale of 0–100 points)","No usable data for effect sizes"
"CD007024_pub3_data","2::7::Depression (measured on a scale of 0–52 points)","No usable data for effect sizes"
"CD007024_pub3_data","2::8::Anxiety (measured on a scale of 0–56 points)","No usable data for effect sizes"
"CD007079_pub4_data","1::7::Maternal bone mineral density (g/cm2) – first phalanx (calcium 300 mg)","No usable data for effect sizes"
"CD007079_pub4_data","1::8::Maternal bone mineral density (g/cm2) – second metacarpal (calcium 300 mg)","No usable data for effect sizes"
"CD007079_pub4_data","1::9::Maternal bone mineral density (g/cm2) – fourth metacarpal (calcium 300 mg)","No usable data for effect sizes"
"CD007079_pub4_data","1::10::Maternal bone mineral density (g/cm2) – first phalanx (calcium 600 mg)","No usable data for effect sizes"
"CD007079_pub4_data","1::11::Maternal bone mineral density (g/cm2) – second metacarpal (calcium 600 mg)","No usable data for effect sizes"
"CD007079_pub4_data","1::12::Maternal bone mineral density (g/cm2) – fourth metacarpal (calcium 600 mg)","No usable data for effect sizes"
"CD007079_pub4_data","1::13::Maternal admission to intensive care unit","No usable data for effect sizes"
"CD007079_pub4_data","3::4::Renal colic","No usable data for effect sizes"
"CD007079_pub4_data","3::5::Impaired renal function","No usable data for effect sizes"
"CD007079_pub4_data","3::6::Maternal anaemia","No usable data for effect sizes"
"CD007110_pub4_data","3::2::Cardiac disease-related mortality","No usable data for effect sizes"
"CD007110_pub4_data","6::3::Cardiac disease-related mortality","No usable data for effect sizes"
"CD007110_pub4_data","8::1::All trials","No usable data for effect sizes"
"CD007110_pub4_data","9::1::Cardiac disease-related mortality","No usable data for effect sizes"
"CD007110_pub4_data","10::1::All trials","No usable data for effect sizes"
"CD007110_pub4_data","11::1::All trials","No usable data for effect sizes"
"CD007110_pub4_data","12::1::Second-cancer-related mortality","No usable data for effect sizes"
"CD007110_pub4_data","12::2::Cardiac disease-related mortality","No usable data for effect sizes"
"CD007110_pub4_data","15::1::Infection-related mortality","No usable data for effect sizes"
"CD007156_pub3_data","2::5::Difficulty in mouth opening","No usable data for effect sizes"
"CD007156_pub3_data","2::6::Intolerance to spicy food","No usable data for effect sizes"
"CD007156_pub3_data","3::1::Interincisal distance (mm)","No usable data for effect sizes"
"CD007156_pub3_data","3::2::Burning sensation (VAS)","No usable data for effect sizes"
"CD007156_pub3_data","5::3::Difficulty in speech","No usable data for effect sizes"
"CD007156_pub3_data","5::4::Difficulty in swallowing","No usable data for effect sizes"
"CD007156_pub3_data","9::1::Interincisal distance (mm)","No usable data for effect sizes"
"CD007156_pub3_data","10::1::Interincisal distance (mm)","No usable data for effect sizes"
"CD007156_pub3_data","11::1::Interincisal distance (mm)","No usable data for effect sizes"
"CD007156_pub3_data","12::1::Interincisal distance (mm)","No usable data for effect sizes"
"CD007156_pub3_data","13::1::Interincisal distance (mm)","No usable data for effect sizes"
"CD007156_pub3_data","14::1::Interincisal distance (mm)","No usable data for effect sizes"
"CD007310_pub3_data","1::5::Adverse events (pre-procedure expulsion)","No usable data for effect sizes"
"CD007310_pub3_data","1::11::Patient acceptability and/or satisfaction","No usable data for effect sizes"
"CD007310_pub3_data","1::14::Provider acceptability and/or satisfaction","No usable data for effect sizes"
"CD007310_pub3_data","2::1::Procedure time (minutes)","No usable data for effect sizes"
"CD007310_pub3_data","2::2::Dilation achieved (mm)","No usable data for effect sizes"
"CD007310_pub3_data","2::3::Need for additional dilation","No usable data for effect sizes"
"CD007310_pub3_data","2::4::Ability to complete procedure","No usable data for effect sizes"
"CD007310_pub3_data","2::5::Side effects: nausea/vomiting","No usable data for effect sizes"
"CD007310_pub3_data","2::6::Patient acceptability","No usable data for effect sizes"
"CD007310_pub3_data","2::7::Pain experienced by participants between initiation of cervical preparation method and abortion procedure","No usable data for effect sizes"
"CD007310_pub3_data","2::8::Provider assessment of difficulty of procedure","No usable data for effect sizes"
"CD007310_pub3_data","3::6::Ability to complete procedure (number completed on first attempt)","No usable data for effect sizes"
"CD007310_pub3_data","3::15::Provider acceptability/satisfaction","No usable data for effect sizes"
"CD007310_pub3_data","4::2::Dilation achieved (mm)","No usable data for effect sizes"
"CD007310_pub3_data","4::3::Need for additional dilation","No usable data for effect sizes"
"CD007310_pub3_data","4::4::Ability to complete procedure (number completed on first attempt)","No usable data for effect sizes"
"CD007310_pub3_data","4::5::Adverse events: cervical laceration","No usable data for effect sizes"
"CD007310_pub3_data","4::6::Side effects: fever","No usable data for effect sizes"
"CD007310_pub3_data","4::7::Patient satisfaction","No usable data for effect sizes"
"CD007310_pub3_data","4::9::Provider acceptability/satisfaction","No usable data for effect sizes"
"CD007310_pub3_data","4::10::Provider assessment of the procedure as very difficult","No usable data for effect sizes"
"CD007310_pub3_data","5::2::Dilation achieved (mm)","No usable data for effect sizes"
"CD007310_pub3_data","5::3::Need for additional dilation","No usable data for effect sizes"
"CD007310_pub3_data","5::4::Ability to complete procedure (number completed on first attempt)","No usable data for effect sizes"
"CD007310_pub3_data","5::6::Side effects: fever","No usable data for effect sizes"
"CD007310_pub3_data","5::7::Side effects: chills","No usable data for effect sizes"
"CD007310_pub3_data","5::8::Patient satisfaction","No usable data for effect sizes"
"CD007310_pub3_data","5::10::Provider acceptability/satisfaction","No usable data for effect sizes"
"CD007310_pub3_data","5::11::Provider assessment of the procedure as very difficult","No usable data for effect sizes"
"CD007310_pub3_data","6::1::Procedure time (minutes)","No usable data for effect sizes"
"CD007310_pub3_data","6::4::Need for additional dilation","No usable data for effect sizes"
"CD007310_pub3_data","6::6::Complications: uterine perforations","No usable data for effect sizes"
"CD007310_pub3_data","7::1::Procedure time (minutes)","No usable data for effect sizes"
"CD007310_pub3_data","7::2::Dilation achieved (mm)","No usable data for effect sizes"
"CD007310_pub3_data","7::3::Need for additional dilation","No usable data for effect sizes"
"CD007310_pub3_data","7::4::Ability to complete procedure","No usable data for effect sizes"
"CD007310_pub3_data","7::5::Side effects: chills","No usable data for effect sizes"
"CD007310_pub3_data","7::6::Complications: uterine perforation","No usable data for effect sizes"
"CD007310_pub3_data","7::8::Provider assessment of difficulty","No usable data for effect sizes"
"CD007310_pub3_data","8::3::Ability to complete procedure","No usable data for effect sizes"
"CD007310_pub3_data","8::4::Adverse events: cervical injury","No usable data for effect sizes"
"CD007310_pub3_data","8::5::Complications","No usable data for effect sizes"
"CD007310_pub3_data","9::1::Procedure time (minutes)","No usable data for effect sizes"
"CD007310_pub3_data","9::2::Dilation achieved (mm)","No usable data for effect sizes"
"CD007310_pub3_data","9::3::Need for additional dilation","No usable data for effect sizes"
"CD007310_pub3_data","9::4::Ability to complete procedure","No usable data for effect sizes"
"CD007310_pub3_data","9::5::Adverse events: cervical tear","No usable data for effect sizes"
"CD007310_pub3_data","9::8::Diarrhea","No usable data for effect sizes"
"CD007310_pub3_data","10::1::Procedure time (minutes)","No usable data for effect sizes"
"CD007310_pub3_data","10::3::Need for additional dilation","No usable data for effect sizes"
"CD007310_pub3_data","10::4::Ability to complete procedure","No usable data for effect sizes"
"CD007310_pub3_data","10::6::Side effects: vomiting","No usable data for effect sizes"
"CD007310_pub3_data","10::7::Side effects: diarrhea","No usable data for effect sizes"
"CD007310_pub3_data","10::8::Side effects: fever and/or chills","No usable data for effect sizes"
"CD007310_pub3_data","10::11::Provider assessment of difficulty of procedure","No usable data for effect sizes"
"CD007310_pub3_data","11::1::Procedure time","No usable data for effect sizes"
"CD007310_pub3_data","11::3::Adverse events: pre-procedure expulsion","No usable data for effect sizes"
"CD007310_pub3_data","11::5::Side effects: diarrhea","No usable data for effect sizes"
"CD007310_pub3_data","11::7::Provider assessment of difficulty of procedure","No usable data for effect sizes"
"CD007310_pub3_data","12::3::Need for additional dilation","No usable data for effect sizes"
"CD007310_pub3_data","12::4::Adverse events: cervical laceration","No usable data for effect sizes"
"CD007310_pub3_data","12::5::Complications: uterine perforation","No usable data for effect sizes"
"CD007310_pub3_data","13::3::Need for additional dilation","No usable data for effect sizes"
"CD007310_pub3_data","13::4::Adverse events: cervical laceration","No usable data for effect sizes"
"CD007310_pub3_data","13::5::Complications: uterine perforation","No usable data for effect sizes"
"CD007310_pub3_data","14::3::Dilation achieved (mm)","No usable data for effect sizes"
"CD007310_pub3_data","14::5::Need for additional dilation","No usable data for effect sizes"
"CD007310_pub3_data","14::6::Ability to complete procedure","No usable data for effect sizes"
"CD007310_pub3_data","14::12::Patient acceptability and/or satisfaction","No usable data for effect sizes"
"CD007310_pub3_data","14::13::Provider acceptability and/or satisfaction","No usable data for effect sizes"
"CD007310_pub3_data","15::1::Procedure time (minutes)","No usable data for effect sizes"
"CD007310_pub3_data","15::2::Dilation achieved (mm)","No usable data for effect sizes"
"CD007310_pub3_data","15::3::Provider assessment of difficulty of procedure","No usable data for effect sizes"
"CD007374_pub3_data","1::3::Attaining HbA1c < 6.5%","No usable data for effect sizes"
"CD007374_pub3_data","1::4::Kidney failure","No usable data for effect sizes"
"CD007374_pub3_data","1::14::Estimated GFR [mL/min/1.73 m2]","No usable data for effect sizes"
"CD007374_pub3_data","1::15::Urinary albumin-creatinine ratio [mg/g]","No usable data for effect sizes"
"CD007374_pub3_data","1::21::Adverse events: non-fatal (including hypoglycaemic and CVD events)","No usable data for effect sizes"
"CD007374_pub3_data","2::1::HbA1c [%]","No usable data for effect sizes"
"CD007374_pub3_data","2::2::Kidney failure","No usable data for effect sizes"
"CD007374_pub3_data","2::3::Estimated GFR  [mL/min/1.73 m2]","No usable data for effect sizes"
"CD007388_pub3_data","1::1::Recurrence of convulsion","No usable data for effect sizes"
"CD007388_pub3_data","1::2::Maternal death","No usable data for effect sizes"
"CD007388_pub3_data","1::3::Maternal admission to intensive care unit","No usable data for effect sizes"
"CD007388_pub3_data","1::4::Caesarean section","No usable data for effect sizes"
"CD007388_pub3_data","1::5::Vaginal birth","No usable data for effect sizes"
"CD007388_pub3_data","2::1::Recurrence of convulsions","No usable data for effect sizes"
"CD007388_pub3_data","2::2::Perinatal death","No usable data for effect sizes"
"CD007388_pub3_data","2::3::Maternal death","No usable data for effect sizes"
"CD007388_pub3_data","2::4::Severe morbidity: renal failure","No usable data for effect sizes"
"CD007388_pub3_data","2::5::Caesarean section","No usable data for effect sizes"
"CD007388_pub3_data","2::6::Placental abruption","No usable data for effect sizes"
"CD007388_pub3_data","3::1::Recurrence of convulsions","No usable data for effect sizes"
"CD007388_pub3_data","3::2::Stillbirth","No usable data for effect sizes"
"CD007388_pub3_data","3::3::Neonatal death","No usable data for effect sizes"
"CD007388_pub3_data","3::4::Maternal death","No usable data for effect sizes"
"CD007388_pub3_data","3::5::Severe morbidity: left heart failure and pulmonary oedema","No usable data for effect sizes"
"CD007388_pub3_data","3::6::Postpartum haemorrhage","No usable data for effect sizes"
"CD007388_pub3_data","4::1::Recurrence of convulsions","No usable data for effect sizes"
"CD007388_pub3_data","4::2::Severe morbidity: renal failure","No usable data for effect sizes"
"CD007388_pub3_data","4::3::Side effect: respiratory failure","No usable data for effect sizes"
"CD007388_pub3_data","4::4::Side effect: nausea","No usable data for effect sizes"
"CD007388_pub3_data","4::5::Side effect: flushing","No usable data for effect sizes"
"CD007388_pub3_data","5::3::Stillbirth","No usable data for effect sizes"
"CD007388_pub3_data","5::6::Admission to intensive care unit (maternal)","No usable data for effect sizes"
"CD007388_pub3_data","5::7::Poor blood pressure control: non-use of antihypertensive drugs","No usable data for effect sizes"
"CD007388_pub3_data","5::8::Severe maternal morbidity: HELLP syndrome","No usable data for effect sizes"
"CD007388_pub3_data","5::10::Severe morbidity: liver failure","No usable data for effect sizes"
"CD007388_pub3_data","5::11::Severe morbidity: coagulopathy","No usable data for effect sizes"
"CD007388_pub3_data","5::16::Admission to neonatal intensive care unit","No usable data for effect sizes"
"CD007388_pub3_data","5::17::Neonatal respiratory morbidity: respiratory depression requiring intubation","No usable data for effect sizes"
"CD007388_pub3_data","6::1::Eclampsia","No usable data for effect sizes"
"CD007388_pub3_data","6::2::Stillbirth","No usable data for effect sizes"
"CD007388_pub3_data","6::3::Caesarean section","No usable data for effect sizes"
"CD007388_pub3_data","6::4::Vaginal delivery","No usable data for effect sizes"
"CD007388_pub3_data","6::5::Assisted vaginal delivery","No usable data for effect sizes"
"CD007388_pub3_data","7::4::Treatment discontinued because of side effects or adverse effects","No usable data for effect sizes"
"CD007388_pub3_data","7::7::Poor blood pressure control: postpartum IV antihypertensive therapy","No usable data for effect sizes"
"CD007388_pub3_data","7::8::Need for additional anticonvulsant","No usable data for effect sizes"
"CD007388_pub3_data","7::9::Severe morbidity: liver failure","No usable data for effect sizes"
"CD007388_pub3_data","7::10::Severe morbidity: renal failure","No usable data for effect sizes"
"CD007388_pub3_data","7::11::Severe morbidity: disseminated intravascular coagulation","No usable data for effect sizes"
"CD007388_pub3_data","7::12::Severe morbidity: stroke","No usable data for effect sizes"
"CD007388_pub3_data","7::13::Severe morbidity: pulmonary oedema","No usable data for effect sizes"
"CD007388_pub3_data","7::15::Placental abruption","No usable data for effect sizes"
"CD007388_pub3_data","8::2::Side effects","No usable data for effect sizes"
"CD007388_pub3_data","8::3::Severe morbidity: kidney failure","No usable data for effect sizes"
"CD007388_pub3_data","8::6::Side effects: vomiting","No usable data for effect sizes"
"CD007388_pub3_data","8::7::Side effects: problems at injection site","No usable data for effect sizes"
"CD007388_pub3_data","8::8::Perinatal death","No usable data for effect sizes"
"CD007388_pub3_data","8::9::Maternal intensive care unit admission","No usable data for effect sizes"
"CD007388_pub3_data","8::10::Need for additional anticonvulsant: need to extend treatment","No usable data for effect sizes"
"CD007388_pub3_data","8::11::Need for additional anticonvulsant: need to reinitiate treatment","No usable data for effect sizes"
"CD007388_pub3_data","8::13::Vaginal birth","No usable data for effect sizes"
"CD007388_pub3_data","8::14::Instrumental vaginal delivery","No usable data for effect sizes"
"CD007388_pub3_data","8::15::Postpartum haemorrhage","No usable data for effect sizes"
"CD007388_pub3_data","8::17::Composite neonatal morbidity","No usable data for effect sizes"
"CD007388_pub3_data","9::1::Eclampsia","No usable data for effect sizes"
"CD007388_pub3_data","9::2::Side effect","No usable data for effect sizes"
"CD007388_pub3_data","9::3::Treatment discontinuation","No usable data for effect sizes"
"CD007388_pub3_data","9::4::Perinatal death","No usable data for effect sizes"
"CD007388_pub3_data","9::5::Maternal death","No usable data for effect sizes"
"CD007388_pub3_data","9::6::Caesarean section","No usable data for effect sizes"
"CD007388_pub3_data","9::7::Vaginal birth","No usable data for effect sizes"
"CD007388_pub3_data","9::8::Postpartum haemorrhage","No usable data for effect sizes"
"CD007388_pub3_data","9::9::Admission to neonatal intensive care unit","No usable data for effect sizes"
"CD007388_pub3_data","9::10::Neonatal respiratory morbidity","No usable data for effect sizes"
"CD007569_pub4_data","2::1::Return to work","No usable data for effect sizes"
"CD007572_pub4_data","2::1::Failure to induce clinical remission (8 weeks)","No usable data for effect sizes"
"CD007572_pub4_data","2::2::Failure to induce clinical response (PCDAI ≥ 15 points)","No usable data for effect sizes"
"CD007572_pub4_data","2::3::Serious adverse events","No usable data for effect sizes"
"CD007572_pub4_data","2::4::Withdrawals due to adverse events","No usable data for effect sizes"
"CD007639_pub3_data","1::1::Bronchoconstriction (sidestream versus Pari LC plus)","No usable data for effect sizes"
"CD007639_pub3_data","1::2::Increased cough (Sidestream versus Pari LC plus)","No usable data for effect sizes"
"CD007639_pub3_data","1::3::Chest pain (Sidestream versus Pari LC plus)","No usable data for effect sizes"
"CD007639_pub3_data","1::4::Bronchoconstriction (CR60 versus Portaneb)","No usable data for effect sizes"
"CD007639_pub3_data","1::5::FEV1 (% predicted)","No usable data for effect sizes"
"CD007639_pub3_data","1::6::Satisfaction with device","No usable data for effect sizes"
"CD007639_pub3_data","2::4::Deposition (serum levels)","No usable data for effect sizes"
"CD007639_pub3_data","2::5::Deposition (plasma levels)","No usable data for effect sizes"
"CD007639_pub3_data","2::8::Deposition (lung)","No usable data for effect sizes"
"CD007639_pub3_data","2::9::Deposition (lung - central to peripheral ratio)","No usable data for effect sizes"
"CD007639_pub3_data","2::13::FEV1: reduction over 20%","No usable data for effect sizes"
"CD007639_pub3_data","3::2::C max","No usable data for effect sizes"
"CD007639_pub3_data","3::3::Serum AUC","No usable data for effect sizes"
"CD007639_pub3_data","3::4::Tmax","No usable data for effect sizes"
"CD007639_pub3_data","3::6::FEV1 % predicted (change from baseline)","No usable data for effect sizes"
"CD007639_pub3_data","3::7::Satisfaction","No usable data for effect sizes"
"CD007639_pub3_data","4::1::Treatment time","No usable data for effect sizes"
"CD007639_pub3_data","4::3::Deposition by gamma scintigraphy","No usable data for effect sizes"
"CD007639_pub3_data","5::1::Treatment time","No usable data for effect sizes"
"CD007639_pub3_data","5::2::Cmax","No usable data for effect sizes"
"CD007639_pub3_data","5::3::AUC 0-24","No usable data for effect sizes"
"CD007639_pub3_data","5::4::Tmax","No usable data for effect sizes"
"CD007639_pub3_data","5::5::C trough","No usable data for effect sizes"
"CD007639_pub3_data","6::1::Treatment time (seconds)","No usable data for effect sizes"
"CD007639_pub3_data","6::2::Deposition (lung uptake MBq)","No usable data for effect sizes"
"CD007639_pub3_data","6::3::Deposition (lung uptake as % of dose used)","No usable data for effect sizes"
"CD007639_pub3_data","6::5::Satisfaction with device","No usable data for effect sizes"
"CD007639_pub3_data","7::1::Treatment time","No usable data for effect sizes"
"CD007639_pub3_data","7::2::Adverse events: haemoptysis","No usable data for effect sizes"
"CD007639_pub3_data","7::3::Adverse events: chest pain","No usable data for effect sizes"
"CD007639_pub3_data","7::6::Adverse events: cough","No usable data for effect sizes"
"CD007639_pub3_data","7::8::% Change in FEV1","No usable data for effect sizes"
"CD007639_pub3_data","7::9::FVC","No usable data for effect sizes"
"CD007639_pub3_data","7::10::FEF25-75","No usable data for effect sizes"
"CD007639_pub3_data","8::1::Deposition (sputum) (µg)","No usable data for effect sizes"
"CD007639_pub3_data","9::1::Lung function (FEV1 % predicted)","No usable data for effect sizes"
"CD007639_pub3_data","9::2::Lung function (FVC % predicted)","No usable data for effect sizes"
"CD007639_pub3_data","9::3::Lung function (FEF25 - 75% predicted)","No usable data for effect sizes"
"CD007639_pub3_data","11::1::Sodium chloride: deposition","No usable data for effect sizes"
"CD007639_pub3_data","12::1::Treatment time","No usable data for effect sizes"
"CD007639_pub3_data","12::2::Intrapulmonary deposition","No usable data for effect sizes"
"CD007639_pub3_data","13::1::SCG: treatment time (min)","No usable data for effect sizes"
"CD007639_pub3_data","13::2::SCG: deposition measured by urinary levels (mg)","No usable data for effect sizes"
"CD007639_pub3_data","13::3::SCG: residual medication in nebuliser (mg)","No usable data for effect sizes"
"CD007674_pub3_data","1::8::Overall quality of life (post-treatment)","No usable data for effect sizes"
"CD007693_pub3_data","11::1::Fluorosis","No usable data for effect sizes"
"CD007784_pub3_data","1::8::Hospitilsation due to heart failure","No usable data for effect sizes"
"CD007784_pub3_data","1::10::Doubling serum creatinine","No usable data for effect sizes"
"CD007784_pub3_data","1::16::Onset of diabetes","No usable data for effect sizes"
"CD007784_pub3_data","2::3::Stroke","No usable data for effect sizes"
"CD007784_pub3_data","2::4::Hospitilisation due to heart failure","No usable data for effect sizes"
"CD007784_pub3_data","2::6::Elevated liver enzyme","No usable data for effect sizes"
"CD007784_pub3_data","2::7::eGFR [mL/min/1.73 m2]","No usable data for effect sizes"
"CD007809_pub3_data","1::1::Pain (0-10 numerical rating scale) at 12 weeks","No usable data for effect sizes"
"CD007809_pub3_data","1::2::Function (FHSQ) at 12 weeks","No usable data for effect sizes"
"CD007809_pub3_data","1::3::Quality of life (Assessment of Quality of Life instrument) at 12 weeks","No usable data for effect sizes"
"CD007809_pub3_data","1::4::Number of participants reporting an adverse event at 12 weeks","No usable data for effect sizes"
"CD007809_pub3_data","1::5::Number of participants withdrawing due to an adverse event at 12 weeks","No usable data for effect sizes"
"CD007809_pub3_data","3::11::Number of participants reporting an adverse event","No usable data for effect sizes"
"CD007809_pub3_data","4::3::Quality of life (SF-12 Physical Component Summary)","No usable data for effect sizes"
"CD007809_pub3_data","4::4::Quality of life (SF-12 Mental Component Summary)","No usable data for effect sizes"
"CD007809_pub3_data","4::5::Number of participants reporting an adverse event at 12 weeks","No usable data for effect sizes"
"CD007809_pub3_data","5::1::Pain (VAS) at 2 weeks","No usable data for effect sizes"
"CD007809_pub3_data","5::2::Pain (VAS) at 6 weeks","No usable data for effect sizes"
"CD007809_pub3_data","5::3::Function (FAOS Function in Daily Living) at 2 weeks","No usable data for effect sizes"
"CD007809_pub3_data","5::4::Function (FAOS Function in Daily Living) at 6 weeks","No usable data for effect sizes"
"CD007809_pub3_data","5::5::Quality of life (SF-36 - Physical Functioning) at 2 weeks","No usable data for effect sizes"
"CD007809_pub3_data","5::6::Quality of life (SF-36 - Physical Functioning) at 6 weeks","No usable data for effect sizes"
"CD007809_pub3_data","5::7::Quality of life (SF-36 - Role-Physical) at 2 weeks","No usable data for effect sizes"
"CD007809_pub3_data","5::8::Quality of life (SF-36 - Role-Physical) at 6 weeks","No usable data for effect sizes"
"CD007809_pub3_data","5::9::Quality of life (SF-36 - Bodily Pain) at 2 weeks","No usable data for effect sizes"
"CD007809_pub3_data","5::10::Quality of life (SF-36 - Bodily Pain) at 6 weeks","No usable data for effect sizes"
"CD007809_pub3_data","5::11::Quality of life (SF-36 - General Health) at 2 weeks","No usable data for effect sizes"
"CD007809_pub3_data","5::12::Quality of life (SF-36 - General Health) at 6 weeks","No usable data for effect sizes"
"CD007809_pub3_data","5::13::Quality of life (SF-36 - Vitality) at 2 weeks","No usable data for effect sizes"
"CD007809_pub3_data","5::14::Quality of life (SF-36 - Vitality) at 6 weeks","No usable data for effect sizes"
"CD007809_pub3_data","5::15::Quality of life (SF-36 - Social Functioning) at 2 weeks","No usable data for effect sizes"
"CD007809_pub3_data","5::16::Quality of life (SF-36 - Social Functioning) at 6 weeks","No usable data for effect sizes"
"CD007809_pub3_data","5::17::Quality of life (SF-36 - Role-Emotional) at 2 weeks","No usable data for effect sizes"
"CD007809_pub3_data","5::18::Quality of life (SF-36 - Role-Emotional) at 6 weeks","No usable data for effect sizes"
"CD007809_pub3_data","5::19::Quality of life (SF-36 - Mental Health) at 2 weeks","No usable data for effect sizes"
"CD007809_pub3_data","5::20::Quality of life (SF-36 - Mental Health) at 6 weeks","No usable data for effect sizes"
"CD007809_pub3_data","6::1::Pain (0-10 numerical rating scale)","No usable data for effect sizes"
"CD007809_pub3_data","6::2::Number of participants reporting an adverse event ","No usable data for effect sizes"
"CD007809_pub3_data","6::3::Number of participants withdrawing due to an adverse event","No usable data for effect sizes"
"CD007809_pub3_data","6::4::Big toe joint passive dorsiflexion range of motion ","No usable data for effect sizes"
"CD007837_pub3_data","1::2::Angle of trunk rotation (ATR) (°)","No usable data for effect sizes"
"CD007837_pub3_data","1::3::Objective surface measurements (waist asymmetry) (cm)","No usable data for effect sizes"
"CD007837_pub3_data","1::4::Subjective evaluation (Spinal Appearance Questionnaire – General) (points)","No usable data for effect sizes"
"CD007837_pub3_data","1::5::Subjective evaluation (SRS-22 Self-Image) (points)","No usable data for effect sizes"
"CD007837_pub3_data","2::2::Angle of trunk rotation (°)","No usable data for effect sizes"
"CD007837_pub3_data","2::3::Subjective evaluation (Spinal Appearance Questionnaire – General) (points)","No usable data for effect sizes"
"CD007837_pub3_data","2::4::Subjective evaluation (SRS-22 Self-Image) (points)","No usable data for effect sizes"
"CD007837_pub3_data","2::5::Quality of life (SRS-22 Total score) (points)","No usable data for effect sizes"
"CD007837_pub3_data","2::6::Back pain (SRS-22 Pain) (points)","No usable data for effect sizes"
"CD007837_pub3_data","2::7::Back pain (Visual Analogue Scale 0–10 scale)","No usable data for effect sizes"
"CD007837_pub3_data","2::8::Mental health (SRS-22 Mental Health) (points)","No usable data for effect sizes"
"CD007837_pub3_data","3::1::Cobb angle (°)","No usable data for effect sizes"
"CD007837_pub3_data","3::2::Subjective evaluation (SRS-22 Self-Image) (points)","No usable data for effect sizes"
"CD007837_pub3_data","3::3::Quality of life (SRS-22 Total score) (points)","No usable data for effect sizes"
"CD007837_pub3_data","3::4::Back pain (SRS-22 Pain) (points)","No usable data for effect sizes"
"CD007837_pub3_data","3::5::Mental health (SRS-22 Mental Health) (points)","No usable data for effect sizes"
"CD007837_pub3_data","4::3::Number progressed > 5° Cobb angle","No usable data for effect sizes"
"CD007859_pub5_data","2::2::Time to working arch wire (months)","No usable data for effect sizes"
"CD007859_pub5_data","2::4::Pain (analgesic consumption)","No usable data for effect sizes"
"CD007859_pub5_data","3::3::Time to working arch wire (months)","No usable data for effect sizes"
"CD007859_pub5_data","3::4::Time to alignment (alignment rate ratio)","No usable data for effect sizes"
"CD007859_pub5_data","4::4::Time to working arch wire (months)","No usable data for effect sizes"
"CD007859_pub5_data","4::5::Time to alignment (months)","No usable data for effect sizes"
"CD007872_pub4_data","1::6::Severe morbidity","No usable data for effect sizes"
"CD007872_pub4_data","1::11::Hysterectomy","No usable data for effect sizes"
"CD007872_pub4_data","1::13::Breastfeeding at discharge","No usable data for effect sizes"
"CD007872_pub4_data","1::21::ICU admission","No usable data for effect sizes"
"CD008145_pub4_data","1::3::Uptake of OPV3 vaccine","No usable data for effect sizes"
"CD008145_pub4_data","1::4::Uptake of HBV3 vaccine","No usable data for effect sizes"
"CD008145_pub4_data","1::5::Uptake of BCG + DTP3 + OPV vaccines","No usable data for effect sizes"
"CD008145_pub4_data","1::7::Uptake of at least 1 vaccine","No usable data for effect sizes"
"CD008145_pub4_data","2::1::Uptake of BCG vaccine","No usable data for effect sizes"
"CD008145_pub4_data","4::2::Reception of all recommended vaccines by 2 years of age ","No usable data for effect sizes"
"CD008145_pub4_data","4::3::Uptake of BCG vaccine","No usable data for effect sizes"
"CD008145_pub4_data","4::4::Uptake of OPV3 vaccine","No usable data for effect sizes"
"CD008145_pub4_data","4::5::Uptake of HBV3 vaccine","No usable data for effect sizes"
"CD008145_pub4_data","4::6::Uptake of measles vaccine","No usable data for effect sizes"
"CD008145_pub4_data","5::2::Uptake of DTP3 (SMS + monetary incentive intervention)","No usable data for effect sizes"
"CD008145_pub4_data","5::7::Uptake of yellow fever vaccine","No usable data for effect sizes"
"CD008145_pub4_data","6::2::Uptake of BCG vaccine","No usable data for effect sizes"
"CD008145_pub4_data","6::3::Uptake of measles vaccine","No usable data for effect sizes"
"CD008145_pub4_data","7::1::Uptake of all recommended vaccines by 2 years of age ","No usable data for effect sizes"
"CD008145_pub4_data","8::1::Uptake of all recommended vaccines by 2 years of age ","No usable data for effect sizes"
"CD008145_pub4_data","8::2::Uptake of OPV3 vaccine","No usable data for effect sizes"
"CD008145_pub4_data","8::3::Uptake of measles vaccine","No usable data for effect sizes"
"CD008145_pub4_data","9::1::Reception of DTP3 by 1 year of age","No usable data for effect sizes"
"CD008145_pub4_data","9::2::Uptake of all recommended vaccines by 2 years of age","No usable data for effect sizes"
"CD008145_pub4_data","9::3::Uptake of BCG vaccine","No usable data for effect sizes"
"CD008145_pub4_data","9::4::Uptake of HBV3 vaccine","No usable data for effect sizes"
"CD008145_pub4_data","9::5::Uptake of OPV3 vaccine","No usable data for effect sizes"
"CD008145_pub4_data","9::6::Uptake of measles vaccine","No usable data for effect sizes"
"CD008145_pub4_data","10::1::Reception of DTP3/Penta 3 by 1 year of age","No usable data for effect sizes"
"CD008145_pub4_data","10::2::Uptake of all recommended vaccines by 2 years of age ","No usable data for effect sizes"
"CD008145_pub4_data","10::3::Uptake of BCG vaccine","No usable data for effect sizes"
"CD008145_pub4_data","10::4::Uptake of measles vaccine","No usable data for effect sizes"
"CD008145_pub4_data","10::5::Uptake of yellow fever vaccine","No usable data for effect sizes"
"CD008145_pub4_data","11::1::Reception of DTP3/Penta 3 vaccine by 1 year of age","No usable data for effect sizes"
"CD008145_pub4_data","11::2::Uptake of measles vaccine","No usable data for effect sizes"
"CD008176_pub3_data","1::21::Graft failure","No usable data for effect sizes"
"CD008176_pub3_data","2::1::Death (any cause)","No usable data for effect sizes"
"CD008176_pub3_data","3::1::Death (any cause)","No usable data for effect sizes"
"CD008176_pub3_data","4::5::Heart failure","No usable data for effect sizes"
"CD008176_pub3_data","4::8::Kidney failure","No usable data for effect sizes"
"CD008176_pub3_data","4::15::Albuminuria at end of study","No usable data for effect sizes"
"CD008176_pub3_data","4::16::Change in albuminuria","No usable data for effect sizes"
"CD008176_pub3_data","4::18::Graft loss","No usable data for effect sizes"
"CD008176_pub3_data","4::20::Malignancy","No usable data for effect sizes"
"CD008176_pub3_data","5::20::Graft failure","No usable data for effect sizes"
"CD008176_pub3_data","7::19::Vascular access thrombosis","No usable data for effect sizes"
"CD008176_pub3_data","7::21::Graft failure","No usable data for effect sizes"
"CD008237_pub4_data","1::1::Composite score of competency","No usable data for effect sizes"
"CD008237_pub4_data","1::6::Overall global rating of performance or competency","No usable data for effect sizes"
"CD008237_pub4_data","1::7::Visualisation of mucosa","No usable data for effect sizes"
"CD008237_pub4_data","2::3::Overall global rating of performance or competency","No usable data for effect sizes"
"CD008237_pub4_data","2::4::Visualisation of mucosa","No usable data for effect sizes"
"CD008309_pub3_data","1::5::Apnoea (cessation of spontaneous breathing > 20 seconds) during the intervention","No usable data for effect sizes"
"CD008309_pub3_data","1::8::Number of doses of intratracheal surfactant received postintervention","No usable data for effect sizes"
"CD008309_pub3_data","1::9::Mechanical ventilation within first 72 hours","No usable data for effect sizes"
"CD008309_pub3_data","1::10::Mechanical ventilation within first 72 hours or not ventilated but reached failure criteria as defined by the study authors","No usable data for effect sizes"
"CD008309_pub3_data","1::14::Postnatal systemic corticosteroid therapy for BPD prevention","No usable data for effect sizes"
"CD008309_pub3_data","1::17::Intraventricular haemorrhage grade III and IV","No usable data for effect sizes"
"CD008309_pub3_data","1::18::Cystic periventricular leukomalacia","No usable data for effect sizes"
"CD008309_pub3_data","1::19::Patent ductus arteriosus requiring medical therapy","No usable data for effect sizes"
"CD008309_pub3_data","1::20::Necrotising enterocolitis, modified Bell stage 2 or greater","No usable data for effect sizes"
"CD008309_pub3_data","1::21::Spontaneous intestinal perforation","No usable data for effect sizes"
"CD008309_pub3_data","1::22::Retinopathy of prematurity (ROP), any grade","No usable data for effect sizes"
"CD008309_pub3_data","1::23::ROP, stage 3 or greater","No usable data for effect sizes"
"CD008309_pub3_data","1::25::Neonatal death (all causes) during the first 28 days","No usable data for effect sizes"
"CD008309_pub3_data","1::27::Use of home oxygen","No usable data for effect sizes"
"CD008309_pub3_data","2::5::Intraventricular haemorrhage grade III and IV","No usable data for effect sizes"
"CD008309_pub3_data","3::5::Intraventricular haemorrhage grade III and IV","No usable data for effect sizes"
"CD008309_pub3_data","4::1::Failure to place LMA or ETT at first attempt","No usable data for effect sizes"
"CD008309_pub3_data","4::6::Duration of any respiratory support (mechanical ventilation, continuous positive airway pressure, high flow) (days; in survivors)","No usable data for effect sizes"
"CD008309_pub3_data","4::8::Number of hospital readmissions with respiratory illness in the first two years","No usable data for effect sizes"
"CD008309_pub3_data","5::1::Postintervention intratracheal surfactant received","No usable data for effect sizes"
"CD008309_pub3_data","5::2::Mechanical ventilation at any time","No usable data for effect sizes"
"CD008309_pub3_data","5::3::Pulmonary air leak, any (during first hospitalisation)","No usable data for effect sizes"
"CD008309_pub3_data","5::4::Intraventricular haemorrhage grade III and IV","No usable data for effect sizes"
"CD008309_pub3_data","5::5::Death (all causes) during the first hospitalisation","No usable data for effect sizes"
"CD008309_pub3_data","6::2::Bradycardia (heart rate < 100 beats per minute) during the intervention","No usable data for effect sizes"
"CD008309_pub3_data","6::3::Apnoea (cessation of spontaneous breathing > 20 seconds) during the intervention","No usable data for effect sizes"
"CD008309_pub3_data","6::5::Number of doses of intratracheal surfactant received postintervention","No usable data for effect sizes"
"CD008309_pub3_data","6::6::Mechanical ventilation within first 72 hours","No usable data for effect sizes"
"CD008309_pub3_data","6::11::Duration of oxygen therapy (days; in survivors)","No usable data for effect sizes"
"CD008309_pub3_data","6::13::Any intraventricular haemorrhage","No usable data for effect sizes"
"CD008309_pub3_data","6::14::Intraventricular haemorrhage grade III and IV","No usable data for effect sizes"
"CD008309_pub3_data","6::15::Cystic periventricular leukomalacia","No usable data for effect sizes"
"CD008309_pub3_data","6::16::Neonatal death (all causes) during the first 28 days","No usable data for effect sizes"
"CD008309_pub3_data","6::17::Death (all causes) during the first hospitalisation","No usable data for effect sizes"
"CD008469_pub3_data","2::3::Day symptoms (change in mean symptom-free days in past 2 weeks)","No usable data for effect sizes"
"CD008493_pub5_data","1::2::Major adverse cardiac events","No usable data for effect sizes"
"CD008564_pub3_data","1::6::Participant withdrawals due to adverse events","No usable data for effect sizes"
"CD008628_pub3_data","1::5::Chronic pain; measured using VAS","No usable data for effect sizes"
"CD008628_pub3_data","2::2::Chronic pain","No usable data for effect sizes"
"CD008709_pub4_data","1::1::Objective cure or improvement of urinary incontinence: between 12 and 24 months","No usable data for effect sizes"
"CD008709_pub4_data","1::2::Dyspareunia","No usable data for effect sizes"
"CD008709_pub4_data","1::3::Number of women affected by mesh exposure, extrusion or erosion in any area","No usable data for effect sizes"
"CD008709_pub4_data","1::4::Bladder or urethral injuries: less than 30 days after surgery","No usable data for effect sizes"
"CD008709_pub4_data","1::5::Infections (e.g. UTI, mesh infection)","No usable data for effect sizes"
"CD008709_pub4_data","2::4::Objective cure or improvement of urinary incontinence: 36+ months","No usable data for effect sizes"
"CD008709_pub4_data","4::2::Subjective cure or improvement of urinary incontinence: 24 months","No usable data for effect sizes"
"CD008709_pub4_data","4::3::Subjective cure or improvement of urinary incontinence: 36+ months","No usable data for effect sizes"
"CD008709_pub4_data","4::5::Objective cure or improvement of urinary incontinence: 24 months","No usable data for effect sizes"
"CD008709_pub4_data","4::6::Objective cure or improvement of urinary incontinence: 36+ months","No usable data for effect sizes"
"CD008709_pub4_data","4::8::Patient-reported pain: 12 to 24 months","No usable data for effect sizes"
"CD008709_pub4_data","4::9::Patient-reported pain: 24+ months","No usable data for effect sizes"
"CD008709_pub4_data","4::14::Other injuries: less than 30 days after surgery","No usable data for effect sizes"
"CD008709_pub4_data","4::15::Infections","No usable data for effect sizes"
"CD008709_pub4_data","4::16::De novo urgency","No usable data for effect sizes"
"CD008709_pub4_data","4::17::Quality of life: at 12 months","No usable data for effect sizes"
"CD008771_pub3_data","1::1::Length","No usable data for effect sizes"
"CD008771_pub3_data","1::3::Neurodevelopmental outcome","No usable data for effect sizes"
"CD008771_pub3_data","1::6::Metabolic acidosis, pH at 2 days after birth","No usable data for effect sizes"
"CD008771_pub3_data","1::10::Plasma ammonia level at day 1 after birth","No usable data for effect sizes"
"CD008771_pub3_data","1::15::Direct bilirubin level at day 1 after birth","No usable data for effect sizes"
"CD008771_pub3_data","1::16::Direct bilirubin level at day 4 after birth","No usable data for effect sizes"
"CD008771_pub3_data","1::17::Blood glucose level at day 1 after birth","No usable data for effect sizes"
"CD008771_pub3_data","1::18::Blood glucose level at day 2 after birth","No usable data for effect sizes"
"CD008771_pub3_data","1::19::Hypoglycaemia","No usable data for effect sizes"
"CD008771_pub3_data","1::21::Duration of hospital stay in days","No usable data for effect sizes"
"CD008771_pub3_data","1::22::Time to full feeds in days","No usable data for effect sizes"
"CD008858_pub5_data","2::2::Incidence of herpes zoster at least 4 years follow-up","No usable data for effect sizes"
"CD008873_pub5_data","1::1::Pre-eclampsia (ALL)","No usable data for effect sizes"
"CD008873_pub5_data","1::2::Gestational diabetes (ALL)","No usable data for effect sizes"
"CD008873_pub5_data","1::8::Maternal death (death while pregnant or within 42 days of termination of pregnancy) (ALL)","No usable data for effect sizes"
"CD008873_pub5_data","1::15::Apgar score less than seven at five minutes","No usable data for effect sizes"
"CD008873_pub5_data","2::1::Low birthweight (less than 2500 g) (ALL)","No usable data for effect sizes"
"CD008873_pub5_data","2::2::Birth length (cm)","No usable data for effect sizes"
"CD008873_pub5_data","2::3::Head circumference at birth (cm)","No usable data for effect sizes"
"CD008873_pub5_data","2::4::Birthweight (g)","No usable data for effect sizes"
"CD008873_pub5_data","3::1::Gestational diabetes (ALL)","No usable data for effect sizes"
"CD008873_pub5_data","3::3::Preterm birth (less than 37 weeks' gestation) (ALL)","No usable data for effect sizes"
"CD008873_pub5_data","3::4::Low birthweight (less than 2500 g) (ALL)","No usable data for effect sizes"
"CD008873_pub5_data","3::5::Caesarean section","No usable data for effect sizes"
"CD008873_pub5_data","3::6::Gestational hypertension","No usable data for effect sizes"
"CD008873_pub5_data","3::7::Maternal death (death while pregnant or within 42 days of termination of pregnancy)","No usable data for effect sizes"
"CD008873_pub5_data","3::8::Maternal vitamin D concentration at term (25-hydroxyvitamin D) (nmol/L) (ALL)","No usable data for effect sizes"
"CD008873_pub5_data","3::9::Birth length (cm)","No usable data for effect sizes"
"CD008873_pub5_data","3::10::Head circumference at birth (cm)","No usable data for effect sizes"
"CD008873_pub5_data","3::11::Birthweight (g)","No usable data for effect sizes"
"CD008873_pub5_data","3::12::Stillbirth","No usable data for effect sizes"
"CD008873_pub5_data","3::13::Neonatal death","No usable data for effect sizes"
"CD008940_pub4_data","2::1::Participants abstinent at end of treatment","No usable data for effect sizes"
"CD008940_pub4_data","3::2::Participants experiencing adverse events","No usable data for effect sizes"
"CD008940_pub4_data","4::1::Participants abstinent at end of treatment","No usable data for effect sizes"
"CD008940_pub4_data","4::3::Participants experiencing severe adverse events","No usable data for effect sizes"
"CD008940_pub4_data","5::1::Participants abstinent at end of treatment","No usable data for effect sizes"
"CD008940_pub4_data","6::2::Participants experiencing adverse events","No usable data for effect sizes"
"CD008940_pub4_data","6::3::Participants withdrawn due to adverse effects","No usable data for effect sizes"
"CD008940_pub4_data","7::1::Participants abstinent at end of treatment","No usable data for effect sizes"
"CD008940_pub4_data","8::1::Participants abstinent at end of treatment","No usable data for effect sizes"
"CD008940_pub4_data","8::2::Participants experiencing adverse events","No usable data for effect sizes"
"CD008940_pub4_data","8::3::Participants experiencing severe adverse events","No usable data for effect sizes"
"CD008940_pub4_data","8::4::Participants withdrawn due to adverse effects","No usable data for effect sizes"
"CD008940_pub4_data","8::5::Completion of scheduled treatment","No usable data for effect sizes"
"CD008940_pub4_data","10::1::Participants abstinent at end of treatment","No usable data for effect sizes"
"CD008940_pub4_data","10::2::Participants experiencing adverse events","No usable data for effect sizes"
"CD008940_pub4_data","10::3::Participants experiencing severe adverse events","No usable data for effect sizes"
"CD008940_pub4_data","10::4::Completion of scheduled treatment","No usable data for effect sizes"
"CD008940_pub4_data","12::1::Participants experiencing severe adverse events","No usable data for effect sizes"
"CD008940_pub4_data","12::2::Participants withdrawn due to adverse effects","No usable data for effect sizes"
"CD008940_pub4_data","12::3::Completion of scheduled treatment","No usable data for effect sizes"
"CD008940_pub4_data","13::1::Participants abstinent at end of treatment","No usable data for effect sizes"
"CD008940_pub4_data","13::2::Participants experiencing adverse events","No usable data for effect sizes"
"CD008940_pub4_data","13::3::Participants experiencing severe adverse events","No usable data for effect sizes"
"CD008940_pub4_data","13::4::Participants withdrawn due to adverse effects","No usable data for effect sizes"
"CD008940_pub4_data","13::5::Completion of scheduled treatment","No usable data for effect sizes"
"CD008940_pub4_data","14::1::Participants experiencing adverse events","No usable data for effect sizes"
"CD008940_pub4_data","14::2::Participants experiencing severe adverse events","No usable data for effect sizes"
"CD008940_pub4_data","14::3::Participants withdrawn due to adverse effects","No usable data for effect sizes"
"CD008940_pub4_data","14::4::Completion of scheduled treatment","No usable data for effect sizes"
"CD008940_pub4_data","15::1::Participants abstinent at end of treatment","No usable data for effect sizes"
"CD008940_pub4_data","15::2::Participants experiencing adverse events","No usable data for effect sizes"
"CD008940_pub4_data","15::3::Participants experiencing severe adverse events","No usable data for effect sizes"
"CD008940_pub4_data","15::4::Participants withdrawn due to adverse effects","No usable data for effect sizes"
"CD008940_pub4_data","15::5::Completion of scheduled treatment","No usable data for effect sizes"
"CD008940_pub4_data","16::1::Participants abstinent at end of treatment","No usable data for effect sizes"
"CD008940_pub4_data","16::4::Participants withdrawn due to adverse effects","No usable data for effect sizes"
"CD008940_pub4_data","16::6::Cannabis use at end of treatment","No usable data for effect sizes"
"CD008940_pub4_data","17::1::Participants abstinent at end of treatment","No usable data for effect sizes"
"CD008940_pub4_data","17::2::Participants experiencing adverse events","No usable data for effect sizes"
"CD008940_pub4_data","17::3::Participants withdrawn due to adverse effects","No usable data for effect sizes"
"CD008940_pub4_data","17::4::Completion of scheduled treatment","No usable data for effect sizes"
"CD008940_pub4_data","18::1::Completion of scheduled treatment","No usable data for effect sizes"
"CD008940_pub4_data","19::1::Completion of scheduled treatment","No usable data for effect sizes"
"CD008940_pub4_data","20::1::Completion of scheduled treatment","No usable data for effect sizes"
"CD008940_pub4_data","21::1::Completion of scheduled treatment","No usable data for effect sizes"
"CD008940_pub4_data","22::1::Completion of scheduled treatment","No usable data for effect sizes"
"CD008940_pub4_data","23::1::Completion of scheduled treatment","No usable data for effect sizes"
"CD008995_pub3_data","1::1::Live birth rate","No usable data for effect sizes"
"CD008995_pub3_data","1::3::Genital tract colonization","No usable data for effect sizes"
"CD008995_pub3_data","1::4::Miscarriage","No usable data for effect sizes"
"CD009102_pub2_data","1::4::Use of adrenaline (epinephrine) in the DR","No usable data for effect sizes"
"CD009102_pub2_data","1::7::Intubation and mechanical ventilation outside the DR (during hospitalisation) ","No usable data for effect sizes"
"CD009102_pub2_data","1::10::Duration of supplemental oxygen requirement (days)","No usable data for effect sizes"
"CD009244_pub3_data","1::1::Development of anal cancer","No usable data for effect sizes"
"CD009244_pub3_data","2::1::AIN eradication","No usable data for effect sizes"
"CD009244_pub3_data","2::2::Development of anal cancer","No usable data for effect sizes"
"CD009244_pub3_data","2::3::Downgrading from AIN-III or II to AIN-I, or from HSIL to LSIL","No usable data for effect sizes"
"CD009244_pub3_data","2::4::Recurrence","No usable data for effect sizes"
"CD009244_pub3_data","3::1::AIN eradication","No usable data for effect sizes"
"CD009244_pub3_data","3::2::Development of anal cancer","No usable data for effect sizes"
"CD009244_pub3_data","3::3::Downgrading from AIN-III or II to AIN-I, or from HSIL to LSIL","No usable data for effect sizes"
"CD009244_pub3_data","3::4::Recurrence","No usable data for effect sizes"
"CD009244_pub3_data","4::1::AIN eradication","No usable data for effect sizes"
"CD009244_pub3_data","4::2::Development of anal cancer","No usable data for effect sizes"
"CD009244_pub3_data","4::3::Downgrading from AIN-III or II to AIN-I, or from HSIL to LSIL","No usable data for effect sizes"
"CD009244_pub3_data","4::4::Recurrence","No usable data for effect sizes"
"CD009244_pub3_data","5::1::AIN HSIL eradication","No usable data for effect sizes"
"CD009244_pub3_data","5::2::Development of  anal cancer","No usable data for effect sizes"
"CD009244_pub3_data","5::3::Downgrading from AIN-III or II to AIN-I, or from HSIL to LSIL","No usable data for effect sizes"
"CD009244_pub3_data","6::1::AIN HSIL eradication","No usable data for effect sizes"
"CD009244_pub3_data","6::2::AIN HSIL recurrence","No usable data for effect sizes"
"CD009244_pub3_data","7::1::AIN eradication","No usable data for effect sizes"
"CD009244_pub3_data","7::2::Downgrading from AIN-III or II to AIN-I, or from HSIL to LSIL","No usable data for effect sizes"
"CD009244_pub3_data","7::3::Recurrence","No usable data for effect sizes"
"CD009244_pub3_data","8::1::AIN eradication","No usable data for effect sizes"
"CD009244_pub3_data","8::2::Downgrading from AIN-III or II to AIN-I, or from HSIL to LSIL","No usable data for effect sizes"
"CD009244_pub3_data","8::3::Recurrence","No usable data for effect sizes"
"CD009244_pub3_data","9::1::AIN eradication","No usable data for effect sizes"
"CD009244_pub3_data","9::2::Downgrading from AIN-III or II to AIN-I, or from HSIL to LSIL","No usable data for effect sizes"
"CD009244_pub3_data","9::3::Recurrence","No usable data for effect sizes"
"CD009252_pub2_data","4::1::Number or change in number of leakage episodes in 24 hours","No usable data for effect sizes"
"CD009252_pub2_data","4::2::Subjective symptom of cure or improvement","No usable data for effect sizes"
"CD009252_pub2_data","4::3::Satisfaction with treatment outcome","No usable data for effect sizes"
"CD009252_pub2_data","6::1::Number or change in number of leakage episodes in 24 hours","No usable data for effect sizes"
"CD009252_pub2_data","6::2::Subjective symptom of cure or improvement","No usable data for effect sizes"
"CD009298_pub3_data","1::41::Non-reassuring or pathological cardiotocograph during procedure","No usable data for effect sizes"
"CD009298_pub3_data","1::42::Non-reassuring or pathological cardiotocograph at any time after allocation","No usable data for effect sizes"
"CD009298_pub3_data","1::45::Neonatal resuscitation (positive pressure ventilation, cardiac compression or drug therapy)","No usable data for effect sizes"
"CD009298_pub3_data","1::46::Mechanical ventilation (intermittent positive-pressure ventilation/continuous positive airways pressure after resuscitation)","No usable data for effect sizes"
"CD009362_pub4_data","3::1::Pressure ulcer ","No usable data for effect sizes"
"CD009362_pub4_data","6::1::Pressure ulcer","No usable data for effect sizes"
"CD009362_pub4_data","8::1::Pressure ulcer","No usable data for effect sizes"
"CD009362_pub4_data","9::1::Pressure ulcer","No usable data for effect sizes"
"CD009362_pub4_data","10::1::Pressure ulcer","No usable data for effect sizes"
"CD009362_pub4_data","11::1::Pressure ulcer","No usable data for effect sizes"
"CD009362_pub4_data","12::1::Pressure ulcer","No usable data for effect sizes"
"CD009362_pub4_data","13::1::Pressure ulcer","No usable data for effect sizes"
"CD009362_pub4_data","15::3::Time to pressure ulcer development","No usable data for effect sizes"
"CD009362_pub4_data","16::1::Pressure ulcer","No usable data for effect sizes"
"CD009362_pub4_data","18::1::Pressure ulcer","No usable data for effect sizes"
"CD009362_pub4_data","19::1::Pressure ulcer","No usable data for effect sizes"
"CD009508_pub2_data","1::3::Subjective cure/improvement","No usable data for effect sizes"
"CD009508_pub2_data","2::4::Satisfaction","No usable data for effect sizes"
"CD009531_pub3_data","1::2::Mental state: clinically important change (binary) - 12 months ","No usable data for effect sizes"
"CD009531_pub3_data","1::3::Psychiatric hospital admissions - 12 months","No usable data for effect sizes"
"CD009531_pub3_data","2::9::Medication adherence (patient-reported) (MARS)","No usable data for effect sizes"
"CD009531_pub3_data","2::10::Social functioning (binary)","No usable data for effect sizes"
"CD009531_pub3_data","2::16::Cost of treatment","No usable data for effect sizes"
"CD009531_pub3_data","2::17::Cost of treatment (international dollars)","No usable data for effect sizes"
"CD009531_pub3_data","3::1::Mental state: clinically important change (sensitivity analysis: assumptions for attrition)","No usable data for effect sizes"
"CD009679_pub3_data","1::9::Knee range of motion (degrees) at 24 months","No usable data for effect sizes"
"CD009679_pub3_data","1::12::Length of hospital stay (days)","No usable data for effect sizes"
"CD009679_pub3_data","2::2::Knee range of motion","No usable data for effect sizes"
"CD009679_pub3_data","2::3::Operative duration (minutes)","No usable data for effect sizes"
"CD009679_pub3_data","2::4::Intraoperative blood loss (mL)","No usable data for effect sizes"
"CD009679_pub3_data","2::5::Time to radiological union (weeks)","No usable data for effect sizes"
"CD009679_pub3_data","3::4::Knee range of motion (degrees)","No usable data for effect sizes"
"CD009679_pub3_data","3::7::Incision length (cm)","No usable data for effect sizes"
"CD009679_pub3_data","4::3::Pain","No usable data for effect sizes"
"CD009679_pub3_data","4::6::Incision length (cm) ","No usable data for effect sizes"
"CD009679_pub3_data","4::7::Blood loss (mL)","No usable data for effect sizes"
"CD009679_pub3_data","5::1::Generic quality of life","No usable data for effect sizes"
"CD009679_pub3_data","5::3::Lower limb function – Lysholm Knee Score","No usable data for effect sizes"
"CD009679_pub3_data","5::5::Pain","No usable data for effect sizes"
"CD009730_pub3_data","1::1::FVC % predicted (relative change)","No usable data for effect sizes"
"CD009730_pub3_data","1::2::Weight (relative change)","No usable data for effect sizes"
"CD009730_pub3_data","2::1::FEV1 % predicted (absolute change)","No usable data for effect sizes"
"CD009730_pub3_data","2::2::FVC % predicted (absolute change)","No usable data for effect sizes"
"CD009730_pub3_data","4::5::Time to next exacerbation (weeks)","No usable data for effect sizes"
"CD009730_pub3_data","4::7::Adverse effects – sensitivity reaction","No usable data for effect sizes"
"CD009730_pub3_data","5::1::FEV1 (millilitres) (absolute change)","No usable data for effect sizes"
"CD009730_pub3_data","5::3::FEV1 % (relative change)","No usable data for effect sizes"
"CD009730_pub3_data","5::5::FVC (millilitres) (absolute change)","No usable data for effect sizes"
"CD009730_pub3_data","5::6::FVC % predicted (absolute change)","No usable data for effect sizes"
"CD009730_pub3_data","5::7::FVC % predicted (relative change)","No usable data for effect sizes"
"CD009730_pub3_data","5::9::Time to readmission (months)","No usable data for effect sizes"
"CD009730_pub3_data","5::11::Weight (% change)","No usable data for effect sizes"
"CD009730_pub3_data","6::3::FEV1 (millilitres) (absolute change)","No usable data for effect sizes"
"CD009730_pub3_data","6::5::FEV1 (litres) (relative change)","No usable data for effect sizes"
"CD009730_pub3_data","6::9::FVC (millilitres) (absolute change)","No usable data for effect sizes"
"CD009730_pub3_data","7::1::FEV1 % predicted (absolute change)","No usable data for effect sizes"
"CD009730_pub3_data","7::2::FEV1 % predicted (relative % change)","No usable data for effect sizes"
"CD009730_pub3_data","7::3::Participants experiencing an exacerbation","No usable data for effect sizes"
"CD009730_pub3_data","7::4::Antibiotic resistance","No usable data for effect sizes"
"CD009730_pub3_data","8::1::FEV1 % predicted (absolute change)","No usable data for effect sizes"
"CD009730_pub3_data","8::2::Time to next exacerbation (weeks)","No usable data for effect sizes"
"CD009730_pub3_data","8::3::Antibiotic resistance","No usable data for effect sizes"
"CD009730_pub3_data","9::1::FEV1 (millilitres) (absolute change)","No usable data for effect sizes"
"CD009730_pub3_data","9::2::FVC (millilitres) (absolute change)","No usable data for effect sizes"
"CD009730_pub3_data","9::4::Adverse effects","No usable data for effect sizes"
"CD009730_pub3_data","10::1::FVC % predicted (absolute change)","No usable data for effect sizes"
"CD009730_pub3_data","10::2::Adverse effects","No usable data for effect sizes"
"CD009730_pub3_data","10::3::Adverse effects – antibiotic resistance","No usable data for effect sizes"
"CD009730_pub3_data","11::1::FEV1 % predicted (absolute change)","No usable data for effect sizes"
"CD009730_pub3_data","11::2::FVC % predicted (absolute change)","No usable data for effect sizes"
"CD009730_pub3_data","12::1::FEV1 % predicted change from baseline after 14 days","No usable data for effect sizes"
"CD009730_pub3_data","12::2::Quality of life – number of participants achieving a minimal clinically important difference in the CFQ-R respiratory domain","No usable data for effect sizes"
"CD009730_pub3_data","13::1::FVC % predicted (absolute change)","No usable data for effect sizes"
"CD009730_pub3_data","13::2::Adverse effects","No usable data for effect sizes"
"CD009730_pub3_data","14::1::FEV1 % predicted (absolute change)","No usable data for effect sizes"
"CD009730_pub3_data","14::2::FVC % predicted (absolute change)","No usable data for effect sizes"
"CD009730_pub3_data","15::1::FEV1 (litres) (absolute change)","No usable data for effect sizes"
"CD009730_pub3_data","15::2::FVC (litres) (absolute change)","No usable data for effect sizes"
"CD009730_pub3_data","16::1::Proportion experiencing exacerbation 9–30 days post-treatment","No usable data for effect sizes"
"CD009730_pub3_data","16::2::Adverse effects","No usable data for effect sizes"
"CD009730_pub3_data","17::3::FEV1 (litres) (absolute change)","No usable data for effect sizes"
"CD009730_pub3_data","17::4::FEV1 % predicted (absolute change)","No usable data for effect sizes"
"CD009730_pub3_data","17::5::FVC (litres) (absolute change)","No usable data for effect sizes"
"CD009730_pub3_data","17::6::FVC % predicted (absolute change)","No usable data for effect sizes"
"CD009730_pub3_data","18::1::FEV1 % predicted absolute change from baseline ","No usable data for effect sizes"
"CD009730_pub3_data","18::2::FEV1 % predicted relative change from baseline","No usable data for effect sizes"
"CD009730_pub3_data","18::3::Symptom score – change in CRISS score","No usable data for effect sizes"
"CD009730_pub3_data","18::4::Change in weight (kilograms) from baseline","No usable data for effect sizes"
"CD009730_pub3_data","19::1::FEV1 % predicted absolute change from baseline ","No usable data for effect sizes"
"CD009730_pub3_data","19::2::FEV1 % predicted relative change from baseline","No usable data for effect sizes"
"CD009730_pub3_data","19::3::Symptom score – change from baseline in CRISS score","No usable data for effect sizes"
"CD009730_pub3_data","19::4::Change in weight (kilograms) from baseline","No usable data for effect sizes"
"CD009752_pub3_data","1::2::All-cause mortality: long term (31 days to two years post-surgery)","No usable data for effect sizes"
"CD009752_pub3_data","1::5::Severe adverse events: stroke","No usable data for effect sizes"
"CD009752_pub3_data","1::6::Severe adverse events: thromboembolism","No usable data for effect sizes"
"CD009752_pub3_data","1::13::Number of participants receiving any platelet transfusion","No usable data for effect sizes"
"CD009752_pub3_data","1::15::Postoperative chest drain output mL per participant","No usable data for effect sizes"
"CD009752_pub3_data","1::18::Cerebral oxygen content post surgery (rSO2)","No usable data for effect sizes"
"CD009752_pub3_data","1::19::'Peak' lactate levels (mmol/L)","No usable data for effect sizes"
"CD009752_pub3_data","2::2::All-cause mortality: long term (31 days to 2 years post-surgery)","No usable data for effect sizes"
"CD009752_pub3_data","2::3::Severe adverse events: cardiac events","No usable data for effect sizes"
"CD009752_pub3_data","2::4::Severe adverse event: thromboembolism","No usable data for effect sizes"
"CD009752_pub3_data","2::5::Severe adverse events: infection","No usable data for effect sizes"
"CD009752_pub3_data","2::6::Severe adverse events: haemorrhage (return to theatre for bleeding)","No usable data for effect sizes"
"CD009752_pub3_data","2::7::Haematocrit (%) levels postoperatively","No usable data for effect sizes"
"CD009752_pub3_data","2::8::Duration of intensive care unit stay (days)","No usable data for effect sizes"
"CD009752_pub3_data","2::9::Postoperative chest drain output (number of days of mediastinal drainage)","No usable data for effect sizes"
"CD009752_pub3_data","2::11::Lactate levels prior to cardiopulmonary bypass in prime","No usable data for effect sizes"
"CD009752_pub3_data","2::12::Lactate levels (mmol/L) in CPB circuit prime after line connection and 5 min recirculation","No usable data for effect sizes"
"CD009752_pub3_data","2::13::Lactate levels (mmol/L) at up to 15 minutes after the start of cardiopulmonary bypass","No usable data for effect sizes"
"CD009752_pub3_data","2::14::Lactate levels at 28 degrees during rewarming","No usable data for effect sizes"
"CD009752_pub3_data","2::15::Lactate levels (mmol/L) immediately after cardiopulmonary bypass and clamp of arterial cannula","No usable data for effect sizes"
"CD009752_pub3_data","2::16::Sodium (Na+) levels (mmol/L) prior to cardiopulmonary bypass in prime","No usable data for effect sizes"
"CD009752_pub3_data","2::17::Sodium (Na+) levels (mmol/L) at 36 degrees after rewarming","No usable data for effect sizes"
"CD009752_pub3_data","2::18::Sodium (Na+) levels (mmol/L) immediately after cardiopulmonary bypass and clamp of arterial cannula","No usable data for effect sizes"
"CD009752_pub3_data","2::20::Potassium (K+) levels (mmol/L) at 28 degrees during rewarming","No usable data for effect sizes"
"CD009752_pub3_data","2::21::Potassium (K+) levels (mmol/L) immediately after cardiopulmonary bypass and clamp of arterial cannula","No usable data for effect sizes"
"CD009752_pub3_data","2::23::Blood glucose levels (mg/dL) at up to 15 minutes after the start of cardiopulmonary bypass","No usable data for effect sizes"
"CD009752_pub3_data","3::1::Oxygen content post surgery CaO2 (ml dl-1)","No usable data for effect sizes"
"CD009752_pub3_data","3::2::Haematocrit (%) levels postoperatively","No usable data for effect sizes"
"CD009752_pub3_data","4::1::All-cause mortality: short term (0 to 30 days post-surgery)","No usable data for effect sizes"
"CD009752_pub3_data","4::2::Duration of mechanical ventilation (hours)","No usable data for effect sizes"
"CD009752_pub3_data","4::3::Duration of ICU stay (days)","No usable data for effect sizes"
"CD009752_pub3_data","5::1::Haematocrit (%) levels postoperatively","No usable data for effect sizes"
"CD009752_pub3_data","5::2::Duration of mechanical ventilation (hours)","No usable data for effect sizes"
"CD009752_pub3_data","5::3::Duration of intensive care unit stay","No usable data for effect sizes"
"CD009752_pub3_data","5::4::Lactate levels (mmol/L at up to 15 minutes after the start of cardiopulmonary bypass","No usable data for effect sizes"
"CD009752_pub3_data","5::5::Lactate levels (mmol/L) immediately after cardiopulmonary bypass and clamp of arterial cannula","No usable data for effect sizes"
"CD009752_pub3_data","6::1::All-cause mortality: short term (0 to 30 days post-surgery)","No usable data for effect sizes"
"CD009752_pub3_data","6::2::Severe adverse events: acute lung injury","No usable data for effect sizes"
"CD009752_pub3_data","6::3::Severe adverse events: renal failure (creatinine increasing at least twofold within 72 hours of surgery) ","No usable data for effect sizes"
"CD009752_pub3_data","7::1::Duration of mechanical ventilation (hours)","No usable data for effect sizes"
"CD009752_pub3_data","7::2::Duration of intensive care unit stay (days)","No usable data for effect sizes"
"CD009788_pub3_data","1::3::Satisfaction with care: clinically important change in satisfaction","No usable data for effect sizes"
"CD009788_pub3_data","1::4::Global state (secondary outcomes)","No usable data for effect sizes"
"CD009788_pub3_data","1::5::Service use: number of hospitalizations","No usable data for effect sizes"
"CD009788_pub3_data","1::6::Service use: time in hospital (days)","No usable data for effect sizes"
"CD009945_pub3_data","1::3::Any adverse effects","No usable data for effect sizes"
"CD010001_pub4_data","2::1::Live birth or ongoing pregnancy","No usable data for effect sizes"
"CD010001_pub4_data","2::6::Other adverse effects","No usable data for effect sizes"
"CD010136_pub4_data","1::1::Swelling at 7 days","No usable data for effect sizes"
"CD010136_pub4_data","1::2::Number of participants who required ibuprofen","No usable data for effect sizes"
"CD010136_pub4_data","2::4::Pain at 7 days","No usable data for effect sizes"
"CD010136_pub4_data","2::8::Swelling at 7 days","No usable data for effect sizes"
"CD010136_pub4_data","2::9::Percussion pain at 24 hours","No usable data for effect sizes"
"CD010136_pub4_data","2::10::Percussion pain at 48 hours","No usable data for effect sizes"
"CD010136_pub4_data","2::11::Percussion pain at 72 hours","No usable data for effect sizes"
"CD010136_pub4_data","2::12::Percussion pain at 7 days","No usable data for effect sizes"
"CD010136_pub4_data","2::13::Incidence of endodontic flare-up","No usable data for effect sizes"
"CD010136_pub4_data","2::14::Total number of ibuprofen tablets","No usable data for effect sizes"
"CD010136_pub4_data","2::15::Total number of paracetamol (acetaminophen) with codeine tablets","No usable data for effect sizes"
"CD010145_pub2_data","1::1::Quality of life via FACT (short term)","No usable data for effect sizes"
"CD010145_pub2_data","1::2::Change in quality of life after treatment via QLQ-C30 (short term)","No usable data for effect sizes"
"CD010145_pub2_data","1::3::Change in quality of life after treatment via QLI (short term)","No usable data for effect sizes"
"CD010145_pub2_data","1::4::Quality of life via FACT (intermediate term)","No usable data for effect sizes"
"CD010145_pub2_data","1::5::Change in sleep after treatment via PSQI (short term)","No usable data for effect sizes"
"CD010145_pub2_data","1::6::Adverse event (headache)","No usable data for effect sizes"
"CD010145_pub2_data","1::8::Adverse event (nausea)","No usable data for effect sizes"
"CD010145_pub2_data","1::12::Two-year disease-free survival (DFS) rate","No usable data for effect sizes"
"CD010145_pub2_data","1::13::Five-year disease-free survival (DFS) rate","No usable data for effect sizes"
"CD010145_pub2_data","1::14::Tumour complete response rate (CR) (short term)","No usable data for effect sizes"
"CD010145_pub2_data","1::15::Tumour partial response rate (PR) (short term)","No usable data for effect sizes"
"CD010145_pub2_data","1::16::Tumour stable disease rate (SD) (short term)","No usable data for effect sizes"
"CD010145_pub2_data","1::17::Tumour progressive disease rate (PD) (short term)","No usable data for effect sizes"
"CD010145_pub2_data","1::18::Positive tumour response rate (CR + PR) (intermediate term)","No usable data for effect sizes"
"CD010145_pub2_data","1::19::Negative tumour response rate (SD + PD) (intermediate term)","No usable data for effect sizes"
"CD010145_pub2_data","2::1::Improvement in quality of life via Karnofsky's score","No usable data for effect sizes"
"CD010145_pub2_data","2::7::Five-year survival rate","No usable data for effect sizes"
"CD010145_pub2_data","2::9::One-year disease-free survival (DFS) rate","No usable data for effect sizes"
"CD010145_pub2_data","2::10::Tumour complete response rate (CR) defined by RECIST (intermediate term)","No usable data for effect sizes"
"CD010145_pub2_data","2::11::Tumour partial response rate (PR) defined by RECIST (intermediate term)","No usable data for effect sizes"
"CD010145_pub2_data","2::12::Tumour stable disease rate (SD) defined by RECIST (intermediate term)","No usable data for effect sizes"
"CD010145_pub2_data","2::13::Tumour progressive disease rate (PD) defined by RECIST (intermediate term)","No usable data for effect sizes"
"CD010145_pub2_data","2::14::Tumour complete response rate (CR) defined by RECIST (long term)","No usable data for effect sizes"
"CD010145_pub2_data","2::15::Tumour partial response rate (PR) defined by RECIST (long term)","No usable data for effect sizes"
"CD010145_pub2_data","2::16::Tumour stable disease rate (SD) defined by RECIST (long term)","No usable data for effect sizes"
"CD010145_pub2_data","2::17::Tumour progressive disease rate (PD) defined by RECIST (long term)","No usable data for effect sizes"
"CD010145_pub2_data","3::2::Incidence of anaemia at least grade 3","No usable data for effect sizes"
"CD010145_pub2_data","3::3::Incidence of neutropenia at least grade 3","No usable data for effect sizes"
"CD010145_pub2_data","3::4::Incidence of nausea at least grade 3","No usable data for effect sizes"
"CD010145_pub2_data","3::5::Incidence of vomiting at least grade 3","No usable data for effect sizes"
"CD010145_pub2_data","3::6::Incidence of anorexia at least grade 3","No usable data for effect sizes"
"CD010145_pub2_data","3::7::Incidence of renal failure at least grade 3","No usable data for effect sizes"
"CD010145_pub2_data","3::8::Incidence of oral mucositis at least grade 3","No usable data for effect sizes"
"CD010145_pub2_data","3::9::Incidence of cheilitis at least grade 3","No usable data for effect sizes"
"CD010145_pub2_data","3::10::Incidence of radiation skin injury at least grade 3","No usable data for effect sizes"
"CD010145_pub2_data","3::12::Incidence of allergies at least grade 3","No usable data for effect sizes"
"CD010145_pub2_data","3::13::Incidence of pneumonia at least grade 3","No usable data for effect sizes"
"CD010145_pub2_data","3::14::Incidence of asthenia at least grade 3","No usable data for effect sizes"
"CD010163_pub3_data","1::1::Tumour response","No usable data for effect sizes"
"CD010163_pub3_data","2::1::All-cause mortality at 2-year follow-up","No usable data for effect sizes"
"CD010163_pub3_data","2::2::Any adverse events or complications","No usable data for effect sizes"
"CD010216_pub9_data","1::8::3-HPMA (pmol/mg creatinine)","No usable data for effect sizes"
"CD010216_pub9_data","1::9::NNAL (pmol/mg creatinine))","No usable data for effect sizes"
"CD010216_pub9_data","1::10::2-HPMA (pmol/mg creatinine)","No usable data for effect sizes"
"CD010216_pub9_data","1::11::HMPMA (pmol/mg creatinine)","No usable data for effect sizes"
"CD010216_pub9_data","1::12::PheT (pmol/mg creatinine)","No usable data for effect sizes"
"CD010216_pub9_data","1::13::CEMA (pmol/mg creatinine)","No usable data for effect sizes"
"CD010216_pub9_data","1::14::AAMA (pmol/mg creatinine)","No usable data for effect sizes"
"CD010216_pub9_data","1::17::PEF (L/min)","No usable data for effect sizes"
"CD010216_pub9_data","2::1::Smoking cessation","No usable data for effect sizes"
"CD010216_pub9_data","2::2::Serious adverse events","No usable data for effect sizes"
"CD010216_pub9_data","3::1::Adverse events at 12 weeks","No usable data for effect sizes"
"CD010216_pub9_data","3::2::SAEs at 12 weeks","No usable data for effect sizes"
"CD010216_pub9_data","3::3::Carbon monoxide (ppm) absolute values at 12 weeks","No usable data for effect sizes"
"CD010216_pub9_data","3::4::VO2 Max at 12 weeks","No usable data for effect sizes"
"CD010216_pub9_data","4::5::Heart rate","No usable data for effect sizes"
"CD010216_pub9_data","4::6::Systolic blood pressure","No usable data for effect sizes"
"CD010216_pub9_data","4::7::FeNO (ppb)","No usable data for effect sizes"
"CD010216_pub9_data","4::8::FEV1 (l)","No usable data for effect sizes"
"CD010216_pub9_data","4::9::FEV1/FVC","No usable data for effect sizes"
"CD010216_pub9_data","5::5::Heart rate (bpm)","No usable data for effect sizes"
"CD010216_pub9_data","5::7::Blood oxygen saturation","No usable data for effect sizes"
"CD010216_pub9_data","5::10::2-HPMA (pmol/mg creatinine)","No usable data for effect sizes"
"CD010216_pub9_data","5::11::HMPMA (pmol/mg creatinine)","No usable data for effect sizes"
"CD010216_pub9_data","5::12::PheT (pmol/mg creatinine)","No usable data for effect sizes"
"CD010216_pub9_data","5::13::CEMA (pmol/mg creatinine)","No usable data for effect sizes"
"CD010216_pub9_data","5::14::AAMA (pmol/mg creatinine)","No usable data for effect sizes"
"CD010216_pub9_data","5::15::S-PMA (nanograms)","No usable data for effect sizes"
"CD010216_pub9_data","5::18::PEF 25-75 (litres/minute)","No usable data for effect sizes"
"CD010216_pub9_data","5::19::FEV1/FVC","No usable data for effect sizes"
"CD010216_pub9_data","6::1::Smoking cessation","No usable data for effect sizes"
"CD010216_pub9_data","6::2::Adverse events at 1 week","No usable data for effect sizes"
"CD010216_pub9_data","6::5::Heart rate","No usable data for effect sizes"
"CD010216_pub9_data","6::6::Systolic blood pressure","No usable data for effect sizes"
"CD010216_pub9_data","6::7::FeNO (ppb)","No usable data for effect sizes"
"CD010216_pub9_data","6::8::FEV1 (l)","No usable data for effect sizes"
"CD010216_pub9_data","6::9::FVC (l)","No usable data for effect sizes"
"CD010216_pub9_data","6::10::FEV1/FVC","No usable data for effect sizes"
"CD010216_pub9_data","6::11::NNAL (pg/mg creatinine) at 24 weeks","No usable data for effect sizes"
"CD010216_pub9_data","6::12::Product use at 6+ months","No usable data for effect sizes"
"CD010216_pub9_data","7::1::Smoking cessation","No usable data for effect sizes"
"CD010216_pub9_data","7::2::Product use at 6+ months","No usable data for effect sizes"
"CD010216_pub9_data","8::1::Serious adverse events","No usable data for effect sizes"
"CD010216_pub9_data","8::2::NNAL (ng/g)","No usable data for effect sizes"
"CD010216_pub9_data","8::3::FEV1 (% predicted)","No usable data for effect sizes"
"CD010216_pub9_data","8::4::FEV1/FVC","No usable data for effect sizes"
"CD010216_pub9_data","9::1::Exhaled CO","No usable data for effect sizes"
"CD010216_pub9_data","10::1::Smoking cessation","No usable data for effect sizes"
"CD010216_pub9_data","10::2::Product use at 6+ months","No usable data for effect sizes"
"CD010216_pub9_data","11::2::Adverse events at 12 weeks","No usable data for effect sizes"
"CD010216_pub9_data","12::1::Smoking cessation","No usable data for effect sizes"
"CD010216_pub9_data","12::2::Adverse events","No usable data for effect sizes"
"CD010216_pub9_data","12::3::Serious adverse events","No usable data for effect sizes"
"CD010216_pub9_data","13::2::Adverse events","No usable data for effect sizes"
"CD010216_pub9_data","13::3::Serious adverse events","No usable data for effect sizes"
"CD010216_pub9_data","13::4::Change in carbon monoxide (ppm) at 6 months","No usable data for effect sizes"
"CD010216_pub9_data","14::2::Adverse events at 3 months","No usable data for effect sizes"
"CD010216_pub9_data","14::3::Serious adverse events at 3 months","No usable data for effect sizes"
"CD010216_pub9_data","14::4::Product use at 6+ months","No usable data for effect sizes"
"CD010216_pub9_data","15::5::FeNO (ppb)","No usable data for effect sizes"
"CD010216_pub9_data","15::6::FEV1 (%)","No usable data for effect sizes"
"CD010216_pub9_data","15::7::FVC (%)","No usable data for effect sizes"
"CD010216_pub9_data","15::8::Study product use at 6+ months","No usable data for effect sizes"
"CD010216_pub9_data","17::1::Adverse events at 12 weeks","No usable data for effect sizes"
"CD010216_pub9_data","17::2::Serious adverse events at 12 weeks","No usable data for effect sizes"
"CD010290_pub4_data","1::8::Ectopic pregnancy ","No usable data for effect sizes"
"CD010290_pub4_data","3::1::Ongoing pregnancy rate per woman","No usable data for effect sizes"
"CD010290_pub4_data","3::2::Clinical pregnancy rate per woman","No usable data for effect sizes"
"CD010290_pub4_data","3::3::Miscarriage rate per woman","No usable data for effect sizes"
"CD010290_pub4_data","3::4::Incidence of OHSS per woman","No usable data for effect sizes"
"CD010290_pub4_data","4::1::Live birth rate per woman","No usable data for effect sizes"
"CD010290_pub4_data","4::2::Multiple pregnancy per woman","No usable data for effect sizes"
"CD010290_pub4_data","4::3::Clinical pregnancy rate per woman","No usable data for effect sizes"
"CD010290_pub4_data","4::4::Multiple pregnancy (per clinical pregnancy)","No usable data for effect sizes"
"CD010290_pub4_data","4::5::Miscarriage rate per woman","No usable data for effect sizes"
"CD010290_pub4_data","4::6::Ectopic pregnancy per woman","No usable data for effect sizes"
"CD010290_pub4_data","4::7::Stillbirth","No usable data for effect sizes"
"CD010290_pub4_data","4::8::Incidence of OHSS per woman","No usable data for effect sizes"
"CD010290_pub4_data","4::9::Birthweight per live birth","No usable data for effect sizes"
"CD010290_pub4_data","4::10::Sensitivity analysis: live birth rate per woman - odds ratio","No usable data for effect sizes"
"CD010290_pub4_data","4::11::Sensitivity analysis: live birth rate per woman - random effects model","No usable data for effect sizes"
"CD010290_pub4_data","4::12::Sensitivity analysis: multiple pregnancy per woman - odds ratio","No usable data for effect sizes"
"CD010290_pub4_data","4::13::Sensitivity analysis: multiple pregnancy per woman - random effects model","No usable data for effect sizes"
"CD010333_pub4_data","1::1::Cerebral palsy","No usable data for effect sizes"
"CD010333_pub4_data","1::2::Mental Developmental Index (Bayley II) at 18 to 22 months' corrected age","No usable data for effect sizes"
"CD010333_pub4_data","1::3::Normal auditory functioning at discharge (measured using automated auditory brainstem response)","No usable data for effect sizes"
"CD010333_pub4_data","1::4::All-cause mortality during hospital stay","No usable data for effect sizes"
"CD010333_pub4_data","1::5::Weight (kg) at 18 to 22 months' corrected age","No usable data for effect sizes"
"CD010333_pub4_data","1::6::Height (cm) at 18 to 22 months' corrected age","No usable data for effect sizes"
"CD010333_pub4_data","1::7::Days of assisted ventilation","No usable data for effect sizes"
"CD010333_pub4_data","1::8::Days of initial hospitalisation","No usable data for effect sizes"
"CD010441_pub3_data","1::7::Incidence of neonatal Apgar scores less than 7 at five minutes","No usable data for effect sizes"
"CD010441_pub3_data","2::5::Incidence of perineal oedema 1 hour after vaginal delivery","No usable data for effect sizes"
"CD010441_pub3_data","2::6::Incidence of perineal oedema 24 hours after vaginal delivery","No usable data for effect sizes"
"CD010441_pub3_data","2::7::Incidence of neonatal Apgar scores less than 7 at five minutes","No usable data for effect sizes"
"CD010533_pub3_data","1::3::Treatment-related mortality","No usable data for effect sizes"
"CD010533_pub3_data","2::1::Overall survival (OS)","No usable data for effect sizes"
"CD010533_pub3_data","3::4::Serious adverse events","No usable data for effect sizes"
"CD010533_pub3_data","6::1::Overall survival","No usable data for effect sizes"
"CD010533_pub3_data","6::2::Progression-free survival","No usable data for effect sizes"
"CD010533_pub3_data","6::3::Incidence of second primary malignancy","No usable data for effect sizes"
"CD010533_pub3_data","7::3::Treatment-related mortality","No usable data for effect sizes"
"CD010533_pub3_data","7::4::Serious adverse events","No usable data for effect sizes"
"CD010533_pub3_data","7::6::Any grade adverse event","No usable data for effect sizes"
"CD010533_pub3_data","9::1::Progression-free survival","No usable data for effect sizes"
"CD010533_pub3_data","12::1::progression-free survival","No usable data for effect sizes"
"CD010583_pub6_data","1::2::Mortality (90 days)","No usable data for effect sizes"
"CD010583_pub6_data","2::2::Intra-abdominal infection","No usable data for effect sizes"
"CD010583_pub6_data","3::7::Additional radiological interventions for postoperative complications","No usable data for effect sizes"
"CD010779_pub2_data","1::3::Stiffness (newton-metres)","No usable data for effect sizes"
"CD010856_pub3_data","1::3::Change in the number of decayed, missing or filled permanent surfaces (DMFS) ","No usable data for effect sizes"
"CD010861_pub3_data","1::2::Fatigue 0-7 days","No usable data for effect sizes"
"CD010861_pub3_data","1::5::Psychological wellbeing","No usable data for effect sizes"
"CD010861_pub3_data","2::1::Maternal mortality ","No usable data for effect sizes"
"CD010861_pub3_data","2::3::Fatigue 8-28 days","No usable data for effect sizes"
"CD010861_pub3_data","2::5::Breastfeeding at hospital discharge","No usable data for effect sizes"
"CD010861_pub3_data","2::6::Breastfeeding > 6 weeks postpartum","No usable data for effect sizes"
"CD010861_pub3_data","2::7::Flushing/Fishbane reaction","No usable data for effect sizes"
"CD010861_pub3_data","2::9::Hb (g/dL) 8-28 days","No usable data for effect sizes"
"CD010861_pub3_data","3::1::Persistent anaemia symptoms","No usable data for effect sizes"
"CD010861_pub3_data","3::2::Compliance to treatment","No usable data for effect sizes"
"CD010861_pub3_data","3::3::Length of hospital stay","No usable data for effect sizes"
"CD010861_pub3_data","3::5::Constipation","No usable data for effect sizes"
"CD010861_pub3_data","3::7::Hb (g/dL) 0-7 days","No usable data for effect sizes"
"CD010861_pub3_data","3::8::Hb (g/dL) 8-28 days","No usable data for effect sizes"
"CD010861_pub3_data","4::1::Fatigue 0-7 days","No usable data for effect sizes"
"CD010861_pub3_data","4::2::Fatigue > 28 days","No usable data for effect sizes"
"CD010861_pub3_data","4::3::Psychological wellbeing","No usable data for effect sizes"
"CD010861_pub3_data","4::4::Infection","No usable data for effect sizes"
"CD010861_pub3_data","4::5::Compliance to treatment","No usable data for effect sizes"
"CD010861_pub3_data","4::6::Breastfeeding > 6 weeks postpartum","No usable data for effect sizes"
"CD010861_pub3_data","4::7::Serious adverse events","No usable data for effect sizes"
"CD010861_pub3_data","4::8::Hb (g/dL) 0-7 days","No usable data for effect sizes"
"CD010861_pub3_data","4::9::Hb (g/dL) > 28 days","No usable data for effect sizes"
"CD010861_pub3_data","5::1::Hb (g/dL) 0-7 days","No usable data for effect sizes"
"CD010861_pub3_data","6::2::Compliance to treatment","No usable data for effect sizes"
"CD010861_pub3_data","6::6::Flushing/Fishbane reaction","No usable data for effect sizes"
"CD010861_pub3_data","6::10::Hb (g/dL) > 28 days","No usable data for effect sizes"
"CD010966_pub4_data","1::1::FEV1 % predicted (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","1::6::Sweat chloride concentration (change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","2::1::CFQR respiratory domain: absolute change from baseline","No usable data for effect sizes"
"CD010966_pub4_data","2::2::CFQR eating domain: absolute change from baseline","No usable data for effect sizes"
"CD010966_pub4_data","2::4::Sweat chloride","No usable data for effect sizes"
"CD010966_pub4_data","4::1::Mean change in CFQ-R respiratory domain","No usable data for effect sizes"
"CD010966_pub4_data","4::2::FEV1 % predicted absolute change (% points)","No usable data for effect sizes"
"CD010966_pub4_data","4::4::Sweat chloride change from baseline (mmol/L)","No usable data for effect sizes"
"CD010966_pub4_data","5::1::Mean change in CFQ-R respiratory domain","No usable data for effect sizes"
"CD010966_pub4_data","5::2::FEV1 % predicted absolute change (% points)","No usable data for effect sizes"
"CD010966_pub4_data","5::4::Sweat chloride change from baseline (mmol/L)","No usable data for effect sizes"
"CD010966_pub4_data","6::1::Mean change in CFQ-R respiratory domain","No usable data for effect sizes"
"CD010966_pub4_data","6::2::FEV1 % predicted absolute change (% points)","No usable data for effect sizes"
"CD010966_pub4_data","6::4::Sweat chloride change from baseline (mmol/L)","No usable data for effect sizes"
"CD010966_pub4_data","8::2::Participants requiring study drug termination or a reduced dosage at up to 1 month","No usable data for effect sizes"
"CD010966_pub4_data","9::1::Absolute change from baseline in lung clearance index 2.5 (LCI2.5) ","No usable data for effect sizes"
"CD010966_pub4_data","9::3::Absolute change from baseline in sweat chloride","No usable data for effect sizes"
"CD010966_pub4_data","9::4::Absolute change from baseline in MRI global chest score","No usable data for effect sizes"
"CD010966_pub4_data","9::5::Absolute change from baseline in weight-for-age z score","No usable data for effect sizes"
"CD010966_pub4_data","9::6::Absolute change from baseline in BMI-for-age z score","No usable data for effect sizes"
"CD010966_pub4_data","9::7::Absolute change from baseline in stature-for-age z score ","No usable data for effect sizes"
"CD010966_pub4_data","11::11::BMI (relative change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","15::1::Quality of life - CFQ-R respiratory domain (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","15::2::FEV1 % predicted (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","15::3::LCI2.5 (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","15::5::Sweat chloride concentration (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","15::6::CT Brody score (mean change)","No usable data for effect sizes"
"CD010966_pub4_data","15::7::CT Brody score bronchiectasis score (mean change)","No usable data for effect sizes"
"CD010966_pub4_data","15::8::CT Brody score air trapping score (mean change)","No usable data for effect sizes"
"CD010966_pub4_data","15::9::BMI (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","15::10::BMI-for-age z score (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","16::1::FEV1 % predicted (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","16::3::Sweat chloride concentration (mmol/L) (change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","17::1::Absolute change from baseline in CFQ-R respiratory domain score","No usable data for effect sizes"
"CD010966_pub4_data","17::2::Relative change from baseline in % predicted FEV1","No usable data for effect sizes"
"CD010966_pub4_data","17::3::Absolute change from baseline in % predicted FEV1","No usable data for effect sizes"
"CD010966_pub4_data","17::5::Absolute change from baseline in sweat chloride","No usable data for effect sizes"
"CD010966_pub4_data","17::6::Absolute change from baseline in body weight (kg)","No usable data for effect sizes"
"CD010966_pub4_data","17::7::Absolute change from baseline BMI","No usable data for effect sizes"
"CD010966_pub4_data","18::2::CFQ-R physical functioning domain (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","18::3::CFQ-R treatment burden domain (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","18::4::CFQ-R health perceptions domain (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","18::5::CFQ-R vitality domain (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","18::6::CFQ-R social functioning domain (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","18::7::CFQ-R role functioning domain (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","18::8::CFQ-R eating problems domain (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","18::9::CFQ-R emotional functioning (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","18::10::CFQ-R weight domain (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","18::11::CFQ-R digestive symptoms domain(absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","18::12::CFQ-R body image domain (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","18::15::Absolute change from baseline in mucociliary clearance ","No usable data for effect sizes"
"CD010966_pub4_data","18::17::Time to first pulmonary exacerbation","No usable data for effect sizes"
"CD010966_pub4_data","18::18::Number of participants with at least 1 pulmonary exacerbation","No usable data for effect sizes"
"CD010966_pub4_data","18::19::Number of pulmonary exacerbations","No usable data for effect sizes"
"CD010966_pub4_data","18::21::Absolute change in total Brody/CF-CT score from baseline","No usable data for effect sizes"
"CD010966_pub4_data","18::22::Lung infection (pseudomonal)","No usable data for effect sizes"
"CD010966_pub4_data","18::25::Absolute change from baseline in BMI z score","No usable data for effect sizes"
"CD010966_pub4_data","19::1::Quality of life: change in CFQ-R respiratory domain","No usable data for effect sizes"
"CD010966_pub4_data","19::2::FEV1 % predicted (relative change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","19::3::FEV1 L (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","19::5::Sweat chloride (change from baseline) (mmol/L)","No usable data for effect sizes"
"CD010966_pub4_data","20::1::FEV1 % predicted (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","20::3::Sweat chloride (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","21::2::FEV1 % predicted (relative change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","21::4::FEV1 L (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","21::7::Number of pulmonary exacerbations","No usable data for effect sizes"
"CD010966_pub4_data","21::9::Body weight (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","21::10::BMI (change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","21::11::BMI z score (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","22::1::Quality of life: absolute change in CFQ-R respiratory domain","No usable data for effect sizes"
"CD010966_pub4_data","22::2::FEV1 % predicted (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","22::4::Sweat chloride (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","23::1::Quality of life: change in CFQ-R respiratory domain","No usable data for effect sizes"
"CD010966_pub4_data","23::2::FEV1 % predicted (relative change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","23::3::FEV1 L (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","23::5::Sweat chloride (absolute change from baseline) ","No usable data for effect sizes"
"CD010966_pub4_data","24::1::Quality of life: change in CFQ-R respiratory domain","No usable data for effect sizes"
"CD010966_pub4_data","24::2::FEV1 % predicted (relative change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","24::3::FEV1 L (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","24::5::Sweat chloride (change from baseline) (mmol/L)","No usable data for effect sizes"
"CD010966_pub4_data","25::1::Quality of life: change in CFQ-R respiratory domain","No usable data for effect sizes"
"CD010966_pub4_data","25::2::FEV1 % predicted (relative change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","25::3::FEV1 L (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","25::5::Sweat chloride (change from baseline) (mmol/L)","No usable data for effect sizes"
"CD010966_pub4_data","26::1::Quality of life: change in CFQ-R respiratory domain","No usable data for effect sizes"
"CD010966_pub4_data","26::2::FEV1 % predicted (relative change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","26::3::FEV1 L (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","26::5::Sweat chloride (change from baseline) (mmol/L)","No usable data for effect sizes"
"CD010966_pub4_data","27::1::Quality of life: change in CFQ-R respiratory sub-domain","No usable data for effect sizes"
"CD010966_pub4_data","27::2::FEV1 % predicted (relative change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","27::3::FEV1 L (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","27::5::Sweat chloride (change from baseline) (mmol/L)","No usable data for effect sizes"
"CD010966_pub4_data","28::2::FEV1 % predicted (relative change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","28::4::FEV1 L (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","28::7::Hospitalisation","No usable data for effect sizes"
"CD010966_pub4_data","28::8::Exacerbation (need for antibiotics)","No usable data for effect sizes"
"CD010966_pub4_data","28::10::Weight (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","28::11::BMI z score (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","29::2::FEV1 % predicted (relative change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","29::4::FEV1 L (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","29::8::Weight (change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","29::9::BMI (change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","30::1::Quality of life: change in CFQ-R respiratory domain","No usable data for effect sizes"
"CD010966_pub4_data","30::2::FEV1 % predicted (relative change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","30::3::FEV1 L (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","30::5::Sweat chloride (change from baseline) (mmol/L)","No usable data for effect sizes"
"CD010966_pub4_data","31::1::Quality of life - CFQ-R respiratory domain (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","31::2::FEV1 % predicted (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","31::4::Sweat chloride (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","32::1::CFQ-R respiratory domain score (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","32::2::FEV1 % predicted (relative change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","32::3::FEV1 % predicted (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","32::5::Sweat chloride (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","33::1::CFQ-R respiratory domain score (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","33::2::FEV1 % predicted (relative change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","33::3::FEV1% predicted (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","33::5::Sweat chloride (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","34::1::CFQ-R Respiratory domain score (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","34::2::FEV1 % predicted (relative change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","34::3::FEV1 % predicted (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","34::5::Sweat chloride (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","35::1::CFQ-R respiratory domain score (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","35::2::FEV1 % predicted (relative change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","35::3::FEV1 % predicted (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","35::5::Sweat chloride (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","36::1::CFQ-R respiratory domain score (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","36::2::FEV1 % predicted (relative change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","36::3::FEV1 % predicted (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","36::5::Sweat chloride (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","37::1::CFQ-R respiratory domain score (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","37::2::FEV1 % predicted (relative change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","37::3::FEV1 % predicted (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","37::5::Sweat chloride (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","38::1::CFQ-R respiratory domain score (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","38::2::FEV1 % predicted (relative change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","38::3::FEV1 % predicted (absolute change from baseline)","No usable data for effect sizes"
"CD010966_pub4_data","38::5::Sweat chloride (absolute change from baseline)","No usable data for effect sizes"
"CD011039_pub2_data","1::7::Participants without improvement in kidney function (first 24 months of follow-up)","No usable data for effect sizes"
"CD011039_pub2_data","1::10::Length of hospitalisation measured in days (first 12 months of follow-up)","No usable data for effect sizes"
"CD011044_pub3_data","2::10::Grade 3/4 neuropathy","No usable data for effect sizes"
"CD011044_pub3_data","5::7::Grade 3/4 fatigue","No usable data for effect sizes"
"CD011060_pub2_data","1::1::Readmission for hyperbilirubinemia","No usable data for effect sizes"
"CD011060_pub2_data","1::2::Exchange transfusion","No usable data for effect sizes"
"CD011060_pub2_data","1::3::Phototherapy before discharge","No usable data for effect sizes"
"CD011060_pub2_data","1::4::Acute bilirubin encephalopathy","No usable data for effect sizes"
"CD011120_pub3_data","1::2::Quit attempts","No usable data for effect sizes"
"CD011120_pub3_data","2::1::Tobacco use cessation","No usable data for effect sizes"
"CD011120_pub3_data","3::2::Quit attempts","No usable data for effect sizes"
"CD011120_pub3_data","4::1::Tobacco use cessation","No usable data for effect sizes"
"CD011120_pub3_data","4::2::Serious adverse events","No usable data for effect sizes"
"CD011120_pub3_data","4::3::All-cause mortality","No usable data for effect sizes"
"CD011120_pub3_data","6::1::Tobacco use cessation","No usable data for effect sizes"
"CD011120_pub3_data","7::1::Tobacco use cessation","No usable data for effect sizes"
"CD011120_pub3_data","8::1::Tobacco use cessation","No usable data for effect sizes"
"CD011120_pub3_data","9::1::Tobacco use cessation","No usable data for effect sizes"
"CD011192_pub4_data","1::1::Pre-eclampsia or pregnancy loss at any time after conception","No usable data for effect sizes"
"CD011192_pub4_data","1::2::Pre-eclampsia","No usable data for effect sizes"
"CD011192_pub4_data","1::3::Pregnancy loss at any time after conception","No usable data for effect sizes"
"CD011192_pub4_data","1::4::Maternal death","No usable data for effect sizes"
"CD011192_pub4_data","1::5::Maternal death or severe morbidity","No usable data for effect sizes"
"CD011192_pub4_data","1::7::Eclampsia","No usable data for effect sizes"
"CD011192_pub4_data","1::8::HELLP syndrome","No usable data for effect sizes"
"CD011192_pub4_data","1::9::ICU admission","No usable data for effect sizes"
"CD011192_pub4_data","1::10::Stroke","No usable data for effect sizes"
"CD011192_pub4_data","1::11::Pulmonary oedema","No usable data for effect sizes"
"CD011192_pub4_data","1::12::Acute kidney injury","No usable data for effect sizes"
"CD011192_pub4_data","1::13::Placental abruption","No usable data for effect sizes"
"CD011192_pub4_data","1::14::Hypertension","No usable data for effect sizes"
"CD011192_pub4_data","1::15::Gestational hypertension","No usable data for effect sizes"
"CD011192_pub4_data","1::16::Severe hypertension","No usable data for effect sizes"
"CD011192_pub4_data","1::17::Proteinuria","No usable data for effect sizes"
"CD011192_pub4_data","1::18::Raised liver enzymes","No usable data for effect sizes"
"CD011192_pub4_data","1::19::Low platelets","No usable data for effect sizes"
"CD011192_pub4_data","1::21::Preterm delivery before 37 weeks","No usable data for effect sizes"
"CD011192_pub4_data","1::23::Stillbirth","No usable data for effect sizes"
"CD011192_pub4_data","1::26::Early preterm birth < 34 weeks","No usable data for effect sizes"
"CD011192_pub4_data","1::27::Apgar score less than 7 at 5 minutes","No usable data for effect sizes"
"CD011204_pub3_data","3::1::ADAS-cog, ≥ 4-point improvement at 3 months (ITT)","No usable data for effect sizes"
"CD011204_pub3_data","4::1::ADAS-cog, ≥ 4-point improvement at 3 months (OC)","No usable data for effect sizes"
"CD011204_pub3_data","5::1::MMSE, change from baseline at 6 months (ITT)","No usable data for effect sizes"
"CD011204_pub3_data","5::2::MMSE, change from baseline at 24 months (ITT)","No usable data for effect sizes"
"CD011204_pub3_data","6::1::MMSE, change from baseline at 6 months (OC)","No usable data for effect sizes"
"CD011204_pub3_data","9::1::Global rating, no change or improvement, galantamine 8 mg/day","No usable data for effect sizes"
"CD011204_pub3_data","10::1::Global rating, no change or improvement, galantamine 8 mg/day","No usable data for effect sizes"
"CD011204_pub3_data","10::4::Global rating, no change or improvement, galantamine 30 mg/day","No usable data for effect sizes"
"CD011204_pub3_data","13::1::DAD, change from baseline at 3 months (ITT)","No usable data for effect sizes"
"CD011204_pub3_data","13::3::DAD, change from baseline at 12 months (ITT)","No usable data for effect sizes"
"CD011204_pub3_data","13::4::DAD, change from baseline at 24 months (ITT)","No usable data for effect sizes"
"CD011204_pub3_data","14::1::DAD, change from baseline at 3 months (OC)","No usable data for effect sizes"
"CD011204_pub3_data","15::1::NPI, change from baseline at 3 months (ITT)","No usable data for effect sizes"
"CD011204_pub3_data","16::1::NPI, change from baseline at 3 months (OC)","No usable data for effect sizes"
"CD011204_pub3_data","17::3::Proportion of all-cause discontinuations at 24 months","No usable data for effect sizes"
"CD011204_pub3_data","18::3::Proportion of discontinuations due to adverse events at 24 months","No usable data for effect sizes"
"CD011204_pub3_data","19::1::Proportion of participants experiencing nausea & vomiting","No usable data for effect sizes"
"CD011204_pub3_data","19::2::Proportion of participants experiencing dizziness","No usable data for effect sizes"
"CD011204_pub3_data","19::3::Proportion of participants experiencing diarrhoea","No usable data for effect sizes"
"CD011204_pub3_data","19::5::Proportion of participants experiencing decreased appetite","No usable data for effect sizes"
"CD011204_pub3_data","20::6::Proportion of participants experiencing somnolence","No usable data for effect sizes"
"CD011204_pub3_data","20::7::Proportion of participants experiencing abdominal pain","No usable data for effect sizes"
"CD011204_pub3_data","20::9::Proportion of participants experiencing agitation","No usable data for effect sizes"
"CD011204_pub3_data","22::1::Proportion of participants experiencing nausea","No usable data for effect sizes"
"CD011204_pub3_data","22::2::Proportion of participants experiencing dizziness","No usable data for effect sizes"
"CD011204_pub3_data","22::3::Proportion of participants experiencing headache","No usable data for effect sizes"
"CD011204_pub3_data","23::3::Proportion of participants deceased at 24 months","No usable data for effect sizes"
"CD011204_pub3_data","29::1::Proportion of participants experiencing headache","No usable data for effect sizes"
"CD011218_pub2_data","1::4::Frequency of wearing a seat belt (Ehrlich 2010)","No usable data for effect sizes"
"CD011218_pub2_data","3::1::Frequency of wearing a seat belt (Hempel 1992)","No usable data for effect sizes"
"CD011218_pub2_data","3::2::Frequency of wearing a seat belt (Bojesen 2020)","No usable data for effect sizes"
"CD011218_pub2_data","4::1::Frequency of wearing a seat belt (Sullman 2019)","No usable data for effect sizes"
"CD011305_pub3_data","1::13::Toxicity score for HSCT recipients - Bearman Toxicity Score ≥ grade 3 or equivalent (0 to 3 months)","No usable data for effect sizes"
"CD011305_pub3_data","1::18::Number of PLT transfusion episodes per participant (0 to 3 months)","No usable data for effect sizes"
"CD011305_pub3_data","1::20::Length of hospital admission (days) (0 to 3 months)","No usable data for effect sizes"
"CD011305_pub3_data","1::21::Length of intensive care admission (0 to 3 months)","No usable data for effect sizes"
"CD011305_pub3_data","1::22::Hospital readmission (0 to 3 months)","No usable data for effect sizes"
"CD011330_pub2_data","1::6::Functional symptoms","No usable data for effect sizes"
"CD011330_pub2_data","2::2::Withdrawal due to adverse effects","No usable data for effect sizes"
"CD011381_pub3_data","3::5::Comparisons for quality of life total (non-MS related: EQ-5D VAS)","No usable data for effect sizes"
"CD011381_pub3_data","3::6::Comparisons for quality of life total (non-MS related) (INDEX)","No usable data for effect sizes"
"CD011381_pub3_data","3::7::Comparisons for quality of life - physical (non-MS related: SF-36)","No usable data for effect sizes"
"CD011381_pub3_data","3::9::Comparisons for quality of life - mental (Non-MS related: SF-36)","No usable data for effect sizes"
"CD011468_pub2_data","2::4::Adverse events","No usable data for effect sizes"
"CD011468_pub2_data","3::1::Secondary patency","No usable data for effect sizes"
"CD011535_pub7_data","2::13::Ixekizumab versus secukinumab","No usable data for effect sizes"
"CD011535_pub7_data","4::3::Fumaric acid esters versus methotrexate","No usable data for effect sizes"
"CD011535_pub7_data","4::13::Ixekizumab versus secukinumab","No usable data for effect sizes"
"CD011535_pub7_data","5::2::Fumaric acid esters versus methotrexate","No usable data for effect sizes"
"CD011535_pub7_data","5::8::Etanercept versus other anti TNF alpha","No usable data for effect sizes"
"CD011535_pub7_data","6::13::Ixekizumab versus secukinumab","No usable data for effect sizes"
"CD011535_pub7_data","7::2::Small molecule 1 versus small molecule 2","No usable data for effect sizes"
"CD011535_pub7_data","8::2::Small molecule 1 versus small molecule 2","No usable data for effect sizes"
"CD011575_pub3_data","1::9::Total serious adverse events","No usable data for effect sizes"
"CD011600_pub3_data","1::8::All exacerbations (Rate)","No usable data for effect sizes"
"CD011600_pub3_data","1::11::SGRQ, end of study","No usable data for effect sizes"
"CD011600_pub3_data","1::17::TDI, ≥ 1-unit increase","No usable data for effect sizes"
"CD011600_pub3_data","1::20::Trough FEV1, end of study (mL)","No usable data for effect sizes"
"CD011600_pub3_data","1::21::FEV1 AUC 0 to 4 (mL), end of study","No usable data for effect sizes"
"CD011600_pub3_data","1::22::Change in trough FVC (mL)","No usable data for effect sizes"
"CD011600_pub3_data","1::27::Death, COPD-related","No usable data for effect sizes"
"CD011600_pub3_data","2::7::Severe exacerbations (Time-to-first)","No usable data for effect sizes"
"CD011600_pub3_data","2::8::All exacerbations (Rate)","No usable data for effect sizes"
"CD011600_pub3_data","2::11::SGRQ, end of study","No usable data for effect sizes"
"CD011600_pub3_data","2::16::Change in E-RS","No usable data for effect sizes"
"CD011600_pub3_data","2::17::TDI, ≥ 1-unit increase","No usable data for effect sizes"
"CD011600_pub3_data","2::20::Trough FEV1, end of study (mL)","No usable data for effect sizes"
"CD011600_pub3_data","2::21::FEV1 AUC 0 to 4 (mL), end of study","No usable data for effect sizes"
"CD011600_pub3_data","2::22::Change in trough FVC (mL)","No usable data for effect sizes"
"CD011600_pub3_data","2::27::Death, COPD-related","No usable data for effect sizes"
"CD011624_pub3_data","1::6::Gestational weight gain","No usable data for effect sizes"
"CD011624_pub3_data","1::7::Induction of labour","No usable data for effect sizes"
"CD011624_pub3_data","1::8::Maternal hypoglycaemia","No usable data for effect sizes"
"CD011624_pub3_data","1::9::Mean daily fasting blood glucose mmol/L","No usable data for effect sizes"
"CD011624_pub3_data","1::10::Mean daily postprandial blood glucose","No usable data for effect sizes"
"CD011624_pub3_data","1::11::Glycated haemoglobin","No usable data for effect sizes"
"CD011624_pub3_data","1::13::Triglycerides mg/dL","No usable data for effect sizes"
"CD011624_pub3_data","1::14::NEFA mmol/L","No usable data for effect sizes"
"CD011624_pub3_data","1::15::Total cholesterol mg/dL","No usable data for effect sizes"
"CD011624_pub3_data","1::16::LDL mg/dL","No usable data for effect sizes"
"CD011624_pub3_data","1::17::HDL mg/dL","No usable data for effect sizes"
"CD011624_pub3_data","1::18::Breastfeeding","No usable data for effect sizes"
"CD011624_pub3_data","1::19::Adherence with treatment","No usable data for effect sizes"
"CD011624_pub3_data","1::20::Composite of serious maternal health outcomes","No usable data for effect sizes"
"CD011624_pub3_data","1::25::Shoulder dystocia","No usable data for effect sizes"
"CD011624_pub3_data","1::28::Birthweight z score","No usable data for effect sizes"
"CD011624_pub3_data","1::29::Head circumference","No usable data for effect sizes"
"CD011624_pub3_data","1::30::Head circumference z score","No usable data for effect sizes"
"CD011624_pub3_data","1::31::Length","No usable data for effect sizes"
"CD011624_pub3_data","1::32::Length z score","No usable data for effect sizes"
"CD011624_pub3_data","1::35::Adiposity (% fat mass)","No usable data for effect sizes"
"CD011624_pub3_data","1::36::C-peptide ng/mL","No usable data for effect sizes"
"CD011624_pub3_data","1::37::Cord leptin/adiponectin ratio","No usable data for effect sizes"
"CD011624_pub3_data","1::38::ANGPTL4 in cord serum ng/mL","No usable data for effect sizes"
"CD011624_pub3_data","1::39::Cord adiponectin ng/mL","No usable data for effect sizes"
"CD011624_pub3_data","1::40::Cord leptin ng/mL","No usable data for effect sizes"
"CD011624_pub3_data","1::42::Length of antenatal stay","No usable data for effect sizes"
"CD011624_pub3_data","1::43::Length of postnatal stay (maternal)","No usable data for effect sizes"
"CD011624_pub3_data","1::44::Length of postnatal stay (infant)","No usable data for effect sizes"
"CD011627_pub3_data","3::3::Number of participants with intervention-related itch","No usable data for effect sizes"
"CD011627_pub3_data","3::4::Number of participants satisfied with skin care products or procedures for prevention of IAD ","No usable data for effect sizes"
"CD011670_pub3_data","1::6::Unplanned bowel resection","No usable data for effect sizes"
"CD011670_pub3_data","1::9::Time away from normal activities (days)","No usable data for effect sizes"
"CD011670_pub3_data","2::1::Unplanned bowel resection","No usable data for effect sizes"
"CD011670_pub3_data","2::2::Total length of hospital stay (days)","No usable data for effect sizes"
"CD011670_pub3_data","2::3::Quality of life (score on a scale from 0 to 100)","No usable data for effect sizes"
"CD011689_pub4_data","1::4::Severe maternal morbidity: intensive care admissions","No usable data for effect sizes"
"CD011689_pub4_data","1::10::Breastfeeding","No usable data for effect sizes"
"CD011689_pub4_data","1::14::Abdominal pain","No usable data for effect sizes"
"CD011689_pub4_data","1::16::Shivering","No usable data for effect sizes"
"CD011689_pub4_data","1::17::Fever","No usable data for effect sizes"
"CD011689_pub4_data","2::2::PPH >= 1000 mL","No usable data for effect sizes"
"CD011689_pub4_data","2::6::PPH >= 500 mL","No usable data for effect sizes"
"CD011689_pub4_data","2::7::Additional uterotonics","No usable data for effect sizes"
"CD011689_pub4_data","2::8::Blood loss","No usable data for effect sizes"
"CD011689_pub4_data","2::9::Change in haemoglobin","No usable data for effect sizes"
"CD011689_pub4_data","2::13::Headache","No usable data for effect sizes"
"CD011689_pub4_data","3::4::Severe maternal morbidity: intensive care admissions","No usable data for effect sizes"
"CD011689_pub4_data","3::13::Headache","No usable data for effect sizes"
"CD011689_pub4_data","4::1::Death","No usable data for effect sizes"
"CD011689_pub4_data","4::2::PPH >= 1000 mL","No usable data for effect sizes"
"CD011689_pub4_data","4::3::Blood transfusion","No usable data for effect sizes"
"CD011689_pub4_data","4::6::PPH >= 500 mL","No usable data for effect sizes"
"CD011689_pub4_data","4::9::Change in haemoglobin","No usable data for effect sizes"
"CD011689_pub4_data","4::11::Nausea","No usable data for effect sizes"
"CD011689_pub4_data","5::1::Death","No usable data for effect sizes"
"CD011689_pub4_data","5::2::PPH >= 1000 mL","No usable data for effect sizes"
"CD011689_pub4_data","5::6::PPH >= 500 mL","No usable data for effect sizes"
"CD011689_pub4_data","5::9::Change in haemoglobin","No usable data for effect sizes"
"CD011689_pub4_data","5::11::Nausea","No usable data for effect sizes"
"CD011689_pub4_data","5::12::Vomiting","No usable data for effect sizes"
"CD011689_pub4_data","5::13::Headache","No usable data for effect sizes"
"CD011689_pub4_data","5::14::Abdominal pain","No usable data for effect sizes"
"CD011689_pub4_data","5::15::Hypertension","No usable data for effect sizes"
"CD011689_pub4_data","6::11::Nausea","No usable data for effect sizes"
"CD011689_pub4_data","9::2::PPH >= 1000 mL","No usable data for effect sizes"
"CD011689_pub4_data","9::6::PPH >= 500 mL","No usable data for effect sizes"
"CD011689_pub4_data","9::7::Additional uterotonics","No usable data for effect sizes"
"CD011689_pub4_data","9::8::Blood loss","No usable data for effect sizes"
"CD011689_pub4_data","9::11::Nausea","No usable data for effect sizes"
"CD011689_pub4_data","11::1::Death","No usable data for effect sizes"
"CD011689_pub4_data","11::17::Fever","No usable data for effect sizes"
"CD011689_pub4_data","11::18::Diarrhoea","No usable data for effect sizes"
"CD011689_pub4_data","12::1::Death","No usable data for effect sizes"
"CD011689_pub4_data","12::10::Breastfeeding","No usable data for effect sizes"
"CD011689_pub4_data","12::14::Abdominal pain","No usable data for effect sizes"
"CD011689_pub4_data","13::4::Severe maternal morbidity: intensive care admissions","No usable data for effect sizes"
"CD011689_pub4_data","14::1::Death","No usable data for effect sizes"
"CD011689_pub4_data","14::2::PPH >= 1000 mL","No usable data for effect sizes"
"CD011689_pub4_data","16::4::Severe maternal morbidity: intensive care admissions","No usable data for effect sizes"
"CD011689_pub4_data","16::15::Hypertension","No usable data for effect sizes"
"CD011689_pub4_data","17::14::Abdominal pain","No usable data for effect sizes"
"CD011689_pub4_data","17::20::Maternal satisfaction","No usable data for effect sizes"
"CD011689_pub4_data","18::8::Blood loss","No usable data for effect sizes"
"CD011689_pub4_data","18::11::Nausea","No usable data for effect sizes"
"CD011689_pub4_data","20::6::PPH >= 500 mL","No usable data for effect sizes"
"CD011689_pub4_data","20::9::Change in haemoglobin","No usable data for effect sizes"
"CD011689_pub4_data","21::2::PPH >= 1000 mL","No usable data for effect sizes"
"CD011689_pub4_data","21::6::PPH >= 500 mL","No usable data for effect sizes"
"CD011689_pub4_data","21::7::Additional uterotonics","No usable data for effect sizes"
"CD011689_pub4_data","21::8::Blood loss","No usable data for effect sizes"
"CD011689_pub4_data","21::11::Nausea","No usable data for effect sizes"
"CD011689_pub4_data","21::12::Vomiting","No usable data for effect sizes"
"CD011689_pub4_data","24::1::Death","No usable data for effect sizes"
"CD011689_pub4_data","26::6::PPH >= 500 mL","No usable data for effect sizes"
"CD011689_pub4_data","26::8::Blood loss","No usable data for effect sizes"
"CD011689_pub4_data","28::8::Blood loss","No usable data for effect sizes"
"CD011689_pub4_data","29::4::Severe maternal morbidity: intensive care admissions","No usable data for effect sizes"
"CD011689_pub4_data","29::10::Breastfeeding","No usable data for effect sizes"
"CD011689_pub4_data","29::14::Abdominal pain","No usable data for effect sizes"
"CD011689_pub4_data","29::16::Shivering","No usable data for effect sizes"
"CD011689_pub4_data","29::17::Fever","No usable data for effect sizes"
"CD011689_pub4_data","30::2::PPH >= 1000 mL","No usable data for effect sizes"
"CD011689_pub4_data","30::6::PPH >= 500 mL","No usable data for effect sizes"
"CD011689_pub4_data","30::7::Additional uterotonics","No usable data for effect sizes"
"CD011689_pub4_data","30::8::Blood loss","No usable data for effect sizes"
"CD011689_pub4_data","30::9::Change in haemoglobin","No usable data for effect sizes"
"CD011689_pub4_data","30::13::Headache","No usable data for effect sizes"
"CD011689_pub4_data","31::4::Severe maternal morbidity: intensive care admissions","No usable data for effect sizes"
"CD011689_pub4_data","31::13::Headache","No usable data for effect sizes"
"CD011689_pub4_data","32::1::Death","No usable data for effect sizes"
"CD011689_pub4_data","32::2::PPH >= 1000 mL","No usable data for effect sizes"
"CD011689_pub4_data","32::3::Blood transfusion","No usable data for effect sizes"
"CD011689_pub4_data","32::6::PPH >= 500 mL","No usable data for effect sizes"
"CD011689_pub4_data","32::9::Change in haemoglobin","No usable data for effect sizes"
"CD011689_pub4_data","32::11::Nausea","No usable data for effect sizes"
"CD011689_pub4_data","33::1::Death","No usable data for effect sizes"
"CD011689_pub4_data","33::2::PPH >= 1000 mL","No usable data for effect sizes"
"CD011689_pub4_data","33::6::PPH >= 500 mL","No usable data for effect sizes"
"CD011689_pub4_data","33::9::Change in haemoglobin","No usable data for effect sizes"
"CD011689_pub4_data","33::11::Nausea","No usable data for effect sizes"
"CD011689_pub4_data","33::12::Vomiting","No usable data for effect sizes"
"CD011689_pub4_data","33::13::Headache","No usable data for effect sizes"
"CD011689_pub4_data","33::14::Abdominal pain","No usable data for effect sizes"
"CD011689_pub4_data","33::15::Hypertension","No usable data for effect sizes"
"CD011689_pub4_data","34::11::Nausea","No usable data for effect sizes"
"CD011689_pub4_data","37::2::PPH >= 1000 mL","No usable data for effect sizes"
"CD011689_pub4_data","37::6::PPH >= 500 mL","No usable data for effect sizes"
"CD011689_pub4_data","37::7::Additional uterotonics","No usable data for effect sizes"
"CD011689_pub4_data","37::8::Blood loss","No usable data for effect sizes"
"CD011689_pub4_data","37::11::Nausea","No usable data for effect sizes"
"CD011689_pub4_data","39::1::Death","No usable data for effect sizes"
"CD011689_pub4_data","39::17::Fever","No usable data for effect sizes"
"CD011689_pub4_data","39::18::Diarrhoea","No usable data for effect sizes"
"CD011689_pub4_data","40::1::Death","No usable data for effect sizes"
"CD011689_pub4_data","40::10::Breastfeeding","No usable data for effect sizes"
"CD011689_pub4_data","40::14::Abdominal pain","No usable data for effect sizes"
"CD011689_pub4_data","41::4::Severe maternal morbidity: intensive care admissions","No usable data for effect sizes"
"CD011689_pub4_data","42::1::Death","No usable data for effect sizes"
"CD011689_pub4_data","42::2::PPH >= 1000 mL","No usable data for effect sizes"
"CD011689_pub4_data","44::4::Severe maternal morbidity: intensive care admissions","No usable data for effect sizes"
"CD011689_pub4_data","44::15::Hypertension","No usable data for effect sizes"
"CD011689_pub4_data","45::14::Abdominal pain","No usable data for effect sizes"
"CD011689_pub4_data","45::20::Maternal satisfaction","No usable data for effect sizes"
"CD011689_pub4_data","46::8::Blood loss","No usable data for effect sizes"
"CD011689_pub4_data","46::11::Nausea","No usable data for effect sizes"
"CD011689_pub4_data","48::6::PPH >= 500 mL","No usable data for effect sizes"
"CD011689_pub4_data","48::9::Change in haemoglobin","No usable data for effect sizes"
"CD011689_pub4_data","49::2::PPH >= 1000 mL","No usable data for effect sizes"
"CD011689_pub4_data","49::6::PPH >= 500 mL","No usable data for effect sizes"
"CD011689_pub4_data","49::7::Additional uterotonics","No usable data for effect sizes"
"CD011689_pub4_data","49::8::Blood loss","No usable data for effect sizes"
"CD011689_pub4_data","49::11::Nausea","No usable data for effect sizes"
"CD011689_pub4_data","49::12::Vomiting","No usable data for effect sizes"
"CD011689_pub4_data","52::1::Death","No usable data for effect sizes"
"CD011689_pub4_data","54::6::PPH >= 500 mL","No usable data for effect sizes"
"CD011689_pub4_data","54::8::Blood loss","No usable data for effect sizes"
"CD011689_pub4_data","56::8::Blood loss","No usable data for effect sizes"
"CD011689_pub4_data","57::4::Severe maternal morbidity: intensive care admissions","No usable data for effect sizes"
"CD011689_pub4_data","57::10::Breastfeeding","No usable data for effect sizes"
"CD011689_pub4_data","57::14::Abdominal pain","No usable data for effect sizes"
"CD011689_pub4_data","57::16::Shivering","No usable data for effect sizes"
"CD011689_pub4_data","57::17::Fever","No usable data for effect sizes"
"CD011689_pub4_data","58::2::PPH >= 1000 mL","No usable data for effect sizes"
"CD011689_pub4_data","58::6::PPH >= 500 mL","No usable data for effect sizes"
"CD011689_pub4_data","58::7::Additional uterotonics","No usable data for effect sizes"
"CD011689_pub4_data","58::8::Blood loss","No usable data for effect sizes"
"CD011689_pub4_data","58::9::Change in haemoglobin","No usable data for effect sizes"
"CD011689_pub4_data","58::13::Headache","No usable data for effect sizes"
"CD011689_pub4_data","59::4::Severe maternal morbidity: intensive care admissions","No usable data for effect sizes"
"CD011689_pub4_data","59::13::Headache","No usable data for effect sizes"
"CD011689_pub4_data","60::1::Death","No usable data for effect sizes"
"CD011689_pub4_data","60::2::PPH >= 1000 mL","No usable data for effect sizes"
"CD011689_pub4_data","60::3::Blood transfusion","No usable data for effect sizes"
"CD011689_pub4_data","60::6::PPH >= 500 mL","No usable data for effect sizes"
"CD011689_pub4_data","60::9::Change in haemoglobin","No usable data for effect sizes"
"CD011689_pub4_data","60::11::Nausea","No usable data for effect sizes"
"CD011689_pub4_data","61::1::Death","No usable data for effect sizes"
"CD011689_pub4_data","61::2::PPH >= 1000 mL","No usable data for effect sizes"
"CD011689_pub4_data","61::6::PPH >= 500 mL","No usable data for effect sizes"
"CD011689_pub4_data","61::9::Change in haemoglobin","No usable data for effect sizes"
"CD011689_pub4_data","61::11::Nausea","No usable data for effect sizes"
"CD011689_pub4_data","61::12::Vomiting","No usable data for effect sizes"
"CD011689_pub4_data","61::13::Headache","No usable data for effect sizes"
"CD011689_pub4_data","61::14::Abdominal pain","No usable data for effect sizes"
"CD011689_pub4_data","61::15::Hypertension","No usable data for effect sizes"
"CD011689_pub4_data","62::11::Nausea","No usable data for effect sizes"
"CD011689_pub4_data","65::2::PPH >= 1000 mL","No usable data for effect sizes"
"CD011689_pub4_data","65::6::PPH >= 500 mL","No usable data for effect sizes"
"CD011689_pub4_data","65::7::Additional uterotonics","No usable data for effect sizes"
"CD011689_pub4_data","65::8::Blood loss","No usable data for effect sizes"
"CD011689_pub4_data","65::11::Nausea","No usable data for effect sizes"
"CD011689_pub4_data","67::1::Death","No usable data for effect sizes"
"CD011689_pub4_data","67::17::Fever","No usable data for effect sizes"
"CD011689_pub4_data","67::18::Diarrhoea","No usable data for effect sizes"
"CD011689_pub4_data","68::1::Death","No usable data for effect sizes"
"CD011689_pub4_data","68::10::Breastfeeding","No usable data for effect sizes"
"CD011689_pub4_data","68::14::Abdominal pain","No usable data for effect sizes"
"CD011689_pub4_data","69::4::Severe maternal morbidity: intensive care admissions","No usable data for effect sizes"
"CD011689_pub4_data","70::1::Death","No usable data for effect sizes"
"CD011689_pub4_data","70::2::PPH >= 1000 mL","No usable data for effect sizes"
"CD011689_pub4_data","72::4::Severe maternal morbidity: intensive care admissions","No usable data for effect sizes"
"CD011689_pub4_data","72::15::Hypertension","No usable data for effect sizes"
"CD011689_pub4_data","73::14::Abdominal pain","No usable data for effect sizes"
"CD011689_pub4_data","73::20::Maternal satisfaction","No usable data for effect sizes"
"CD011689_pub4_data","74::8::Blood loss","No usable data for effect sizes"
"CD011689_pub4_data","74::11::Nausea","No usable data for effect sizes"
"CD011689_pub4_data","76::6::PPH >= 500 mL","No usable data for effect sizes"
"CD011689_pub4_data","76::9::Change in haemoglobin","No usable data for effect sizes"
"CD011689_pub4_data","77::2::PPH >= 1000 mL","No usable data for effect sizes"
"CD011689_pub4_data","77::6::PPH >= 500 mL","No usable data for effect sizes"
"CD011689_pub4_data","77::7::Additional uterotonics","No usable data for effect sizes"
"CD011689_pub4_data","77::8::Blood loss","No usable data for effect sizes"
"CD011689_pub4_data","77::11::Nausea","No usable data for effect sizes"
"CD011689_pub4_data","77::12::Vomiting","No usable data for effect sizes"
"CD011689_pub4_data","80::1::Death","No usable data for effect sizes"
"CD011689_pub4_data","82::6::PPH >= 500 mL","No usable data for effect sizes"
"CD011689_pub4_data","82::8::Blood loss","No usable data for effect sizes"
"CD011689_pub4_data","84::8::Blood loss","No usable data for effect sizes"
"CD011762_pub2_data","9::7::Serious hepatic adverse events","No usable data for effect sizes"
"CD011762_pub2_data","10::7::Serious hepatic adverse events","No usable data for effect sizes"
"CD011762_pub2_data","11::7::Serious hepatic adverse events","No usable data for effect sizes"
"CD011778_pub2_data","2::8::REC (change from baseline (mm)); 6 months","No usable data for effect sizes"
"CD011778_pub2_data","3::1::PPD (change from baseline(mm)); 3 months","No usable data for effect sizes"
"CD011778_pub2_data","3::2::BOP (change from baseline (%)); 3 months","No usable data for effect sizes"
"CD011800_pub2_data","1::1::Vitamin D status (achieved 25-hydroxyvitamin D level)","No usable data for effect sizes"
"CD011800_pub2_data","1::2::Secondary hyperparathyroidism (achieved parathyroid hormone level)","No usable data for effect sizes"
"CD011800_pub2_data","2::3::All-cause mortality","No usable data for effect sizes"
"CD011800_pub2_data","2::4::Bone mineral density change – lumbar spine  ","No usable data for effect sizes"
"CD011800_pub2_data","2::5::Bone mineral density change – hip  ","No usable data for effect sizes"
"CD011800_pub2_data","2::6::Bone mineral density change – forearm  ","No usable data for effect sizes"
"CD011806_pub2_data","1::1::Clinical response","No usable data for effect sizes"
"CD011806_pub2_data","1::11::Disease activity at end of follow-up – change in disease activity score (Crohn's disease)","No usable data for effect sizes"
"CD011806_pub2_data","1::16::Normalisation of vitamin D levels – numbers of people with vitamin D deficiency at end of study (dichotomous outcome)","No usable data for effect sizes"
"CD011806_pub2_data","2::1::Clinical relapse (Crohn's disease)","No usable data for effect sizes"
"CD011806_pub2_data","2::4::Normalisation of vitamin D levels (change in vitamin D levels) – high-treatment-dose vitamin D versus low-treatment-dose vitamin D (mixed measures)","No usable data for effect sizes"
"CD011806_pub2_data","3::2::Disease activity at end of follow-up – any-treatment-dose vitamin D versus supplemental-dose vitamin D (Crohn's disease – Pediatric Crohn's Disease Activity Index < 10 at end of follow-up)","No usable data for effect sizes"
"CD011806_pub2_data","3::4::Normalisation of vitamin D levels (change in vitamin D levels) – any-treatment-dose vitamin D versus supplemental-dose vitamin D (mixed measures)","No usable data for effect sizes"
"CD011841_pub3_data","1::2::Recurrence of central serous chorioretinopathy at 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","1::3::Persistent central serous chorioretinopathy at 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","1::4::Mean change in central retinal thickness between baseline and 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","2::2::Persistent central serous chorioretinopathy at 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","4::1::Mean change in BCVA between baseline and 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","4::2::Recurrence of central serous chorioretinopathy at 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","5::2::Persistent central serous chorioretinopathy at 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","5::3::Mean change in central retinal thickness between baseline and 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","5::4::Quality of life at 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","5::5::Adverse events","No usable data for effect sizes"
"CD011841_pub3_data","7::1::Mean change in BCVA between baseline and 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","7::2::Mean change in central retinal thickness between baseline and 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","8::1::Mean change in BCVA between baseline and 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","8::2::Mean change in central retinal thickness between baseline and 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","9::3::Persistent central serous chorioretinopathy at 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","10::5::Adverse events (e.g. loss of vision due to treatment, retinal atrophy, CNV, RPE damage)","No usable data for effect sizes"
"CD011841_pub3_data","10::6::Adverse events (e.g. conjunctival hyperemia)","No usable data for effect sizes"
"CD011841_pub3_data","11::1::Recurrence of central serous chorioretinopathy at 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","12::1::Mean change in BCVA between baseline and 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","12::3::Persistent central serous chorioretinopathy at 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","12::4::Mean change in central retinal thickness between baseline and 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","13::1::Mean change in BCVA between baseline and 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","13::2::Persistent central serous chorioretinopathy at 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","13::3::Mean change in central retinal thickness between baseline and 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","13::4::Harms (e.g. loss of vision due to treatment, retinal atrophy, CNV, RPE damage)","No usable data for effect sizes"
"CD011841_pub3_data","14::1::Mean change in best-corrected visual acuity between baseline and 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","14::3::Mean change in central retinal thickness between baseline and 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","15::1::Mean change in best-corrected visual acuity between baseline and 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","15::2::Recurrence of central serous chorioretinopathy at 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","15::3::Mean change in central retinal thickness between baseline and 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","16::1::Mean change in best-corrected visual acuity between baseline and 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","16::2::Recurrence of central serous chorioretinopathy at 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","16::3::Mean change in central retinal thickness between baseline and 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","17::3::Persistent central serous chorioretinopathy at 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","18::1::Mean change in best-corrected visual acuity between baseline and 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","18::2::Recurrence of central serous chorioretinopathy at 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","18::3::Mean change in central retinal thickness between baseline and 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","19::1::Mean change in best-corrected visual acuity between baseline and 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","19::2::Mean change in central retinal thickness between baseline and 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","20::1::Mean change in best-corrected visual acuity between baseline and 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","20::2::Recurrence of central serous chorioretinopathy at 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","20::3::Persistent central serous chorioretinopathy at 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","20::4::Mean change in central retinal thickness between baseline and 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","21::1::Mean change in best-corrected visual acuity between baseline and 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","21::2::Persistent central serous chorioretinopathy at 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","21::3::Mean change in central retinal thickness between baseline and 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","22::7::Adverse events at 12 months","No usable data for effect sizes"
"CD011841_pub3_data","23::1::Mean change in best-corrected visual acuity between baseline and 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","23::2::Recurrence of central serous chorioretinopathy at 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","23::3::Persistent central serous chorioretinopathy at 12 months (± 6)","No usable data for effect sizes"
"CD011841_pub3_data","23::4::Quality of life at 12 months (± 6)","No usable data for effect sizes"
"CD011851_pub3_data","1::15::Heart rate: sensitivity analysis excluding studies with high risk of bias","No usable data for effect sizes"
"CD011858_pub2_data","1::1::Extracorporeal circuit thrombosis","No usable data for effect sizes"
"CD011858_pub2_data","1::2::Activated partial thromboplastin time","No usable data for effect sizes"
"CD011858_pub2_data","1::3::Platelet count","No usable data for effect sizes"
"CD011858_pub2_data","2::1::Extracorporeal circuit thrombosis","No usable data for effect sizes"
"CD011858_pub2_data","2::2::Activated partial thromboplastin time","No usable data for effect sizes"
"CD011858_pub2_data","2::3::Platelet count","No usable data for effect sizes"
"CD011858_pub2_data","3::3::Dialysis adequacy (Kt/V)","No usable data for effect sizes"
"CD011858_pub2_data","3::5::Plasma anti-Xa level","No usable data for effect sizes"
"CD011858_pub2_data","3::6::Activated partial thromboplastin time","No usable data for effect sizes"
"CD011858_pub2_data","3::7::Platelet count","No usable data for effect sizes"
"CD011858_pub2_data","3::8::Potassium","No usable data for effect sizes"
"CD011858_pub2_data","4::1::Extracorporeal circuit thrombosis","No usable data for effect sizes"
"CD011858_pub2_data","4::2::Major bleeding","No usable data for effect sizes"
"CD011858_pub2_data","4::4::Subcutaneous bleeding","No usable data for effect sizes"
"CD011858_pub2_data","4::5::Subconjunctival bleeding","No usable data for effect sizes"
"CD011858_pub2_data","4::6::Haemorrhoid bleeding","No usable data for effect sizes"
"CD011858_pub2_data","4::7::Vascular access bleeding","No usable data for effect sizes"
"CD011858_pub2_data","4::8::Death (any cause)","No usable data for effect sizes"
"CD011858_pub2_data","4::10::Activated clotting time","No usable data for effect sizes"
"CD011858_pub2_data","4::11::Thrombin antithrombin complex ","No usable data for effect sizes"
"CD011858_pub2_data","4::12::Thrombin time","No usable data for effect sizes"
"CD011858_pub2_data","4::13::Prothrombin time","No usable data for effect sizes"
"CD011858_pub2_data","4::14::Activated partial thromboplastin time","No usable data for effect sizes"
"CD011858_pub2_data","4::15::Time to stop bleeding","No usable data for effect sizes"
"CD011858_pub2_data","5::1::Dialysis access (urea reduction ratio)","No usable data for effect sizes"
"CD011858_pub2_data","5::2::Plasma anti-Xa level","No usable data for effect sizes"
"CD011858_pub2_data","6::1::Extracorporeal circuit thrombosis (clotting bloodlines)","No usable data for effect sizes"
"CD011858_pub2_data","6::2::Any bleeding","No usable data for effect sizes"
"CD011858_pub2_data","7::1::Plasma anti-Xa level","No usable data for effect sizes"
"CD011858_pub2_data","8::1::Extracorporeal circuit thrombosis","No usable data for effect sizes"
"CD011858_pub2_data","8::2::Worsening haemorrhage","No usable data for effect sizes"
"CD011858_pub2_data","9::1::Potassium","No usable data for effect sizes"
"CD011858_pub2_data","10::1::Minor bleeding","No usable data for effect sizes"
"CD011858_pub2_data","11::1::Extracorporeal circuit thrombosis","No usable data for effect sizes"
"CD011858_pub2_data","11::2::Any bleeding","No usable data for effect sizes"
"CD011858_pub2_data","12::1::Extracorporeal circuit thrombosis","No usable data for effect sizes"
"CD011858_pub2_data","13::1::Extracorporeal circuit thrombosis","No usable data for effect sizes"
"CD011858_pub2_data","14::1::Extracorporeal circuit thrombosis","No usable data for effect sizes"
"CD011858_pub2_data","14::2::Cardiovascular adverse events","No usable data for effect sizes"
"CD011858_pub2_data","15::1::Cost per treatment","No usable data for effect sizes"
"CD011858_pub2_data","16::1::Extracorporeal circuit thrombosis","No usable data for effect sizes"
"CD011858_pub2_data","17::1::Major bleeding","No usable data for effect sizes"
"CD011858_pub2_data","17::2::Any bleeding","No usable data for effect sizes"
"CD011858_pub2_data","17::3::Minor bleeding","No usable data for effect sizes"
"CD011858_pub2_data","17::4::Death (any cause)","No usable data for effect sizes"
"CD011858_pub2_data","17::5::Cardiovascular death","No usable data for effect sizes"
"CD011858_pub2_data","17::6::Blood transfusion","No usable data for effect sizes"
"CD011858_pub2_data","18::1::Extracorporeal circuit thrombosis","No usable data for effect sizes"
"CD011858_pub2_data","18::2::Clotting leading to discontinuation","No usable data for effect sizes"
"CD011858_pub2_data","18::3::Gastrointestinal bleeding","No usable data for effect sizes"
"CD011858_pub2_data","18::4::Cerebral haemorrhage","No usable data for effect sizes"
"CD011858_pub2_data","18::5::Vascular access site haemorrhage","No usable data for effect sizes"
"CD011858_pub2_data","18::6::Vascular access thrombosis","No usable data for effect sizes"
"CD011858_pub2_data","18::7::Vascular access site haematoma","No usable data for effect sizes"
"CD011858_pub2_data","18::8::Vascular access complication","No usable data for effect sizes"
"CD011858_pub2_data","18::9::Cardiovascular death","No usable data for effect sizes"
"CD011858_pub2_data","18::10::Cardiorespiratory arrest","No usable data for effect sizes"
"CD011858_pub2_data","18::11::Pain","No usable data for effect sizes"
"CD011866_pub3_data","2::2::Point abstinence, end of treatment","No usable data for effect sizes"
"CD011866_pub3_data","2::4::Continuous abstinence, end of treatment","No usable data for effect sizes"
"CD011866_pub3_data","2::6::Longest period of abstinence","No usable data for effect sizes"
"CD011866_pub3_data","2::7::Craving","No usable data for effect sizes"
"CD011866_pub3_data","2::9::Depression","No usable data for effect sizes"
"CD011866_pub3_data","3::4::Frequency of drug intake, end of treatment","No usable data for effect sizes"
"CD011866_pub3_data","3::5::Severity of dependence","No usable data for effect sizes"
"CD011866_pub3_data","4::5::Continuous abstinence, longest follow-up","No usable data for effect sizes"
"CD011866_pub3_data","4::6::Frequency of drug intake, end of treatment","No usable data for effect sizes"
"CD011866_pub3_data","4::7::Longest period of abstinence","No usable data for effect sizes"
"CD011866_pub3_data","4::8::Severity of dependence","No usable data for effect sizes"
"CD011866_pub3_data","4::9::Depression","No usable data for effect sizes"
"CD011885_pub2_data","1::3::Quality of life: SF-36 score change (higher is better)","No usable data for effect sizes"
"CD011885_pub2_data","1::12::Global state: CGI-Improvement endpoint score (lower is better)","No usable data for effect sizes"
"CD011885_pub2_data","1::17::Negative symptoms: average endpoint SANS score (lower is better)","No usable data for effect sizes"
"CD011885_pub2_data","1::20::Depressive symptoms: average change in MADRS score (lower is better)","No usable data for effect sizes"
"CD011885_pub2_data","1::21::Anxiety: average endpoint m-COVI score (lower is better)","No usable data for effect sizes"
"CD011885_pub2_data","1::28::Adverse effects: extrapyramidal – akathisia measured by mean score change in ESRS-A (lower is better)","No usable data for effect sizes"
"CD011885_pub2_data","1::29::Adverse effects: extrapyramidal – dyskinesia as a dichotomous outcome","No usable data for effect sizes"
"CD011885_pub2_data","1::30::Adverse effects: extrapyramidal – dyskinesia measured by mean score change in AIMS (lower is better)","No usable data for effect sizes"
"CD011885_pub2_data","1::31::Adverse effects: extrapyramidal – dyskinesia measured by mean score change in ESRS-A (lower is better)","No usable data for effect sizes"
"CD011885_pub2_data","1::32::Adverse effects: extrapyramidal – dystonia measured by mean score change in ESRS-A (lower is better)","No usable data for effect sizes"
"CD011885_pub2_data","1::34::Adverse effects: extrapyramidal – parkinsonism as a dichotomous outcome","No usable data for effect sizes"
"CD011885_pub2_data","1::36::Adverse effects: extrapyramidal – parkinsonism measured by mean score change in ESRS-A (lower is better)","No usable data for effect sizes"
"CD011885_pub2_data","1::43::Adverse effects: increased appetite","No usable data for effect sizes"
"CD011885_pub2_data","1::47::Adverse effects: prolactin – mean change in ng/dL (lower is better)","No usable data for effect sizes"
"CD011885_pub2_data","1::51::Adverse effects: suicidal ideation","No usable data for effect sizes"
"CD011885_pub2_data","1::52::Adverse effects: triglycerides average change in mg/dL (lower is better)","No usable data for effect sizes"
"CD011885_pub2_data","1::55::Functioning: average change in PSP score (high is better)","No usable data for effect sizes"
"CD011885_pub2_data","1::56::Quality of life: average endpoint SF-36 score (higher is better)","No usable data for effect sizes"
"CD011885_pub2_data","1::57::Quality of life: average change in SWN score (higher is better)","No usable data for effect sizes"
"CD011885_pub2_data","1::58::Satisfaction with care: clinically important change in MSQ score","No usable data for effect sizes"
"CD011885_pub2_data","1::59::Satisfaction with care: average change in DAI-10 score (higher is better)","No usable data for effect sizes"
"CD011885_pub2_data","1::60::Satisfaction with care: average endpoint MSQ score (higher is better)","No usable data for effect sizes"
"CD012067_pub3_data","1::1::Serum creatinine [mg/dL]","No usable data for effect sizes"
"CD012067_pub3_data","1::2::Doubling of serum creatinine","No usable data for effect sizes"
"CD012067_pub3_data","1::5::Death","No usable data for effect sizes"
"CD012067_pub3_data","1::7::Systolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD012067_pub3_data","1::8::Diastolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD012067_pub3_data","1::9::Total kidney volume [mL/cm]","No usable data for effect sizes"
"CD012067_pub3_data","1::12::Albuminuria [mg/mmol]","No usable data for effect sizes"
"CD012067_pub3_data","2::1::Serum creatinine [mg/dL]","No usable data for effect sizes"
"CD012067_pub3_data","2::2::Systolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD012067_pub3_data","2::3::Diastolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD012067_pub3_data","4::1::eGFR change [mL/min/1.73 m2/month]","No usable data for effect sizes"
"CD012067_pub3_data","4::2::Systolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD012067_pub3_data","4::3::Diastolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD012067_pub3_data","4::5::Urinary albumin-creatinine ratio [mg/g]","No usable data for effect sizes"
"CD012067_pub3_data","5::6::Kidney failure or doubling of serum creatinine","No usable data for effect sizes"
"CD012067_pub3_data","5::7::30% or more decrease in GFR or kidney failure","No usable data for effect sizes"
"CD012067_pub3_data","5::8::Acute kidney injury","No usable data for effect sizes"
"CD012067_pub3_data","5::9::Death","No usable data for effect sizes"
"CD012067_pub3_data","5::10::Back or flank pain","No usable data for effect sizes"
"CD012067_pub3_data","5::11::Health-related quality of life","No usable data for effect sizes"
"CD012067_pub3_data","5::12::Depression and anxiety","No usable data for effect sizes"
"CD012067_pub3_data","5::15::Mean arterial pressure [mm Hg]","No usable data for effect sizes"
"CD012067_pub3_data","5::20::Proteinuria [g/24 hours]","No usable data for effect sizes"
"CD012067_pub3_data","5::24::Withdrawal due to adverse events","No usable data for effect sizes"
"CD012067_pub3_data","6::4::Received transplantation","No usable data for effect sizes"
"CD012067_pub3_data","6::5::Death","No usable data for effect sizes"
"CD012067_pub3_data","6::10::Percent change in total kidney volume [L]","No usable data for effect sizes"
"CD012067_pub3_data","6::12::Cyst volume [mL]","No usable data for effect sizes"
"CD012067_pub3_data","6::14::Parenchymal volume [mL]","No usable data for effect sizes"
"CD012067_pub3_data","6::18::Doubling of proteinuria","No usable data for effect sizes"
"CD012067_pub3_data","8::1::Doubling of serum creatinine","No usable data for effect sizes"
"CD012067_pub3_data","9::2::Rate of eGFR decline","No usable data for effect sizes"
"CD012067_pub3_data","9::3::Annual rate of eGFR decline","No usable data for effect sizes"
"CD012067_pub3_data","9::4::Kidney failure","No usable data for effect sizes"
"CD012067_pub3_data","9::5::Death","No usable data for effect sizes"
"CD012067_pub3_data","9::9::Mean annual percent change in height-adjusted total kidney volume","No usable data for effect sizes"
"CD012067_pub3_data","9::10::Absolute change in height-adjusted total kidney volume","No usable data for effect sizes"
"CD012067_pub3_data","9::11::Height-adjusted liver volume","No usable data for effect sizes"
"CD012067_pub3_data","9::15::C-reactive protein","No usable data for effect sizes"
"CD012067_pub3_data","11::5::Serious adverse events","No usable data for effect sizes"
"CD012067_pub3_data","13::3::Doubling of serum creatinine","No usable data for effect sizes"
"CD012067_pub3_data","13::6::Mean arterial pressure [mm Hg]","No usable data for effect sizes"
"CD012067_pub3_data","14::1::Serum creatinine [mg/dL]","No usable data for effect sizes"
"CD012067_pub3_data","14::2::GFR [mL/min/1.73 m²]","No usable data for effect sizes"
"CD012067_pub3_data","14::3::Systolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD012067_pub3_data","14::4::Diastolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD012067_pub3_data","14::5::Mean arterial pressure [mm Hg]","No usable data for effect sizes"
"CD012067_pub3_data","14::6::Albuminuria [mg/g]","No usable data for effect sizes"
"CD012067_pub3_data","15::2::GFR [mL/min/1.73 m²]","No usable data for effect sizes"
"CD012067_pub3_data","15::3::Systolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD012067_pub3_data","15::4::Diastolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD012067_pub3_data","15::5::Mean arterial pressure [mm Hg]","No usable data for effect sizes"
"CD012067_pub3_data","16::7::Total kidney volume change [%]","No usable data for effect sizes"
"CD012067_pub3_data","16::8::Hospitalisations","No usable data for effect sizes"
"CD012067_pub3_data","17::1::Serum creatinine [mg/dL]","No usable data for effect sizes"
"CD012067_pub3_data","17::4::Need for kidney replacement therapy","No usable data for effect sizes"
"CD012067_pub3_data","17::5::Cardiovascular events","No usable data for effect sizes"
"CD012067_pub3_data","17::6::Systolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD012067_pub3_data","17::7::Diastolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD012067_pub3_data","17::8::Mean arterial pressure [mm Hg]","No usable data for effect sizes"
"CD012067_pub3_data","18::1::Serum creatinine [mg/dL]","No usable data for effect sizes"
"CD012067_pub3_data","18::2::GFR [mL/min/1.73 m²]","No usable data for effect sizes"
"CD012067_pub3_data","18::3::Doubling of serum creatinine","No usable data for effect sizes"
"CD012067_pub3_data","18::4::Proteinuria [mg/day]","No usable data for effect sizes"
"CD012067_pub3_data","18::5::Albuminuria [mg/day]","No usable data for effect sizes"
"CD012067_pub3_data","19::1::Change in eGFR","No usable data for effect sizes"
"CD012067_pub3_data","20::1::Change in eGFR [mL/min/1.7 3 m2]","No usable data for effect sizes"
"CD012067_pub3_data","20::2::Acute kidney injury","No usable data for effect sizes"
"CD012067_pub3_data","20::3::Death","No usable data for effect sizes"
"CD012067_pub3_data","20::5::Per cent annual change in total kidney volume [mL/cm]","No usable data for effect sizes"
"CD012067_pub3_data","20::6::All cause hospitalisation ","No usable data for effect sizes"
"CD012067_pub3_data","20::7::Albuminuria [mg/24 hours]","No usable data for effect sizes"
"CD012067_pub3_data","20::8::Serious adverse events","No usable data for effect sizes"
"CD012067_pub3_data","22::3::Creatinine clearance [mL/min/1.73 m2]","No usable data for effect sizes"
"CD012067_pub3_data","22::6::Change in height-adjusted total kidney volume","No usable data for effect sizes"
"CD012067_pub3_data","22::8::Urinary albumin excretion: > 20% increase","No usable data for effect sizes"
"CD012067_pub3_data","22::9::Adverse events","No usable data for effect sizes"
"CD012067_pub3_data","23::1::Serum creatinine [mg/dL]","No usable data for effect sizes"
"CD012067_pub3_data","23::2::GFR [mL/min/1.73 m²]","No usable data for effect sizes"
"CD012067_pub3_data","23::3::Total kidney volume [mL]","No usable data for effect sizes"
"CD012067_pub3_data","23::4::Albuminuria [mg/day]","No usable data for effect sizes"
"CD012067_pub3_data","24::2::Doubling of serum creatinine","No usable data for effect sizes"
"CD012067_pub3_data","24::4::Annual rate of eGFR","No usable data for effect sizes"
"CD012067_pub3_data","24::5::Decrease in eGFR: > 25%","No usable data for effect sizes"
"CD012067_pub3_data","24::6::Kidney failure","No usable data for effect sizes"
"CD012067_pub3_data","24::7::ADPKD disease progression","No usable data for effect sizes"
"CD012067_pub3_data","24::8::Pain","No usable data for effect sizes"
"CD012067_pub3_data","24::9::Systolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD012067_pub3_data","24::10::Diastolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD012067_pub3_data","24::12::Height-adjusted total kidney volume [mL]","No usable data for effect sizes"
"CD012067_pub3_data","24::13::Annual rate of height-adjusted total kidney volume [%]","No usable data for effect sizes"
"CD012067_pub3_data","24::14::UACR [mg/g]","No usable data for effect sizes"
"CD012067_pub3_data","24::15::Urine volume [mL]","No usable data for effect sizes"
"CD012067_pub3_data","24::17::Serious adverse events","No usable data for effect sizes"
"CD012067_pub3_data","24::19::Adherence","No usable data for effect sizes"
"CD012067_pub3_data","25::1::Change in urine osmolality [mOsm/kg]","No usable data for effect sizes"
"CD012067_pub3_data","26::2::Total kidney volume [mL]","No usable data for effect sizes"
"CD012067_pub3_data","26::3::Adverse events","No usable data for effect sizes"
"CD012067_pub3_data","27::1::eGFR [mL/min/1.73 m2]","No usable data for effect sizes"
"CD012067_pub3_data","27::2::Systolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD012067_pub3_data","27::3::Diastolic blood pressure [mm Hg]","No usable data for effect sizes"
"CD012067_pub3_data","28::1::Serum creatinine [µmol/L]","No usable data for effect sizes"
"CD012067_pub3_data","28::2::GFR [mL/min]","No usable data for effect sizes"
"CD012067_pub3_data","29::2::Frequency scale of back or abdominal pain","No usable data for effect sizes"
"CD012067_pub3_data","29::3::Quality of life score","No usable data for effect sizes"
"CD012067_pub3_data","29::4::Total kidney volume change [%]","No usable data for effect sizes"
"CD012079_pub2_data","2::1::Awareness of prolapse (2 years)","No usable data for effect sizes"
"CD012079_pub2_data","2::2::Repeat surgery (2 years) ","No usable data for effect sizes"
"CD012079_pub2_data","2::3::Recurrent prolapse on examination (any)","No usable data for effect sizes"
"CD012079_pub2_data","2::5::Recurrent prolapse on examination (posterior compartment) ","No usable data for effect sizes"
"CD012079_pub2_data","2::10::Bladder function: de novo stress urinary incontinence ","No usable data for effect sizes"
"CD012079_pub2_data","3::7::Mesh exposure","No usable data for effect sizes"
"CD012079_pub2_data","3::13::Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire 12 (PISQ-12) (0-48) ","No usable data for effect sizes"
"CD012079_pub2_data","3::17::Length of stay (days)","No usable data for effect sizes"
"CD012079_pub2_data","4::2::Repeat surgery ","No usable data for effect sizes"
"CD012079_pub2_data","4::17::Length of stay (days)","No usable data for effect sizes"
"CD012079_pub2_data","4::18::Blood transfusion","No usable data for effect sizes"
"CD012079_pub2_data","5::6::Visceral injury ","No usable data for effect sizes"
"CD012079_pub2_data","5::10::Bladder function: de novo stress urinary incontinence ","No usable data for effect sizes"
"CD012079_pub2_data","5::11::Bladder function: de novo urge incontinence or voiding dysfunction ","No usable data for effect sizes"
"CD012079_pub2_data","5::12::Painful intercourse - de novo dyspareunia ","No usable data for effect sizes"
"CD012079_pub2_data","5::16::Operating time (minutes)","No usable data for effect sizes"
"CD012079_pub2_data","5::17::Length of stay (days)","No usable data for effect sizes"
"CD012152_pub4_data","1::3::Major neurological disability at six to seven years of age","No usable data for effect sizes"
"CD012152_pub4_data","1::10::Developmental disability at six to seven years of age","No usable data for effect sizes"
"CD012152_pub4_data","1::16::Number of episodes of hypoglycaemia (glucose oxidase method) (total number per infant)","No usable data for effect sizes"
"CD012152_pub4_data","1::24::Developmental delay/intellectual impairment at two years of age - mild (70 to 84)","No usable data for effect sizes"
"CD012152_pub4_data","1::25::Developmental delay/intellectual impairment at two years of age - moderate or severe (< 70)","No usable data for effect sizes"
"CD012152_pub4_data","1::29::Executive dysfunction at six to seven years of age","No usable data for effect sizes"
"CD012152_pub4_data","1::33::Emotional-behavioural difficulty at six to seven years of age","No usable data for effect sizes"
"CD012214_pub3_data","1::4::Abnormal uterine bleeding","No usable data for effect sizes"
"CD012214_pub3_data","2::2::Recurrence of endometrial hyperplasia","No usable data for effect sizes"
"CD012214_pub3_data","3::1::Regression of endometrial hyperplasia (with or without atypia) to proliferative, secretory, or atrophic endometrium","No usable data for effect sizes"
"CD012214_pub3_data","3::2::Progression of endometrial hyperplasia to endometrial cancer","No usable data for effect sizes"
"CD012214_pub3_data","3::3::Hysterectomy rate","No usable data for effect sizes"
"CD012214_pub3_data","3::4::Abnormal uterine bleeding","No usable data for effect sizes"
"CD012265_pub2_data","1::1::Proven sepsis","No usable data for effect sizes"
"CD012265_pub2_data","1::2::Time to full enteral feeds","No usable data for effect sizes"
"CD012265_pub2_data","1::3::Duration of hospital admission","No usable data for effect sizes"
"CD012265_pub2_data","1::4::Non-pathogenic intestinal microflora","No usable data for effect sizes"
"CD012335_pub2_data","1::9::Lymphovascular adverse event: all grades","No usable data for effect sizes"
"CD012335_pub2_data","1::10::Genitourinary adverse events: all grades","No usable data for effect sizes"
"CD012335_pub2_data","1::11::Direct surgical adverse events: all grades","No usable data for effect sizes"
"CD012397_pub2_data","1::2::Specific behaviours: aggression – clinically important change in aggressive/violent behaviour, as defined by the individual studies (random-effects)","No usable data for effect sizes"
"CD012397_pub2_data","1::6::Self-harm, including suicide","No usable data for effect sizes"
"CD012397_pub2_data","1::10::Adverse event (escape)","No usable data for effect sizes"
"CD012397_pub2_data","1::11::Adverse event (fall down)","No usable data for effect sizes"
"CD012397_pub2_data","1::12::Adverse event (choking)","No usable data for effect sizes"
"CD012429_pub2_data","4::24::Diabetes mellitus","No usable data for effect sizes"
"CD012429_pub2_data","4::25::Dry mouth","No usable data for effect sizes"
"CD012429_pub2_data","4::26::Stiffness in jaw","No usable data for effect sizes"
"CD012445_pub2_data","1::5::Parental depression/anxiety – postintervention","No usable data for effect sizes"
"CD012445_pub2_data","1::6::Parental depression or anxiety – latest follow-up","No usable data for effect sizes"
"CD012445_pub2_data","2::5::Parental depression/anxiety – postintervention","No usable data for effect sizes"
"CD012445_pub2_data","2::6::Parental depression/anxiety – latest follow-up","No usable data for effect sizes"
"CD012532_pub2_data","1::1::Overall Survival","No usable data for effect sizes"
"CD012532_pub2_data","1::2::Progression-free survival","No usable data for effect sizes"
"CD012532_pub2_data","2::1::Overall survival","No usable data for effect sizes"
"CD012532_pub2_data","2::2::Progression-free survival","No usable data for effect sizes"
"CD012532_pub2_data","3::1::Overall survival","No usable data for effect sizes"
"CD012532_pub2_data","3::2::Progression-free survival","No usable data for effect sizes"
"CD012532_pub2_data","4::1::Overall survival","No usable data for effect sizes"
"CD012532_pub2_data","4::2::Progression-free survival","No usable data for effect sizes"
"CD012532_pub2_data","5::1::Overall survival","No usable data for effect sizes"
"CD012532_pub2_data","5::2::Progression-free survival","No usable data for effect sizes"
"CD012532_pub2_data","6::1::Overall survival","No usable data for effect sizes"
"CD012532_pub2_data","6::2::Progression-free survival","No usable data for effect sizes"
"CD012532_pub2_data","7::1::Overall survival","No usable data for effect sizes"
"CD012532_pub2_data","7::2::Progression-free survival","No usable data for effect sizes"
"CD012570_pub2_data","1::7::Heart rate","No usable data for effect sizes"
"CD012572_pub3_data","1::2::Cardiovascular mortality","No usable data for effect sizes"
"CD012572_pub3_data","1::4::Hospitalisation","No usable data for effect sizes"
"CD012572_pub3_data","1::12::Quality of life","No usable data for effect sizes"
"CD012586_pub2_data","1::9::Blastocyst number","No usable data for effect sizes"
"CD012586_pub2_data","3::3::Ectopic","No usable data for effect sizes"
"CD012586_pub2_data","5::4::Miscarriage","No usable data for effect sizes"
"CD012586_pub2_data","5::7::Blastocyst number","No usable data for effect sizes"
"CD012586_pub2_data","7::1::Live birth or ongoing pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","7::2::Cancellation","No usable data for effect sizes"
"CD012586_pub2_data","7::3::Oocyte number","No usable data for effect sizes"
"CD012586_pub2_data","9::2::Oocyte number","No usable data for effect sizes"
"CD012586_pub2_data","9::3::Blastocyst number","No usable data for effect sizes"
"CD012586_pub2_data","10::6::Ectopic","No usable data for effect sizes"
"CD012586_pub2_data","12::8::Frozen embryo number","No usable data for effect sizes"
"CD012586_pub2_data","14::1::Live birth or ongoing pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","14::2::Multiple pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","14::3::Miscarriage","No usable data for effect sizes"
"CD012586_pub2_data","14::4::Ectopic","No usable data for effect sizes"
"CD012586_pub2_data","14::5::Cancellation","No usable data for effect sizes"
"CD012586_pub2_data","14::6::Oocyte number","No usable data for effect sizes"
"CD012586_pub2_data","16::1::Live birth or ongoing pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","16::4::Miscarriage","No usable data for effect sizes"
"CD012586_pub2_data","16::5::Cancellation","No usable data for effect sizes"
"CD012586_pub2_data","16::6::Oocyte number","No usable data for effect sizes"
"CD012586_pub2_data","17::6::Ectopic","No usable data for effect sizes"
"CD012586_pub2_data","17::9::Frozen embryo number","No usable data for effect sizes"
"CD012586_pub2_data","19::1::Clinical pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","19::2::Miscarriage","No usable data for effect sizes"
"CD012586_pub2_data","19::3::Cancellation","No usable data for effect sizes"
"CD012586_pub2_data","19::4::Oocyte number","No usable data for effect sizes"
"CD012586_pub2_data","20::1::Clinical pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","20::2::Miscarriage","No usable data for effect sizes"
"CD012586_pub2_data","20::3::Cancellation","No usable data for effect sizes"
"CD012586_pub2_data","20::4::Oocyte number","No usable data for effect sizes"
"CD012586_pub2_data","21::1::Live birth or ongoing pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","21::2::OHSS","No usable data for effect sizes"
"CD012586_pub2_data","21::3::Clinical pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","21::4::Cancellation","No usable data for effect sizes"
"CD012586_pub2_data","21::5::Oocyte number","No usable data for effect sizes"
"CD012586_pub2_data","22::1::Live birth or ongoing pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","22::2::OHSS","No usable data for effect sizes"
"CD012586_pub2_data","22::4::Multiple pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","22::5::Miscarriage","No usable data for effect sizes"
"CD012586_pub2_data","22::6::Ectopic","No usable data for effect sizes"
"CD012586_pub2_data","22::7::Cancellation","No usable data for effect sizes"
"CD012586_pub2_data","22::9::Cleavage embryo number","No usable data for effect sizes"
"CD012586_pub2_data","23::1::Live birth or ongoing pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","24::1::Live birth or ongoing pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","24::2::OHSS","No usable data for effect sizes"
"CD012586_pub2_data","24::3::Clinical pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","24::4::Multiple pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","26::1::OHSS","No usable data for effect sizes"
"CD012586_pub2_data","26::2::Cancellation","No usable data for effect sizes"
"CD012586_pub2_data","26::3::Oocyte number","No usable data for effect sizes"
"CD012586_pub2_data","27::4::Multiple pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","27::8::Cleavage embryo number","No usable data for effect sizes"
"CD012586_pub2_data","27::10::Frozen embryo number","No usable data for effect sizes"
"CD012586_pub2_data","29::1::Live birth or ongoing pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","29::2::OHSS","No usable data for effect sizes"
"CD012586_pub2_data","29::4::Multiple pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","31::1::Live birth or ongoing pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","31::2::Clinical pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","31::3::Cancellation","No usable data for effect sizes"
"CD012586_pub2_data","31::4::Oocyte number","No usable data for effect sizes"
"CD012586_pub2_data","31::5::Frozen embryo number","No usable data for effect sizes"
"CD012586_pub2_data","32::1::Live birth or ongoing pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","32::2::OHSS","No usable data for effect sizes"
"CD012586_pub2_data","32::3::Clinical pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","32::4::Miscarriage","No usable data for effect sizes"
"CD012586_pub2_data","32::5::Ectopic","No usable data for effect sizes"
"CD012586_pub2_data","32::6::Cancellation","No usable data for effect sizes"
"CD012586_pub2_data","32::7::Oocyte number","No usable data for effect sizes"
"CD012586_pub2_data","32::8::Cleavage embryo number","No usable data for effect sizes"
"CD012586_pub2_data","33::1::OHSS","No usable data for effect sizes"
"CD012586_pub2_data","33::2::Clinical pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","33::3::Cancellation","No usable data for effect sizes"
"CD012586_pub2_data","33::4::Oocyte number","No usable data for effect sizes"
"CD012586_pub2_data","34::1::OHSS","No usable data for effect sizes"
"CD012586_pub2_data","35::1::Live birth or ongoing pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","35::2::Clinical pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","35::3::Miscarriage","No usable data for effect sizes"
"CD012586_pub2_data","35::4::Cancellation","No usable data for effect sizes"
"CD012586_pub2_data","35::5::Oocyte number","No usable data for effect sizes"
"CD012586_pub2_data","36::1::Live birth or ongoing pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","36::2::Clinical pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","36::3::Oocyte number","No usable data for effect sizes"
"CD012586_pub2_data","37::1::Live birth or ongoing pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","37::2::Miscarriage","No usable data for effect sizes"
"CD012586_pub2_data","37::3::Oocyte number","No usable data for effect sizes"
"CD012586_pub2_data","37::4::Blastocyst number","No usable data for effect sizes"
"CD012586_pub2_data","39::1::Live birth or ongoing pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","39::2::Miscarriage","No usable data for effect sizes"
"CD012586_pub2_data","39::3::Cancellation","No usable data for effect sizes"
"CD012586_pub2_data","41::1::Live birth or ongoing pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","41::2::Clinical pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","43::1::Clinical pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","43::2::Miscarriage","No usable data for effect sizes"
"CD012586_pub2_data","43::3::Ectopic","No usable data for effect sizes"
"CD012586_pub2_data","43::4::Cancellation","No usable data for effect sizes"
"CD012586_pub2_data","43::5::Oocyte number","No usable data for effect sizes"
"CD012586_pub2_data","43::6::Frozen embryo number","No usable data for effect sizes"
"CD012586_pub2_data","44::1::Cancellation","No usable data for effect sizes"
"CD012586_pub2_data","44::2::Oocyte number","No usable data for effect sizes"
"CD012586_pub2_data","45::1::Cancellation","No usable data for effect sizes"
"CD012586_pub2_data","45::2::Oocyte number","No usable data for effect sizes"
"CD012586_pub2_data","46::1::Live birth or ongoing pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","46::2::Clinical pregnancy","No usable data for effect sizes"
"CD012586_pub2_data","46::3::Cancellation","No usable data for effect sizes"
"CD012586_pub2_data","47::1::Live birth or ongoing pregnancy","No usable data for effect sizes"
"CD012609_pub2_data","1::2::Loss of clinical response","No usable data for effect sizes"
"CD012609_pub2_data","1::3::Loss of clinical response in patients with exclusively fistulating disease","No usable data for effect sizes"
"CD012609_pub2_data","1::5::Serious adverse events ","No usable data for effect sizes"
"CD012609_pub2_data","2::1::Clinical relapse","No usable data for effect sizes"
"CD012609_pub2_data","2::2::Endoscopic relapse","No usable data for effect sizes"
"CD012609_pub2_data","2::3::Withdrawal due to adverse events","No usable data for effect sizes"
"CD012609_pub2_data","3::1::Serious adverse events","No usable data for effect sizes"
"CD012609_pub2_data","4::1::Clinical relapse","No usable data for effect sizes"
"CD012609_pub2_data","4::2::Loss of clinical response","No usable data for effect sizes"
"CD012609_pub2_data","4::3::Withdrawal due to adverse events ","No usable data for effect sizes"
"CD012609_pub2_data","4::4::Serious adverse events ","No usable data for effect sizes"
"CD012609_pub2_data","4::5::Total adverse events ","No usable data for effect sizes"
"CD012609_pub2_data","5::1::Clinical relapse","No usable data for effect sizes"
"CD012609_pub2_data","5::2::Loss of clinical response","No usable data for effect sizes"
"CD012609_pub2_data","5::3::Endoscopic relapse","No usable data for effect sizes"
"CD012609_pub2_data","5::4::Withdrawal due to adverse events ","No usable data for effect sizes"
"CD012609_pub2_data","6::1::Loss of clinical response","No usable data for effect sizes"
"CD012609_pub2_data","6::2::Withdrawal due to adverse events ","No usable data for effect sizes"
"CD012609_pub2_data","6::3::Serious adverse events ","No usable data for effect sizes"
"CD012609_pub2_data","6::4::Total adverse events ","No usable data for effect sizes"
"CD012635_pub2_data","1::3::All-cause mortality at 30 days","No usable data for effect sizes"
"CD012635_pub2_data","1::7::Requirement for surgery or interventional procedure within first 24 hours ","No usable data for effect sizes"
"CD012635_pub2_data","2::4::All-cause mortality at 30 days ","No usable data for effect sizes"
"CD012635_pub2_data","2::7::Total thromboembolic events in the first 30 days after injury","No usable data for effect sizes"
"CD012635_pub2_data","2::10::Venous thromboembolic events in the first 30 days after injury","No usable data for effect sizes"
"CD012635_pub2_data","3::1::All-cause mortality at 24 hours","No usable data for effect sizes"
"CD012635_pub2_data","3::2::All-cause mortality at 30 days","No usable data for effect sizes"
"CD012635_pub2_data","3::3::Mortality due to haemorrhage within 24 hours","No usable data for effect sizes"
"CD012635_pub2_data","4::1::All-cause mortality at 24 hours","No usable data for effect sizes"
"CD012635_pub2_data","4::4::Total thromboembolic events in the first 30 days after injury","No usable data for effect sizes"
"CD012642_pub2_data","1::4::Necrotising enterocolitis","No usable data for effect sizes"
"CD012642_pub2_data","1::6::Bronchopulmonary dysplasia (≥ 28 days age)","No usable data for effect sizes"
"CD012642_pub2_data","1::8::Periventricular leukomalacia","No usable data for effect sizes"
"CD012642_pub2_data","1::9::Maximal weight loss %","No usable data for effect sizes"
"CD012642_pub2_data","2::1::Mortality (latest time reported up to hospital discharge)","No usable data for effect sizes"
"CD012642_pub2_data","2::4::Postnatal growth failure (weight < 10th percentile)","No usable data for effect sizes"
"CD012642_pub2_data","2::5::Necrotising enterocolitis","No usable data for effect sizes"
"CD012642_pub2_data","2::6::Patent ductus arteriosus","No usable data for effect sizes"
"CD012642_pub2_data","2::7::Chronic lung disease (36 weeks' PMA)","No usable data for effect sizes"
"CD012642_pub2_data","2::8::Maximal weight loss %","No usable data for effect sizes"
"CD012642_pub2_data","2::10::Linear growth cm/week","No usable data for effect sizes"
"CD012642_pub2_data","2::11::Percent weight change from birth to 2 weeks","No usable data for effect sizes"
"CD012642_pub2_data","3::1::Hypernatraemia (≥ 150 mmol/L)","No usable data for effect sizes"
"CD012642_pub2_data","3::2::Weight gain","No usable data for effect sizes"
"CD012642_pub2_data","4::4::Necrotising enterocolitis","No usable data for effect sizes"
"CD012642_pub2_data","4::5::Bronchopulmonary dysplasia (≥ 28 days age)","No usable data for effect sizes"
"CD012642_pub2_data","5::1::Mortality (latest time reported up to hospital discharge)","No usable data for effect sizes"
"CD012642_pub2_data","5::4::Postnatal growth failure (weight < 10th percentile)","No usable data for effect sizes"
"CD012642_pub2_data","5::5::Necrotising enterocolitis","No usable data for effect sizes"
"CD012642_pub2_data","5::6::Chronic lung disease (36 weeks' PMA)","No usable data for effect sizes"
"CD012642_pub2_data","6::4::Necrotising enterocolitis","No usable data for effect sizes"
"CD012642_pub2_data","6::5::Bronchopulmonary dysplasia (≥ 28 days age)","No usable data for effect sizes"
"CD012642_pub2_data","8::4::Necrotising enterocolitis","No usable data for effect sizes"
"CD012642_pub2_data","8::5::Bronchopulmonary dysplasia (≥ 28 days age)","No usable data for effect sizes"
"CD012642_pub2_data","9::4::Necrotising enterocolitis","No usable data for effect sizes"
"CD012642_pub2_data","9::5::Bronchopulmonary dysplasia (≥ 28 days age)","No usable data for effect sizes"
"CD012642_pub2_data","10::1::Mortality (latest time reported up to hospital discharge)","No usable data for effect sizes"
"CD012642_pub2_data","10::4::Postnatal growth failure (weight < 10th percentile)","No usable data for effect sizes"
"CD012642_pub2_data","10::5::Necrotising enterocolitis","No usable data for effect sizes"
"CD012642_pub2_data","10::6::Chronic lung disease (36 weeks' PMA)","No usable data for effect sizes"
"CD012642_pub2_data","11::4::Necrotising enterocolitis","No usable data for effect sizes"
"CD012642_pub2_data","11::5::Bronchopulmonary dysplasia (≥ 28 days age)","No usable data for effect sizes"
"CD012693_pub3_data","1::9::Normal response to stimulation","No usable data for effect sizes"
"CD012693_pub3_data","1::10::Hyper-response to stimulation","No usable data for effect sizes"
"CD012693_pub3_data","1::19::Cumulative live birth: 18 months","No usable data for effect sizes"
"CD012693_pub3_data","2::19::Cumulative live birth: 18 months","No usable data for effect sizes"
"CD012693_pub3_data","3::1::Live birth or ongoing pregnancy","No usable data for effect sizes"
"CD012693_pub3_data","3::2::Severe OHSS","No usable data for effect sizes"
"CD012693_pub3_data","3::3::Clinical pregnancy","No usable data for effect sizes"
"CD012693_pub3_data","3::5::Moderate or severe OHSS","No usable data for effect sizes"
"CD012693_pub3_data","3::6::Multiple pregnancy in randomised women","No usable data for effect sizes"
"CD012693_pub3_data","3::7::Log(N oocytes retrieved); data presented on the log scale - cannot interpret pooled estimates as N of oocytes","No usable data for effect sizes"
"CD012693_pub3_data","3::8::Poor response to stimulation","No usable data for effect sizes"
"CD012693_pub3_data","3::9::Normal response to stimulation","No usable data for effect sizes"
"CD012693_pub3_data","3::10::Hyper-response to stimulation","No usable data for effect sizes"
"CD012693_pub3_data","3::11::Cycle cancellations for poor response","No usable data for effect sizes"
"CD012693_pub3_data","3::12::Cycle cancellations for hyper-response","No usable data for effect sizes"
"CD012693_pub3_data","3::13::Cycle cancellations for poor or hyper-response","No usable data for effect sizes"
"CD012693_pub3_data","3::14::Women with at least one transferable embryo","No usable data for effect sizes"
"CD012693_pub3_data","3::15::Total dose of FSH","No usable data for effect sizes"
"CD012693_pub3_data","3::16::Duration of FSH administration","No usable data for effect sizes"
"CD012693_pub3_data","3::17::Cost per woman randomised","No usable data for effect sizes"
"CD012693_pub3_data","3::18::Cumulative live birth: 1 cycle (fresh + frozen)","No usable data for effect sizes"
"CD012693_pub3_data","3::19::Cumulative live birth: 18 months","No usable data for effect sizes"
"CD012693_pub3_data","3::20::Multiple pregnancy in women with clinical pregnancy","No usable data for effect sizes"
"CD012693_pub3_data","4::19::Cumulative live birth: 18 months","No usable data for effect sizes"
"CD012693_pub3_data","5::2::Severe OHSS","No usable data for effect sizes"
"CD012693_pub3_data","5::3::Clinical pregnancy","No usable data for effect sizes"
"CD012693_pub3_data","5::5::Moderate or severe OHSS","No usable data for effect sizes"
"CD012693_pub3_data","5::6::Multiple pregnancy in randomised women","No usable data for effect sizes"
"CD012693_pub3_data","5::7::Log(N oocytes retrieved); data presented on the log scale - cannot interpret pooled estimates as N of oocytes","No usable data for effect sizes"
"CD012693_pub3_data","5::8::Poor response to stimulation","No usable data for effect sizes"
"CD012693_pub3_data","5::9::Normal response to stimulation","No usable data for effect sizes"
"CD012693_pub3_data","5::10::Hyper-response to stimulation","No usable data for effect sizes"
"CD012693_pub3_data","5::11::Cycle cancellations for poor response","No usable data for effect sizes"
"CD012693_pub3_data","5::12::Cycle cancellations for hyper-response","No usable data for effect sizes"
"CD012693_pub3_data","5::13::Cycle cancellations for poor or hyper-response","No usable data for effect sizes"
"CD012693_pub3_data","5::14::Women with at least one transferable embryo","No usable data for effect sizes"
"CD012693_pub3_data","5::15::Total dose of FSH","No usable data for effect sizes"
"CD012693_pub3_data","5::16::Duration of FSH administration","No usable data for effect sizes"
"CD012693_pub3_data","5::19::Multiple pregnancy in women with clinical pregnancy","No usable data for effect sizes"
"CD012693_pub3_data","6::1::Live birth or ongoing pregnancy","No usable data for effect sizes"
"CD012693_pub3_data","6::2::Severe OHSS","No usable data for effect sizes"
"CD012693_pub3_data","6::3::Clinical pregnancy","No usable data for effect sizes"
"CD012693_pub3_data","6::5::Moderate or severe OHSS","No usable data for effect sizes"
"CD012693_pub3_data","6::6::Multiple pregnancy in randomised women","No usable data for effect sizes"
"CD012693_pub3_data","6::7::Log(N oocytes retrieved); data presented on the log scale - cannot interpret pooled estimates as N of oocytes","No usable data for effect sizes"
"CD012693_pub3_data","6::8::Poor response to stimulation","No usable data for effect sizes"
"CD012693_pub3_data","6::9::Normal response to stimulation","No usable data for effect sizes"
"CD012693_pub3_data","6::10::Hyper-response to stimulation","No usable data for effect sizes"
"CD012693_pub3_data","6::11::Cycle cancellations for poor response","No usable data for effect sizes"
"CD012693_pub3_data","6::12::Cycle cancellations for hyper-response","No usable data for effect sizes"
"CD012693_pub3_data","6::13::Cycle cancellations for poor or hyper-response","No usable data for effect sizes"
"CD012693_pub3_data","6::14::Women with at least one transferable embryo","No usable data for effect sizes"
"CD012693_pub3_data","6::15::Total dose of FSH","No usable data for effect sizes"
"CD012693_pub3_data","6::16::Duration of FSH administration","No usable data for effect sizes"
"CD012693_pub3_data","6::18::Live birth or ongoing pregnancy (including FET for freeze-all)","No usable data for effect sizes"
"CD012693_pub3_data","6::19::Multiple pregnancy in women with clinical pregnancy","No usable data for effect sizes"
"CD012693_pub3_data","7::1::Live birth or ongoing pregnancy","No usable data for effect sizes"
"CD012693_pub3_data","7::3::Clinical pregnancy","No usable data for effect sizes"
"CD012693_pub3_data","7::7::Log(N oocytes retrieved); data presented on the log scale - cannot interpret pooled estimates as N of oocytes","No usable data for effect sizes"
"CD012693_pub3_data","7::8::Poor response to stimulation","No usable data for effect sizes"
"CD012693_pub3_data","7::9::Normal response to stimulation","No usable data for effect sizes"
"CD012693_pub3_data","7::10::Hyper-response to stimulation","No usable data for effect sizes"
"CD012693_pub3_data","7::15::Total dose of FSH","No usable data for effect sizes"
"CD012693_pub3_data","7::16::Duration of FSH administration","No usable data for effect sizes"
"CD012712_pub2_data","1::1::Mortality before hospital discharge","No usable data for effect sizes"
"CD012712_pub2_data","1::2::Duration of respiratory support, days","No usable data for effect sizes"
"CD012712_pub2_data","1::5::Length of hospital stay, days","No usable data for effect sizes"
"CD012712_pub2_data","2::8::Death or chronic lung disease at 36 weeks","No usable data for effect sizes"
"CD012712_pub2_data","2::13::Necrotising enterocolitis (NEC) (Bell stage ≥ 2)","No usable data for effect sizes"
"CD012712_pub2_data","2::14::Spontaneous intestinal perforation","No usable data for effect sizes"
"CD012712_pub2_data","2::17::Periventricular leukomalacia","No usable data for effect sizes"
"CD012712_pub2_data","2::19::Retinopathy of prematurity, stage ≥ 3","No usable data for effect sizes"
"CD012712_pub2_data","5::3::Failure of respiratory support","No usable data for effect sizes"
"CD012712_pub2_data","5::5::Death or chronic lung disease at 36 weeks","No usable data for effect sizes"
"CD012712_pub2_data","6::4::Failure of extubation","No usable data for effect sizes"
"CD012712_pub2_data","6::16::Periventricular leukomalacia","No usable data for effect sizes"
"CD012712_pub2_data","9::3::Failure of extubation","No usable data for effect sizes"
"CD012712_pub2_data","10::1::Mortality before hospital discharge","No usable data for effect sizes"
"CD012712_pub2_data","10::2::Endotracheal intubation","No usable data for effect sizes"
"CD012712_pub2_data","10::3::Failure of respiratory support","No usable data for effect sizes"
"CD012712_pub2_data","10::4::Duration of oxygen therapy, days","No usable data for effect sizes"
"CD012712_pub2_data","10::5::Chronic lung disease at 36 weeks","No usable data for effect sizes"
"CD012712_pub2_data","10::6::Pulmonary air leak syndromes","No usable data for effect sizes"
"CD012712_pub2_data","10::7::Necrotising enterocolitis","No usable data for effect sizes"
"CD012712_pub2_data","10::8::Spontaneous intestinal perforation","No usable data for effect sizes"
"CD012712_pub2_data","10::9::Intraventricular haemorrhage, Papile grade 3/4","No usable data for effect sizes"
"CD012712_pub2_data","10::10::Periventricular leukomalacia","No usable data for effect sizes"
"CD012712_pub2_data","10::11::Retinopathy of prematurity, stage ≥ 3","No usable data for effect sizes"
"CD012718_pub2_data","1::5::Secondary prevention of caries (at end of study follow-up; analysed with OR)","No usable data for effect sizes"
"CD012718_pub2_data","1::7::Secondary prevention of caries (at end of study follow-up; analysed with OR)","No usable data for effect sizes"
"CD012718_pub2_data","2::3::Secondary prevention of caries (at end of study follow-up)","No usable data for effect sizes"
"CD012718_pub2_data","2::4::Secondary prevention of caries (end of study follow-up)","No usable data for effect sizes"
"CD012718_pub2_data","2::5::Adverse effects","No usable data for effect sizes"
"CD012718_pub2_data","3::6::Secondary prevention of caries (at end of study follow-up)","No usable data for effect sizes"
"CD012718_pub2_data","3::7::Secondary prevention of caries (at end of study follow-up)","No usable data for effect sizes"
"CD012718_pub2_data","3::9::Pain (at end of study follow-up)","No usable data for effect sizes"
"CD012718_pub2_data","3::10::Aesthetics (end of study follow-up)","No usable data for effect sizes"
"CD012718_pub2_data","4::1::Primary caries prevention (at end of study follow-up)","No usable data for effect sizes"
"CD012718_pub2_data","5::1::Caries arrest (at end of study follow-up)","No usable data for effect sizes"
"CD012718_pub2_data","5::2::Caries arrest (at end of study follow-up)","No usable data for effect sizes"
"CD012718_pub2_data","6::1::Primary caries prevention (at end of study follow-up)","No usable data for effect sizes"
"CD012718_pub2_data","6::2::Secondary prevention of caries (at end of study follow-up)","No usable data for effect sizes"
"CD012718_pub2_data","7::1::Caries arrest (at end of study follow-up)","No usable data for effect sizes"
"CD012718_pub2_data","7::3::Dental pain or sensitivity (number of people with tooth sensitivity; end of study follow-up)","No usable data for effect sizes"
"CD012718_pub2_data","8::1::Caries arrest (at end of study follow-up)","No usable data for effect sizes"
"CD012718_pub2_data","9::1::Caries arrest (at end of study follow-up)","No usable data for effect sizes"
"CD012718_pub2_data","10::1::Caries arrest (at end of study follow-up)","No usable data for effect sizes"
"CD012718_pub2_data","10::2::Pain (at end of study follow-up)","No usable data for effect sizes"
"CD012757_pub2_data","1::5::Mortality at 50 months' follow-up","No usable data for effect sizes"
"CD012850_pub2_data","1::1::Self-reported joint pain at rest (dichotomous data)","No usable data for effect sizes"
"CD012850_pub2_data","1::2::Self-reported joint pain at rest (continuous data)","No usable data for effect sizes"
"CD012850_pub2_data","1::5::Self-reported joint pain at mastication (dichotomous data)","No usable data for effect sizes"
"CD012850_pub2_data","1::6::Muscle pain at rest (dichotomous data)","No usable data for effect sizes"
"CD012850_pub2_data","1::7::Muscle pain at rest (continuous data)","No usable data for effect sizes"
"CD012850_pub2_data","1::8::Muscle pain at rest (continuous data)","No usable data for effect sizes"
"CD012850_pub2_data","1::9::Muscle pain at rest (continuous data)","No usable data for effect sizes"
"CD012850_pub2_data","1::10::Muscle pain at rest (continuous data)","No usable data for effect sizes"
"CD012850_pub2_data","1::11::Muscle pain at rest (continuous data)","No usable data for effect sizes"
"CD012850_pub2_data","1::12::Muscle pain at rest (continuous data)","No usable data for effect sizes"
"CD012850_pub2_data","1::13::Muscle pain at mastication (dichotomous data)","No usable data for effect sizes"
"CD012850_pub2_data","1::14::Muscle pain at mastication (dichotomous data)","No usable data for effect sizes"
"CD012850_pub2_data","1::15::Muscle pain at mastication (continuous data)","No usable data for effect sizes"
"CD012850_pub2_data","1::16::Severity of joint noise","No usable data for effect sizes"
"CD012850_pub2_data","1::19::Frequency of joint noise","No usable data for effect sizes"
"CD012850_pub2_data","1::24::Range of mandibular motion (unassisted (mandibular) opening without pain)","No usable data for effect sizes"
"CD012850_pub2_data","1::25::Range of mandibular motion (unassisted (mandibular) opening without pain)","No usable data for effect sizes"
"CD012850_pub2_data","1::26::Range of mandibular motion (unassisted (mandibular) opening without pain)","No usable data for effect sizes"
"CD012850_pub2_data","2::1::Self-reported joint pain at rest","No usable data for effect sizes"
"CD012850_pub2_data","2::2::Self-reported joint pain at rest","No usable data for effect sizes"
"CD012850_pub2_data","2::3::Self-reported joint pain at rest","No usable data for effect sizes"
"CD012850_pub2_data","2::4::Clinically assessed joint pain at rest","No usable data for effect sizes"
"CD012850_pub2_data","2::5::Clinically assessed joint pain at rest","No usable data for effect sizes"
"CD012850_pub2_data","2::6::Participant satisfaction or quality of life","No usable data for effect sizes"
"CD012850_pub2_data","2::7::Frequency of joint noise","No usable data for effect sizes"
"CD012850_pub2_data","2::8::Frequency of joint noise","No usable data for effect sizes"
"CD012850_pub2_data","2::9::Range of mandibular motion (maximum assisted (mandibular opening)","No usable data for effect sizes"
"CD012850_pub2_data","2::11::Range of mandibular motion (unassisted (mandibular) opening without pain)","No usable data for effect sizes"
"CD012850_pub2_data","3::1::Self-reported joint pain at rest","No usable data for effect sizes"
"CD012850_pub2_data","3::3::Self-reported joint pain at rest","No usable data for effect sizes"
"CD012850_pub2_data","3::4::Self-reported joint pain at rest","No usable data for effect sizes"
"CD012850_pub2_data","3::5::Clinically assessed joint pain at rest","No usable data for effect sizes"
"CD012850_pub2_data","3::7::Muscle pain at rest","No usable data for effect sizes"
"CD012850_pub2_data","3::8::Muscle pain at rest","No usable data for effect sizes"
"CD012850_pub2_data","3::10::Muscle pain at rest","No usable data for effect sizes"
"CD012850_pub2_data","3::11::Muscle pain at mastication","No usable data for effect sizes"
"CD012850_pub2_data","3::12::Muscle pain at mastication","No usable data for effect sizes"
"CD012850_pub2_data","3::14::Severity of joint noise","No usable data for effect sizes"
"CD012850_pub2_data","3::15::Frequency of joint noise","No usable data for effect sizes"
"CD012850_pub2_data","3::17::Frequency of joint noise","No usable data for effect sizes"
"CD012850_pub2_data","3::21::Range of mandibular motion (maximum unassisted (mandibular) opening","No usable data for effect sizes"
"CD012850_pub2_data","3::24::Depression","No usable data for effect sizes"
"CD012850_pub2_data","3::25::Depression","No usable data for effect sizes"
"CD012850_pub2_data","3::26::Somatisation","No usable data for effect sizes"
"CD012850_pub2_data","4::1::Self-reported joint pain at rest","No usable data for effect sizes"
"CD012850_pub2_data","4::3::Range of mandibular motion (unassisted opening without pain)","No usable data for effect sizes"
"CD012850_pub2_data","5::1::Muscle pain at mastication","No usable data for effect sizes"
"CD012850_pub2_data","5::2::Participant satisfaction or quality of life","No usable data for effect sizes"
"CD012850_pub2_data","5::4::Range of mandibular motion (maximum assisted opening)","No usable data for effect sizes"
"CD012850_pub2_data","6::1::Clinically assessed joint pain at rest (dichotomous)","No usable data for effect sizes"
"CD012850_pub2_data","6::2::Clinically assessed joint pain at rest (continuous)","No usable data for effect sizes"
"CD012850_pub2_data","6::3::Self-reported joint pain at mastication","No usable data for effect sizes"
"CD012850_pub2_data","6::4::Range of mandibular motion (maximum assisted opening)","No usable data for effect sizes"
"CD012850_pub2_data","6::5::Range of mandibular motion (maximum unassisted opening)","No usable data for effect sizes"
"CD012850_pub2_data","6::6::Range of mandibular motion (unassisted opening without pain)","No usable data for effect sizes"
"CD012886_pub3_data","1::1::Outcome 1 Newly diagnosed musculoskeletal disorders or symptoms (new onset of musculoskeletal pain - neck)","No usable data for effect sizes"
"CD012886_pub3_data","1::2::Outcome 2 Newly diagnosed musculoskeletal disorders or symptoms (new onset of musculoskeletal pain - back)","No usable data for effect sizes"
"CD012886_pub3_data","1::3::Outcome 3 Intensity of musculoskeletal symptoms (pain - overall)","No usable data for effect sizes"
"CD012886_pub3_data","1::4::Outcome 4 Intensity of musculoskeletal symptoms (pain - neck)","No usable data for effect sizes"
"CD012886_pub3_data","1::5::Outcome 5 Intensity of musculoskeletal symptoms (pain - back)","No usable data for effect sizes"
"CD012886_pub3_data","1::11::Outcome 11 Intensity of musculoskeletal symptoms (discomfort - right elbow)","No usable data for effect sizes"
"CD012886_pub3_data","1::12::Outcome 12 Intensity of musculoskeletal symptoms (discomfort - left elbow)","No usable data for effect sizes"
"CD012886_pub3_data","1::15::Outcome 15 Intensity of musculoskeletal symptoms (discomfort - left forearm/wrist/hand)","No usable data for effect sizes"
"CD012886_pub3_data","1::20::Outcome 20 Productivity or work performance (productivity - words types per three hours (compared to baseline))","No usable data for effect sizes"
"CD012886_pub3_data","1::21::Outcome 21 Productivity or work performance (work performance - functioning)","No usable data for effect sizes"
"CD012886_pub3_data","1::22::Outcome 22 Productivity or work performance (work performance - manual precision)","No usable data for effect sizes"
"CD012886_pub3_data","2::1::Outcome 1 Intensity of musculoskeletal symptoms (discomfort - neck)","No usable data for effect sizes"
"CD012886_pub3_data","2::2::Outcome 2 Intensity of musculoskeletal symptoms (discomfort - back)","No usable data for effect sizes"
"CD012886_pub3_data","2::3::Outcome 3 Intensity of musculoskeletal symptoms (discomfort - shoulders)","No usable data for effect sizes"
"CD012886_pub3_data","2::4::Outcome 4 Intensity of musculoskeletal symptoms (discomfort - forearms/wrists)","No usable data for effect sizes"
"CD012886_pub3_data","2::5::Outcome 5 Productivity or work performance (productivity - words typed per three hours)","No usable data for effect sizes"
"CD012891_pub2_data","1::1::Standard controlled ovarian hyperstimulation with gonadotropins versus controlled ovarian hyperstimulation with gonadotropins + letrozole: number of oocytes retrieved after ovarian stimulation","No usable data for effect sizes"
"CD012891_pub2_data","1::2::Standard controlled ovarian hyperstimulation with gonadotropins versus controlled ovarian hyperstimulation with gonadotropins + tamoxifen: number of oocytes retrieved after ovarian stimulation","No usable data for effect sizes"
"CD012891_pub2_data","3::4::Overall survival at 5 years","No usable data for effect sizes"
"CD012891_pub2_data","3::5::Overall survival at 12 years","No usable data for effect sizes"
"CD012891_pub2_data","3::9::Disease-free survival at 5 years","No usable data for effect sizes"
"CD012891_pub2_data","3::10::Disease-free survival at 12 years","No usable data for effect sizes"
"CD012891_pub2_data","4::2::Live birth","No usable data for effect sizes"
"CD012891_pub2_data","4::3::Overall survival","No usable data for effect sizes"
"CD012891_pub2_data","4::6::Disease-free survival","No usable data for effect sizes"
"CD012905_pub2_data","2::6::Adverse events","No usable data for effect sizes"
"CD012905_pub2_data","3::3::Death","No usable data for effect sizes"
"CD012905_pub2_data","3::5::Duration of ICU stay [days]","No usable data for effect sizes"
"CD012905_pub2_data","3::6::Adverse events","No usable data for effect sizes"
"CD012925_pub2_data","1::2::Provider adherence to recommended practice (continuous outcomes)","No usable data for effect sizes"
"CD012925_pub2_data","1::4::Patient/client health status and well-being (desirable outcomes)","No usable data for effect sizes"
"CD012925_pub2_data","2::1::Client's health behaviour","No usable data for effect sizes"
"CD012925_pub2_data","2::3::Patient/client health status and well-being (inverse variance)","No usable data for effect sizes"
"CD012925_pub2_data","2::5::Client utilisation of primary healthcare and/or services - hospitalisations for stroke","No usable data for effect sizes"
"CD012925_pub2_data","3::7::Client utilisation of primary healthcare and/or services (odds ratio) - never-missed early infant diagnosis visit","No usable data for effect sizes"
"CD012925_pub2_data","3::9::Patient/client acceptability/satisfaction with the intervention","No usable data for effect sizes"
"CD012942_pub2_data","1::8::Comparison 8 Vilazodone versus placebo, Outcome 1 Rate of treatment response measured as a reduction of at least 50% on the HAM-A","No usable data for effect sizes"
"CD012942_pub2_data","1::9::Comparison 9 Vortioxetine versus placebo, Outcome 1 Rate of treatment response measured as a reduction of at least 50% on the HAM-A","No usable data for effect sizes"
"CD012942_pub2_data","2::9::Comparison 9 Vilazodone versus placebo, Outcome 2 Acceptability","No usable data for effect sizes"
"CD012942_pub2_data","2::10::Comparison 10 Vortioxetine versus placebo, Outcome 2 Acceptability","No usable data for effect sizes"
"CD012942_pub2_data","3::3::Comparison 3 Duloxetine versus placebo, Outcome 3 Rate of treatment response (defined by study authors)","No usable data for effect sizes"
"CD012942_pub2_data","3::8::Comparison 8 Vilazodone versus placebo, Outcome 3 Rate of treatment response (defined by study authors)","No usable data for effect sizes"
"CD012942_pub2_data","4::7::Comparison 7 Sertraline versus placebo, Outcome 4 Remission rate","No usable data for effect sizes"
"CD012942_pub2_data","4::9::Comparison 8 Vortioxetine versus placebo, Outcome 4 Remission rate","No usable data for effect sizes"
"CD012942_pub2_data","5::6::Comparison 7 Imipramine versus placebo, Outcome 4 Change in symptom levels","No usable data for effect sizes"
"CD012942_pub2_data","5::10::Comparison 11 Vilazodone versus placebo, Outcome 4 Change in symptom levels","No usable data for effect sizes"
"CD012942_pub2_data","5::11::Comparison 12 Vortioxetine versus placebo, Outcome 4 Change in symptom levels","No usable data for effect sizes"
"CD012942_pub2_data","6::7::Comparison 7 Sertraline versus placebo, Outcome 6 Total number of participants reporting adverse events","No usable data for effect sizes"
"CD012942_pub2_data","6::9::Comparison 9 Vilazodone versus placebo, Outcome 6 Total number of participants reporting adverse events","No usable data for effect sizes"
"CD012942_pub2_data","6::10::Comparison 10 Vortioxetine versus placebo, Outcome 6 Total number of participants reporting adverse events","No usable data for effect sizes"
"CD012942_pub2_data","7::7::Comparison 7 Sertraline versus placebo, Outcome 7 Sleepiness/drowsiness","No usable data for effect sizes"
"CD012942_pub2_data","7::9::Comparison 9 Vilazodone versus placebo, Outcome 7 Sleepiness/drowsiness","No usable data for effect sizes"
"CD012942_pub2_data","7::10::Comparison 10 Vortioxetine versus placebo, Outcome 7 Sleepiness/drowsiness","No usable data for effect sizes"
"CD012942_pub2_data","8::6::Comparison 6 Venlafaxine versus placebo, Outcome 8 Agitation/anxiety","No usable data for effect sizes"
"CD012942_pub2_data","9::3::Comparison 3 Duloxetine versus placebo, Outcome 9 Suicide wishes/gestures/attempts","No usable data for effect sizes"
"CD012942_pub2_data","9::4::Comparison 4 Paroxetine versus placebo, Outcome 9 Suicide wishes/gestures/attempts","No usable data for effect sizes"
"CD012942_pub2_data","9::5::Comparison 5 Vilazodone versus placebo, Outcome 9 Suicide wishes/gestures/attempts","No usable data for effect sizes"
"CD012942_pub2_data","10::3::Comparison 3 Escitalopram versus placebo, Outcome 10 Average score/change in quality of life/satisfaction","No usable data for effect sizes"
"CD012942_pub2_data","10::4::Comparison 4 Paroxetine versus placebo, Outcome 10 Average score/change in quality of life/satisfaction","No usable data for effect sizes"
"CD012942_pub2_data","10::5::Comparison 5 Sertraline versus placebo, Outcome 10 Average score/change in quality of life/satisfaction","No usable data for effect sizes"
"CD012942_pub2_data","10::6::Comparison 6 Venlafaxine versus placebo, Outcome 10 Average score/change in quality of life/satisfaction","No usable data for effect sizes"
"CD012942_pub2_data","11::9::Comparison 9 Vilazodone versus placebo, Outcome 11 Dropouts due to a lack of efficacy","No usable data for effect sizes"
"CD012942_pub2_data","11::10::Comparison 10 Vortioxetine versus placebo, Outcome 11 Dropouts due to a lack of efficacy","No usable data for effect sizes"
"CD012942_pub2_data","12::9::Comparison 9 Vilazodone versus placebo, Outcome 12 Dropouts due to adverse effects","No usable data for effect sizes"
"CD012942_pub2_data","12::10::Comparison 10 Vortioxetine versus placebo, Outcome 12 Dropouts due to adverse effects","No usable data for effect sizes"
"CD012967_pub2_data","1::1::Change in validated symptom score at 6 months","No usable data for effect sizes"
"CD012967_pub2_data","1::2::Change in validated symptom score at 24 months","No usable data for effect sizes"
"CD012967_pub2_data","1::3::Change in impairment score at 6 months","No usable data for effect sizes"
"CD012993_pub2_data","1::1::Change in 6MWT from baseline","No usable data for effect sizes"
"CD012993_pub2_data","1::2::Change in FVC from baseline","No usable data for effect sizes"
"CD012993_pub2_data","1::3::Infusion reactions","No usable data for effect sizes"
"CD012993_pub2_data","1::4::Quality of life (measured by PCS in SF-36)","No usable data for effect sizes"
"CD012993_pub2_data","1::5::Treatment-related adverse events","No usable data for effect sizes"
"CD012993_pub2_data","3::3::Adverse events","No usable data for effect sizes"
"CD012993_pub2_data","4::1::Infusion-associated reactions","No usable data for effect sizes"
"CD012993_pub2_data","5::2::Change in sitting FVC (% predicted) from baseline to 52 weeks","No usable data for effect sizes"
"CD012993_pub2_data","5::3::Change in % predicted SNIP from baseline to 52 weeks","No usable data for effect sizes"
"CD012993_pub2_data","5::4::Infusion reactions - total","No usable data for effect sizes"
"CD012993_pub2_data","5::5::Quality of life - PROMIS - physical function score","No usable data for effect sizes"
"CD012993_pub2_data","5::6::Quality of life - PROMIS - fatigue score","No usable data for effect sizes"
"CD012993_pub2_data","5::7::Treatment-emergent adverse events - total","No usable data for effect sizes"
"CD012993_pub2_data","6::1::Change in 6MWT","No usable data for effect sizes"
"CD012993_pub2_data","6::2::Change in % predicted 6MWT","No usable data for effect sizes"
"CD012993_pub2_data","6::3::Change in FVC from baseline","No usable data for effect sizes"
"CD012993_pub2_data","6::4::Infusion reactions","No usable data for effect sizes"
"CD012993_pub2_data","6::7::Treatment-emergent adverse events","No usable data for effect sizes"
"CD012997_pub3_data","1::1::Incidence of HUS","No usable data for effect sizes"
"CD012997_pub3_data","2::1::Incidence of HUS","No usable data for effect sizes"
"CD012997_pub3_data","2::2::Adverse events","No usable data for effect sizes"
"CD012997_pub3_data","3::1::Incidence of HUS","No usable data for effect sizes"
"CD013023_pub2_data","2::1::Arterial catheter failure","No usable data for effect sizes"
"CD013023_pub2_data","2::5::Adverse events","No usable data for effect sizes"
"CD013023_pub2_data","3::1::Arterial catheter failure","No usable data for effect sizes"
"CD013023_pub2_data","3::2::Occlusion","No usable data for effect sizes"
"CD013023_pub2_data","4::1::Arterial catheter failure","No usable data for effect sizes"
"CD013023_pub2_data","4::2::Dislodgement","No usable data for effect sizes"
"CD013023_pub2_data","4::3::Occlusion","No usable data for effect sizes"
"CD013023_pub2_data","6::1::Arterial catheter failure","No usable data for effect sizes"
"CD013023_pub2_data","6::2::Occlusion","No usable data for effect sizes"
"CD013023_pub2_data","7::1::Arterial catheter failure","No usable data for effect sizes"
"CD013023_pub2_data","7::2::Dislodgement","No usable data for effect sizes"
"CD013023_pub2_data","7::3::Occlusion","No usable data for effect sizes"
"CD013023_pub2_data","7::4::Adverse events","No usable data for effect sizes"
"CD013023_pub2_data","9::1::Arterial catheter failure","No usable data for effect sizes"
"CD013023_pub2_data","9::2::Dislodgement","No usable data for effect sizes"
"CD013023_pub2_data","9::3::Occlusion","No usable data for effect sizes"
"CD013023_pub2_data","9::4::Adverse events","No usable data for effect sizes"
"CD013023_pub2_data","10::1::Arterial catheter failure","No usable data for effect sizes"
"CD013023_pub2_data","10::2::Dislodgement","No usable data for effect sizes"
"CD013023_pub2_data","10::3::Occlusion","No usable data for effect sizes"
"CD013023_pub2_data","11::1::Arterial catheter failure","No usable data for effect sizes"
"CD013023_pub2_data","11::2::Dislodgement","No usable data for effect sizes"
"CD013023_pub2_data","11::3::Adverse events","No usable data for effect sizes"
"CD013042_pub2_data","1::1::Mean pain (0 to 10, 0 is no pain)","No usable data for effect sizes"
"CD013042_pub2_data","1::2::Mean disability (0 to 100, 0 is no disability)","No usable data for effect sizes"
"CD013042_pub2_data","1::3::Mean grip strength (lb/in2)","No usable data for effect sizes"
"CD013042_pub2_data","2::8::Proportion on sick leave","No usable data for effect sizes"
"CD013042_pub2_data","3::3::Mean health related quality of life","No usable data for effect sizes"
"CD013042_pub2_data","3::8::Proportion on sick leave","No usable data for effect sizes"
"CD013042_pub2_data","4::5::Proportion with any adverse event","No usable data for effect sizes"
"CD013042_pub2_data","4::6::Mean pain free grip strength (kg)","No usable data for effect sizes"
"CD013042_pub2_data","5::3::Mean health-related quality of life","No usable data for effect sizes"
"CD013042_pub2_data","5::6::Proportion with any adverse event","No usable data for effect sizes"
"CD013042_pub2_data","7::4::Proportion of overall withdrawals","No usable data for effect sizes"
"CD013042_pub2_data","7::5::Proportion with any adverse event","No usable data for effect sizes"
"CD013042_pub2_data","8::7::Mean grip strength (affected side/unaffected side x 100)","No usable data for effect sizes"
"CD013042_pub2_data","9::5::Proportion of overall withdrawals","No usable data for effect sizes"
"CD013042_pub2_data","9::6::Proportion with any adverse event","No usable data for effect sizes"
"CD013042_pub2_data","10::3::Participant-reported treatment success","No usable data for effect sizes"
"CD013042_pub2_data","10::4::Proportion of overall withdrawals","No usable data for effect sizes"
"CD013042_pub2_data","10::6::Mean grip strength (affected side/unaffected side x 100)","No usable data for effect sizes"
"CD013051_pub3_data","1::1::Resolution of ear discharge","No usable data for effect sizes"
"CD013051_pub3_data","3::3::Ear pain/discomfort/local irritation","No usable data for effect sizes"
"CD013051_pub3_data","4::1::Resolution of ear discharge (1 to up to 2 weeks)","No usable data for effect sizes"
"CD013052_pub3_data","2::4::Ear pain","No usable data for effect sizes"
"CD013052_pub3_data","3::1::Resolution of ear discharge (2 to 4 weeks)","No usable data for effect sizes"
"CD013052_pub3_data","3::2::Resolution of ear discharge (after 4 weeks)","No usable data for effect sizes"
"CD013052_pub3_data","3::3::Serious complications","No usable data for effect sizes"
"CD013052_pub3_data","4::1::Resolution of ear discharge at 2 to 4 weeks","No usable data for effect sizes"
"CD013052_pub3_data","4::2::Resolution of ear discharge after 4 weeks","No usable data for effect sizes"
"CD013052_pub3_data","5::2::Resolution of ear discharge (2 to 4 weeks)","No usable data for effect sizes"
"CD013052_pub3_data","6::2::Resolution of ear discharge (2 to 4 weeks)","No usable data for effect sizes"
"CD013052_pub3_data","8::1::Resolution of ear discharge (1 to 2 weeks)","No usable data for effect sizes"
"CD013053_pub3_data","2::1::Resolution of ear discharge","No usable data for effect sizes"
"CD013053_pub3_data","3::1::Resolution of ear discharge","No usable data for effect sizes"
"CD013053_pub3_data","3::2::Resolution of ear discharge – sensitivity analysis, re-including excluded case","No usable data for effect sizes"
"CD013054_pub3_data","2::3::Ear pain or discomfort","No usable data for effect sizes"
"CD013054_pub3_data","3::3::Resolution of ear discharge 2 to 4 weeks","No usable data for effect sizes"
"CD013054_pub3_data","3::4::Resolution of ear discharge after 4 weeks","No usable data for effect sizes"
"CD013054_pub3_data","3::5::Ear pain or discomfort","No usable data for effect sizes"
"CD013054_pub3_data","3::6::Dizziness/vertigo/balance","No usable data for effect sizes"
"CD013054_pub3_data","4::1::Resolution of ear discharge 1 to 2 weeks","No usable data for effect sizes"
"CD013054_pub3_data","4::2::Ear pain or discomfort","No usable data for effect sizes"
"CD013054_pub3_data","4::3::Dizziness/vertigo/balance","No usable data for effect sizes"
"CD013054_pub3_data","5::1::Resolution of ear discharge 2 to 4 weeks","No usable data for effect sizes"
"CD013054_pub3_data","5::2::Ear pain or discomfort at 2 to 4 weeks","No usable data for effect sizes"
"CD013054_pub3_data","7::1::Resolution of ear discharge 1 to 2 weeks","No usable data for effect sizes"
"CD013054_pub3_data","8::1::Resolution of ear discharge 1 to 2 weeks","No usable data for effect sizes"
"CD013054_pub3_data","9::1::Resolution of ear discharge 1 to 2 weeks","No usable data for effect sizes"
"CD013054_pub3_data","10::1::Resolution of ear discharge 1 to 2 weeks","No usable data for effect sizes"
"CD013054_pub3_data","11::2::Resolution of ear discharge 2 to 4 weeks","No usable data for effect sizes"
"CD013054_pub3_data","12::1::Resolution of ear discharge 1 to 2 weeks","No usable data for effect sizes"
"CD013054_pub3_data","13::1::Resolution of ear discharge 1 to 2 weeks","No usable data for effect sizes"
"CD013055_pub3_data","1::1::Resolution of ear discharge (2 to 4 weeks)","No usable data for effect sizes"
"CD013055_pub3_data","1::2::Resolution of ear discharge (after 4 weeks)","No usable data for effect sizes"
"CD013055_pub3_data","3::1::Resolution of ear discharge (1 to 2 weeks)","No usable data for effect sizes"
"CD013055_pub3_data","4::1::Resolution of ear discharge (2 to 4 weeks)","No usable data for effect sizes"
"CD013055_pub3_data","4::2::Ear pain, discomfort, irritation","No usable data for effect sizes"
"CD013056_pub3_data","1::2::Resolution of ear discharge (2–4 weeks)","No usable data for effect sizes"
"CD013056_pub3_data","2::1::Resolution of ear discharge (1–2 weeks)","No usable data for effect sizes"
"CD013056_pub3_data","2::4::Change in hearing","No usable data for effect sizes"
"CD013056_pub3_data","3::1::Resolution of ear discharge (1–2 weeks)","No usable data for effect sizes"
"CD013056_pub3_data","3::2::Resolution of ear discharge (2–4 weeks)","No usable data for effect sizes"
"CD013056_pub3_data","7::1::Resolution of ear discharge (1–2 weeks)","No usable data for effect sizes"
"CD013057_pub3_data","1::1::Resolution of ear discharge (after 4 weeks)","No usable data for effect sizes"
"CD013057_pub3_data","2::1::Resolution of ear discharge (1–2 weeks)","No usable data for effect sizes"
"CD013057_pub3_data","2::2::Vertigo/dizziness/tinnitus","No usable data for effect sizes"
"CD013071_pub2_data","2::1::Erectile function (IIEF-EF)","No usable data for effect sizes"
"CD013071_pub2_data","3::1::Erectile function (IIEF-5)","No usable data for effect sizes"
"CD013071_pub2_data","3::2::Sexual quality of life (AMS total)","No usable data for effect sizes"
"CD013071_pub2_data","3::3::Prostate-related events","No usable data for effect sizes"
"CD013071_pub2_data","4::4::Sexual quality of life (AMS total)","No usable data for effect sizes"
"CD013078_pub2_data","1::3::Function at 6 months' follow-up","No usable data for effect sizes"
"CD013078_pub2_data","3::1::Pain intensity at 12 months' follow-up","No usable data for effect sizes"
"CD013078_pub2_data","3::2::Function at end of treatment","No usable data for effect sizes"
"CD013078_pub2_data","3::3::Function at 6 months' follow-up","No usable data for effect sizes"
"CD013078_pub2_data","3::4::Function at 12 months' follow-up","No usable data for effect sizes"
"CD013078_pub2_data","3::5::Global assessment treatment success at the end of treatment","No usable data for effect sizes"
"CD013078_pub2_data","3::6::Global assessment treatment success at 6 months' follow-up","No usable data for effect sizes"
"CD013078_pub2_data","3::7::Global assessment treatment success at 12 months' follow-up","No usable data for effect sizes"
"CD013078_pub2_data","3::8::Return to sport at 12 months' follow-up","No usable data for effect sizes"
"CD013078_pub2_data","4::1::Muscle strength at the end of treatment","No usable data for effect sizes"
"CD013105_pub2_data","1::1::Awareness of prolapse ","No usable data for effect sizes"
"CD013105_pub2_data","1::2::Repeat surgery for recurrent prolapse","No usable data for effect sizes"
"CD013105_pub2_data","1::3::Objective failure at any site ","No usable data for effect sizes"
"CD013105_pub2_data","2::2::Patient-reported outcome measures ","No usable data for effect sizes"
"CD013105_pub2_data","3::1::Adverse events ","No usable data for effect sizes"
"CD013105_pub2_data","3::3::Patient-reported outcome measures ","No usable data for effect sizes"
"CD013105_pub2_data","5::1::Awareness of prolapse  ","No usable data for effect sizes"
"CD013105_pub2_data","6::1::Postoperative pain ","No usable data for effect sizes"
"CD013105_pub2_data","6::3::Patient Global impression of Improvement (PGI-I)","No usable data for effect sizes"
"CD013105_pub2_data","8::1::Bladder function ","No usable data for effect sizes"
"CD013105_pub2_data","9::1::Adverse events ","No usable data for effect sizes"
"CD013105_pub2_data","9::2::Perioperative outcomes ","No usable data for effect sizes"
"CD013105_pub2_data","10::1::Awareness of prolapse","No usable data for effect sizes"
"CD013105_pub2_data","10::2::Objective failure at any site","No usable data for effect sizes"
"CD013105_pub2_data","10::5::Patient Global impression of Improvement (PGI-I)","No usable data for effect sizes"
"CD013105_pub2_data","11::2::Patient-reported outcome measures ","No usable data for effect sizes"
"CD013105_pub2_data","12::1::Adverse events ","No usable data for effect sizes"
"CD013105_pub2_data","12::4::Patient Global impression of Improvement (PGI-I)","No usable data for effect sizes"
"CD013105_pub2_data","13::3::Patient Global impression of Improvement (PGI-I)","No usable data for effect sizes"
"CD013111_pub2_data","1::5::Metformin plus progestin compared to progestin. Severe adverse events grade 3-4.","No usable data for effect sizes"
"CD013111_pub2_data","2::1::Levonorgestrel intrauterine system compared to oral progestin. Live birth rate","No usable data for effect sizes"
"CD013111_pub2_data","2::2::Levonorgestrel intrauterine system compared to oral progestin.Complete pathological response rate. ","No usable data for effect sizes"
"CD013111_pub2_data","2::3::Levonorgestrel intrauterine system compared to oral progestin.Severe adverse events (weight gain)","No usable data for effect sizes"
"CD013111_pub2_data","2::4::Levonorgestrel intrauterine system compared to oral progestin. Complete pathological response rate. ","No usable data for effect sizes"
"CD013111_pub2_data","3::1::Oral progestin plus levonorgestrel intrauterine system compared to oral progestin. Live birth rate.","No usable data for effect sizes"
"CD013111_pub2_data","3::2::Oral progestin plus levonorgestrel intrauterine system compared to oral progestin. Complete pathological response rate","No usable data for effect sizes"
"CD013111_pub2_data","3::3::Oral progestin plus levonorgestrel intrauterine system compared to oral progestin. Severe adverse events (weight gain)","No usable data for effect sizes"
"CD013111_pub2_data","3::4::Oral progestin plus levonorgestrel intrauterine system compared to oral progestin. Surgery  for persistent/progressive disease (hysterectomy)","No usable data for effect sizes"
"CD013111_pub2_data","3::5::Oral progestin plus levonorgestrel intrauterine system compared to oral progestin. (EC) Live birth rate","No usable data for effect sizes"
"CD013111_pub2_data","3::6::Oral progestin plus levonorgestrel intrauterine system compared to oral progestin.(EC) Complete pathological response rate","No usable data for effect sizes"
"CD013111_pub2_data","3::7::Oral progestin plus levonorgestrel intrauterine system compared to oral progestin.(EC). Severe adverse event (weight gain)","No usable data for effect sizes"
"CD013111_pub2_data","3::8::Oral progestin plus levonorgestrel intrauterine system compared to oral progestin.(EC) Surgery for persistent/progressive disease (Hysterectomy)","No usable data for effect sizes"
"CD013197_pub2_data","1::3::Health-related quality of life medium-term","No usable data for effect sizes"
"CD013197_pub2_data","1::11::Postoperative pain one week after surgery","No usable data for effect sizes"
"CD013232_pub2_data","1::4::Aggression","No usable data for effect sizes"
"CD013232_pub2_data","1::5::Self-injury","No usable data for effect sizes"
"CD013232_pub2_data","1::10::Adverse effects: metabolic (continuous)","No usable data for effect sizes"
"CD013232_pub2_data","1::20::Subgroup analysis: age - aggression","No usable data for effect sizes"
"CD013232_pub2_data","2::5::Adverse effects: immune system","No usable data for effect sizes"
"CD013232_pub2_data","2::7::Adverse effects: metabolic (continuous)","No usable data for effect sizes"
"CD013232_pub2_data","3::2::Self-injury","No usable data for effect sizes"
"CD013232_pub2_data","3::13::Quality of life","No usable data for effect sizes"
"CD013232_pub2_data","5::1::Irritability","No usable data for effect sizes"
"CD013232_pub2_data","5::2::Adverse effects: cardiovascular (tachycardia)","No usable data for effect sizes"
"CD013232_pub2_data","5::7::Adverse effects: respiratory","No usable data for effect sizes"
"CD013232_pub2_data","5::8::Adverse effects: skin","No usable data for effect sizes"
"CD013232_pub2_data","6::5::Adverse effects: musculoskeletal","No usable data for effect sizes"
"CD013232_pub2_data","6::7::Adverse effects: psychological","No usable data for effect sizes"
"CD013232_pub2_data","6::8::Adverse effects: skin","No usable data for effect sizes"
"CD013232_pub2_data","7::1::Irritability","No usable data for effect sizes"
"CD013232_pub2_data","7::2::Adverse effects: neurological","No usable data for effect sizes"
"CD013232_pub2_data","7::3::Tolerability","No usable data for effect sizes"
"CD013232_pub2_data","8::2::Adverse effects: metabolic","No usable data for effect sizes"
"CD013232_pub2_data","9::6::Adverse effects: metabolic (continuous)","No usable data for effect sizes"
"CD013232_pub2_data","9::8::Adverse effects: psychological","No usable data for effect sizes"
"CD013232_pub2_data","9::10::Adverse effects: urinary","No usable data for effect sizes"
"CD013232_pub2_data","10::1::Adverse effects: cardiovascular","No usable data for effect sizes"
"CD013232_pub2_data","11::6::Adverse effects: musculoskeletal pain","No usable data for effect sizes"
"CD013232_pub2_data","11::12::Serious adverse events","No usable data for effect sizes"
"CD013232_pub2_data","12::1::Irritability","No usable data for effect sizes"
"CD013232_pub2_data","12::5::Adverse effects: psychological","No usable data for effect sizes"
"CD013232_pub2_data","12::6::Tolerability/acceptability: loss to follow-up","No usable data for effect sizes"
"CD013232_pub2_data","13::1::Irritabilty (continuous)","No usable data for effect sizes"
"CD013232_pub2_data","13::2::Irritability (dichotomous)","No usable data for effect sizes"
"CD013232_pub2_data","14::6::Adverse effects: metabolic (continuous)","No usable data for effect sizes"
"CD013232_pub2_data","15::1::Self-injury","No usable data for effect sizes"
"CD013232_pub2_data","15::2::Adverse effects: musculoskeletal","No usable data for effect sizes"
"CD013232_pub2_data","15::3::Adverse effects: neurological","No usable data for effect sizes"
"CD013232_pub2_data","15::4::Adverse effects: psychological","No usable data for effect sizes"
"CD013278_pub3_data","1::6::Duration of ventilator support (days)","No usable data for effect sizes"
"CD013278_pub3_data","1::7::Duration of need for supplementary oxygen (days)","No usable data for effect sizes"
"CD013278_pub3_data","1::8::Postnatal corticosteroid use for CLD any time during hospital stay","No usable data for effect sizes"
"CD013278_pub3_data","1::15::Time to full enteral feeds (postnatal age at time of achieving full enteral feeds)","No usable data for effect sizes"
"CD013278_pub3_data","1::16::Time to regain birth weight (days)","No usable data for effect sizes"
"CD013278_pub3_data","2::25::Moderate/severe cognitive delay at 18 to 24 months","No usable data for effect sizes"
"CD013278_pub3_data","2::26::Moderate/severe motor delay at 18 to 24 months","No usable data for effect sizes"
"CD013278_pub3_data","2::27::Moderate/severe language delay at 18 to 24 months","No usable data for effect sizes"
"CD013278_pub3_data","2::28::Moderate/severe cerebral palsy at 18 to 24 months","No usable data for effect sizes"
"CD013294_pub2_data","1::2::Severe retinopathy of prematurity","No usable data for effect sizes"
"CD013294_pub2_data","1::3::Chronic lung disease or bronchopulmonary dysplasia","No usable data for effect sizes"
"CD013294_pub2_data","1::10::Periventricular leukomalacia","No usable data for effect sizes"
"CD013294_pub2_data","2::2::Time (%) above alarm limit or desired oxygen saturation range, regardless of fraction of inspired oxygen received","No usable data for effect sizes"
"CD013294_pub2_data","2::3::Time (%) below alarm limits or desired oxygen saturation range","No usable data for effect sizes"
"CD013294_pub2_data","2::4::Time (%) with oxygen saturation below 80%","No usable data for effect sizes"
"CD013294_pub2_data","2::5::Time (%) with oxygen saturation between 97% and 100%, excluding time in room air","No usable data for effect sizes"
"CD013294_pub2_data","3::1::Time (%) in desired oxygen saturation range","No usable data for effect sizes"
"CD013294_pub2_data","3::2::Time (%) above alarm limit or desired oxygen saturation range, regardless of fraction of inspired oxygen received","No usable data for effect sizes"
"CD013294_pub2_data","3::3::Time (%) below alarm limit or desired oxygen saturation range","No usable data for effect sizes"
"CD013294_pub2_data","3::4::Time (%) with oxygen saturation below 80%","No usable data for effect sizes"
"CD013295_pub2_data","3::3::Length of hospital stay","No usable data for effect sizes"
"CD013295_pub2_data","3::6::Risk of experiencing MI","No usable data for effect sizes"
"CD013295_pub2_data","4::3::Reoperation","No usable data for effect sizes"
"CD013295_pub2_data","4::4::Length of hospital stay","No usable data for effect sizes"
"CD013295_pub2_data","4::7::Risk of experiencing CVA","No usable data for effect sizes"
"CD013295_pub2_data","4::8::Risk of transfusion reactions","No usable data for effect sizes"
"CD013295_pub2_data","5::1::Risk of allogeneic blood transfusion","No usable data for effect sizes"
"CD013295_pub2_data","5::2::Length of hospital stay","No usable data for effect sizes"
"CD013295_pub2_data","5::3::Risk of experiencing DVT","No usable data for effect sizes"
"CD013295_pub2_data","5::4::Risk of experiencing PE","No usable data for effect sizes"
"CD013295_pub2_data","6::10::Risk of suspected serious drug reactions","No usable data for effect sizes"
"CD013295_pub2_data","11::1::Risk of allogeneic blood transfusion","No usable data for effect sizes"
"CD013295_pub2_data","11::2::Risk of experiencing DVT","No usable data for effect sizes"
"CD013295_pub2_data","12::2::Units of red blood cells transfused","No usable data for effect sizes"
"CD013295_pub2_data","12::3::Reoperation","No usable data for effect sizes"
"CD013295_pub2_data","12::4::Length of hospital stay","No usable data for effect sizes"
"CD013295_pub2_data","13::1::Risk of allogeneic blood transfusion","No usable data for effect sizes"
"CD013295_pub2_data","13::2::All-cause mortality","No usable data for effect sizes"
"CD013295_pub2_data","13::3::Reoperation","No usable data for effect sizes"
"CD013295_pub2_data","13::4::Risk of experiencing DVT","No usable data for effect sizes"
"CD013295_pub2_data","13::5::Risk of experiencing PE","No usable data for effect sizes"
"CD013295_pub2_data","13::6::Risk of experiencing MI","No usable data for effect sizes"
"CD013295_pub2_data","13::7::Risk of experiencing CVA","No usable data for effect sizes"
"CD013295_pub2_data","13::8::Risk of suspected serious drug reactions","No usable data for effect sizes"
"CD013295_pub2_data","14::1::Risk of allogeneic blood transfusion","No usable data for effect sizes"
"CD013295_pub2_data","14::2::Length of hospital stay","No usable data for effect sizes"
"CD013295_pub2_data","14::3::Risk of experiencing DVT","No usable data for effect sizes"
"CD013295_pub2_data","14::4::Risk of experiencing PE","No usable data for effect sizes"
"CD013295_pub2_data","15::1::Risk of allogeneic blood transfusion","No usable data for effect sizes"
"CD013295_pub2_data","15::2::All-cause mortality","No usable data for effect sizes"
"CD013295_pub2_data","15::3::Units of red blood cells transfused","No usable data for effect sizes"
"CD013295_pub2_data","15::5::Risk of experiencing DVT","No usable data for effect sizes"
"CD013295_pub2_data","15::6::Risk of experiencing PE","No usable data for effect sizes"
"CD013295_pub2_data","16::1::Risk of allogeneic blood transfusion","No usable data for effect sizes"
"CD013295_pub2_data","16::2::All-cause mortality","No usable data for effect sizes"
"CD013295_pub2_data","16::3::Reoperation","No usable data for effect sizes"
"CD013295_pub2_data","16::4::Length of hospital stay","No usable data for effect sizes"
"CD013295_pub2_data","16::5::Risk of experiencing DVT","No usable data for effect sizes"
"CD013295_pub2_data","16::6::Risk of experiencing PE","No usable data for effect sizes"
"CD013295_pub2_data","16::7::Risk of experiencing CVA","No usable data for effect sizes"
"CD013295_pub2_data","17::4::Reoperation","No usable data for effect sizes"
"CD013295_pub2_data","17::5::Length of hospital stay","No usable data for effect sizes"
"CD013295_pub2_data","18::2::Units of red blood cells transfused","No usable data for effect sizes"
"CD013295_pub2_data","18::3::Reoperation","No usable data for effect sizes"
"CD013295_pub2_data","18::6::Risk of experiencing MI","No usable data for effect sizes"
"CD013295_pub2_data","18::7::Risk of experiencing CVA","No usable data for effect sizes"
"CD013295_pub2_data","19::1::Risk of allogeneic blood transfusion","No usable data for effect sizes"
"CD013295_pub2_data","19::2::Reoperation","No usable data for effect sizes"
"CD013295_pub2_data","19::3::Risk of experiencing DVT","No usable data for effect sizes"
"CD013295_pub2_data","19::4::Risk of experiencing PE","No usable data for effect sizes"
"CD013295_pub2_data","20::4::Risk of experiencing PE","No usable data for effect sizes"
"CD013295_pub2_data","21::1::Risk of allogeneic blood transfusion","No usable data for effect sizes"
"CD013295_pub2_data","21::2::All-cause mortality","No usable data for effect sizes"
"CD013295_pub2_data","21::3::Reoperation","No usable data for effect sizes"
"CD013295_pub2_data","21::4::Length of hospital stay","No usable data for effect sizes"
"CD013295_pub2_data","21::5::Risk of experiencing DVT","No usable data for effect sizes"
"CD013295_pub2_data","21::6::Risk of experiencing PE","No usable data for effect sizes"
"CD013295_pub2_data","21::7::Risk of experiencing CVA","No usable data for effect sizes"
"CD013295_pub2_data","22::2::All-cause mortality","No usable data for effect sizes"
"CD013295_pub2_data","22::3::Reoperation","No usable data for effect sizes"
"CD013295_pub2_data","22::4::Length of hospital stay","No usable data for effect sizes"
"CD013295_pub2_data","24::1::Risk of allogeneic blood transfusion","No usable data for effect sizes"
"CD013295_pub2_data","24::2::Length of hospital stay","No usable data for effect sizes"
"CD013295_pub2_data","24::3::Risk of experiencing DVT","No usable data for effect sizes"
"CD013295_pub2_data","24::4::Risk of experiencing PE","No usable data for effect sizes"
"CD013295_pub2_data","24::5::Risk of experiencing CVA","No usable data for effect sizes"
"CD013295_pub2_data","25::1::Risk of allogeneic blood transfusion","No usable data for effect sizes"
"CD013295_pub2_data","27::1::Risk of allogeneic blood transfusion","No usable data for effect sizes"
"CD013295_pub2_data","27::2::Length of hospital stay","No usable data for effect sizes"
"CD013295_pub2_data","27::3::Risk of experiencing DVT","No usable data for effect sizes"
"CD013295_pub2_data","30::1::Risk of allogeneic blood transfusion","No usable data for effect sizes"
"CD013295_pub2_data","30::2::Risk of experiencing DVT","No usable data for effect sizes"
"CD013295_pub2_data","30::3::Risk of experiencing PE","No usable data for effect sizes"
"CD013295_pub2_data","31::1::Risk of allogeneic blood transfusion","No usable data for effect sizes"
"CD013295_pub2_data","31::2::Risk of experiencing MI","No usable data for effect sizes"
"CD013295_pub2_data","31::3::Risk of experiencing CVA","No usable data for effect sizes"
"CD013295_pub2_data","31::4::Risk of experiencing DVT","No usable data for effect sizes"
"CD013295_pub2_data","31::5::Risk of experiencing PE","No usable data for effect sizes"
"CD013295_pub2_data","32::1::Risk of allogeneic blood transfusion","No usable data for effect sizes"
"CD013295_pub2_data","32::2::Risk of experiencing MI","No usable data for effect sizes"
"CD013295_pub2_data","32::3::Risk of experiencing CVA","No usable data for effect sizes"
"CD013295_pub2_data","32::4::Risk of experiencing DVT","No usable data for effect sizes"
"CD013295_pub2_data","32::5::Risk of experiencing PE","No usable data for effect sizes"
"CD013295_pub2_data","33::1::Risk of allogeneic blood transfusion","No usable data for effect sizes"
"CD013295_pub2_data","33::2::Risk of experiencing MI","No usable data for effect sizes"
"CD013295_pub2_data","33::3::Risk of experiencing CVA","No usable data for effect sizes"
"CD013295_pub2_data","33::4::Risk of experiencing DVT","No usable data for effect sizes"
"CD013295_pub2_data","33::5::Risk of experiencing PE","No usable data for effect sizes"
"CD013303_pub2_data","1::1::HIV health literacy: understanding HIV terms (short-term: immediately post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","1::2::HIV health literacy: recognition of HIV terms (short-term: immediately post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","1::3::Health-related knowledge: HIV global disease/treatment knowledge, 0 to 100 (short-term: immediately post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","1::4::Health-related knowledge: HIV knowledge, risk of getting sicker (short-term: immediately post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","1::5::Health outcomes: subjective health status (short-term: immediately post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","1::6::Health behaviour: blood glucose self-monitoring 2 times per day (capped at 2), self-report (short-term: immediately post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","1::7::Health behaviour: physical activity, average daily steps (short-term: immediately post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","1::8::Health behaviour: physical activity, average daily steps (short-term: three months post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","2::1::Generic health literacy: health numeracy, NVS (short-term: immediately post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","2::2::Generic health literacy: print literacy, REALM (short-term: immediately post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","2::7::High blood pressure health literacy, HBP health literacy scale (medium-term: 6 months post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","2::8::Health literacy - appraise: decisional balance for using mammography and Pap testing (short-term: immediately post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","2::17::Health behaviour: diabetes self-care activities (short-term: immediately post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","2::18::Health behaviour: oral hygiene self-care behaviour (short-term: immediately post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","2::19::Health behaviour: screening adherence (mammogram and Pap test), medical record review (short-term: immediately post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","2::20::Health behaviour: non-adherence to blood pressure medication (short-term: immediately post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","2::21::Health behaviour: non-adherence to blood pressure medication (medium-term: 6 months post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","2::22::Health behaviour: blood glucose self-monitoring 2 times per day (capped at 2), self-report (medium-term: 4 1/2 months post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","2::25::Self-efficacy to manage one's disease (medium-term: 6 months post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","3::2::Depression literacy, D-Lit (short-term: outcome assessment immediately post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","3::4::Hepatitis B knowledge (medium-term: 6 months post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","3::5::Health behaviour: fat-related dietary habits, self-report (short-term: 1-month post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","4::1::Health literacy - appraise: decisional conflict (long-term: approx. 7 months post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","4::2::Health literacy - apply: prostate cancer screening intention (long-term: approx. 7 months post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","4::3::Prostate cancer knowledge, 0 to 100 (long-term: approx. 7 months post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","4::4::Health behaviour: prostate cancer testing (long-term: 2 years post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","4::5::Adverse events: anxiety (long-term: approx. 7 months post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","5::1::Health literacy: depression literacy, D-Lit (short-term: at 1-week post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","5::2::Health literacy: apply - intent to seek treatment (short-term: immediately post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","5::5::Health behaviour: child's up-to-date immunisation (short-term: immediately up to 3 months post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","5::6::Self-efficacy to identify need for treatment (short-term: immediately post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","5::7::Health service use: emergency room visits, medical record review (short-term: immediately up to 3 months post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","6::1::Diabetes health literacy, DHLS (short-term: immediately post-intervention )","No usable data for effect sizes"
"CD013303_pub2_data","6::3::Health literacy - understanding physician's instructions (medium-term: 3 months post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","6::4::Health literacy - appraise: decisional conflict (short-term: 1 month post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","6::5::Health literacy - apply: informed decision against HPV vaccination (short-term: 1 month post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","6::10::Health outcome: depression, PHQ-8 (long-term: 12 months post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","6::12::Health behaviour: new documentation of advance care planning (long-term: 12 months post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","6::13::Breast cancer self-efficacy (short-term: immediately post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","6::15::Self-efficacy regarding Pap testing (medium-term: at 6-month follow-up)","No usable data for effect sizes"
"CD013303_pub2_data","6::16::Adverse event: anxiety, GAD-7 (long-term: 12 months post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","7::2::Health literacy - understanding physician's instruction (medium-term: 3 months post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","7::3::Health literacy - apply: Pap testing intention, self-report (medium-term: 6 months post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","7::4::Cervical cancer knowledge, 0 to 100 (medium-term: 6 months post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","7::5::Asthma knowledge (medium-term: 3 months post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","7::6::Health behaviour: cervical cancer screening (medium-term: at 6-month follow-up)","No usable data for effect sizes"
"CD013303_pub2_data","8::1::Understand: medication understanding (short-term: immediately post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","9::1::Generic health literacy, TOFHLA (short-term: immediately post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","9::2::Diabetes health literacy, DHLS (short-term: immediately post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","9::3::Cardiovascular health behaviour (short-term: immediately post-intervention)","No usable data for effect sizes"
"CD013303_pub2_data","9::4::Health behaviour: new documentation of advance care planning (long-term: approx. 12 months post-intervention)","No usable data for effect sizes"
"CD013329_pub2_data","1::1::Child health, functioning, and quality of life (effect size estimate functional status)","No usable data for effect sizes"
"CD013329_pub2_data","1::2::Child and family satisfaction (CAHPS healthcare quality rating)","No usable data for effect sizes"
"CD013329_pub2_data","1::3::Child and family satisfaction (CAHPS help with coordinating multiple providers)","No usable data for effect sizes"
"CD013329_pub2_data","1::4::Child and family satisfaction (CAHPS getting needed care quickly)","No usable data for effect sizes"
"CD013329_pub2_data","1::5::Child and family satisfaction (family-centred care)","No usable data for effect sizes"
"CD013329_pub2_data","1::6::Child and family satisfaction (child health care)","No usable data for effect sizes"
"CD013329_pub2_data","1::7::Child and family satisfaction (care coordination)","No usable data for effect sizes"
"CD013329_pub2_data","1::8::Child and family satisfaction (getting care quickly)","No usable data for effect sizes"
"CD013329_pub2_data","1::9::Number of healthcare encounters (ED visits per child year)","No usable data for effect sizes"
"CD013329_pub2_data","1::10::Number of hospitalised days per child-year","No usable data for effect sizes"
"CD013329_pub2_data","1::11::Costs to healthcare system (health plan and clinic costs)","No usable data for effect sizes"
"CD013331_pub2_data","1::5::Limitation of daily activities: high-frequency TENS versus placebo or no treatment","No usable data for effect sizes"
"CD013331_pub2_data","1::6::Absence from work or school: high-frequency TENS versus placebo or no treatment","No usable data for effect sizes"
"CD013331_pub2_data","2::2::Requirements for additional analgesics - number of tablets: low-frequency TENS versus placebo or no treatment","No usable data for effect sizes"
"CD013331_pub2_data","2::3::Absence from work or school: low-frequency TENS versus placebo or no treatment","No usable data for effect sizes"
"CD013331_pub2_data","3::2::Adverse effects: high-frequency TENS versus low-frequency TENS","No usable data for effect sizes"
"CD013331_pub2_data","3::3::Requirements of additional analgesics - number of tablets: high-frequency TENS versus low-frequency TENS","No usable data for effect sizes"
"CD013331_pub2_data","3::4::Absence from work or school: high-frequency TENS versus low-frequency TENS","No usable data for effect sizes"
"CD013331_pub2_data","4::1::Pain relief: high-frequency TENS versus acupressure","No usable data for effect sizes"
"CD013331_pub2_data","4::2::Pain relief: high-frequency TENS versus acetaminophen","No usable data for effect sizes"
"CD013331_pub2_data","4::5::Requirements for additional analgesics - number of women: high-frequency TENS versus NSAIDs","No usable data for effect sizes"
"CD013331_pub2_data","4::6::Requirements for additional analgesics - number of women: high-frequency TENS versus interferential current therapy","No usable data for effect sizes"
"CD013331_pub2_data","5::1::Pain relief: low-frequency TENS versus other treatment","No usable data for effect sizes"
"CD013342_pub2_data","1::11::Treatment failure","No usable data for effect sizes"
"CD013342_pub2_data","2::3::Participant-reported global assessment of success","No usable data for effect sizes"
"CD013342_pub2_data","2::4::Withdrawals due to adverse events","No usable data for effect sizes"
"CD013342_pub2_data","2::5::Serious adverse events","No usable data for effect sizes"
"CD013342_pub2_data","2::6::Total adverse events","No usable data for effect sizes"
"CD013342_pub2_data","2::7::MRI joint progression (bone marrow lesions)","No usable data for effect sizes"
"CD013342_pub2_data","3::1::Mean pain (0 to 10, 0 is no pain)","No usable data for effect sizes"
"CD013342_pub2_data","3::2::Mean function (0 to 100, 0 is best function)","No usable data for effect sizes"
"CD013342_pub2_data","3::3::Mean quality of life (0 to 100, 100 is best score)","No usable data for effect sizes"
"CD013342_pub2_data","3::4::Participant-reported global assessment of success","No usable data for effect sizes"
"CD013342_pub2_data","3::5::Withdrawals due to adverse events","No usable data for effect sizes"
"CD013342_pub2_data","3::6::Serious adverse events","No usable data for effect sizes"
"CD013342_pub2_data","3::7::Total adverse events","No usable data for effect sizes"
"CD013342_pub2_data","3::8::Treatment failure","No usable data for effect sizes"
"CD013342_pub2_data","4::4::Participant-reported global assessment of success","No usable data for effect sizes"
"CD013342_pub2_data","4::9::MRI measure of joint pathology (e.g. cartilage volume, bone marrow lesions, synovitis)","No usable data for effect sizes"
"CD013342_pub2_data","5::3::Participant-reported global assessment of success","No usable data for effect sizes"
"CD013342_pub2_data","7::2::Withdrawals due to adverse events","No usable data for effect sizes"
"CD013342_pub2_data","7::3::Serious adverse events","No usable data for effect sizes"
"CD013342_pub2_data","7::4::Total adverse events","No usable data for effect sizes"
"CD013342_pub2_data","7::5::Treatment failure","No usable data for effect sizes"
"CD013342_pub2_data","8::4::Serious adverse events","No usable data for effect sizes"
"CD013344_pub2_data","1::1::Graft loss","No usable data for effect sizes"
"CD013344_pub2_data","1::2::Persistence of decoy cells/viraemia at 12 months","No usable data for effect sizes"
"CD013344_pub2_data","2::6::BK viruria","No usable data for effect sizes"
"CD013344_pub2_data","2::7::Viral load reduction at 6 months","No usable data for effect sizes"
"CD013344_pub2_data","2::9::Initial BK titre copies/L","No usable data for effect sizes"
"CD013344_pub2_data","2::11::Donor-specific antibodies","No usable data for effect sizes"
"CD013344_pub2_data","2::13::Malignancy","No usable data for effect sizes"
"CD013344_pub2_data","3::2::Rejection","No usable data for effect sizes"
"CD013344_pub2_data","3::3::Serum creatinine [mg/dL]","No usable data for effect sizes"
"CD013344_pub2_data","3::4::eGFR [mL/min]","No usable data for effect sizes"
"CD013344_pub2_data","3::6::BK virus-associated nephropathy (BKVAN)","No usable data for effect sizes"
"CD013344_pub2_data","3::8::Patient survival at 5 years","No usable data for effect sizes"
"CD013344_pub2_data","3::9::Malignancy","No usable data for effect sizes"
"CD013344_pub2_data","3::10::Therapy-related adverse events: new-onset diabetes after transplantation (NODAT)","No usable data for effect sizes"
"CD013344_pub2_data","4::1::Graft loss","No usable data for effect sizes"
"CD013344_pub2_data","4::2::Rejection","No usable data for effect sizes"
"CD013344_pub2_data","4::3::BK viraemia","No usable data for effect sizes"
"CD013344_pub2_data","4::4::Death","No usable data for effect sizes"
"CD013344_pub2_data","4::5::Malignancy","No usable data for effect sizes"
"CD013344_pub2_data","5::1::Graft loss","No usable data for effect sizes"
"CD013344_pub2_data","5::2::Rejection","No usable data for effect sizes"
"CD013344_pub2_data","5::3::BK viraemia","No usable data for effect sizes"
"CD013344_pub2_data","5::4::BK viruria","No usable data for effect sizes"
"CD013344_pub2_data","5::5::BK virus-associated nephropathy (BKVAN)","No usable data for effect sizes"
"CD013344_pub2_data","5::6::Death","No usable data for effect sizes"
"CD013344_pub2_data","6::1::Rejection","No usable data for effect sizes"
"CD013344_pub2_data","6::2::BK viraemia at 12 months","No usable data for effect sizes"
"CD013344_pub2_data","6::3::Reduction of BK viruria by 50%","No usable data for effect sizes"
"CD013344_pub2_data","6::4::BK virus-associated nepropathy (BKVAN)","No usable data for effect sizes"
"CD013344_pub2_data","7::1::Graft loss","No usable data for effect sizes"
"CD013344_pub2_data","7::2::BK viraemia","No usable data for effect sizes"
"CD013344_pub2_data","7::3::BK virus-associated nephropathy (BKVAN)","No usable data for effect sizes"
"CD013344_pub2_data","8::1::BK viral load < 600 copies/mL","No usable data for effect sizes"
"CD013344_pub2_data","8::2::BK virus-associated nephropathy (BKVAN)","No usable data for effect sizes"
"CD013344_pub2_data","9::1::Graft loss","No usable data for effect sizes"
"CD013344_pub2_data","9::2::Rejection","No usable data for effect sizes"
"CD013344_pub2_data","9::3::BK viraemia","No usable data for effect sizes"
"CD013344_pub2_data","9::4::BK viruria","No usable data for effect sizes"
"CD013344_pub2_data","9::5::BK virus-associated nephropathy (BKVAN)","No usable data for effect sizes"
"CD013344_pub2_data","9::6::Death","No usable data for effect sizes"
"CD013344_pub2_data","10::1::Graft loss","No usable data for effect sizes"
"CD013344_pub2_data","10::2::Rejection","No usable data for effect sizes"
"CD013344_pub2_data","10::3::BK viraemia","No usable data for effect sizes"
"CD013344_pub2_data","10::4::BK viruria","No usable data for effect sizes"
"CD013344_pub2_data","10::5::BK virus-associated nephropathy (BKVAN)","No usable data for effect sizes"
"CD013344_pub2_data","10::6::Death","No usable data for effect sizes"
"CD013344_pub2_data","11::1::Graft loss","No usable data for effect sizes"
"CD013344_pub2_data","11::2::Change in serum creatinine [mg/dL]","No usable data for effect sizes"
"CD013344_pub2_data","11::3::Serum creatinine increase","No usable data for effect sizes"
"CD013344_pub2_data","11::4::Change in creatinine clearance [mL/min]","No usable data for effect sizes"
"CD013344_pub2_data","11::5::Change in plasma BK viral load [copies/µL]","No usable data for effect sizes"
"CD013344_pub2_data","11::6::Change in urine BK viral load [copies/µL]","No usable data for effect sizes"
"CD013344_pub2_data","11::7::Biopsy-confirmed acute rejection (BKVAN)","No usable data for effect sizes"
"CD013344_pub2_data","11::8::Death","No usable data for effect sizes"
"CD013344_pub2_data","11::9::Malignancy: skin cancer","No usable data for effect sizes"
"CD013353_pub2_data","1::2::ALPS-Neo Scale during endotracheal suctioning","No usable data for effect sizes"
"CD013353_pub2_data","1::5::Stress and defence behaviours (SDB) during endotracheal suctioning","No usable data for effect sizes"
"CD013353_pub2_data","1::6::Self-regulatory behaviours (SRB) during endotracheal suctioning","No usable data for effect sizes"
"CD013353_pub2_data","4::1::PIPP during endotracheal suctioning","No usable data for effect sizes"
"CD013353_pub2_data","4::2::Heart rate during endotracheal suctioning (bpm)","No usable data for effect sizes"
"CD013353_pub2_data","4::3::Oxygen saturation during endotracheal suctioning (%)","No usable data for effect sizes"
"CD013353_pub2_data","5::1::PIPP during endotracheal suctioning","No usable data for effect sizes"
"CD013358_pub2_data","1::6::Well-being","No usable data for effect sizes"
"CD013358_pub2_data","1::7::Total cholesterol (mmol/L), change from baseline","No usable data for effect sizes"
"CD013358_pub2_data","1::9::HDL cholesterol (mmol/L), change from baseline","No usable data for effect sizes"
"CD013358_pub2_data","1::10::Triglycerides (mmol/L), change from baseline","No usable data for effect sizes"
"CD013358_pub2_data","2::1::Clinical CVD events (CVD mortality and non-fatal MI)","No usable data for effect sizes"
"CD013358_pub2_data","2::8::Adverse events","No usable data for effect sizes"
"CD013358_pub2_data","2::20::Coping strategies, change from baseline","No usable data for effect sizes"
"CD013358_pub2_data","2::21::Self-management, change from baseline","No usable data for effect sizes"
"CD013358_pub2_data","3::1::Clinical CVD events (CVD mortality, non-fatal MI and stroke, revascularisations)","No usable data for effect sizes"
"CD013358_pub2_data","3::11::Weight (kg), change from baseline","No usable data for effect sizes"
"CD013358_pub2_data","3::13::Quality of life, change from baseline","No usable data for effect sizes"
"CD013358_pub2_data","4::3::Anxiety, change from baseline","No usable data for effect sizes"
"CD013358_pub2_data","4::4::Depression, change from baseline","No usable data for effect sizes"
"CD013358_pub2_data","4::5::Coping strategies, change from baseline","No usable data for effect sizes"
"CD013366_pub2_data","1::15::Skin reaction","No usable data for effect sizes"
"CD013366_pub2_data","2::1::PICC-associated BSI","No usable data for effect sizes"
"CD013366_pub2_data","2::3::All-cause mortality","No usable data for effect sizes"
"CD013366_pub2_data","2::5::PICC-related BSI ","No usable data for effect sizes"
"CD013366_pub2_data","2::7::PICC dwell time","No usable data for effect sizes"
"CD013366_pub2_data","3::1::PICC-associated BSI","No usable data for effect sizes"
"CD013366_pub2_data","3::3::Catheter failure","No usable data for effect sizes"
"CD013366_pub2_data","3::4::Catheter breakage","No usable data for effect sizes"
"CD013366_pub2_data","3::5::PICC dwell time","No usable data for effect sizes"
"CD013366_pub2_data","4::1::Venous thromboembolism","No usable data for effect sizes"
"CD013366_pub2_data","4::2::Occlusion","No usable data for effect sizes"
"CD013366_pub2_data","4::3::Catheter breakage","No usable data for effect sizes"
"CD013366_pub2_data","5::3::All-cause mortality","No usable data for effect sizes"
"CD013366_pub2_data","5::4::Catheter breakage","No usable data for effect sizes"
"CD013366_pub2_data","5::5::PICC dwell time","No usable data for effect sizes"
"CD013366_pub2_data","6::1::PICC-associated BSI","No usable data for effect sizes"
"CD013366_pub2_data","6::7::PICC dwell time","No usable data for effect sizes"
"CD013366_pub2_data","7::1::PICC-associated BSI","No usable data for effect sizes"
"CD013366_pub2_data","7::4::All-cause mortality","No usable data for effect sizes"
"CD013366_pub2_data","7::7::PICC dwell time","No usable data for effect sizes"
"CD013366_pub2_data","8::9::Skin reaction","No usable data for effect sizes"
"CD013366_pub2_data","9::1::Venous thromboembolism ","No usable data for effect sizes"
"CD013366_pub2_data","9::2::PICC-associated BSI","No usable data for effect sizes"
"CD013366_pub2_data","9::5::Catheter failure","No usable data for effect sizes"
"CD013366_pub2_data","9::7::Catheter breakage","No usable data for effect sizes"
"CD013377_pub2_data","1::2::Progression-free survival ","No usable data for effect sizes"
"CD013377_pub2_data","1::4::Survival rates at 3 years","No usable data for effect sizes"
"CD013377_pub2_data","2::1::Overall survival","No usable data for effect sizes"
"CD013377_pub2_data","2::4::Survival rates at 5 years","No usable data for effect sizes"
"CD013377_pub2_data","2::5::Health-related quality of life","No usable data for effect sizes"
"CD013377_pub2_data","3::1::Overall survival","No usable data for effect sizes"
"CD013377_pub2_data","3::2::Survival rates at 40 months","No usable data for effect sizes"
"CD013377_pub2_data","3::3::Survival rates at 5 years","No usable data for effect sizes"
"CD013377_pub2_data","4::1::Overall survival","No usable data for effect sizes"
"CD013377_pub2_data","4::2::Progression-free survival ","No usable data for effect sizes"
"CD013377_pub2_data","4::3::Adverse events grade 3-5 (Participants with at least one serious adverse event)","No usable data for effect sizes"
"CD013377_pub2_data","4::4::Survival rates at 3 years","No usable data for effect sizes"
"CD013377_pub2_data","4::5::Survival rates at 5 years","No usable data for effect sizes"
"CD013377_pub2_data","5::1::Adverse events grades 3 to 5 (Participants with at least one serious adverse event)","No usable data for effect sizes"
"CD013377_pub2_data","6::1::Overall survival","No usable data for effect sizes"
"CD013377_pub2_data","6::2::Progression-free survival ","No usable data for effect sizes"
"CD013377_pub2_data","7::1::Overall survival","No usable data for effect sizes"
"CD013377_pub2_data","7::2::Adverse events grades 3 to 5 (Participants with at least one serious adverse event)","No usable data for effect sizes"
"CD013377_pub2_data","8::1::Adverse events grade 3-5 (Participants with at least one serious adverse event)","No usable data for effect sizes"
"CD013377_pub2_data","8::2::Quality of life: mean change from baseline in Global Health Status score","No usable data for effect sizes"
"CD013396_pub2_data","1::1::Asthma","No usable data for effect sizes"
"CD013396_pub2_data","1::2::Wheeze","No usable data for effect sizes"
"CD013396_pub2_data","1::8::Allergic sensitisation – total IgE (continuous)","No usable data for effect sizes"
"CD013396_pub2_data","1::9::Allergic sensitisation – skin prick against common allergens","No usable data for effect sizes"
"CD013396_pub2_data","1::10::Airway inflammation – eosinophil counts (continuous)","No usable data for effect sizes"
"CD013396_pub2_data","1::11::Airway inflammation – exhaled nitric oxide (continuous)","No usable data for effect sizes"
"CD013396_pub2_data","2::6::Lower respiratory tract infection","No usable data for effect sizes"
"CD013396_pub2_data","2::7::Upper respiratory tract infection","No usable data for effect sizes"
"CD013396_pub2_data","2::8::Allergic sensitisation – specific IgE against common allergens (dichotomous)","No usable data for effect sizes"
"CD013396_pub2_data","2::9::Allergic sensitisation – skin prick against common allergens","No usable data for effect sizes"
"CD013396_pub2_data","2::10::Airway inflammation – elevated eosinophil counts (dichotomous)","No usable data for effect sizes"
"CD013396_pub2_data","3::8::Allergic sensitisation – total IgE (continuous)","No usable data for effect sizes"
"CD013396_pub2_data","3::10::Allergic sensitisation – skin prick against common allergens","No usable data for effect sizes"
"CD013396_pub2_data","4::3::Atopic dermatitis","No usable data for effect sizes"
"CD013396_pub2_data","4::8::Allergic sensitisation – specific IgE against common allergens (dichotomous)","No usable data for effect sizes"
"CD013408_pub2_data","1::4::All-cause hospitalisation - sensitivity analysis","No usable data for effect sizes"
"CD013408_pub2_data","1::10::AF-related emergency department visits - sensitivity analysis","No usable data for effect sizes"
"CD013408_pub2_data","1::14::Major cerebrovascular bleeding events - sensitivity analysis","No usable data for effect sizes"
"CD013414_pub2_data","1::2::eGFR: final measure","No usable data for effect sizes"
"CD013414_pub2_data","1::5::Kidney failure","No usable data for effect sizes"
"CD013414_pub2_data","2::1::eGFR: change","No usable data for effect sizes"
"CD013414_pub2_data","2::8::Progression to UACR > 30 mg/g","No usable data for effect sizes"
"CD013429_pub2_data","8::1::Primary: Obstructive Eustachian tube dysfunction symptoms - severity (patient-reported): ETDQ-7","No usable data for effect sizes"
"CD013429_pub2_data","8::2::Primary: Eustachian tube function measured by an objective or semi-objective test: improvement of tympanometry (by ear)","No usable data for effect sizes"
"CD013429_pub2_data","8::3::Primary: Eustachian tube function measured by an objective or semi-objective test: Ability to perform positive Valsalva/Toynbee (by ear)","No usable data for effect sizes"
"CD013429_pub2_data","8::4::Secondary: Tympanic membrane abnormalities: normalisation of TM position","No usable data for effect sizes"
"CD013445_pub2_data","1::9::Duration of postprocedure drainage tube or stent","No usable data for effect sizes"
"CD013445_pub2_data","1::14::Narcotic analgesic use","No usable data for effect sizes"
"CD013445_pub2_data","1::15::Primary treatment failure","No usable data for effect sizes"
"CD013462_pub3_data","2::3::Adverse events","No usable data for effect sizes"
"CD013462_pub3_data","2::6::Overall rate of surgical complications","No usable data for effect sizes"
"CD013462_pub3_data","2::7::Length of hospital stay","No usable data for effect sizes"
"CD013468_pub2_data","1::2::Adverse events","No usable data for effect sizes"
"CD013468_pub2_data","2::1::Change in burn-related pruritus","No usable data for effect sizes"
"CD013468_pub2_data","2::2::Adverse events","No usable data for effect sizes"
"CD013468_pub2_data","3::1::Change in burn‐related pruritus","No usable data for effect sizes"
"CD013468_pub2_data","3::2::Adverse events (somnolence)","No usable data for effect sizes"
"CD013468_pub2_data","4::1::Change in burn-related pruritus","No usable data for effect sizes"
"CD013468_pub2_data","4::2::Adverse events (somnolence)","No usable data for effect sizes"
"CD013468_pub2_data","5::1::Change in burn‐related pruritus","No usable data for effect sizes"
"CD013468_pub2_data","6::1::Change in burn-related pruritus (visual analogue JW pruritic score)","No usable data for effect sizes"
"CD013468_pub2_data","7::1::Change in burn-related pruritus ","No usable data for effect sizes"
"CD013468_pub2_data","7::2::Pain","No usable data for effect sizes"
"CD013468_pub2_data","8::1::Change in burn-related pruritus","No usable data for effect sizes"
"CD013468_pub2_data","9::1::Change in burn-related pruritus","No usable data for effect sizes"
"CD013468_pub2_data","9::2::Adverse events","No usable data for effect sizes"
"CD013468_pub2_data","12::1::Change in burn-related pruritus","No usable data for effect sizes"
"CD013468_pub2_data","12::2::Pain","No usable data for effect sizes"
"CD013468_pub2_data","13::2::Pain","No usable data for effect sizes"
"CD013468_pub2_data","13::3::Participant health-related quality of life","No usable data for effect sizes"
"CD013468_pub2_data","14::1::Change in burn-related pruritus","No usable data for effect sizes"
"CD013468_pub2_data","14::2::Pain","No usable data for effect sizes"
"CD013468_pub2_data","15::1::Change in burn-related pruritus","No usable data for effect sizes"
"CD013468_pub2_data","17::1::Change in burn-related pruritus","No usable data for effect sizes"
"CD013468_pub2_data","17::2::Pain","No usable data for effect sizes"
"CD013468_pub2_data","17::3::Participant health-related quality of life","No usable data for effect sizes"
"CD013468_pub2_data","18::1::Change in burn-related pruritus","No usable data for effect sizes"
"CD013468_pub2_data","19::1::Change in burn‐related pruritus","No usable data for effect sizes"
"CD013468_pub2_data","19::2::Pain","No usable data for effect sizes"
"CD013468_pub2_data","20::1::Change in burn-related pruritus","No usable data for effect sizes"
"CD013468_pub2_data","21::1::Change in burn-related pruritus (VAS)","No usable data for effect sizes"
"CD013474_pub2_data","1::3::Health-related quality of life","No usable data for effect sizes"
"CD013474_pub2_data","3::1::Progression-free survival (time to event)","No usable data for effect sizes"
"CD013474_pub2_data","3::2::Complete response rate","No usable data for effect sizes"
"CD013474_pub2_data","3::3::Overall response rate","No usable data for effect sizes"
"CD013476_pub2_data","1::2::Disease-specific health-related quality of life scores at 6 months follow-up (SNOT-score) (excluding high risk of bias studies)","No usable data for effect sizes"
"CD013476_pub2_data","1::3::Disease-specific health-related quality of life scores at 36 months follow-up (Rhinosinusitis Disability Index) (all studies)","No usable data for effect sizes"
"CD013476_pub2_data","1::4::Asthma control at 6 months follow-up (Asthma Control Questionnaire) ","No usable data for effect sizes"
"CD013476_pub2_data","1::5::Asthma control at 6 months follow-up (Asthma Control Test)","No usable data for effect sizes"
"CD013476_pub2_data","1::7::Mean change from baseline in peak nasal inspiratory flow (PNIF) at 6 months follow-up (L/min)","No usable data for effect sizes"
"CD013476_pub2_data","1::8::Nasal endoscopy score at 36 months follow-up  (Lildholdt score)","No usable data for effect sizes"
"CD013476_pub2_data","1::9::Change in dosage of inhaled corticosteroids at 6 months follow-up (µg)","No usable data for effect sizes"
"CD013476_pub2_data","1::10::Change in dosage of nasal corticosteroids at 6 months follow-up (µg)","No usable data for effect sizes"
"CD013476_pub2_data","1::14::Chronic rhinosinusitis exacerbations after 36 months follow-up","No usable data for effect sizes"
"CD013539_pub2_data","1::2::Duration of response","No usable data for effect sizes"
"CD013539_pub2_data","2::7::Event-free survival","No usable data for effect sizes"
"CD013561_pub2_data","1::1::Adverse events","No usable data for effect sizes"
"CD013561_pub2_data","2::1::Disease-related complications","No usable data for effect sizes"
"CD013561_pub2_data","2::6::Surgery for recurrent or persistent disease","No usable data for effect sizes"
"CD013571_pub2_data","1::1::Participant-reported cure or improvement: immediately after treatment","No usable data for effect sizes"
"CD013571_pub2_data","1::2::Participant-reported cure or improvement: long-term effect (> 2 months after treatment)","No usable data for effect sizes"
"CD013571_pub2_data","1::3::Number of incontinence episodes per 24 hours: immediately after treatment","No usable data for effect sizes"
"CD013571_pub2_data","2::6::Adverse events: long-term effect (> 2 months after treatment)","No usable data for effect sizes"
"CD013571_pub2_data","2::10::Number of urgency episodes per 24 hours: long-term effect (> 2 months after treatment)","No usable data for effect sizes"
"CD013571_pub2_data","3::2::Symptom-related QoL: long-term effect (> 2 months after treatment)","No usable data for effect sizes"
"CD013571_pub2_data","3::3::Adverse events: immediately after treatment","No usable data for effect sizes"
"CD013571_pub2_data","3::4::Number of incontinence episodes per 24 hours: immediately after treatment","No usable data for effect sizes"
"CD013571_pub2_data","3::5::Number of incontinence episodes per 24 hours: long-term effect (> 2 months after treatment)","No usable data for effect sizes"
"CD013571_pub2_data","3::6::Number of micturition episodes per 24 hours: immediately after treatment","No usable data for effect sizes"
"CD013571_pub2_data","3::7::Number of micturition episodes per 24 hours: long-term effect (> 2 months after treatment)","No usable data for effect sizes"
"CD013571_pub2_data","4::5::Adverse events: long-term effect (> 2 months after treatment)","No usable data for effect sizes"
"CD013571_pub2_data","4::6::Participant-reported satisfaction: immediately after treatment","No usable data for effect sizes"
"CD013571_pub2_data","4::7::Participant-reported satisfaction: long-term effect (> 2 months after treatment)","No usable data for effect sizes"
"CD013590_pub2_data","1::1::Frequency of crisis (mean number of pain crises)","No usable data for effect sizes"
"CD013590_pub2_data","1::3::SCD-related complications (number of participants)","No usable data for effect sizes"
"CD013590_pub2_data","2::1::Frequency of crisis (number of participants with pain crisis)","No usable data for effect sizes"
"CD013590_pub2_data","2::3::Adverse events","No usable data for effect sizes"
"CD013590_pub2_data","3::2::Frequency of crisis (mean number of pain crises)","No usable data for effect sizes"
"CD013590_pub2_data","3::3::QoL of participants living with SCD and their caregivers","No usable data for effect sizes"
"CD013590_pub2_data","3::4::Frequency of hospitalization","No usable data for effect sizes"
"CD013590_pub2_data","3::6::Frequency of SCD-related complications (number of participants with infections) at 6 months","No usable data for effect sizes"
"CD013590_pub2_data","3::8::Haemoglobin status (g/dL) (at up to 6 months)","No usable data for effect sizes"
"CD013590_pub2_data","3::9::Haemoglobin % (at over 12 months)","No usable data for effect sizes"
"CD013590_pub2_data","4::1::Frequency of crisis (mean change from baseline: number of vaso-occlusive crises (at up to 12 months))","No usable data for effect sizes"
"CD013590_pub2_data","4::3::Frequency of SCD-related complications (mean change from baseline)","No usable data for effect sizes"
"CD013590_pub2_data","4::4:: Laboratory markers of haemolysis and inflammation","No usable data for effect sizes"
"CD013590_pub2_data","5::1::Frequency of crisis (mean change from baseline: number of vaso-occlusive crises (at up to 12 months))","No usable data for effect sizes"
"CD013590_pub2_data","5::3::Frequency of SCD-related complications","No usable data for effect sizes"
"CD013590_pub2_data","5::4:: Laboratory markers of haemolysis and inflammation","No usable data for effect sizes"
"CD013590_pub2_data","6::1::Frequency of crisis","No usable data for effect sizes"
"CD013590_pub2_data","7::2::Pain severity (pain intensity)","No usable data for effect sizes"
"CD013590_pub2_data","7::3::Pain severity (home analgesia)","No usable data for effect sizes"
"CD013590_pub2_data","7::5::Adverse effects","No usable data for effect sizes"
"CD013590_pub2_data","7::6:: Frequency of hospitalization","No usable data for effect sizes"
"CD013590_pub2_data","7::8::Haemoglobin status (g/dL)","No usable data for effect sizes"
"CD013590_pub2_data","8::1::Frequency of crises","No usable data for effect sizes"
"CD013590_pub2_data","10::1::Frequency of crisis","No usable data for effect sizes"
"CD013590_pub2_data","11::1::Severity of pain crises","No usable data for effect sizes"
"CD013590_pub2_data","11::2:: Frequency of hospitalization","No usable data for effect sizes"
"CD013590_pub2_data","12::1::Haemoglobin status","No usable data for effect sizes"
"CD013590_pub2_data","13::1::Frequency of SCD-related complications","No usable data for effect sizes"
"CD013590_pub2_data","14::1::Frequency of crisis","No usable data for effect sizes"
"CD013590_pub2_data","14::3::Frequency of SCD-related complications","No usable data for effect sizes"
"CD013590_pub2_data","14::4::Laboratory markers of haemolysis and inflammation","No usable data for effect sizes"
"CD013590_pub2_data","16::1::Haemoglobin status (g/dL)","No usable data for effect sizes"
"CD013590_pub2_data","17::1::Frequency of crisis","No usable data for effect sizes"
"CD013590_pub2_data","17::2::Haemoglobin status (g/dL)","No usable data for effect sizes"
"CD013591_pub2_data","2::1::Physical activity (moderate to vigorous physical activity)","No usable data for effect sizes"
"CD013591_pub2_data","2::2::Physical activity (other measures)","No usable data for effect sizes"
"CD013591_pub2_data","2::3::Anthropometric measures (BMI)","No usable data for effect sizes"
"CD013591_pub2_data","2::4::Dietary behaviour (energy intake)","No usable data for effect sizes"
"CD013591_pub2_data","2::5::Dietary behaviour (other measures -  healthy)","No usable data for effect sizes"
"CD013591_pub2_data","3::1::Anthropometric measures (BMI z-score)","No usable data for effect sizes"
"CD013613_pub2_data","1::1::PTSD severity at three months","No usable data for effect sizes"
"CD013613_pub2_data","1::3::Dropouts due to adverse events at three months","No usable data for effect sizes"
"CD013613_pub2_data","1::4::Dropouts due to adverse events at study endpoint","No usable data for effect sizes"
"CD013613_pub2_data","1::5::PTSD rate at three months","No usable data for effect sizes"
"CD013613_pub2_data","1::6::Sensitivity analysis: PTSD rate at three months (cases out of randomised)","No usable data for effect sizes"
"CD013613_pub2_data","1::9::Depression severity at three months","No usable data for effect sizes"
"CD013613_pub2_data","1::11::Anxiety severity at three months","No usable data for effect sizes"
"CD013613_pub2_data","1::12::Anxiety severity at study endpoint","No usable data for effect sizes"
"CD013613_pub2_data","1::13::Functional disability at study endpoint","No usable data for effect sizes"
"CD013613_pub2_data","1::14::Dropout for any reason at three months","No usable data for effect sizes"
"CD013613_pub2_data","2::13::Quality of life at three months","No usable data for effect sizes"
"CD013613_pub2_data","3::1::PTSD severity at three months","No usable data for effect sizes"
"CD013613_pub2_data","3::2::PTSD severity at study endpoint","No usable data for effect sizes"
"CD013613_pub2_data","3::3::Depression severity at three months","No usable data for effect sizes"
"CD013613_pub2_data","3::4::Depression severity at study endpoint","No usable data for effect sizes"
"CD013613_pub2_data","3::5::Anxiety severity at three months","No usable data for effect sizes"
"CD013613_pub2_data","3::6::Anxiety severity at study endpoint","No usable data for effect sizes"
"CD013613_pub2_data","3::7::Dropout for any reason at three months","No usable data for effect sizes"
"CD013613_pub2_data","3::8::Dropout for any reason at study endpoint","No usable data for effect sizes"
"CD013613_pub2_data","4::1::PTSD severity at study endpoint","No usable data for effect sizes"
"CD013613_pub2_data","4::2::Dropouts due to adverse events at study endpoint","No usable data for effect sizes"
"CD013613_pub2_data","4::3::PTSD rate at study endpoint","No usable data for effect sizes"
"CD013613_pub2_data","4::4::Sensitivity analysis: PTSD rate at study endpoint (cases out of randomised)","No usable data for effect sizes"
"CD013613_pub2_data","4::5::Dropout for any reason at study endpoint","No usable data for effect sizes"
"CD013614_pub2_data","2::30::Improvement in psoriasis in patients with psoriasis at baseline as measured by the PASI75 response at 12 weeks.","No usable data for effect sizes"
"CD013614_pub2_data","2::31::Improvement in fatigue as measured by FACIT-F scale or by the FATIGUE VAS at 12 weeks.","No usable data for effect sizes"
"CD013614_pub2_data","3::1::Number of patients with serious adverse events at any time","No usable data for effect sizes"
"CD013614_pub2_data","3::2::Withdrawal due to adverse events","No usable data for effect sizes"
"CD013614_pub2_data","3::3::Improvement in psoriasis in patients with psoriasis at baseline as measured by the PASI75 response at 24 weeks.","No usable data for effect sizes"
"CD013614_pub2_data","4::13::Health-related quality of life as measured by the SF-36 or by the PSAQOL at 12 weeks. (SF-36 MCS). ","No usable data for effect sizes"
"CD013614_pub2_data","4::17::Health-related quality of life as measured by the SF-36 or by the PSAQOL at 52 weeks (SF-36 MCS). ","No usable data for effect sizes"
"CD013614_pub2_data","4::19::Radiographic progression (change from baseline) at 52 weeks","No usable data for effect sizes"
"CD013614_pub2_data","4::20::Radiographic progression (change from baseline) at 24 weeks","No usable data for effect sizes"
"CD013614_pub2_data","4::27::Improvement in enthesitis in patients with enthesitis at baseline as measured by the LEI or by the MASES at 12 weeks","No usable data for effect sizes"
"CD013614_pub2_data","4::33::Improvement in dactylitis in patients with dactylitis at baseline as measured by a simple quantitative scoring of dactylitis or by LDI or by LDI basic at 12 weeks.","No usable data for effect sizes"
"CD013614_pub2_data","4::35::Improvement in dactylitis in patients with dactylitis at baseline as measured by a simple quantitative scoring of dactylitis or by LDI or by LDI basic at 24 weeks.","No usable data for effect sizes"
"CD013614_pub2_data","4::37::Improvement in dactylitis in patients with dactylitis at baseline as measured by a simple quantitative scoring of dactylitis or by LDI or by LDI basic at 52 weeks.","No usable data for effect sizes"
"CD013614_pub2_data","4::44::Improvement in fatigue as measured by FACIT-F scale or by the FATIGUE VAS at 12 weeks.","No usable data for effect sizes"
"CD013614_pub2_data","4::45::Improvement in fatigue as measured by FACIT-F scale or by the FATIGUE VAS at 24 weeks.","No usable data for effect sizes"
"CD013614_pub2_data","4::46::Improvement in fatigue as measured by FACIT-F scale or by the FATIGUE VAS at 52 weeks.","No usable data for effect sizes"
"CD013614_pub2_data","5::10::MCID in HAQ proportion of patients at 24 weeks","No usable data for effect sizes"
"CD013614_pub2_data","5::12::MCID in HAQ proportion of patients at 52 weeks","No usable data for effect sizes"
"CD013614_pub2_data","5::19::Radiographic progression (change from baseline) at 24 weeks","No usable data for effect sizes"
"CD013614_pub2_data","5::27::Improvement in enthesitis in patients with enthesitis at baseline as measured by the LEI or by the MASES at 12 weeks.","No usable data for effect sizes"
"CD013614_pub2_data","5::28::Enthesitis: resolution as LEI=0 at 24 weeks","No usable data for effect sizes"
"CD013614_pub2_data","5::29::Improvement in enthesitis in patients with enthesitis at baseline as measured by the LEI or by the MASES at 24 weeks.","No usable data for effect sizes"
"CD013614_pub2_data","5::31::Improvement in enthesitis in patients with enthesitis at baseline as measured by the LEI or by the MASES at 52 weeks.","No usable data for effect sizes"
"CD013614_pub2_data","5::33::Improvement in dactylitis in patients with dactylitis at baseline as measured by a simple quantitative scoring of dactylitis or by LDI or by LDI basic at 12 weeks.","No usable data for effect sizes"
"CD013614_pub2_data","5::34::Resolution of dactylitis as no dactylitis at 24 weeks","No usable data for effect sizes"
"CD013614_pub2_data","5::35::Improvement in dactylitis in patients with dactylitis at baseline as measured by a simple quantitative scoring of dactylitis or by LDI or by LDI basic at 24 weeks.","No usable data for effect sizes"
"CD013614_pub2_data","5::37::Improvement in dactylitis in patients with dactylitis at baseline as measured by a simple quantitative scoring of dactylitis or by LDI or by LDI basic at 52 weeks.","No usable data for effect sizes"
"CD013614_pub2_data","5::39::Improvement in pain as measured by VAS or NRS at week 24.","No usable data for effect sizes"
"CD013614_pub2_data","5::40::Improvement in pain as measured by VAS or NRS at week 52.","No usable data for effect sizes"
"CD013614_pub2_data","6::1::Clinical improvement as measured by ACR20 response criteria or by the EULAR moderate response criteria or by PsARC criteria at 52 weeks","No usable data for effect sizes"
"CD013614_pub2_data","7::1::Clinical improvement as measured by ACR20 response criteria or by the EULAR moderate response criteria or by PsARC criteria at 52 weeks.","No usable data for effect sizes"
"CD013614_pub2_data","8::1::Clinical improvement as measured by ACR20 response criteria or by the EULAR moderate response criteria or by PsARC criteria at 52 weeks","No usable data for effect sizes"
"CD013631_pub2_data","1::1::Patient-reported outcomes: HRQoL at 12 weeks","No usable data for effect sizes"
"CD013631_pub2_data","2::1::Kidney function: eGFR at 4 weeks","No usable data for effect sizes"
"CD013631_pub2_data","2::2::Kidney function: serum creatinine at 8 weeks","No usable data for effect sizes"
"CD013631_pub2_data","2::3::Uraemic toxins: urea at 4 weeks","No usable data for effect sizes"
"CD013631_pub2_data","2::4::Uraemic toxins: indoxyl sulfate at 4 weeks","No usable data for effect sizes"
"CD013631_pub2_data","2::5::Uraemic toxins: p-cresol sulfate at 4 weeks","No usable data for effect sizes"
"CD013631_pub2_data","2::6::GI function: change in any GI upset or intolerance (prevalence of borborygmi) at 4 weeks","No usable data for effect sizes"
"CD013631_pub2_data","2::7::GI function: change in any GI upset or intolerance (GSRS Total Index at 12 months)","No usable data for effect sizes"
"CD013631_pub2_data","2::8::GI function: faecal pH at 7 weeks","No usable data for effect sizes"
"CD013631_pub2_data","2::9::GI function: faecal characteristics (Bristol Stool Chart) at 4 weeks","No usable data for effect sizes"
"CD013631_pub2_data","2::10::GI function: faecal characteristics (Bristol Stool Chart) at 12 months","No usable data for effect sizes"
"CD013631_pub2_data","3::1::Kidney function: eGFR at 12 weeks","No usable data for effect sizes"
"CD013631_pub2_data","3::4::GI function: change in any GI upset or intolerance (burping) at 4 weeks","No usable data for effect sizes"
"CD013631_pub2_data","3::5::GI function: change in any GI upset or intolerance (cramping) at 4 weeks","No usable data for effect sizes"
"CD013631_pub2_data","3::6::GI function: change in any GI upset or intolerance (distension) at 4 weeks","No usable data for effect sizes"
"CD013631_pub2_data","3::7::GI function: change in any GI upset or intolerance (flatulence) at 4 weeks","No usable data for effect sizes"
"CD013631_pub2_data","3::8::GI function: change in any GI upset or intolerance (nausea) at 4 weeks","No usable data for effect sizes"
"CD013631_pub2_data","3::9::GI function: change in any GI upset or intolerance (reflux) at 4 weeks","No usable data for effect sizes"
"CD013631_pub2_data","3::10::GI function: change in any GI upset or intolerance (rumblings) at 4 weeks","No usable data for effect sizes"
"CD013631_pub2_data","3::11::GI function: microbiota composition (Actinobacteria) at 4 weeks","No usable data for effect sizes"
"CD013631_pub2_data","3::12::GI function: microbiota composition (Bacteriodetes) at 4 weeks","No usable data for effect sizes"
"CD013631_pub2_data","3::13::GI function: microbiota composition (Proteobacteria) at 4 weeks","No usable data for effect sizes"
"CD013631_pub2_data","3::14::GI function: microbiota composition (Firmicutes) at 4 weeks","No usable data for effect sizes"
"CD013631_pub2_data","3::15::GI function: microbiota composition (Synergistetes) at 4 weeks","No usable data for effect sizes"
"CD013631_pub2_data","3::16::GI function: microbiota composition (Verrucomicrobia) at 4 weeks","No usable data for effect sizes"
"CD013631_pub2_data","3::17::GI function: microbiota composition (faecal acetate) at 4 weeks","No usable data for effect sizes"
"CD013631_pub2_data","3::18::GI function: microbiota composition (faecal propionate) at 4 weeks","No usable data for effect sizes"
"CD013631_pub2_data","3::19::GI function: microbiota composition (faecal butyrate) at 4 weeks","No usable data for effect sizes"
"CD013631_pub2_data","3::20::GI function: microbiota composition (faecal total short-chain fatty acids) at 4 weeks","No usable data for effect sizes"
"CD013631_pub2_data","3::21::GI function: microbiota composition (faecal indoles) at 4 weeks","No usable data for effect sizes"
"CD013631_pub2_data","3::22::GI function: microbiota composition (faecal p-cresol) at 4 weeks","No usable data for effect sizes"
"CD013631_pub2_data","3::23::GI function: faecal characteristics (bowel movements) at 4 weeks","No usable data for effect sizes"
"CD013631_pub2_data","3::24::GI function: faecal characteristics (ease of passage) at 4 weeks","No usable data for effect sizes"
"CD013631_pub2_data","3::25::GI function: faecal characteristics (consistency) at 4 weeks","No usable data for effect sizes"
"CD013631_pub2_data","3::27::Withdrawals due to adverse events","No usable data for effect sizes"
"CD013631_pub2_data","4::1::Dialysis outcomes: peritonitis at 24 weeks","No usable data for effect sizes"
"CD013631_pub2_data","5::1::Kidney function: GFR at 8 weeks","No usable data for effect sizes"
"CD013631_pub2_data","5::2::Kidney function: serum creatinine at 8 weeks","No usable data for effect sizes"
"CD013631_pub2_data","5::3::Uraemic toxins: urea at 8 weeks","No usable data for effect sizes"
"CD013631_pub2_data","6::4::GI function: GSRS Item 6 (rumbling) at 12 weeks","No usable data for effect sizes"
"CD013631_pub2_data","6::5::GI function: GSRS Item 13 (hard stools) at 12 weeks","No usable data for effect sizes"
"CD013631_pub2_data","6::6::GI function: abdominal pain at 12 weeks","No usable data for effect sizes"
"CD013631_pub2_data","6::7::GI function: constipation syndrome at 12 weeks","No usable data for effect sizes"
"CD013631_pub2_data","7::2::Uraemic toxins: urea at 12 weeks","No usable data for effect sizes"
"CD013631_pub2_data","7::4::Uraemic toxins: p-cresyl sulfate at 8 weeks","No usable data for effect sizes"
"CD013631_pub2_data","7::5::GI function: microbiota composition (Facealibacterium) at 8 weeks","No usable data for effect sizes"
"CD013631_pub2_data","7::6::GI function: microbiota composition (Parabacteroides) at 8 weeks","No usable data for effect sizes"
"CD013631_pub2_data","7::7::GI function: microbiota composition (Bifidobacteria) at 8 weeks","No usable data for effect sizes"
"CD013631_pub2_data","7::8::GI function: microbiota composition (Ruminococcus) at 8 weeks","No usable data for effect sizes"
"CD013631_pub2_data","7::9::GI function: microbiota composition (Prevotella) at 8 weeks","No usable data for effect sizes"
"CD013631_pub2_data","7::10::Adverse events: any adverse event (number of participants)","No usable data for effect sizes"
"CD013631_pub2_data","7::11::Withdrawals due to adverse events","No usable data for effect sizes"
"CD013631_pub2_data","8::4::Kidney function: proteinuria at 12 weeks","No usable data for effect sizes"
"CD013631_pub2_data","8::8::Uraemic toxins: indole-3-acetic acid acid at 12 weeks","No usable data for effect sizes"
"CD013631_pub2_data","8::9::GI function: any GI upset or intolerance (abdominal pain/diarrhoea) at 12 weeks","No usable data for effect sizes"
"CD013631_pub2_data","8::10::GI function: any GI upset or intolerance (constipation) at 12 weeks","No usable data for effect sizes"
"CD013631_pub2_data","8::11::GI function: faecal pH at 12 weeks","No usable data for effect sizes"
"CD013643_pub2_data","1::2::Number of continent women (objective measure as reported by the trialists), medium term (1 to 5 years)","No usable data for effect sizes"
"CD013643_pub2_data","1::4::Improvement in patient-reported incontinence, medium term (1 to 5 years)","No usable data for effect sizes"
"CD013643_pub2_data","1::7::Number of continent women by patient-reported measures, medium term (1 to 5 years)","No usable data for effect sizes"
"CD013643_pub2_data","1::9::Improvement in incontinence-specific quality of life, medium term (1 to 5 years)","No usable data for effect sizes"
"CD013643_pub2_data","1::11::Improvement in clinical measures of urinary incontinence (mean number of voids on 3-day voiding diary), medium term (1 to 5 years)","No usable data for effect sizes"
"CD013643_pub2_data","1::13::Improvement in patient-reported sexual function, medium term (1 to 5 years)","No usable data for effect sizes"
"CD013643_pub2_data","2::1::Improvement in patient-reported incontinence, short term (< 1 year)","No usable data for effect sizes"
"CD013643_pub2_data","2::2::Number of major adverse events (Clavien-Dindo III-V), short term (< 1 year)","No usable data for effect sizes"
"CD013643_pub2_data","2::3::Number of minor adverse events (Clavien-Dindo I, II), short term (< 1 year)","No usable data for effect sizes"
"CD013672_pub2_data","3::1::Major adverse events","No usable data for effect sizes"
"CD013672_pub2_data","4::1::Quality of life","No usable data for effect sizes"
"CD013715_pub2_data","1::2::PedACR70 at 17 to 26 weeks","No usable data for effect sizes"
"CD013715_pub2_data","1::5::Pain at 17 to 26 weeks ","No usable data for effect sizes"
"CD013715_pub2_data","1::8::Participant global assessment of disease activity at 27 to 52 weeks ","No usable data for effect sizes"
"CD013715_pub2_data","1::9::Disease remission at 17 to 26 weeks ","No usable data for effect sizes"
"CD013715_pub2_data","1::10::Disease remission at 27 to 52 weeks ","No usable data for effect sizes"
"CD013715_pub2_data","1::12::Withdrawals due to adverse events at 17 to 26 weeks","No usable data for effect sizes"
"CD013715_pub2_data","1::16::Serious adverse events at 17 to 26 weeks","No usable data for effect sizes"
"CD013715_pub2_data","1::20::PedACR50 at 17 to 26 weeks","No usable data for effect sizes"
"CD013715_pub2_data","2::2::PedACR70 at 17 to 26 weeks","No usable data for effect sizes"
"CD013715_pub2_data","2::3::PedACR70 at up to 52 weeks","No usable data for effect sizes"
"CD013715_pub2_data","2::4::Remission at up 16 weeks","No usable data for effect sizes"
"CD013715_pub2_data","2::5::Remission at 17 to 26 weeks","No usable data for effect sizes"
"CD013715_pub2_data","2::7::Withdrawals due to adverse events up to 26 weeks","No usable data for effect sizes"
"CD013715_pub2_data","2::8::Withdrawals due to adverse events up to 52 weeks","No usable data for effect sizes"
"CD013715_pub2_data","2::10::Serious adverse events up to 26 weeks","No usable data for effect sizes"
"CD013715_pub2_data","2::11::Serious adverse events up to 52 weeks","No usable data for effect sizes"
"CD013715_pub2_data","2::14::PedACR50 at 17 to 26 weeks","No usable data for effect sizes"
"CD013715_pub2_data","2::15::PedACR50 at up to 52 weeks","No usable data for effect sizes"
"CD013715_pub2_data","2::17::Total adverse events","No usable data for effect sizes"
"CD013719_pub2_data","1::3::Health-related quality of life","No usable data for effect sizes"
"CD013719_pub2_data","3::1::Short-term hair regrowth ≥ 75%","No usable data for effect sizes"
"CD013719_pub2_data","4::1::Short-term hair regrowth ≥ 75%","No usable data for effect sizes"
"CD013719_pub2_data","4::2::Incidence of serious adverse events","No usable data for effect sizes"
"CD013719_pub2_data","6::1::Short-term hair regrowth ≥ 75%","No usable data for effect sizes"
"CD013719_pub2_data","6::2::Incidence of serious adverse events","No usable data for effect sizes"
"CD013719_pub2_data","7::1::Short-term hair regrowth ≥ 75%","No usable data for effect sizes"
"CD013719_pub2_data","7::2::Incidence of serious adverse events","No usable data for effect sizes"
"CD013719_pub2_data","8::1::Short-term hair regrowth ≥ 75%","No usable data for effect sizes"
"CD013719_pub2_data","9::1::Short-term hair regrowth ≥ 75%","No usable data for effect sizes"
"CD013719_pub2_data","10::1::Short-term hair regrowth ≥ 75%","No usable data for effect sizes"
"CD013719_pub2_data","10::2::Incidence of serious adverse events","No usable data for effect sizes"
"CD013719_pub2_data","12::1::Short-term hair regrowth ≥ 75%","No usable data for effect sizes"
"CD013719_pub2_data","12::2::Incidence of serious adverse events","No usable data for effect sizes"
"CD013719_pub2_data","13::3::Sensitivity analysis. Intralesional classical immunosuppressants vs placebo: short-term hair regrowth","No usable data for effect sizes"
"CD013719_pub2_data","13::4::Sensitivity analysis. Subcutaneous biologics vs placebo: short-term hair regrowth","No usable data for effect sizes"
"CD013719_pub2_data","13::6::Sensitivity analysis. Oral small molecule inhibitors: ruxolitinib vs tofacitinib","No usable data for effect sizes"
"CD013719_pub2_data","13::7::Sensitivity analysis. Topical small molecule inhibitors: short-term hair regrowth","No usable data for effect sizes"
"CD013719_pub2_data","13::8::Sensitivity analysis. Contact immunotherapy vs placebo: short-term hair regrowth","No usable data for effect sizes"
"CD013719_pub2_data","13::9::Sensitivity analysis. Contact immunotherapy vs minoxidil: short-term hair regrowth","No usable data for effect sizes"
"CD013719_pub2_data","13::10::Sensitivity analysis. Contact immunotherapy + hair growth stimulants vs contact immunotherapy: short term hair regrowth","No usable data for effect sizes"
"CD013719_pub2_data","13::12::Sensitivity analysis. Cryotherapy vs fractional CO2 laser: short-term hair regrowth","No usable data for effect sizes"
"CD013726_pub2_data","1::1::Pain","No usable data for effect sizes"
"CD013726_pub2_data","1::2::Function","No usable data for effect sizes"
"CD013726_pub2_data","1::3::Quality of life","No usable data for effect sizes"
"CD013726_pub2_data","1::4::Participant global assessment of treatment success","No usable data for effect sizes"
"CD013726_pub2_data","1::5::Reoperation (treatment failure)","No usable data for effect sizes"
"CD013726_pub2_data","1::6::Adverse events","No usable data for effect sizes"
"CD013726_pub2_data","1::7::Serious adverse events","No usable data for effect sizes"
"CD013726_pub2_data","2::1::Pain","No usable data for effect sizes"
"CD013726_pub2_data","2::2::Function","No usable data for effect sizes"
"CD013726_pub2_data","2::3::Quality of life","No usable data for effect sizes"
"CD013726_pub2_data","2::4::Participant global assessment of treatment success","No usable data for effect sizes"
"CD013726_pub2_data","2::5::Reoperation (treatment failure)","No usable data for effect sizes"
"CD013726_pub2_data","2::6::Adverse events","No usable data for effect sizes"
"CD013726_pub2_data","2::7::Serious adverse events","No usable data for effect sizes"
"CD013729_pub2_data","1::2::Change in systolic blood pressure: sensitivity analysis (low risk of bias for random sequence generation, allocation concealment, and incomplete outcome data)","No usable data for effect sizes"
"CD013729_pub2_data","1::3::Change in diastolic blood pressure (medium-term follow-up)","No usable data for effect sizes"
"CD013729_pub2_data","1::4::Change in total cholesterol (medium-term follow-up)","No usable data for effect sizes"
"CD013729_pub2_data","1::5::Change in low-density lipoprotein (LDL) cholesterol (medium-term follow-up)","No usable data for effect sizes"
"CD013729_pub2_data","1::6::Change in high-density lipoprotein (HDL) cholesterol (medium-term follow-up)","No usable data for effect sizes"
"CD013729_pub2_data","1::7::Change in triglycerides (medium-term follow-up)","No usable data for effect sizes"
"CD013729_pub2_data","2::3::Change in systolic blood pressure (long-term follow-up)","No usable data for effect sizes"
"CD013729_pub2_data","2::5::Change in diastolic blood pressure (long-term follow-up)","No usable data for effect sizes"
"CD013729_pub2_data","2::6::Change in total cholesterol (medium-term follow-up)","No usable data for effect sizes"
"CD013729_pub2_data","2::7::Change in low-density lipoprotein (LDL) cholesterol (medium-term follow-up)","No usable data for effect sizes"
"CD013729_pub2_data","2::8::Change in high-density lipoprotein (HDL) cholesterol (medium-term follow-up)","No usable data for effect sizes"
"CD013729_pub2_data","2::9::Change in triglycerides (medium-term follow-up)","No usable data for effect sizes"
"CD013729_pub2_data","2::10::Change in health-related quality of life (medium-term follow-up)","No usable data for effect sizes"
"CD013729_pub2_data","2::11::Change in health-related quality of life (long-term follow-up)","No usable data for effect sizes"
"CD013729_pub2_data","2::12::Adverse effects (medium-term follow-up)","No usable data for effect sizes"
"CD013729_pub2_data","3::1::All-cause mortality (medium-term follow-up)","No usable data for effect sizes"
"CD013729_pub2_data","3::2::Change in systolic blood pressure (medium-term follow-up)","No usable data for effect sizes"
"CD013729_pub2_data","3::3::Adverse effects (medium-term follow-up)","No usable data for effect sizes"
"CD013731_pub2_data","1::1::Overall survival at censored observation (measured at end of treatment, i.e. 20 months)","No usable data for effect sizes"
"CD013731_pub2_data","1::2::Serious adverse events (Intention-to-treat) (measured at end of treatment, i.e. 20 months)","No usable data for effect sizes"
"CD013731_pub2_data","1::3::Disease progression (measured at end of treatment, i.e. 20 months)","No usable data for effect sizes"
"CD013731_pub2_data","1::4::Any adverse events considered non-serious (number of participants) (during 20 months of  treatment)","No usable data for effect sizes"
"CD013731_pub2_data","2::1::All-cause mortality (measured at 1-year follow-up)","No usable data for effect sizes"
"CD013731_pub2_data","2::2::All-cause mortality (measured at 2-year follow-up)","No usable data for effect sizes"
"CD013731_pub2_data","2::3::Any adverse events considered non-serious (number of participants)","No usable data for effect sizes"
"CD013731_pub2_data","3::1::All-cause mortality (measured at 1-year follow-up)","No usable data for effect sizes"
"CD013731_pub2_data","3::2::All-cause mortality (measured at 3-year follow-up)","No usable data for effect sizes"
"CD013731_pub2_data","3::3::All-cause mortality (measured at 5-year follow-up) (primary time point)","No usable data for effect sizes"
"CD013731_pub2_data","4::1::Overall survival (measured at 6 months)","No usable data for effect sizes"
"CD013731_pub2_data","4::2::Overall survival (measured at 12 months)","No usable data for effect sizes"
"CD013731_pub2_data","4::3::Disease progression (measured at 6 months)","No usable data for effect sizes"
"CD013731_pub2_data","5::1::Disease progression at median 12.8 months","No usable data for effect sizes"
"CD013731_pub2_data","6::1::Disease progression at 2 weeks","No usable data for effect sizes"
"CD013731_pub2_data","6::2::Any adverse events considered non-serious (number of events)","No usable data for effect sizes"
"CD013731_pub2_data","6::3::Proportion of people without improvement in liver function tests at 2 weeks","No usable data for effect sizes"
"CD013745_pub2_data","1::1::Rivaroxaban versus antiplatelet therapy","No usable data for effect sizes"
"CD013745_pub2_data","1::2::Apixaban versus antiplatelet therapy","No usable data for effect sizes"
"CD013745_pub2_data","1::3::Edoxaban versus antiplatelet therapy","No usable data for effect sizes"
"CD013745_pub2_data","1::5::Apixaban versus VKA","No usable data for effect sizes"
"CD013745_pub2_data","1::6::Edoxaban versus VKA","No usable data for effect sizes"
"CD013745_pub2_data","2::1::Rivaroxaban versus antiplatelet therapy","No usable data for effect sizes"
"CD013745_pub2_data","2::2::Apixaban versus antiplatelet therapy","No usable data for effect sizes"
"CD013745_pub2_data","2::3::Edoxaban versus antiplatelet therapy","No usable data for effect sizes"
"CD013745_pub2_data","2::5::Apixaban versus VKA","No usable data for effect sizes"
"CD013745_pub2_data","2::6::Edoxaban versus VKA","No usable data for effect sizes"
"CD013745_pub2_data","3::1::Rivaroxaban versus antiplatelet therapy","No usable data for effect sizes"
"CD013745_pub2_data","3::2::Edoxaban versus antiplatelet therapy","No usable data for effect sizes"
"CD013745_pub2_data","3::4::Apixaban versus VKA","No usable data for effect sizes"
"CD013745_pub2_data","3::5::Edoxaban versus VKA","No usable data for effect sizes"
"CD013745_pub2_data","4::1::Rivaroxaban versus antiplatelet therapy","No usable data for effect sizes"
"CD013745_pub2_data","4::2::Apixaban versus antiplatelet therapy","No usable data for effect sizes"
"CD013745_pub2_data","4::3::Edoxaban versus antiplatelet therapy","No usable data for effect sizes"
"CD013745_pub2_data","4::5::Apixaban versus VKA","No usable data for effect sizes"
"CD013745_pub2_data","4::6::Edoxaban versus VKA","No usable data for effect sizes"
"CD013745_pub2_data","5::1::Rivaroxaban versus antiplatelet therapy","No usable data for effect sizes"
"CD013745_pub2_data","5::2::Edoxaban versus antiplatelet therapy","No usable data for effect sizes"
"CD013745_pub2_data","5::3::Apixaban versus VKA","No usable data for effect sizes"
"CD013745_pub2_data","5::4::Edoxaban versus VKA","No usable data for effect sizes"
"CD013745_pub2_data","6::1::Rivaroxaban versus antiplatelet therapy","No usable data for effect sizes"
"CD013745_pub2_data","7::1::Rivaroxaban versus antiplatelet therapy","No usable data for effect sizes"
"CD013745_pub2_data","8::1::Rivaroxaban versus antiplatelet therapy","No usable data for effect sizes"
"CD013745_pub2_data","8::2::Apixaban versus antiplatelet therapy","No usable data for effect sizes"
"CD013745_pub2_data","8::3::Apixaban versus VKA","No usable data for effect sizes"
"CD013745_pub2_data","8::4::Edoxaban versus VKA","No usable data for effect sizes"
"CD013745_pub2_data","9::1::Rivaroxaban versus antiplatelet therapy","No usable data for effect sizes"
"CD013745_pub2_data","9::2::Apixaban versus antiplatelet therapy","No usable data for effect sizes"
"CD013745_pub2_data","9::3::Edoxaban versus antiplatelet therapy","No usable data for effect sizes"
"CD013758_pub2_data","1::7::Overweight","No usable data for effect sizes"
"CD013758_pub2_data","1::9::Obesity","No usable data for effect sizes"
"CD013763_pub3_data","1::8::Rate of chronic post-surgical pain after 3 months","No usable data for effect sizes"
"CD013763_pub3_data","1::9::Rate of chronic post-surgical pain after 6 months","No usable data for effect sizes"
"CD013763_pub3_data","1::10::Cumulative mean oral morphine requirement in mg - 2 hours","No usable data for effect sizes"
"CD013763_pub3_data","3::8::Cumulative mean oral morphine requirement in mg - 2 hours","No usable data for effect sizes"
"CD013763_pub3_data","5::2::Mean difference in postoperative pain intensity at rest - 2 hours (VAS)","No usable data for effect sizes"
"CD013763_pub3_data","6::2::Rates of block-related adverse outcomes","No usable data for effect sizes"
"CD013763_pub3_data","7::1::Mean difference in postoperative pain intensity at rest (24 hours postoperatively) (VAS)","No usable data for effect sizes"
"CD013763_pub3_data","7::2::Rates of block-related adverse events","No usable data for effect sizes"
"CD013763_pub3_data","7::3::Mean difference in postoperative pain intensity during activity (24 hours postoperatively)","No usable data for effect sizes"
"CD013763_pub3_data","8::4::Mean difference in postoperative pain intensity at rest - 48 hours (VAS)","No usable data for effect sizes"
"CD013763_pub3_data","8::5::Mean difference in postoperative pain intensity during activity - 48 hours (VAS)","No usable data for effect sizes"
"CD013763_pub3_data","9::2::Rates of block-related adverse events","No usable data for effect sizes"
"CD013763_pub3_data","9::3::Mean difference in postoperative pain intensity during activity (24 hours postoperatively) (VAS)","No usable data for effect sizes"
"CD013763_pub3_data","9::4::Mean difference in postoperative pain intensity at rest - 2 hours (VAS)","No usable data for effect sizes"
"CD013763_pub3_data","9::5::Mean difference in postoperative pain intensity at rest - 48 hours (VAS)","No usable data for effect sizes"
"CD013763_pub3_data","9::6::Mean difference in postoperative pain intensity during activity - 48 hours (VAS)","No usable data for effect sizes"
"CD013763_pub3_data","9::7::Cumulative mean oral morphine requirement in mg - 24 hours","No usable data for effect sizes"
"CD013764_pub2_data","1::6::Adherence","No usable data for effect sizes"
"CD013764_pub2_data","2::3::Blood transfusion","No usable data for effect sizes"
"CD013764_pub2_data","2::4::Hospitalisation","No usable data for effect sizes"
"CD013764_pub2_data","2::6::Satisfaction","No usable data for effect sizes"
"CD013774_pub2_data","1::2::Health-related quality of life","No usable data for effect sizes"
"CD013781_pub2_data","1::1::Secondary outcome: cardiac index (postoperative nadir)","No usable data for effect sizes"
"CD013781_pub2_data","2::1::Primary outcome: incidence of LCOS","No usable data for effect sizes"
"CD013781_pub2_data","2::2::Primary outcome: adverse events - atrial fibrillation","No usable data for effect sizes"
"CD013781_pub2_data","2::3::Primary outcome: adverse events - perioperative myocardial infarction","No usable data for effect sizes"
"CD013781_pub2_data","2::4::Secondary outcome: length of hospital stay (days)","No usable data for effect sizes"
"CD013781_pub2_data","2::5::Secondary outcome: mean arterial pressure (24 hours after surgery)","No usable data for effect sizes"
"CD013781_pub2_data","2::6::Secondary outcome: duration of mechanical ventilation (hours)","No usable data for effect sizes"
"CD013781_pub2_data","2::7::Secondary outcome: number of participants requiring additional inotropic drugs - dopamine","No usable data for effect sizes"
"CD013781_pub2_data","2::8::Secondary outcome: proportion of renal failure","No usable data for effect sizes"
"CD013781_pub2_data","3::2::Primary outcome: adverse events - cardiogenic shock","No usable data for effect sizes"
"CD013781_pub2_data","3::3::Primary outcome: adverse events - atrial fibrillation","No usable data for effect sizes"
"CD013781_pub2_data","3::4::Primary outcome: adverse events - perioperative myocardial infarction","No usable data for effect sizes"
"CD013781_pub2_data","3::5::Primary outcome: adverse events - non-embolic stroke or transient ischaemic attack","No usable data for effect sizes"
"CD013781_pub2_data","3::6::Secondary outcome: length of ICU stay (days)","No usable data for effect sizes"
"CD013781_pub2_data","3::10::Secondary outcome: duration of mechanical ventilation (hours)","No usable data for effect sizes"
"CD013781_pub2_data","3::14::Secondary outcome: number of participants requiring additional inotropic drugs - epinephrine","No usable data for effect sizes"
"CD013781_pub2_data","3::15::Secondary outcome: number of participants requiring additional inotropic drugs - norepinephrine","No usable data for effect sizes"
"CD013781_pub2_data","3::16::Secondary outcome: number of participants requiring additional inotropic drugs - dobutamine","No usable data for effect sizes"
"CD013781_pub2_data","3::17::Secondary outcome: number of participants requiring additional inotropic drugs - phenylephrine","No usable data for effect sizes"
"CD013781_pub2_data","4::2::Secondary outcome: length of hospital stay (days)","No usable data for effect sizes"
"CD013781_pub2_data","4::8::Secondary outcome: number of participants requiring mechanical circulatory support","No usable data for effect sizes"
"CD013781_pub2_data","4::9::Secondary outcome: number of participants requiring  additional inotropic drugs","No usable data for effect sizes"
"CD013781_pub2_data","5::3::Primary outcome: adverse events - cardiogenic shock","No usable data for effect sizes"
"CD013781_pub2_data","5::5::Primary outcome: adverse events - perioperative myocardial infarction","No usable data for effect sizes"
"CD013781_pub2_data","5::6::Primary outcome: adverse events - non-embolic stroke or transient ischaemic attack","No usable data for effect sizes"
"CD013781_pub2_data","5::12::Secondary outcome: duration of mechanical ventilation (hours)","No usable data for effect sizes"
"CD013781_pub2_data","5::13::Secondary outcome: proportion of weaning failure within 48 hours of extubation","No usable data for effect sizes"
"CD013781_pub2_data","5::16::Secondary outcome: number of participants requiring additional inotropic drugs - epinephrine","No usable data for effect sizes"
"CD013781_pub2_data","5::18::Secondary outcome: number of participants requiring additional inotropic drugs - dopamine","No usable data for effect sizes"
"CD013781_pub2_data","5::19::Secondary outcome: number of participants requiring additional inotropic drugs - dobutamine","No usable data for effect sizes"
"CD013781_pub2_data","5::20::Secondary outcome: number of participants requiring cardiac transplantation","No usable data for effect sizes"
"CD013781_pub2_data","5::21::Secondary outcome: number of participants requiring cardiopulmonary resuscitation","No usable data for effect sizes"
"CD013781_pub2_data","6::2::Primary outcome: adverse events - atrial fibrillation","No usable data for effect sizes"
"CD013781_pub2_data","6::3::Primary outcome: adverse events - perioperative myocardial infarction","No usable data for effect sizes"
"CD013781_pub2_data","6::8::Secondary outcome: number of participants requiring additional inotropic drugs - norepinephrine","No usable data for effect sizes"
"CD013781_pub2_data","6::9::Secondary outcome: number of participants requiring additional inotropic drugs - dobutamine","No usable data for effect sizes"
"CD013781_pub2_data","7::18::Secondary outcome: number of participants requiring additional inotropic drugs - dopamine","No usable data for effect sizes"
"CD013781_pub2_data","7::20::Secondary outcome: number of participants requiring additional inotropic drugs - enoximone","No usable data for effect sizes"
"CD013781_pub2_data","7::22::Secondary outcome: number of participants requiring additional inotropic drugs - nitroprusside","No usable data for effect sizes"
"CD013781_pub2_data","7::23::Secondary outcome: number of participants requiring additional inotropic drugs - ephedrine","No usable data for effect sizes"
"CD013781_pub2_data","7::24::Secondary outcome: number of participants requiring additional inotropic drugs - phenylephrine","No usable data for effect sizes"
"CD013781_pub2_data","7::26::Secondary outcome: number of participants requiring cardiopulmonary resuscitation","No usable data for effect sizes"
"CD013801_pub2_data","1::4::Physician-evaluated change in severity of symptoms and signs (long-term)","No usable data for effect sizes"
"CD013801_pub2_data","1::7::Patient-reported change in functional capacity (medium-term) (sensitivity analysis)","No usable data for effect sizes"
"CD013801_pub2_data","1::8::Patient-reported change in functional capacity (long-term)","No usable data for effect sizes"
"CD013801_pub2_data","1::10::Changes in measures that incorporate both physician-evaluated and patient-reported items (medium-term)","No usable data for effect sizes"
"CD013801_pub2_data","1::12::Length of hospitalization","No usable data for effect sizes"
"CD013801_pub2_data","1::22::Incidence of hemolysis","No usable data for effect sizes"
"CD013801_pub2_data","1::23::Incidence of acute renal failure","No usable data for effect sizes"
"CD013801_pub2_data","2::5::Patient-reported change in functional capacity (short-term)","No usable data for effect sizes"
"CD013801_pub2_data","2::6::Patient-reported change in functional capacity (medium-term)","No usable data for effect sizes"
"CD013801_pub2_data","2::13::Incidence of myasthenia gravis-related hospitalizations","No usable data for effect sizes"
"CD013801_pub2_data","2::18::Incidence of allergic reaction","No usable data for effect sizes"
"CD013801_pub2_data","2::19::Incidence of fever (temperature greater than 38 ºC)","No usable data for effect sizes"
"CD013801_pub2_data","2::20::Incidence of headache","No usable data for effect sizes"
"CD013801_pub2_data","2::21::Incidence of hemolysis","No usable data for effect sizes"
"CD013801_pub2_data","2::25::Incidence of bleeding","No usable data for effect sizes"
"CD013801_pub2_data","2::28::Incidence of treatment discontinuation due to adverse events","No usable data for effect sizes"
"CD013801_pub2_data","3::1::Physician-evaluated change in severity of symptoms and signs (short-term)","No usable data for effect sizes"
"CD013810_pub2_data","1::3::Quality of life (Assessment of Quality of Life – 8 Dimensions – Psychosocial Superdimension)","No usable data for effect sizes"
"CD013810_pub2_data","1::4::Quality of life (Assessment of Quality of Life – 8 Dimensions – Physical Superdimension)","No usable data for effect sizes"
"CD013810_pub2_data","1::5::Quality of life (Assessment of Quality of Life – 8 Dimensions – Global Utility)","No usable data for effect sizes"
"CD013810_pub2_data","1::6::Quality of life (EuroQol 5-Dimensions)","No usable data for effect sizes"
"CD013810_pub2_data","1::7::Quality of life (EuroQol Thermometer)","No usable data for effect sizes"
"CD013810_pub2_data","1::8::Quality of life (36-Item Short Form – Physical Component Summary)","No usable data for effect sizes"
"CD013810_pub2_data","1::9::Quality of life (36-Item Short Form – Mental Component Summary)","No usable data for effect sizes"
"CD013810_pub2_data","1::10::Quality of life (Visual Analogical Well-being Scale)","No usable data for effect sizes"
"CD013810_pub2_data","1::11::Cardiovascular event incident rate per 100 participants per year","No usable data for effect sizes"
"CD013810_pub2_data","1::12::Cardiovascular risk factor (body mass index)","No usable data for effect sizes"
"CD013810_pub2_data","1::13::Cardiovascular risk factor (24-hour blood pressure)","No usable data for effect sizes"
"CD013810_pub2_data","1::14::Cardiovascular risk factor (24-hour systolic blood pressure)","No usable data for effect sizes"
"CD013810_pub2_data","1::15::Cardiovascular risk factor (24-hour diastolic blood pressure)","No usable data for effect sizes"
"CD013810_pub2_data","2::3::Quality of life (Functional Outcomes of Sleep Questionnaire)","No usable data for effect sizes"
"CD013810_pub2_data","2::4::Quality of life (Assessment of Quality of Life – 8 Dimensions – Psychosocial Superdimension)","No usable data for effect sizes"
"CD013810_pub2_data","2::5::Quality of life (Assessment of Quality of Life – 8 Dimensions – Physical Superdimension)","No usable data for effect sizes"
"CD013810_pub2_data","2::6::Quality of life (EuroQol Thermometer)","No usable data for effect sizes"
"CD013810_pub2_data","2::7::Quality of life (Visual Analogical Well-being Scale)","No usable data for effect sizes"
"CD013810_pub2_data","2::8::Cardiovascular event incident rate per 100 participants per year","No usable data for effect sizes"
"CD013810_pub2_data","2::9::Cardiovascular risk factor (body mass index)","No usable data for effect sizes"
"CD013810_pub2_data","2::10::Cardiovascular risk factor (systolic blood pressure)","No usable data for effect sizes"
"CD013810_pub2_data","2::11::Cardiovascular risk factor (diastolic blood pressure)","No usable data for effect sizes"
"CD013816_pub2_data","1::8::Valve thrombosis","No usable data for effect sizes"
"CD013816_pub2_data","1::18::General health status (QoL)","No usable data for effect sizes"
"CD013816_pub2_data","2::13::Adverse events - Hematoma (clinically non-significant device-pocket hematoma)","No usable data for effect sizes"
"CD013816_pub2_data","2::14::Adverse events - Pneumothorax","No usable data for effect sizes"
"CD013816_pub2_data","2::16::Economic costs - Days of hospitalization","No usable data for effect sizes"
"CD013822_pub2_data","2::2::Confidence - decisional conflict - dichotomous","No usable data for effect sizes"
"CD013822_pub2_data","2::8::Anxiety - dichotomous","No usable data for effect sizes"
"CD013827_pub2_data","1::1::Live birth or ongoing pregnancy","No usable data for effect sizes"
"CD013827_pub2_data","1::3::Clinical pregnancy","No usable data for effect sizes"
"CD013827_pub2_data","1::4::Cumulative pregnancy rate","No usable data for effect sizes"
"CD013827_pub2_data","2::1::Live birth or ongoing pregnancy","No usable data for effect sizes"
"CD013827_pub2_data","2::2::Oocyte pick-up cancellation","No usable data for effect sizes"
"CD013827_pub2_data","2::3::Clinical Pregnancy","No usable data for effect sizes"
"CD013827_pub2_data","2::6::Premature LH surge","No usable data for effect sizes"
"CD013827_pub2_data","2::7::Total oocytes","No usable data for effect sizes"
"CD013827_pub2_data","2::8::MII oocytes","No usable data for effect sizes"
"CD013827_pub2_data","2::9::Duration of stimulation (days)","No usable data for effect sizes"
"CD013827_pub2_data","2::10::Total dose of gonadotropins (IU)","No usable data for effect sizes"
"CD013827_pub2_data","2::11::Moderate or severe OHSS","No usable data for effect sizes"
"CD013827_pub2_data","4::1::Total oocytes","No usable data for effect sizes"
"CD013827_pub2_data","4::2::MII oocytes","No usable data for effect sizes"
"CD013830_pub2_data","1::1::Death or major neurodevelopmental disability","No usable data for effect sizes"
"CD013830_pub2_data","1::3::Major neurodevelopmental disability","No usable data for effect sizes"
"CD013830_pub2_data","1::4::Cerebral palsy or gross motor disability","No usable data for effect sizes"
"CD013830_pub2_data","1::5::Cognitive delay","No usable data for effect sizes"
"CD013830_pub2_data","1::9::Duration of positive-pressure ventilation after institution of treatment (hours)","No usable data for effect sizes"
"CD013830_pub2_data","1::10::Duration of oxygen therapy (days)","No usable data for effect sizes"
"CD013830_pub2_data","1::12::Patent ductus arteriosus (PDA) requiring ligation","No usable data for effect sizes"
"CD013830_pub2_data","1::14::Severe intraventricular hemorrhage (grades 3 and 4)","No usable data for effect sizes"
"CD013830_pub2_data","1::15::Periventricular leukomalacia (PVL)","No usable data for effect sizes"
"CD013830_pub2_data","1::18::Severe retinopathy of prematurity (ROP) in infants examined (stage 2 or greater)","No usable data for effect sizes"
"CD013830_pub2_data","2::1::Death or major neurodevelopmental disability","No usable data for effect sizes"
"CD013830_pub2_data","2::3::Cerebral palsy or gross motor disability","No usable data for effect sizes"
"CD013830_pub2_data","2::4::Cognitive delay","No usable data for effect sizes"
"CD013830_pub2_data","2::7::Duration of oxygen therapy (days)","No usable data for effect sizes"
"CD013830_pub2_data","2::8::Corrected gestational age at last use of positive-pressure ventilation","No usable data for effect sizes"
"CD013830_pub2_data","2::9::Corrected gestational age at last use of oxygen therapy","No usable data for effect sizes"
"CD013830_pub2_data","2::11::Patent ductus arteriosus (PDA) requiring ligation","No usable data for effect sizes"
"CD013830_pub2_data","2::13::Severe intraventricular hemorrhage (grades 3 and 4)","No usable data for effect sizes"
"CD013830_pub2_data","3::1::Death or major neurodevelopmental disability","No usable data for effect sizes"
"CD013830_pub2_data","3::3::Cerebral palsy or gross motor disability","No usable data for effect sizes"
"CD013830_pub2_data","3::4::Cognitive delay","No usable data for effect sizes"
"CD013830_pub2_data","3::5::Any apneic episodes","No usable data for effect sizes"
"CD013830_pub2_data","3::8::Corrected gestational age at last use of positive-pressure ventilation","No usable data for effect sizes"
"CD013830_pub2_data","3::9::Corrected gestational age at last use of oxygen therapy","No usable data for effect sizes"
"CD013830_pub2_data","3::10::Patent ductus arteriosus (PDA) requiring ligation","No usable data for effect sizes"
"CD013830_pub2_data","3::11::Necrotizing enterocolitis (NEC) (Bell's stage II or greater OR any grade; requiring surgery)","No usable data for effect sizes"
"CD013830_pub2_data","3::12::Chronic lung disease (CLD) defined as use of supplemental oxygen at 36 weeks' postmenstrual age","No usable data for effect sizes"
"CD013830_pub2_data","4::1::Death or major neurodevelopmental disability","No usable data for effect sizes"
"CD013830_pub2_data","4::2::Cerebral palsy or gross motor disability","No usable data for effect sizes"
"CD013830_pub2_data","4::3::Cognitive delay","No usable data for effect sizes"
"CD013830_pub2_data","4::5::Duration of positive-pressure ventilation after institution of treatment (hours)","No usable data for effect sizes"
"CD013830_pub2_data","4::6::Corrected gestational age at last use of positive-pressure ventilation","No usable data for effect sizes"
"CD013830_pub2_data","4::7::Corrected gestational age at last use of oxygen therapy","No usable data for effect sizes"
"CD013830_pub2_data","4::8::Patent ductus arteriosus (PDA) requiring any treatment","No usable data for effect sizes"
"CD013830_pub2_data","4::9::Patent ductus arteriosus (PDA) requiring ligation","No usable data for effect sizes"
"CD013830_pub2_data","4::11::Necrotizing enterocolitis (NEC) (Bell's stage II or greater OR any grade; requiring surgery)","No usable data for effect sizes"
"CD013830_pub2_data","4::12::Retinopathy of prematurity (ROP) in infants examined (any stage)","No usable data for effect sizes"
"CD013830_pub2_data","4::14::Tachycardia leading to cessation of treatment","No usable data for effect sizes"
"CD013830_pub2_data","4::15::Failure to extubate within seven days","No usable data for effect sizes"
"CD013844_pub2_data","1::2::Self-harm at short term (1-3 months) follow-up","No usable data for effect sizes"
"CD013844_pub2_data","1::9::Suicidal ideation at short-term (1-3 months) follow-up","No usable data for effect sizes"
"CD013844_pub2_data","1::10::Hopelessness at postintervention follow-up","No usable data for effect sizes"
"CD013844_pub2_data","2::1::Self-harm at postintervention follow-up","No usable data for effect sizes"
"CD013844_pub2_data","2::2::Self-harm postintervention: sensitivity analysis (ICC 0.01)","No usable data for effect sizes"
"CD013844_pub2_data","2::3::Self-harm postintervention: sensitivity analysis (ICC 0.05)","No usable data for effect sizes"
"CD013844_pub2_data","2::4::Self-harm post intervention: sensitivity analysis (ICC 0.1)","No usable data for effect sizes"
"CD013844_pub2_data","3::5::Self-harm frequency at postintervention follow-up","No usable data for effect sizes"
"CD013844_pub2_data","3::8::Suicide ideation at medium-term (4-12 months) follow-up","No usable data for effect sizes"
"CD013857_pub2_data","1::1::Incidence of new localised tissue injury","No usable data for effect sizes"
"CD013857_pub2_data","1::2::Incidence of new major amputation of the CLL","No usable data for effect sizes"
"CD013857_pub2_data","1::3::Survival","No usable data for effect sizes"
"CD013874_pub3_data","1::1::Disability worsening over 24 months","No usable data for effect sizes"
"CD013874_pub3_data","1::2::Time to relapse over 24 months","No usable data for effect sizes"
"CD013874_pub3_data","1::3::Relapse over 24 months","No usable data for effect sizes"
"CD013874_pub3_data","1::4::Total serious adverse events (SAEs)","No usable data for effect sizes"
"CD013874_pub3_data","1::5::Upper respiratory tract infection ","No usable data for effect sizes"
"CD013874_pub3_data","1::6::Urinary tract infections ","No usable data for effect sizes"
"CD013874_pub3_data","1::7::Skin infections   ","No usable data for effect sizes"
"CD013874_pub3_data","1::8::Viral infections     ","No usable data for effect sizes"
"CD013874_pub3_data","1::9::Annualised relapse rate","No usable data for effect sizes"
"CD013874_pub3_data","1::10::T2 or gadolinium MRI lesions over 24 months","No usable data for effect sizes"
"CD013874_pub3_data","1::11::Treatment discontinuation due to adverse events","No usable data for effect sizes"
"CD013874_pub3_data","1::12::Any adverse event","No usable data for effect sizes"
"CD013874_pub3_data","3::1::Disability worsening over 24 months ","No usable data for effect sizes"
"CD013874_pub3_data","3::2::Relapse over 24 months ","No usable data for effect sizes"
"CD013874_pub3_data","3::3::Serious adverse events over 24 months ","No usable data for effect sizes"
"CD013874_pub3_data","3::4::Common infections over 24 months ","No usable data for effect sizes"
"CD013874_pub3_data","3::5::Cancer over 24 months ","No usable data for effect sizes"
"CD013874_pub3_data","3::6::Mortality over 24 months ","No usable data for effect sizes"
"CD013874_pub3_data","3::7::Treatment discontinuation due to adverse events","No usable data for effect sizes"
"CD013874_pub3_data","3::8::First infusion reactions","No usable data for effect sizes"
"CD013874_pub3_data","3::9::Second infusion reactions","No usable data for effect sizes"
"CD013874_pub3_data","4::1::Relapse over 12 months","No usable data for effect sizes"
"CD013874_pub3_data","4::2::Serious adverse events (SAEs)","No usable data for effect sizes"
"CD013874_pub3_data","4::4::Cancer","No usable data for effect sizes"
"CD013874_pub3_data","4::5::Mortality","No usable data for effect sizes"
"CD013874_pub3_data","4::6::Annualised relapse rate ","No usable data for effect sizes"
"CD013874_pub3_data","4::7::Gadolinium MRI lesions over 12 months","No usable data for effect sizes"
"CD013874_pub3_data","4::9::Cardiovascular events","No usable data for effect sizes"
"CD013874_pub3_data","4::10::First infusion reactions","No usable data for effect sizes"
"CD013874_pub3_data","4::11::Second infusion reactions","No usable data for effect sizes"
"CD013874_pub3_data","5::7::Time to mortality over 24 months' follow-up","No usable data for effect sizes"
"CD013874_pub3_data","5::8::Annualised relapse rate (change from baseline) – by type of DMT","No usable data for effect sizes"
"CD013874_pub3_data","5::9::Annualised relapse rate (end point) – by type of DMT","No usable data for effect sizes"
"CD013874_pub3_data","5::16::First infusion reactions","No usable data for effect sizes"
"CD013874_pub3_data","6::1::Serious adverse events","No usable data for effect sizes"
"CD013874_pub3_data","6::2::Cancer","No usable data for effect sizes"
"CD013874_pub3_data","6::3::Cardiovascular events","No usable data for effect sizes"
"CD013874_pub3_data","7::1::Serious adverse events ","No usable data for effect sizes"
"CD013874_pub3_data","7::3::Annualised relapse rate","No usable data for effect sizes"
"CD013874_pub3_data","7::4::Gadolinium MRI lesions ","No usable data for effect sizes"
"CD013874_pub3_data","7::5::Treatment discontinuation due to adverse events ","No usable data for effect sizes"
"CD013874_pub3_data","7::6::Opportunistic infections","No usable data for effect sizes"
"CD013874_pub3_data","8::1::Time to disability worsening over 36 months' follow-up","No usable data for effect sizes"
"CD013874_pub3_data","9::1::Time to disability worsening over 18 months' follow-up","No usable data for effect sizes"
"CD013874_pub3_data","9::2::Treatment discontinuation due to adverse events","No usable data for effect sizes"
"CD013874_pub3_data","10::8::First infusion reaction","No usable data for effect sizes"
"CD013874_pub3_data","11::1::Relapse over 24 months","No usable data for effect sizes"
"CD013874_pub3_data","11::2::Difference in two-year relapse rate","No usable data for effect sizes"
"CD013875_pub2_data","1::1::Live birth (or ongoing pregnancy) – low risk of bias","No usable data for effect sizes"
"CD013875_pub2_data","1::5::Miscarriage – low risk of bias","No usable data for effect sizes"
"CD013875_pub2_data","1::9::Clinical pregnancy – low risk of bias","No usable data for effect sizes"
"CD013875_pub2_data","1::15::Ectopic pregnancy – low risk of bias","No usable data for effect sizes"
"CD013875_pub2_data","1::16::Ectopic pregnancy – sensitivity analysis (risk ratio)","No usable data for effect sizes"
"CD013875_pub2_data","1::17::Preterm delivery","No usable data for effect sizes"
"CD013875_pub2_data","1::18::Preterm delivery – sensitivity analysis (risk ratio)","No usable data for effect sizes"
"CD013875_pub2_data","2::1::Live birth","No usable data for effect sizes"
"CD013875_pub2_data","2::2::Live birth – sensitivity analysis (risk ratio)","No usable data for effect sizes"
"CD013875_pub2_data","2::3::Miscarriage","No usable data for effect sizes"
"CD013875_pub2_data","2::4::Miscarriage – sensitivity analysis (risk ratio)","No usable data for effect sizes"
"CD013875_pub2_data","2::5::Miscarriage – sensitivity analysis (per clinical pregnancy)","No usable data for effect sizes"
"CD013875_pub2_data","2::8::Clinical pregnancy – sensitivity analysis (full text only)","No usable data for effect sizes"
"CD013875_pub2_data","3::1::Ongoing pregnancy","No usable data for effect sizes"
"CD013875_pub2_data","3::2::Ongoing pregnancy – sensitivity analysis (risk ratio)","No usable data for effect sizes"
"CD013875_pub2_data","3::3::Clinical pregnancy","No usable data for effect sizes"
"CD013875_pub2_data","3::4::Clinical pregnancy – sensitivity analysis (risk ratio)","No usable data for effect sizes"
"CD014089_data","1::3::Severity of attacks (0 to 10 VAS)","No usable data for effect sizes"
"CD014089_data","1::5::Patient global assessment","No usable data for effect sizes"
"CD014089_data","1::8::Physician global assessment","No usable data for effect sizes"
"CD014089_data","1::10::Number of people with new digital ulcers","No usable data for effect sizes"
"CD014089_data","6::3::Severity of attacks (0 to 10 VAS)","No usable data for effect sizes"
"CD014089_data","6::5::Patient global assessment","No usable data for effect sizes"
"CD014145_pub2_data","2::1::'Clinical apnea' after initiation of treatment","No usable data for effect sizes"
"CD014145_pub2_data","2::3::Duration of positive pressure ventilation after initiation of treatment","No usable data for effect sizes"
"CD014145_pub2_data","2::4::Duration of oxygen therapy (days)","No usable data for effect sizes"
"CD014145_pub2_data","2::5::Necrotizing enterocolitis (NEC) stage 2 or greater","No usable data for effect sizes"
"CD014145_pub2_data","2::6::Retinopathy of prematurity (ROP) (any stages)","No usable data for effect sizes"
"CD014145_pub2_data","2::7::Oxygen at 28 to 30 days","No usable data for effect sizes"
"CD014160_pub2_data","1::1::Duration of any pharmacological treatment for neonatal abstinence syndrome","No usable data for effect sizes"
"CD014160_pub2_data","1::3::Length of hospital stay","No usable data for effect sizes"
"CD014160_pub2_data","1::4::Duration of oral morphine therapy for neonatal abstinence syndrome, during hospital admission","No usable data for effect sizes"
"CD014160_pub2_data","1::5::Duration of oral phenobarbital therapy for neonatal abstinence syndrome, during hospital admission","No usable data for effect sizes"
"CD014300_pub2_data","1::2::Mental well-being at follow-up: children","No usable data for effect sizes"
"CD014300_pub2_data","1::4::Mental well-being at follow-up: adults","No usable data for effect sizes"
"CD014300_pub2_data","1::5::Functioning at study endpoint: children","No usable data for effect sizes"
"CD014300_pub2_data","1::6::Functioning at follow-up: children","No usable data for effect sizes"
"CD014300_pub2_data","1::8::Resilience at follow-up: children","No usable data for effect sizes"
"CD014300_pub2_data","1::9::Coping at study endpoint: children","No usable data for effect sizes"
"CD014300_pub2_data","1::10::Hope at study endpoint: children","No usable data for effect sizes"
"CD014428_pub2_data","1::2::Function","No usable data for effect sizes"
"CD014428_pub2_data","1::3::Anxiety (Anxiety Component Summary)","No usable data for effect sizes"
"CD014428_pub2_data","1::4::Depression (Depression Component Summary)","No usable data for effect sizes"
"CD014428_pub2_data","2::3::Health-related quality of life (total summary)","No usable data for effect sizes"
"CD014428_pub2_data","2::6::Fear avoidance (Physical Activity Component Summary)","No usable data for effect sizes"
"CD014428_pub2_data","2::7::Fear avoidance (Work Component Summary)","No usable data for effect sizes"
"CD014428_pub2_data","3::3::Adherence","No usable data for effect sizes"
"CD014428_pub2_data","4::3::Health-related quality of life (total summary)","No usable data for effect sizes"
"CD014428_pub2_data","4::4::Anxiety","No usable data for effect sizes"
"CD014428_pub2_data","4::5::Depression","No usable data for effect sizes"
"CD014428_pub2_data","6::1::Pain intensity","No usable data for effect sizes"
"CD014428_pub2_data","6::2::Function","No usable data for effect sizes"
"CD014497_pub2_data","1::1::Induction of clinical Remision","No usable data for effect sizes"
"CD014497_pub2_data","1::2::Endoscopic remision","No usable data for effect sizes"
"CD014541_pub2_data","1::5::Symptomatic VTE: long-term (more than 45 days)","No usable data for effect sizes"
"CD014541_pub2_data","1::21::All-cause mortality: long-term (more than 45 days)","No usable data for effect sizes"
"CD014541_pub2_data","1::23::Total VTE: long-term (more than 45 days)","No usable data for effect sizes"
"CD014541_pub2_data","1::24::Composite of fatal and irreversible vascular events: short-term (45 days or fewer)","No usable data for effect sizes"
"CD014541_pub2_data","1::25::Composite of fatal and irreversible vascular events: long-term (more than 45 days)","No usable data for effect sizes"
"CD014541_pub2_data","1::28::VTE-related mortality: long-term (more than 45 days)","No usable data for effect sizes"
"CD014544_pub2_data","1::2::Proportion with zero bleeds (risk ratio)","No usable data for effect sizes"
"CD014544_pub2_data","1::4::HRQoL—EQ-5D-5L VAS","No usable data for effect sizes"
"CD014544_pub2_data","1::5::HRQoL—EQ-5D-5L Utility Index Score","No usable data for effect sizes"
"CD014544_pub2_data","2::2::Proportion with zero bleeds (risk ratio)","No usable data for effect sizes"
"CD014544_pub2_data","3::2::Proportion with zero bleeds (risk ratio)","No usable data for effect sizes"
"CD014544_pub2_data","4::2::Proportion of participants with zero bleeds (risk ratio)","No usable data for effect sizes"
"CD014544_pub2_data","4::4::HRQoL—EQ-5D-5L VAS","No usable data for effect sizes"
"CD014544_pub2_data","4::5::HRQoL—EQ-5D-5L Utility Index Score","No usable data for effect sizes"
"CD014544_pub2_data","5::2::Proportion of participants with zero bleeds ","No usable data for effect sizes"
"CD014544_pub2_data","5::4::HRQoL—EQ-5D-5L VAS","No usable data for effect sizes"
"CD014544_pub2_data","5::5::HRQoL—EQ-5D-5L Utility Index Score","No usable data for effect sizes"
"CD014544_pub2_data","6::2::Proportion of participants with zero bleeds","No usable data for effect sizes"
"CD014544_pub2_data","6::4::HRQoL—EQ-5D-5L VAS","No usable data for effect sizes"
"CD014544_pub2_data","6::5::HRQoL—EQ-5D-5L Utility Index Score","No usable data for effect sizes"
"CD014544_pub2_data","7::2::Proportion of participants with zero bleeds (risk ratio)","No usable data for effect sizes"
"CD014573_data","1::1::Cases of cholera (2 doses + booster dose; 2-year follow-up; per-protocol analysis)","No usable data for effect sizes"
"CD014573_data","2::3::Cases of cholera (2 doses; 5-year follow-up; per-protocol analysis)","No usable data for effect sizes"
"CD014573_data","2::4::Cases of cholera (1 dose; 6-month follow-up; per-protocol analysis)","No usable data for effect sizes"
"CD014573_data","2::5::Cases of severe dehydrating cholera (1 dose; 6-month follow-up; per-protocol analysis)","No usable data for effect sizes"
"CD014573_data","2::6::Cases of cholera (1 dose; 2-year follow-up; per-protocol analysis)","No usable data for effect sizes"
"CD014573_data","2::7::Cases of severe dehydrating cholera (1 dose; 2-year follow-up; per-protocol analysis)","No usable data for effect sizes"
"CD014574_pub2_data","2::2::Improvement in symptom severity: short term (< 2 months)","No usable data for effect sizes"
"CD014574_pub2_data","2::4::Improvement in functional ability: short term (< 2 months)","No usable data for effect sizes"
"CD014574_pub2_data","2::7::Clinically significant improvement in QMG: short term (< 2 months)","No usable data for effect sizes"
"CD014574_pub2_data","2::10::Clinically significant improvement in MG-ADL: short term (< 2 months)","No usable data for effect sizes"
"CD014574_pub2_data","2::11::MGC score: long term (> 9 months)","No usable data for effect sizes"
"CD014574_pub2_data","2::12::MGC score: medium term (2-9 months)","No usable data for effect sizes"
"CD014574_pub2_data","2::13::MGC score: short term (< 2 months)","No usable data for effect sizes"
"CD014574_pub2_data","2::14::Clinically significant improvement in MGC score: long term (> 9 months)","No usable data for effect sizes"
"CD014574_pub2_data","2::15::Clinically significant improvement in MGC: medium term (2-9 months)","No usable data for effect sizes"
"CD014574_pub2_data","2::16::Clinically significant improvement in MGC: short term (< 2 months)","No usable data for effect sizes"
"CD014574_pub2_data","2::18::Steroid sparing effect: short term (< 2 months)","No usable data for effect sizes"
"CD014574_pub2_data","2::19::Relapse requiring rescue therapy: medium term (2-9 months)","No usable data for effect sizes"
"CD014574_pub2_data","2::22::Quality of life: short term (< 2 months)","No usable data for effect sizes"
"CD014574_pub2_data","2::24::Antibody titre: long term (> 9 months)","No usable data for effect sizes"
"CD014574_pub2_data","2::27::Treatment-related adverse events: long term","No usable data for effect sizes"
"CD014574_pub2_data","2::28::Adverse events leading to discontinuation of treatment: long term","No usable data for effect sizes"
"CD014580_pub2_data","1::1::Treatment success","No usable data for effect sizes"
"CD014580_pub2_data","1::2::Stool consistency","No usable data for effect sizes"
"CD014580_pub2_data","1::3::Painful defecation","No usable data for effect sizes"
"CD014580_pub2_data","1::4::Faecal incontinence","No usable data for effect sizes"
"CD014580_pub2_data","2::1::Treatment success","No usable data for effect sizes"
"CD014580_pub2_data","2::2::Adverse events","No usable data for effect sizes"
"CD014580_pub2_data","2::3::Painful defecation","No usable data for effect sizes"
"CD014580_pub2_data","2::4::Faecal incontinence","No usable data for effect sizes"
"CD014580_pub2_data","2::5::Abdominal pain","No usable data for effect sizes"
"CD014580_pub2_data","3::1::Treatment success","No usable data for effect sizes"
"CD014580_pub2_data","3::2::Painful defecation","No usable data for effect sizes"
"CD014580_pub2_data","3::3::Faecal incontinence","No usable data for effect sizes"
"CD014580_pub2_data","3::4::Abdominal pain","No usable data for effect sizes"
"CD014580_pub2_data","4::1::Non-fulfilment of Rome criteria","No usable data for effect sizes"
"CD014580_pub2_data","5::1::Non-fulfilment of Rome criteria","No usable data for effect sizes"
"CD014580_pub2_data","5::2::Frequency of defecation","No usable data for effect sizes"
"CD014580_pub2_data","5::3::Adverse events","No usable data for effect sizes"
"CD014580_pub2_data","5::4::Stool consistency","No usable data for effect sizes"
"CD014580_pub2_data","5::5::Painful defecation","No usable data for effect sizes"
"CD014580_pub2_data","5::6::Quality of life","No usable data for effect sizes"
"CD014580_pub2_data","5::7::Faecal incontinence","No usable data for effect sizes"
"CD014580_pub2_data","6::1::Treatment success","No usable data for effect sizes"
"CD014580_pub2_data","6::2::Adverse events","No usable data for effect sizes"
"CD014580_pub2_data","6::3::Painful defecation","No usable data for effect sizes"
"CD014580_pub2_data","6::4::Faecal incontinence","No usable data for effect sizes"
"CD014580_pub2_data","7::1::Frequency of defecation","No usable data for effect sizes"
"CD014580_pub2_data","7::2::Treatment success","No usable data for effect sizes"
"CD014580_pub2_data","7::3::Adverse events","No usable data for effect sizes"
"CD014580_pub2_data","7::4::Painful defecation","No usable data for effect sizes"
"CD014580_pub2_data","7::5::Quality of life (child-reported)","No usable data for effect sizes"
"CD014580_pub2_data","7::6::Quality of life (parent-reported)","No usable data for effect sizes"
"CD014580_pub2_data","7::7::Faecal incontinence","No usable data for effect sizes"
"CD014580_pub2_data","7::8::Abdominal pain","No usable data for effect sizes"
"CD014585_pub2_data","2::1::Incident ulcer","No usable data for effect sizes"
"CD014585_pub2_data","3::1::Incident ulcer","No usable data for effect sizes"
"CD014585_pub2_data","3::2::Adverse events","No usable data for effect sizes"
"CD014594_pub2_data","2::4::Time to successful CFA access: sensitivity analysis from skin penetration","No usable data for effect sizes"
"CD014594_pub2_data","6::1::VAS pain score","No usable data for effect sizes"
"CD014594_pub2_data","6::2::Additional analgesia","No usable data for effect sizes"
"CD014594_pub2_data","13::1::Infection","No usable data for effect sizes"
"CD014617_pub3_data","1::1::Risk of ocular infection within one month of corneal abrasion","No usable data for effect sizes"
"CD014617_pub3_data","1::2::Proportion of eyes healed within 48 hours","No usable data for effect sizes"
"CD014617_pub3_data","1::3::Proportion of eyes healed within 48 hours - Chung 1996","No usable data for effect sizes"
"CD014617_pub3_data","1::4::Adverse events","No usable data for effect sizes"
"CD014623_pub2_data","1::1::Impairment","No usable data for effect sizes"
"CD014623_pub2_data","1::2::Symptoms of peripheral neuropathy","No usable data for effect sizes"
"CD014623_pub2_data","1::3::Quality of life","No usable data for effect sizes"
"CD014623_pub2_data","1::4::Corneal nerve fibre length (mm/mm<sup>2</sup>)","No usable data for effect sizes"
"CD014624_pub2_data","2::10:: Barkin Index of Maternal Functioning (acute phase)","No usable data for effect sizes"
"CD014666_pub2_data","4::1::Activity avoidance: immediate postintervention ","No usable data for effect sizes"
"CD014666_pub2_data","4::4::Anxiety: immediate postintervention","No usable data for effect sizes"
"CD014678_pub2_data","1::3::All-cause mortality (dabigatran versus placebo)","No usable data for effect sizes"
"CD014678_pub2_data","2::3::Cardiovascular mortality (dabigatran versus placebo)","No usable data for effect sizes"
"CD014678_pub2_data","3::3::Major bleeding (dabigatran versus placebo)","No usable data for effect sizes"
"CD014678_pub2_data","4::6::Stent thrombosis","No usable data for effect sizes"
"CD014678_pub2_data","7::1::All-cause mortality","No usable data for effect sizes"
"CD014678_pub2_data","7::2::Cardiovascular mortality","No usable data for effect sizes"
"CD014678_pub2_data","7::3::Major bleeding","No usable data for effect sizes"
"CD014678_pub2_data","7::4::Myocardial infarction","No usable data for effect sizes"
"CD014678_pub2_data","7::5::Stroke","No usable data for effect sizes"
"CD014678_pub2_data","7::6::Non-major bleeding","No usable data for effect sizes"
"CD014678_pub2_data","8::6::Stent thrombosis","No usable data for effect sizes"
"CD014678_pub2_data","9::1::All-cause mortality","No usable data for effect sizes"
"CD014678_pub2_data","9::2::Cardiovascular mortality","No usable data for effect sizes"
"CD014678_pub2_data","9::3::Major bleeding","No usable data for effect sizes"
"CD014678_pub2_data","9::4::Myocardial infarction","No usable data for effect sizes"
"CD014678_pub2_data","9::5::Stroke","No usable data for effect sizes"
"CD014678_pub2_data","9::6::Non-major bleeding","No usable data for effect sizes"
"CD014678_pub2_data","10::1::All-cause mortality","No usable data for effect sizes"
"CD014678_pub2_data","10::2::Cardiovascular mortality","No usable data for effect sizes"
"CD014678_pub2_data","10::3::Major bleeding","No usable data for effect sizes"
"CD014678_pub2_data","10::4::Myocardial infarction","No usable data for effect sizes"
"CD014678_pub2_data","10::5::Stroke","No usable data for effect sizes"
"CD014678_pub2_data","10::6::Non-major bleeding","No usable data for effect sizes"
"CD014678_pub2_data","11::1::All-cause mortality","No usable data for effect sizes"
"CD014678_pub2_data","11::2::Cardiovascular mortality","No usable data for effect sizes"
"CD014678_pub2_data","11::3::Major bleeding","No usable data for effect sizes"
"CD014678_pub2_data","11::4::Myocardial infarction","No usable data for effect sizes"
"CD014678_pub2_data","11::5::Stroke","No usable data for effect sizes"
"CD014678_pub2_data","11::6::Non-major bleeding","No usable data for effect sizes"
"CD014678_pub2_data","12::1::All-cause mortality","No usable data for effect sizes"
"CD014678_pub2_data","12::2::Cardiovascular mortality","No usable data for effect sizes"
"CD014678_pub2_data","12::3::Major bleeding","No usable data for effect sizes"
"CD014678_pub2_data","12::4::Myocardial infarction","No usable data for effect sizes"
"CD014678_pub2_data","12::5::Stroke","No usable data for effect sizes"
"CD014678_pub2_data","12::6::Non-major bleeding","No usable data for effect sizes"
"CD014678_pub2_data","13::1::All-cause mortality","No usable data for effect sizes"
"CD014678_pub2_data","13::2::Cardiovascular mortality","No usable data for effect sizes"
"CD014678_pub2_data","13::3::Major bleeding","No usable data for effect sizes"
"CD014678_pub2_data","13::4::Myocardial infarction","No usable data for effect sizes"
"CD014678_pub2_data","13::5::Stroke","No usable data for effect sizes"
"CD014678_pub2_data","13::6::Non-major bleeding","No usable data for effect sizes"
"CD014678_pub2_data","14::1::All-cause mortality","No usable data for effect sizes"
"CD014678_pub2_data","14::2::Cardiovascular mortality","No usable data for effect sizes"
"CD014678_pub2_data","14::3::Major bleeding","No usable data for effect sizes"
"CD014678_pub2_data","14::4::Myocardial infarction","No usable data for effect sizes"
"CD014678_pub2_data","14::5::Stroke","No usable data for effect sizes"
"CD014678_pub2_data","15::1::All-cause mortality","No usable data for effect sizes"
"CD014678_pub2_data","15::2::Cardiovascular mortality","No usable data for effect sizes"
"CD014678_pub2_data","15::3::Major bleeding","No usable data for effect sizes"
"CD014678_pub2_data","15::4::Myocardial infarction","No usable data for effect sizes"
"CD014678_pub2_data","15::5::Stroke","No usable data for effect sizes"
"CD014678_pub2_data","16::1::All-cause mortality","No usable data for effect sizes"
"CD014678_pub2_data","16::2::Cardiovascular mortality","No usable data for effect sizes"
"CD014678_pub2_data","16::3::Major bleeding","No usable data for effect sizes"
"CD014678_pub2_data","16::4::Myocardial infarction","No usable data for effect sizes"
"CD014678_pub2_data","16::5::Stroke","No usable data for effect sizes"
"CD014678_pub2_data","17::1::All-cause mortality","No usable data for effect sizes"
"CD014678_pub2_data","17::2::Cardiovascular mortality","No usable data for effect sizes"
"CD014678_pub2_data","17::3::Major bleeding","No usable data for effect sizes"
"CD014678_pub2_data","17::4::Myocardial infarction","No usable data for effect sizes"
"CD014678_pub2_data","17::5::Stroke","No usable data for effect sizes"
"CD014678_pub2_data","18::1::All-cause mortality","No usable data for effect sizes"
"CD014678_pub2_data","18::2::Cardiovascular mortality","No usable data for effect sizes"
"CD014678_pub2_data","18::3::Major bleeding","No usable data for effect sizes"
"CD014678_pub2_data","18::4::Myocardial infarction","No usable data for effect sizes"
"CD014678_pub2_data","18::5::Stroke","No usable data for effect sizes"
"CD014678_pub2_data","19::1::All-cause mortality","No usable data for effect sizes"
"CD014678_pub2_data","19::2::Cardiovascular mortality","No usable data for effect sizes"
"CD014678_pub2_data","19::3::Major bleeding","No usable data for effect sizes"
"CD014678_pub2_data","19::4::Myocardial infarction","No usable data for effect sizes"
"CD014678_pub2_data","19::5::Stroke","No usable data for effect sizes"
"CD014687_pub2_data","1::1::Pain: VAS (0-100) (final values): short term (up to 1 month)","No usable data for effect sizes"
"CD014687_pub2_data","1::2::Function: AOFAS (0-100) (final values): short term (up to 1 month)","No usable data for effect sizes"
"CD014687_pub2_data","1::3::Satisfaction (short term)","No usable data for effect sizes"
"CD014687_pub2_data","2::1::Adverse events: short term","No usable data for effect sizes"
"CD014687_pub2_data","3::3::Pain: VAS (0-100) (final values) long-term results","No usable data for effect sizes"
"CD014687_pub2_data","4::3::Function: MFPDS (0-100) (final values) long term","No usable data for effect sizes"
"CD014687_pub2_data","5::1::HRQoL: EQ-5D (0-1) (final values) short term","No usable data for effect sizes"
"CD014687_pub2_data","5::2::HRQoL: EQ-5D (0-1) (final values) intermediate term","No usable data for effect sizes"
"CD014687_pub2_data","5::3::HRQoL: EQ-5D (0-1) (final values) long term","No usable data for effect sizes"
"CD014687_pub2_data","6::1::Satisfaction: intermediate time point (6 months)","No usable data for effect sizes"
"CD014687_pub2_data","8::1::Pain: VAS (0-100) (final values) short term","No usable data for effect sizes"
"CD014687_pub2_data","9::1::Function: MFPDS (17-51) (final values) short term","No usable data for effect sizes"
"CD014687_pub2_data","10::1::Satisfaction: short term","No usable data for effect sizes"
"CD014687_pub2_data","10::3::Satisfaction: long term","No usable data for effect sizes"
"CD014687_pub2_data","12::1::Satisfaction: long term","No usable data for effect sizes"
"CD014687_pub2_data","13::1::Adverse events: long term","No usable data for effect sizes"
"CD014722_pub2_data","1::1::Diagnosis of mental disorders at 1-6 months ","No usable data for effect sizes"
"CD014722_pub2_data","1::2::Diagnosis of mental disorders at 7-24 months","No usable data for effect sizes"
"CD014722_pub2_data","1::4::Quality of life at 7-24 months ","No usable data for effect sizes"
"CD014722_pub2_data","1::6::Depressive symptoms at 1-6 months","No usable data for effect sizes"
"CD014722_pub2_data","1::8::Anxiety symptoms at 0-1 months","No usable data for effect sizes"
"CD014722_pub2_data","1::10::Social outcomes at 0-1 months","No usable data for effect sizes"
"CD014722_pub2_data","2::1::Diagnosis of mental disorders at 7-24 months","No usable data for effect sizes"
"CD014722_pub2_data","2::6::Anxiety symptoms at 1-6 months","No usable data for effect sizes"
"CD014722_pub2_data","2::9::Distress/PTSD symptoms at 7-24 months","No usable data for effect sizes"
"CD014722_pub2_data","2::12::Social outcomes at 7-24 months","No usable data for effect sizes"
"CD014722_pub2_data","3::6::Quality of life at 7-24  months ","No usable data for effect sizes"
"CD014722_pub2_data","3::7::Adverse events at 0-1 months","No usable data for effect sizes"
"CD014722_pub2_data","3::21::Social outcomes at 7-24 months","No usable data for effect sizes"
"CD014722_pub2_data","4::2::Adverse events at 0-1 months","No usable data for effect sizes"
"CD014722_pub2_data","4::4::Psychological functioning and impairment at 1-6 months ","No usable data for effect sizes"
"CD014722_pub2_data","4::5::Psychological functioning and impairment at 7-24 months ","No usable data for effect sizes"
"CD014722_pub2_data","4::6::Depressive symptoms at 0-1 months","No usable data for effect sizes"
"CD014722_pub2_data","4::8::Anxiety symptoms at 0-1 months","No usable data for effect sizes"
"CD014722_pub2_data","4::9::Anxiety symptoms at 1-6 months","No usable data for effect sizes"
"CD014722_pub2_data","4::10::Anxiety symptoms at 7-24 months","No usable data for effect sizes"
"CD014722_pub2_data","4::12::Distress/PTSD symptoms at 1-6 months","No usable data for effect sizes"
"CD014722_pub2_data","4::15::Social outcomes at 7-24 months","No usable data for effect sizes"
"CD014722_pub2_data","5::1::Quality of life at 0-1 months","No usable data for effect sizes"
"CD014722_pub2_data","5::2::Psychological functioning and impairment at 0-1 months","No usable data for effect sizes"
"CD014722_pub2_data","5::5::Depressive symptoms at 7-24 months","No usable data for effect sizes"
"CD014722_pub2_data","5::6::Anxiety symptoms at 0-1 months","No usable data for effect sizes"
"CD014722_pub2_data","5::7::Anxiety symptoms at 1-6 months","No usable data for effect sizes"
"CD014722_pub2_data","5::8::Distress/PTSD symptoms at 0-1 months","No usable data for effect sizes"
"CD014722_pub2_data","5::9::Distress/PTSD symptoms at 1-6 months","No usable data for effect sizes"
"CD014722_pub2_data","6::1::Diagnosis of mental disorders at 0-1 months","No usable data for effect sizes"
"CD014722_pub2_data","6::2::Diagnosis of mental disorders at 1 to 6 months ","No usable data for effect sizes"
"CD014722_pub2_data","6::8::Depressive symptoms at 7-24 months","No usable data for effect sizes"
"CD014736_pub2_data","2::5::Walking Impairment Questionnaire - Total score - Absolute values at end of follow-up","No usable data for effect sizes"
"CD014741_pub2_data","1::1::All-cause mortality","No usable data for effect sizes"
"CD014741_pub2_data","1::7::Stroke (fatal or non-fatal)","No usable data for effect sizes"
"CD014741_pub2_data","2::6::Peripheral vascular disease","No usable data for effect sizes"
"CD014741_pub2_data","2::7::Stroke (fatal or non-fatal)","No usable data for effect sizes"
"CD014741_pub2_data","3::2::Myocardial infarction (fatal or non-fatal)","No usable data for effect sizes"
"CD014741_pub2_data","3::7::Heart failure","No usable data for effect sizes"
"CD014741_pub2_data","5::3::Unstable angina","No usable data for effect sizes"
"CD014741_pub2_data","5::7::Stroke (fatal or non-fatal)","No usable data for effect sizes"
"CD014741_pub2_data","6::5::Quality of life","No usable data for effect sizes"
"CD014755_pub2_data","1::1::Number of chemotherapy cycles to remission","No usable data for effect sizes"
"CD014755_pub2_data","2::1::Treatment success rate","No usable data for effect sizes"
"CD014755_pub2_data","2::2::Relapse ","No usable data for effect sizes"
"CD014755_pub2_data","2::3::Disease-specific mortality","No usable data for effect sizes"
"CD014755_pub2_data","2::4::Death due to treatment","No usable data for effect sizes"
"CD014755_pub2_data","2::5::Pregnancy rate","No usable data for effect sizes"
"CD014755_pub2_data","2::6::Number of chemotherapy cycles to remission","No usable data for effect sizes"
"CD014755_pub2_data","2::7::Any adverse events ","No usable data for effect sizes"
"CD014755_pub2_data","2::8::Adverse events (grade 3 or 4)","No usable data for effect sizes"
"CD014755_pub2_data","2::9::Emergency hysterectomy","No usable data for effect sizes"
"CD014758_pub3_data","2::3::Change in refractive error following cessation of treatment ","No usable data for effect sizes"
"CD014758_pub3_data","4::3::Change in refractive error following cessation of treatment ","No usable data for effect sizes"
"CD014758_pub3_data","4::4::Change in axial length following cessation of treatment ","No usable data for effect sizes"
"CD014758_pub3_data","7::5::Change in refractive error from baseline (3 years)","No usable data for effect sizes"
"CD014758_pub3_data","7::6::Change in axial length from baseline (3 years)","No usable data for effect sizes"
"CD014758_pub3_data","7::7::Change in refractive error  from baseline (5 years)","No usable data for effect sizes"
"CD014758_pub3_data","7::8::Change in axial length from baseline (5 years)","No usable data for effect sizes"
"CD014758_pub3_data","8::5::Change in refractive error from baseline (3 years)","No usable data for effect sizes"
"CD014758_pub3_data","8::6::Change in axial length from baseline (3 years)","No usable data for effect sizes"
"CD014758_pub3_data","8::7::Change in refractive error  from baseline (5 years)","No usable data for effect sizes"
"CD014758_pub3_data","8::8::Change in axial length from baseline (5 years)","No usable data for effect sizes"
"CD014758_pub3_data","9::1::Change in refractive error from baseline (1 year)","No usable data for effect sizes"
"CD014758_pub3_data","9::2::Change in axial length from baseline (1 year)","No usable data for effect sizes"
"CD014758_pub3_data","11::3::Change in refractive error following cessation of treatment ","No usable data for effect sizes"
"CD014758_pub3_data","11::4::Change in axial length following cessation of treatment","No usable data for effect sizes"
"CD014763_pub2_data","2::5::Anastomotic leak","No usable data for effect sizes"
"CD014763_pub2_data","2::6::Intestinal obstruction","No usable data for effect sizes"
"CD014763_pub2_data","3::1::Surgical site infection","No usable data for effect sizes"
"CD014785_pub2_data","1::1::Proportion of children with normal nutrition status","No usable data for effect sizes"
"CD014785_pub2_data","1::2::Proportion of children who had eaten beta-carotene rich foods (paw-paw) the day before interview","No usable data for effect sizes"
"CD014785_pub2_data","1::3::Proportion of children experiencing vomiting in the past 2 weeks","No usable data for effect sizes"
"CD014785_pub2_data","2::1::Mean weight-for-age z-score at 6 months","No usable data for effect sizes"
"CD014785_pub2_data","2::2::Mean height-for-age z-score at 6 months","No usable data for effect sizes"
"CD014785_pub2_data","2::3::Mean weight-for-height z-score at 6 months","No usable data for effect sizes"
"CD014785_pub2_data","2::4::Energy intake (kcal) at 12 months","No usable data for effect sizes"
"CD014785_pub2_data","3::1::Mean length gain (cm per month) after 24 months","No usable data for effect sizes"
"CD014792_pub2_data","2::1::Major postoperative complications as defined by the Clavien-Dindo classification (III-IV)","No usable data for effect sizes"
"CD014792_pub2_data","2::2::Minor postoperative complications as defined by the Clavien-Dindo classification (I-II)","No usable data for effect sizes"
"CD014792_pub2_data","2::6::Minor complications","No usable data for effect sizes"
"CD014792_pub2_data","3::1::Major postoperative complications as defined by the Clavien-Dindo classification (III-IV)","No usable data for effect sizes"
"CD014792_pub2_data","3::2::Minor postoperative complications as defined by the Clavien-Dindo classification (I-II)","No usable data for effect sizes"
"CD014792_pub2_data","3::8::Post pancreatectomy haemorrhage","No usable data for effect sizes"
"CD014792_pub2_data","3::9::Postoperative pancreatic fistula","No usable data for effect sizes"
"CD014802_pub2_data","1::2::Functional outcome, measured by mRS (0 to 4), at 12 months (participants ≤ 70 years)","No usable data for effect sizes"
"CD014802_pub2_data","1::3::Death at 30 days","No usable data for effect sizes"
"CD014802_pub2_data","1::5::Quality of life: EuroQol group 5-dimension (EQ-5D) at 90 days","No usable data for effect sizes"
"CD014802_pub2_data","1::6::Quality of life: EuroQol group 5-dimension (EQ-5D) at 6 months","No usable data for effect sizes"
"CD014802_pub2_data","1::7::Quality of life: EuroQol group 5-dimension (EQ-5D) at 12 months","No usable data for effect sizes"
"CD014802_pub2_data","1::11::Complications: neurological deterioration (3 days)","No usable data for effect sizes"
"CD014802_pub2_data","1::13::Complications: pneumonia (up to 4 years + 11 months)","No usable data for effect sizes"
"CD014833_pub2_data","1::1::Incidence of depression immediately post-intervention","No usable data for effect sizes"
"CD014833_pub2_data","1::2::Incidence of depression short-term 1 to 3 months post-intervention","No usable data for effect sizes"
"CD014833_pub2_data","1::6::Anxiety immediately post-intervention","No usable data for effect sizes"
"CD014833_pub2_data","1::10::Breastfeeding exclusivity long-term 7 to 12 months post-intervention","No usable data for effect sizes"
"CD014833_pub2_data","1::11::Breastfeeding duration immediately post-intervention","No usable data for effect sizes"
"CD014833_pub2_data","1::12::Breastfeeding duration short-term 3 months post-intervention","No usable data for effect sizes"
"CD014833_pub2_data","1::13::Breastfeeding duration long-term 7 to 12 months post-intervention","No usable data for effect sizes"
"CD014833_pub2_data","2::1::Incidence of depression immediately post-intervention","No usable data for effect sizes"
"CD014833_pub2_data","2::2::Anxiety immediately post-intervention","No usable data for effect sizes"
"CD014833_pub2_data","2::3::Stress immediately post-intervention","No usable data for effect sizes"
"CD014844_pub2_data","1::2::Adverse event – vomiting","No usable data for effect sizes"
"CD014844_pub2_data","1::3::Adverse event – diarrhoea","No usable data for effect sizes"
"CD014844_pub2_data","1::4::Adverse event – allergy","No usable data for effect sizes"
"CD014844_pub2_data","1::5::Adverse event – anaphylaxis","No usable data for effect sizes"
"CD014845_pub2_data","2::2::Alcohol selection/purchasing of alcohol (units)","No usable data for effect sizes"
"CD014852_pub2_data","1::1::Disability (modified Rankin Scale 0 to 2, good status) at follow‐up ","No usable data for effect sizes"
"CD014852_pub2_data","1::5::Walking capacity (2-minute walk test) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","1::6::Walking capacity (6-minute walk test) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","1::7::Muscle strength (grip strength) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","1::11::Nutritional status (triceps skinfold thickness) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","1::15::Stroke recurrence at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","1::16::Change in cognitive function score (Mini-Mental State Examination) during intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","1::17::Complication (pressure sores) during intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","1::18::Complications (infections: pneumonia, urinary tract, and septicaemias) during intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","1::19::Complication (pneumonia) during intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","1::20::Complication (urinary tract infection) during intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","1::21::Complication (hyper/hypoglycaemia) during intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","1::22::Complication (gastrointestinal haemorrhage) during intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","1::23::Complication (diarrhoea) during intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","2::1::Disability (modified Rankin Scale 0 to 2, good status) at end of intervention","No usable data for effect sizes"
"CD014852_pub2_data","2::3::Sensitivity analysis: Activities of daily living (change in Barthel Index or Functional Independence Measure) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","2::5::Nutritional status (change in calf circumference) during intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","2::6::All-cause mortality at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","2::7::Muscle strength (change in grip strength) during intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","3::1::Disability (modified Rankin Scale) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","3::2::Walking capacity (6-minute walk test) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","3::3::Nutritional status (proportion of skeletal muscle atrophy) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","3::4::Nutritional status (change in lean mass) during intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","3::5::Quality of life (short-form NeuroQoL measurement tool, fatigue) at end of follow-up ","No usable data for effect sizes"
"CD014852_pub2_data","3::6::Quality of life (short-form NeuroQoL measurement tool, lower extremity mobility) at end of follow-up ","No usable data for effect sizes"
"CD014852_pub2_data","3::7::Quality of life (short-form NeuroQoL measurement tool, cognition) at end of follow-up","No usable data for effect sizes"
"CD014852_pub2_data","3::8::Physical performance (Fugl-Meyer Assessment, lower extremity function) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","3::9::Physical performance (Timed Up & Go test) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","3::10::Physical performance (Berg Balance Scale) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","3::11::Complication (pneumonia) during intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","3::12::Complication (urinary tract infection) during intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","3::13::Neurological impairment (change in NIHSS score) during intervention phase ","No usable data for effect sizes"
"CD014852_pub2_data","4::1::Activities of daily living (Functional Independence Measure, Motor score) at end of intervention phase ","No usable data for effect sizes"
"CD014852_pub2_data","4::3::Walking capacity (6-minute walk test) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","4::4::Nutritional status (skeletal muscle index) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","4::5::Nutritional status (cross-sectional area of total thigh muscle area: paretic side) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","4::6::Nutritional status (cross-sectional area of total thigh muscle area: non-paretic side) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","4::7::Nutritional status (cross-sectional area of normal thigh muscle area: paretic side) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","4::8::Nutritional status (cross-sectional area of normal thigh muscle area: non-paretic side) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","4::9::Nutritional status (cross-sectional area of thigh muscle area with fat infiltration: paretic side) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","4::10::Nutritional status (cross-sectional area of thigh muscle area with fat infiltration: non-paretic side) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","4::11::Nutritional status (body weight) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","4::12::Muscle strength (grip strength, paretic side) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","4::13::Muscle strength (grip strength, non-paretic side) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","4::14::Muscle strength (knee-extensor strength, paretic side) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","4::15::Muscle strength (knee-extensor strength, non-paretic side) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","4::16::Physical performance (30-second chair test) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","4::17::Physical performance (Timed Up & Go test) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","5::1::Stroke recurrence at follow-up","No usable data for effect sizes"
"CD014852_pub2_data","6::1::Neurological impairment (NIHSS score) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","6::2::Nutritional status (body weight) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","7::1::Quality of life (SF-36, physical component scale) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","7::2::Quality of life (SF-36, mental component scale) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","8::4::Activity of daily living (independent) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","8::7::Neurological improvement (NIHSS score, ≥ 90% decrease ) at and of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","8::12::Swallowing function (water swallow test score) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","8::15::Stroke recurrence at follow-up","No usable data for effect sizes"
"CD014852_pub2_data","8::22::Complication (sepsis) during intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","8::24::Complication (vomiting) during intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","8::28::Complication (renal problems) during intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","9::1::Nutritional status (arm muscular circumference) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","9::2::Nutritional status (triceps skinfold thickness) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","9::3::Complication (pneumonia) during intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","9::4::Complication (urinary tract infection) during intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","9::5::Complication (intestinal infection) during intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","9::6::Complication (pressure sores) during intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","10::1::Activity of daily living (ADL score) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","10::4::Physical performance (Fugl-Meyer Assessment score) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","10::5::Quality of life (SF-36, Physiological Function score) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","10::6::Quality of life (SF-36, Role Function score) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","10::7::Quality of life (SF-36, Physical Pain score) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","10::8::Quality of life (SF-36, General Health score) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","10::9::Quality of life (SF-36, Mental Health score) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","10::10::Quality of life (SF-36, Energy score) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","10::11::Quality of life (SF-36, Social Function score) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","10::12::Quality of life (SF-36, Emotional Function score) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","10::13::Complication (pneumonia) during intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","10::14::Complication (urinary tract infection) during intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","10::15::Complication (intestinal infection) during intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","11::1::Complication (pressure sores) during intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","12::1::Activities of daily living (Functional Independence Measure, total score) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","12::2::Nutritional status (body weight) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","12::3::Swallowing function (Dysphagia Outcome and Severity Scale score) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","12::4::Swallowing function (improvement in Dysphagia Outcome and Severity Scale score) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","13::1::Activities of daily living (Functional Independence Measure, motor score) at follow-up","No usable data for effect sizes"
"CD014852_pub2_data","13::4::Nutritional status (thigh circumference, paretic side) at follow-up","No usable data for effect sizes"
"CD014852_pub2_data","13::5::Nutritional status (thigh circumference, non-paretic side) at follow-up","No usable data for effect sizes"
"CD014852_pub2_data","13::6::Nutritional status (calf circumference, paretic side) at follow-up","No usable data for effect sizes"
"CD014852_pub2_data","13::7::Nutritional status (calf circumference, non-paretic side) at follow-up","No usable data for effect sizes"
"CD014852_pub2_data","13::8::Nutritional status (arm circumference, paretic side) at follow-up","No usable data for effect sizes"
"CD014852_pub2_data","13::9::Nutritional status (arm circumference, non-paretic side) at follow-up","No usable data for effect sizes"
"CD014852_pub2_data","13::10::Nutritional status (arm circumference, dominant or non-dominant arm) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","13::11::Nutritional status (arm muscular circumference) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","13::12::Nutritional status (triceps skinfold thickness) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","13::13::Cognitive function (Functional Independence Measure, cognition score) at follow-up","No usable data for effect sizes"
"CD014852_pub2_data","13::14::Quality of life (EQ-5D questionnaire, improvement in mobility) at follow-up","No usable data for effect sizes"
"CD014852_pub2_data","13::15::Quality of life (EQ-5D questionnaire, improvement in self-care) at follow-up","No usable data for effect sizes"
"CD014852_pub2_data","13::16::Quality of life (EQ-5D questionnaire, improvement in usual activities) at follow-up","No usable data for effect sizes"
"CD014852_pub2_data","13::17::Quality of life (EQ-5D questionnaire, improvement in pain/discomfort) at follow-up","No usable data for effect sizes"
"CD014852_pub2_data","13::18::Quality of life (EQ-5D questionnaire, improvement in anxiety/depression) at follow-up","No usable data for effect sizes"
"CD014852_pub2_data","13::19::Muscle strength (change in grip strength) at follow-up","No usable data for effect sizes"
"CD014852_pub2_data","13::20::All-cause mortality at follow-up","No usable data for effect sizes"
"CD014852_pub2_data","14::1::Activity of daily living (independent) at end of intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","14::2::All-cause mortality at follow-up","No usable data for effect sizes"
"CD014852_pub2_data","14::3::Complication (pneumonia) during intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","14::4::Complication (intestinal infection) during intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","14::5::Complication (sepsis) during intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","15::1::Nutritional status (decreased nutritional status) during intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","16::1::Complication (pneumonia) during intervention phase","No usable data for effect sizes"
"CD014852_pub2_data","17::1::Disability (Glasgow Outcome Scale Extended score 1 to 4, poor status) at follow-up","No usable data for effect sizes"
"CD014852_pub2_data","17::2::Stroke recurrence at follow-up","No usable data for effect sizes"
"CD014855_pub2_data","1::6::Hospital costs (VND)","No usable data for effect sizes"
"CD014855_pub2_data","3::3::Morbidity","No usable data for effect sizes"
"CD014861_pub2_data","1::2::Hospital inpatient admission within 48 hours of administration of anti-cancer therapy (mean number of visits)","No usable data for effect sizes"
"CD014861_pub2_data","1::5::Participant preference for future treatment location","No usable data for effect sizes"
"CD014861_pub2_data","1::7::Cost-effectiveness (quality-adjusted life years, Corrie 2013)","No usable data for effect sizes"
"CD014861_pub2_data","2::1::Adverse events (proportion of participants with at least one AE)","No usable data for effect sizes"
"CD014861_pub2_data","2::2::Hospital attendance within 48 hours of treatment administration (proportion of participants with at least one visit)","No usable data for effect sizes"
"CD014861_pub2_data","2::3::Participant preference for future treatment location","No usable data for effect sizes"
"CD014861_pub2_data","2::4::Cost (healthcare system perspective: 2022 AUD value)","No usable data for effect sizes"
"CD014861_pub2_data","2::5::Cost-effectiveness (quality-adjusted life years, Corrie 2013)","No usable data for effect sizes"
"CD014861_pub2_data","2::7::Proportion of participants completing treatment regimen as planned","No usable data for effect sizes"
"CD014869_pub2_data","1::2::Serious adverse events (number of participants) (end of 1 year)","No usable data for effect sizes"
"CD014869_pub2_data","1::3::Quality of life at 9 months' follow-up","No usable data for effect sizes"
"CD014871_pub2_data","1::10::Step time","No usable data for effect sizes"
"CD014871_pub2_data","1::13::Step width","No usable data for effect sizes"
"CD014871_pub2_data","1::15::Forward centre of pressure progression during midstance","No usable data for effect sizes"
"CD014871_pub2_data","1::16::Heel off timing","No usable data for effect sizes"
"CD014871_pub2_data","1::17::Step length variability","No usable data for effect sizes"
"CD014871_pub2_data","1::18::Step width variability","No usable data for effect sizes"
"CD014871_pub2_data","1::19::Step time variability","No usable data for effect sizes"
"CD014871_pub2_data","1::20::Peak ankle dorsiflexion angle in midstance","No usable data for effect sizes"
"CD014871_pub2_data","1::23::Ankle range of motion (plantarflexion - dorsiflexion)","No usable data for effect sizes"
"CD014871_pub2_data","1::24::Ankle range of motion (valgus-varus)","No usable data for effect sizes"
"CD014871_pub2_data","1::26::Peak knee flexion angle in terminal stance","No usable data for effect sizes"
"CD014871_pub2_data","1::27::Knee range of motion (flexion - extension)","No usable data for effect sizes"
"CD014871_pub2_data","1::28::Knee range of motion (valgus-varus)","No usable data for effect sizes"
"CD014871_pub2_data","1::30::Hip range of motion (flexion - extension)","No usable data for effect sizes"
"CD014871_pub2_data","1::31::Hip range of motion (adduction-abduction)","No usable data for effect sizes"
"CD014871_pub2_data","1::33::Mean ankle dorsiflexion moment during midstance","No usable data for effect sizes"
"CD014871_pub2_data","1::35::Peak ankle dorsiflexion moment (whole gait cycle)","No usable data for effect sizes"
"CD014871_pub2_data","1::36::Peak ankle varus moment","No usable data for effect sizes"
"CD014871_pub2_data","1::37::Mean knee flexion moment during midstance","No usable data for effect sizes"
"CD014871_pub2_data","1::38::Mean knee flexion moment during terminal stance","No usable data for effect sizes"
"CD014871_pub2_data","1::39::Peak knee flexion moment (whole gait cycle)","No usable data for effect sizes"
"CD014871_pub2_data","1::40::Minimal knee extension moment in the stance phase","No usable data for effect sizes"
"CD014871_pub2_data","1::41::Peak knee varus moment","No usable data for effect sizes"
"CD014871_pub2_data","1::42::Peak hip flexion moment (whole gait cycle)","No usable data for effect sizes"
"CD014871_pub2_data","1::44::Peak hip adduction moment","No usable data for effect sizes"
"CD014871_pub2_data","1::46::Peak ankle power (whole gait cycle)","No usable data for effect sizes"
"CD014871_pub2_data","1::47::Peak knee power (whole gait cycle)","No usable data for effect sizes"
"CD014871_pub2_data","1::49::Peak hip power (whole gait cycle)","No usable data for effect sizes"
"CD014871_pub2_data","1::50::Ground reaction force (GRF) impulse","No usable data for effect sizes"
"CD014871_pub2_data","1::51::Peak impact force contralateral leg","No usable data for effect sizes"
"CD014871_pub2_data","1::52::Peak impact force affected leg","No usable data for effect sizes"
"CD014871_pub2_data","1::53::Peak push-off force contralateral leg","No usable data for effect sizes"
"CD014871_pub2_data","1::54::Peak push-off force affected leg","No usable data for effect sizes"
"CD014871_pub2_data","1::55::Peak knee adduction moment during loading response contralateral leg","No usable data for effect sizes"
"CD014871_pub2_data","1::56::Peak knee adduction moment during loading response affected leg","No usable data for effect sizes"
"CD014871_pub2_data","1::57::Knee adduction impulse contralateral leg","No usable data for effect sizes"
"CD014871_pub2_data","1::58::Knee adduction impulse affected leg","No usable data for effect sizes"
"CD014871_pub2_data","1::59::Knee adduction impulse corrected for stride length contralateral leg","No usable data for effect sizes"
"CD014871_pub2_data","1::60::Knee adduction impulse corrected for stride length affected leg","No usable data for effect sizes"
"CD014871_pub2_data","1::61::Peak knee flexion moment during loading response contralateral leg","No usable data for effect sizes"
"CD014871_pub2_data","1::62::Peak knee flexion moment during loading response affected leg","No usable data for effect sizes"
"CD014871_pub2_data","1::63::Knee flexion impulse contralateral leg","No usable data for effect sizes"
"CD014871_pub2_data","1::64::Knee flexion impulse affected leg","No usable data for effect sizes"
"CD014871_pub2_data","1::65::Knee flexion impulse corrected for stride leg contralateral leg","No usable data for effect sizes"
"CD014871_pub2_data","1::66::Knee flexion impulse corrected for stride leg affected leg","No usable data for effect sizes"
"CD014872_pub2_data","3::3::Overall survival ","No usable data for effect sizes"
"CD014872_pub2_data","3::6::Severe adverse events","No usable data for effect sizes"
"CD014891_pub2_data","1::4::Corrected distance visual acuity (logMAR) ","No usable data for effect sizes"
"CD014891_pub2_data","1::5::Uncorrected near visual acuity worse than J2","No usable data for effect sizes"
"CD014891_pub2_data","1::7::Corrected near visual acuity (logMAR) ","No usable data for effect sizes"
"CD014891_pub2_data","1::8::Uncorrected intermediate visual acuity worse than 6/9 ","No usable data for effect sizes"
"CD014891_pub2_data","1::10::Corrected intermediate visual acuity (logMAR) ","No usable data for effect sizes"
"CD014891_pub2_data","1::11::Modulation transfer function (MTF) at 40 cycles per degree, 3 mm pupil diameter","No usable data for effect sizes"
"CD014891_pub2_data","1::13::Defocus curve: 0.0 D (far), LogMAR visual acuity","No usable data for effect sizes"
"CD014891_pub2_data","1::14::Defocus curve: -1.5 D (intermediate), LogMAR visual acuity","No usable data for effect sizes"
"CD014891_pub2_data","1::15::Defocus curve: -3.0 D (intermediate), LogMAR visual acuity","No usable data for effect sizes"
"CD014891_pub2_data","1::17::LASEK after all visits for residual refractive error or astigmatism","No usable data for effect sizes"
"CD014891_pub2_data","1::18::Consideration of excimer laser augmentation at end of study ","No usable data for effect sizes"
"CD014914_pub2_data","6::1::Severity of nasal congestion (prevention)","No usable data for effect sizes"
"CD014914_pub2_data","6::2::Severity of nasal drainage (prevention)","No usable data for effect sizes"
"CD014914_pub2_data","6::3::Severity of nasal symptoms (prevention)","No usable data for effect sizes"
"CD014914_pub2_data","7::4::Headache (continuous) (prevention)","No usable data for effect sizes"
"CD014914_pub2_data","7::5::Hoarseness (continuous) (prevention)","No usable data for effect sizes"
"CD014914_pub2_data","7::6::Muscle aches (continuous) (prevention)","No usable data for effect sizes"
"CD014914_pub2_data","7::7::Nasal congestion (continuous) (prevention)","No usable data for effect sizes"
"CD014914_pub2_data","7::8::Sneezing (continuous) (prevention)","No usable data for effect sizes"
"CD014914_pub2_data","7::9::Sore throat (continuous) (prevention)","No usable data for effect sizes"
"CD014914_pub2_data","8::1::Proportion of participants missing days from work or school (prevention)","No usable data for effect sizes"
"CD014914_pub2_data","12::2::Proportion with changes in global symptom severity (treatment)","No usable data for effect sizes"
"CD014914_pub2_data","13::1::Severity of cough (treatment)","No usable data for effect sizes"
"CD014914_pub2_data","13::2::Severity of headache (treatment)","No usable data for effect sizes"
"CD014914_pub2_data","13::3::Severity of hoarseness (treatment)","No usable data for effect sizes"
"CD014914_pub2_data","13::4::Severity of malaise (treatment)","No usable data for effect sizes"
"CD014914_pub2_data","13::5::Severity of muscle aches (treatment)","No usable data for effect sizes"
"CD014914_pub2_data","13::6::Severity of nasal congestion (treatment)","No usable data for effect sizes"
"CD014914_pub2_data","13::7::Severity of nasal drainage (treatment)","No usable data for effect sizes"
"CD014914_pub2_data","13::8::Severity of scratchy throat (treatment)","No usable data for effect sizes"
"CD014914_pub2_data","13::9::Severity of sneezing (treatment)","No usable data for effect sizes"
"CD014914_pub2_data","13::10::Severity of sore throat (treatment)","No usable data for effect sizes"
"CD014914_pub2_data","13::11::Severity of fever (treatment)","No usable data for effect sizes"
"CD014914_pub2_data","14::5::Malaise (continuous) (treatment)","No usable data for effect sizes"
"CD014914_pub2_data","14::9::Scratchy throat (continuous) (treatment)","No usable data for effect sizes"
"CD014914_pub2_data","14::12::Nasal symptoms (continuous) (treatment)","No usable data for effect sizes"
"CD014914_pub2_data","14::13::Throat symptoms (continuous) (treatment)","No usable data for effect sizes"
"CD014914_pub2_data","15::2::Fever (dichotomous) (treatment)","No usable data for effect sizes"
"CD014914_pub2_data","16::1::Proportion of participants missing days from work or school (treatment)","No usable data for effect sizes"
"CD014914_pub2_data","16::2::Proportion of days absent from work or school (treatment)","No usable data for effect sizes"
"CD014920_pub2_data","1::2::Acute myocardial infarction (long term > 30 days)","No usable data for effect sizes"
"CD014920_pub2_data","1::5::Cardiovascular mortality","No usable data for effect sizes"
"CD014920_pub2_data","1::6::Length of hospital stay","No usable data for effect sizes"
"CD014923_pub2_data","2::1::Unpaired parallel assessment < 12 months","No usable data for effect sizes"
"CD014923_pub2_data","2::2::Paired assessment longitudinal < 12 months","No usable data for effect sizes"
"CD014923_pub2_data","4::1::Adverse events < 3 months post-surgery","No usable data for effect sizes"
"CD014932_pub2_data","1::1::Reduction in disease severity, as measured by clinical signs (SCORAD)","No usable data for effect sizes"
"CD014932_pub2_data","2::7::Change in concordance with standard treatment: Parents’ Self-Efficacy with Eczema Care Index","No usable data for effect sizes"
"CD014932_pub2_data","3::1::Reduction in disease severity, as measured by clinical signs (SCORAD)","No usable data for effect sizes"
"CD014932_pub2_data","3::5::Improvement in psychological well-being measures: one-item overall stress-rating scale","No usable data for effect sizes"
"CD014932_pub2_data","4::1::Reduction in disease severity, as measured by clinical signs (SCORAD)","No usable data for effect sizes"
"CD014932_pub2_data","4::2::Improvement in quality-of-life measures: children (CDLQI)","No usable data for effect sizes"
"CD014932_pub2_data","5::1::Reduction in disease severity, as measured by clinical signs (EASI)","No usable data for effect sizes"
"CD014932_pub2_data","5::2::Improvement in psychological measures: State Anxiety","No usable data for effect sizes"
"CD014932_pub2_data","6::1::Improvement in psychological well-being measures: State Anxiety","No usable data for effect sizes"
"CD014932_pub2_data","6::2::Reduction in disease severity, as measured by patient-reported symptoms (VAS)","No usable data for effect sizes"
"CD014932_pub2_data","7::1::Improvement in quality-of-life measures (DFI)","No usable data for effect sizes"
"CD014935_pub2_data","1::8::Non-serious adverse events","No usable data for effect sizes"
"CD014935_pub2_data","1::11::Jarisch-Herxheimer reaction","No usable data for effect sizes"
"CD014937_pub2_data","1::8::Sensitivity analysis: acute kidney injury (low overall risk of bias)","No usable data for effect sizes"
"CD014937_pub2_data","1::16::Sensitivity analysis: any use of KRT (only studies with a ""low"" overall risk of bias)","No usable data for effect sizes"
"CD014944_pub2_data","1::2::Proportion of participants with serious adverse events (pancreatitis, at 1 year)","No usable data for effect sizes"
"CD014944_pub2_data","1::3::Health-related quality of life (measured with SF-36 Physical scale at 1 year)","No usable data for effect sizes"
"CD014944_pub2_data","1::4::Health-related quality of life (measured with SF-36 Mental scale at 1 year)","No usable data for effect sizes"
"CD014944_pub2_data","1::5::Proportion of participants without improvement in liver function tests","No usable data for effect sizes"
"CD014944_pub2_data","2::1::Proportion of participants with serious adverse events (recurrent common bile duct stones, at 1 year)","No usable data for effect sizes"
"CD014944_pub2_data","3::1::Proportion of participants without treatment success (at 1 year)","No usable data for effect sizes"
"CD014959_pub2_data","1::1::All-cause mortality","No usable data for effect sizes"
"CD014959_pub2_data","2::1::Proportion of people with laboratory-confirmed leptospirosis regardless of the presence of an identified clinical syndrome (inclusive of asymptomatic cases) ","No usable data for effect sizes"
"CD014959_pub2_data","2::2::Proportion of people with clinical diagnosis of leptospirosis regardless of the presence of laboratory confirmation ","No usable data for effect sizes"
"CD014959_pub2_data","2::3::Proportion of people with clinical diagnosis of leptospirosis confirmed by laboratory diagnosis (exclusive of asymptomatic cases)","No usable data for effect sizes"
"CD014959_pub2_data","2::4::Proportion of people with non-serious adverse events","No usable data for effect sizes"
"CD014960_pub2_data","2::2::All-cause mortality (penicillin versus doxycycline)","No usable data for effect sizes"
"CD014960_pub2_data","2::3::All-cause mortality (cefotaxime versus doxycycline)","No usable data for effect sizes"
"CD014960_pub2_data","2::4::Serious adverse event (nosocomial infection) (penicillin versus cefotaxime)","No usable data for effect sizes"
"CD014960_pub2_data","2::5::Serious adverse event (nosocomial infection) (penicillin versus doxycycline)","No usable data for effect sizes"
"CD014960_pub2_data","2::6::Serious adverse event (nosocomial infection) (doxycycline versus cefotaxime)","No usable data for effect sizes"
"CD014960_pub2_data","2::7::Proportion of people with adverse events considered non-serious (penicillin versus cefotaxime)","No usable data for effect sizes"
"CD014960_pub2_data","2::8::Proportion of people with adverse events considered non-serious (penicillin versus doxycycline)","No usable data for effect sizes"
"CD014960_pub2_data","2::9::Proportion of people with adverse events considered non-serious (penicillin versus chloramphenicol)","No usable data for effect sizes"
"CD014965_pub2_data","1::2::Aggression","No usable data for effect sizes"
"CD014965_pub2_data","1::8::Metabolic side effects: triglyceride levels as a continuous measure","No usable data for effect sizes"
"CD014965_pub2_data","1::10::Metabolic side effects: total cholesterol levels as a continuous measure","No usable data for effect sizes"
"CD014965_pub2_data","1::17::Other side effects: self-injurious behaviour","No usable data for effect sizes"
"CD014965_pub2_data","1::21::Other side effects: dyskinesia","No usable data for effect sizes"
"CD014965_pub2_data","2::2::Other side effects: sedation","No usable data for effect sizes"
"CD014965_pub2_data","2::3::Other side effects: constipation","No usable data for effect sizes"
"CD014965_pub2_data","2::4::Other side effects: hypersalivation","No usable data for effect sizes"
"CD014965_pub2_data","2::5::Other side effects: dyskinesia","No usable data for effect sizes"
"CD014965_pub2_data","3::1::Irritability","No usable data for effect sizes"
"CD014965_pub2_data","3::2::Aggression","No usable data for effect sizes"
"CD014965_pub2_data","3::3::Weight gain above clinically relevant thresholds","No usable data for effect sizes"
"CD014965_pub2_data","3::4::Obsessive-compulsive behaviours","No usable data for effect sizes"
"CD014965_pub2_data","3::5::Other side effects: sedation","No usable data for effect sizes"
"CD014965_pub2_data","3::6::Other side effects: constipation","No usable data for effect sizes"
"CD014965_pub2_data","3::7::Other side effects: hypersalivation","No usable data for effect sizes"
"CD014965_pub2_data","3::8::Social-communication adaptive functioning","No usable data for effect sizes"
"CD014965_pub2_data","3::9::Stereotypy","No usable data for effect sizes"
"CD014965_pub2_data","3::10::Clinical improvement","No usable data for effect sizes"
"CD014965_pub2_data","4::2::Inappropriate speech","No usable data for effect sizes"
"CD014965_pub2_data","4::3::Other side effects: somnolence","No usable data for effect sizes"
"CD014965_pub2_data","4::4::Other side effects: constipation","No usable data for effect sizes"
"CD014965_pub2_data","4::5::Other side effects: hypersalivation","No usable data for effect sizes"
"CD014965_pub2_data","4::6::Other side effects: tremor","No usable data for effect sizes"
"CD014965_pub2_data","4::7::Other side effects: dyskinesia","No usable data for effect sizes"
"CD014965_pub2_data","4::8::Other side effects: insomnia","No usable data for effect sizes"
"CD014965_pub2_data","4::9::Lethargy/withdrawal","No usable data for effect sizes"
"CD014965_pub2_data","4::10::Hyperactivity","No usable data for effect sizes"
"CD014965_pub2_data","4::11::Stereotypy","No usable data for effect sizes"
"CD014965_pub2_data","5::1::Weight gain above clinically relevant thresholds","No usable data for effect sizes"
"CD014965_pub2_data","5::2::Other side effects: any adverse event","No usable data for effect sizes"
"CD014965_pub2_data","5::3::Other side effects: somnolence","No usable data for effect sizes"
"CD014965_pub2_data","5::4::Other side effects: headache","No usable data for effect sizes"
"CD014965_pub2_data","5::5::Other side effects: constipation","No usable data for effect sizes"
"CD014965_pub2_data","5::6::Other side effects: hypersalivation","No usable data for effect sizes"
"CD014965_pub2_data","5::7::Other side effects: rigidity","No usable data for effect sizes"
"CD014965_pub2_data","5::8::Other side effects: insomnia","No usable data for effect sizes"
"CD014967_pub2_data","1::1::Proportion of infants who achieve seizure control after the first loading dose of ASM","No usable data for effect sizes"
"CD014967_pub2_data","1::2::Proportion of infants who achieve seizure control after the the maximal loading dose of ASM","No usable data for effect sizes"
"CD014967_pub2_data","1::3::Mortality before hospital discharge","No usable data for effect sizes"
"CD014967_pub2_data","1::4::Requirement for mechanical ventilation","No usable data for effect sizes"
"CD014967_pub2_data","1::5::Proportion of infants who develop sedation or drowsiness","No usable data for effect sizes"
"CD014967_pub2_data","1::6::Bradycardia","No usable data for effect sizes"
"CD014967_pub2_data","1::7::Hypotension requiring volume or inotropes","No usable data for effect sizes"
"CD014967_pub2_data","1::8::Shock requiring volume or inotropes","No usable data for effect sizes"
"CD014967_pub2_data","1::9::Recurrence of seizure before hospital discharge","No usable data for effect sizes"
"CD014967_pub2_data","1::10::Proportion of infants with epilepsy post-discharge","No usable data for effect sizes"
"CD014967_pub2_data","2::9::Proportion of infants with an abnormal background pattern in EEG during ASM treatment","No usable data for effect sizes"
"CD014967_pub2_data","2::10::Proportion of infants with an abnormal background pattern in EEG after stopping ASM","No usable data for effect sizes"
"CD014967_pub2_data","2::13::Proportion of infants with persistent seizures and/or requiring ASM at discharge","No usable data for effect sizes"
"CD014967_pub2_data","2::16::Proportion of infants who develop epilepsy post discharge","No usable data for effect sizes"
"CD014967_pub2_data","3::1::Proportion of infants who achieve seizure control after the maximal loading dose of ASM","No usable data for effect sizes"
"CD014967_pub2_data","3::2::Arrythmias causing circulatory disturbance","No usable data for effect sizes"
"CD014967_pub2_data","3::3::Hypotension requiring volume or inotropes","No usable data for effect sizes"
"CD014967_pub2_data","3::4::Bradycardia","No usable data for effect sizes"
"CD014967_pub2_data","4::3::Requirement of mechanical ventilation","No usable data for effect sizes"
"CD014967_pub2_data","4::4::Proportion of infants who develop sedation or drowsiness","No usable data for effect sizes"
"CD014967_pub2_data","4::5::Bradycardia","No usable data for effect sizes"
"CD014967_pub2_data","4::6::Proportion of infants with persistent seizures and/or requiring ASM at discharge","No usable data for effect sizes"
"CD014967_pub2_data","5::1::Proportion of infants who achieve seizure control after the first loading dose of ASM","No usable data for effect sizes"
"CD014967_pub2_data","5::2::Mortality before hospital discharge","No usable data for effect sizes"
"CD014967_pub2_data","5::3::Proportion of infants who develop sedation or drowsiness","No usable data for effect sizes"
"CD014967_pub2_data","5::4::Proportion of infants with persistent seizures and/or requiring ASM at discharge","No usable data for effect sizes"
"CD014967_pub2_data","6::1::Proportion of infants who achieve seizure control after the first loading dose of ASM","No usable data for effect sizes"
"CD014967_pub2_data","6::2::Mortality before hospital discharge","No usable data for effect sizes"
"CD014967_pub2_data","6::3::Proportion of infants who develop sedation or drowsiness","No usable data for effect sizes"
"CD014967_pub2_data","6::4::Proportion of infants with persistent seizures and/or requiring ASM at discharge","No usable data for effect sizes"
"CD014967_pub2_data","7::1::Proportion of infants who achieve seizure control after the first loading dose of ASM","No usable data for effect sizes"
"CD014967_pub2_data","7::2::Mortality before hospital discharge","No usable data for effect sizes"
"CD014967_pub2_data","7::3::Proportion of infants with cognitive impairment at 18-24 months","No usable data for effect sizes"
"CD014967_pub2_data","7::4::Seizure burden during hospitalisation","No usable data for effect sizes"
"CD014967_pub2_data","7::5::Requirement for mechanical ventilation","No usable data for effect sizes"
"CD014967_pub2_data","7::6::Hypotension  requiring volume or inotropes","No usable data for effect sizes"
"CD014967_pub2_data","7::7::Proportion of infants with an abnormal background pattern in EEG during ASM treatment","No usable data for effect sizes"
"CD014967_pub2_data","7::8::Proportion of infants who develop epilepsy post discharge","No usable data for effect sizes"
"CD014967_pub2_data","8::1::Proportion of infants who achieve seizure control after the maximal loading dose of ASM","No usable data for effect sizes"
"CD014967_pub2_data","8::2::Mortality or neurodevelopmental disability at 12 months' corrected age","No usable data for effect sizes"
"CD014967_pub2_data","8::3::Mortality before hospital discharge","No usable data for effect sizes"
"CD014967_pub2_data","8::4::Neurodevelopmental disability at 12 months' corrected age","No usable data for effect sizes"
"CD014967_pub2_data","9::3::Mortality at 18 to 24 months","No usable data for effect sizes"
"CD014967_pub2_data","9::4::Neurodevelopmental disability at 18 to 24 months' corrected age","No usable data for effect sizes"
"CD014967_pub2_data","9::5::Requirement for mechanical ventilation","No usable data for effect sizes"
"CD014967_pub2_data","9::7::Abnormal background pattern in EEG after achieving  seizure control","No usable data for effect sizes"
"CD014967_pub2_data","9::9::Proportion of infants with persistent seizures and/or requiring ASM at discharge","No usable data for effect sizes"
"CD014967_pub2_data","9::11::Proportion of infants who develop epilepsy post-discharge","No usable data for effect sizes"
"CD014967_pub2_data","10::3::Proportion of infants who develop epilepsy post-discharge","No usable data for effect sizes"
"CD014999_pub2_data","1::4::30-day bleeding-related mortality","No usable data for effect sizes"
"CD015003_pub2_data","1::2::Non-fatal myocardial infarction","No usable data for effect sizes"
"CD015003_pub2_data","1::3::Stroke","No usable data for effect sizes"
"CD015003_pub2_data","1::6::Post-cardiac procedure atrial fibrillation","No usable data for effect sizes"
"CD015003_pub2_data","2::1::All-cause mortality","No usable data for effect sizes"
"CD015014_pub2_data","1::19::Adverse events/injurious falls (proportion of residents with an injurious fall)","No usable data for effect sizes"
"CD015014_pub2_data","1::20::Adverse events/injurious falls (mean number of injurious falls per resident)","No usable data for effect sizes"
"CD015014_pub2_data","1::21::Adverse events/infections (proportion of residents with an infection)","No usable data for effect sizes"
"CD015014_pub2_data","1::26::Adherence to clinical guideline-recommended care (proportion of residents with adequate antibiotic therapy)","No usable data for effect sizes"
"CD015014_pub2_data","1::27::Adherence to clinical guidelines (MAI)","No usable data for effect sizes"
"CD015014_pub2_data","1::46::Residents’ satisfaction with the health care received (mean satisfaction score)","No usable data for effect sizes"
"CD015014_pub2_data","1::47::Proportion of residents’ satisfied with the health care received ","No usable data for effect sizes"
"CD015033_pub2_data","2::8::Liver enzyme levels. Serum AST levels (12 months)","No usable data for effect sizes"
"CD015033_pub2_data","2::9::Liver enzyme levels. Serum GGT levels (12 months)","No usable data for effect sizes"
"CD015033_pub2_data","2::10::Imaging response. No-improvements in steatosis on ultrasound (12 months)","No usable data for effect sizes"
"CD015033_pub2_data","2::11::Imaging response. No-improvements in steatosis on ultrasound. Best-worst case scenario sensitivity analysis","No usable data for effect sizes"
"CD015033_pub2_data","2::12::Imaging response. No-improvements in steatosis on ultrasound. Worst-best case scenario sensitivity analysis","No usable data for effect sizes"
"CD015033_pub2_data","2::13::Imaging response. Proportion of participants without a normal ultrasound (12 months)","No usable data for effect sizes"
"CD015033_pub2_data","2::14::Imaging response. Proportion of participants without a normal ultrasound. Best-worst case scenario sensitivity analysis","No usable data for effect sizes"
"CD015033_pub2_data","2::15::Imaging response. Proportion of participants without a normal ultrasound. Worst-best case scenario sensitivity analysis","No usable data for effect sizes"
"CD015038_pub2_data","1::5::Pneumonia","No usable data for effect sizes"
"CD015038_pub2_data","1::6::Venous thromboembolism","No usable data for effect sizes"
"CD015038_pub2_data","1::8::Ileus","No usable data for effect sizes"
"CD015038_pub2_data","1::9::Reoperation","No usable data for effect sizes"
"CD015038_pub2_data","1::12::Pain score (chronic)","No usable data for effect sizes"
"CD015040_pub2_data","4::1::PTSD symptom severity: change from baseline to 4 to 12 weeks after treatment (ITT)","No usable data for effect sizes"
"CD015046_pub2_data","1::1::Adverse events&nbsp;","No usable data for effect sizes"
"CD015046_pub2_data","2::1::Change in severity of ICBs&nbsp;","No usable data for effect sizes"
"CD015046_pub2_data","2::2::Adverse events - dizziness&nbsp;","No usable data for effect sizes"
"CD015046_pub2_data","2::3::Adverse events - nausea","No usable data for effect sizes"
"CD015046_pub2_data","2::4::Adverse events - headache&nbsp;","No usable data for effect sizes"
"CD015046_pub2_data","2::5::Adverse events - blood pressure changes&nbsp;","No usable data for effect sizes"
"CD015046_pub2_data","3::1::Change in frequency of ICBs&nbsp;","No usable data for effect sizes"
"CD015046_pub2_data","3::2::Change in severity of ICBs","No usable data for effect sizes"
"CD015046_pub2_data","3::3::Change in quality of life","No usable data for effect sizes"
"CD015046_pub2_data","3::4::Change in neuropsychiatric symptoms - depression","No usable data for effect sizes"
"CD015046_pub2_data","3::5::Change in neuropsychiatric symptoms - anxiety","No usable data for effect sizes"
"CD015046_pub2_data","3::6::Adverse events - sleepiness","No usable data for effect sizes"
"CD015046_pub2_data","3::7::Adverse events - fall (without orthostatic hypotension)","No usable data for effect sizes"
"CD015046_pub2_data","3::8::Adverse events - nausea","No usable data for effect sizes"
"CD015046_pub2_data","3::9::Adverse events - orthostatic hypotension","No usable data for effect sizes"
"CD015046_pub2_data","3::10::Adverse events - restless legs syndrome","No usable data for effect sizes"
"CD015046_pub2_data","3::11::Adverse events - fatigue&nbsp;","No usable data for effect sizes"
"CD015046_pub2_data","3::12::Adverse events - asymptomatic bradycardia (51 to 59 bpm)","No usable data for effect sizes"
"CD015046_pub2_data","4::1::Change in frequency of ICBs&nbsp;","No usable data for effect sizes"
"CD015046_pub2_data","4::2::Change in severity of ICBs","No usable data for effect sizes"
"CD015060_pub2_data","1::1::Proteinuria: > 50% increase from baseline","No usable data for effect sizes"
"CD015060_pub2_data","1::2::eGFR: ≥ 60% decline from baseline at 3 years","No usable data for effect sizes"
"CD015060_pub2_data","3::2::Proteinuria: > 1 g/d","No usable data for effect sizes"
"CD015060_pub2_data","3::3::eGFR decline or kidney failure","No usable data for effect sizes"
"CD015060_pub2_data","4::1::Worsening proteinuria: > 1 g/1.73 m2/d","No usable data for effect sizes"
"CD015060_pub2_data","4::2::Final proteinuria","No usable data for effect sizes"
"CD015060_pub2_data","4::3::eGFR: ≥ 50% decline from baseline","No usable data for effect sizes"
"CD015060_pub2_data","4::4::Final GFR","No usable data for effect sizes"
"CD015060_pub2_data","6::1::Proteinuria improvement ","No usable data for effect sizes"
"CD015060_pub2_data","7::1::Proteinuria change ","No usable data for effect sizes"
"CD015060_pub2_data","7::2::eGFR at end of treatment","No usable data for effect sizes"
"CD015060_pub2_data","8::1::Proteinuria at end of treatment","No usable data for effect sizes"
"CD015060_pub2_data","8::2::eGFR at end of treatment","No usable data for effect sizes"
"CD015060_pub2_data","9::1::Worsening proteinuria: > 50% increase from baseline","No usable data for effect sizes"
"CD015060_pub2_data","9::2::eGFR: > 50% decline from baseline","No usable data for effect sizes"
"CD015060_pub2_data","10::1::Proteinuria remission ","No usable data for effect sizes"
"CD015060_pub2_data","10::2::Final proteinuria  ","No usable data for effect sizes"
"CD015083_pub2_data","8::1::Referral for or receipt of any lumbar spine imaging at last follow-up within 12 months","No usable data for effect sizes"
"CD015083_pub2_data","8::2::Prescription or use of opioid medication at last follow-up within 12 months","No usable data for effect sizes"
"CD015083_pub2_data","8::3::Referral to surgeon or lumbar spine surgery at last follow-up within 12 months","No usable data for effect sizes"
"CD015083_pub2_data","8::4::Admission to hospital for non-specific LBP at last follow-up within 12 months","No usable data for effect sizes"
"CD015083_pub2_data","8::8::Referral for or receipt of advanced lumbar spine imaging at last follow-up within 12 months","No usable data for effect sizes"
"CD015083_pub2_data","8::9::Referral or use of any injection to the lumbar spine at last follow-up within 12 months","No usable data for effect sizes"
"CD015084_pub2_data","1::1::Clinical remission","No usable data for effect sizes"
"CD015084_pub2_data","1::2::Disease improvement: clinical activity scale (Rachmilewitz index)","No usable data for effect sizes"
"CD015084_pub2_data","1::3::Disease improvement: biochemical markers of inflammation (faecal calprotectin)","No usable data for effect sizes"
"CD015084_pub2_data","1::4::Disease improvement: biochemical markers of inflammation (IL-8 in rectal dialysis fluid)","No usable data for effect sizes"
"CD015084_pub2_data","1::5::Disease improvement: biochemical markers of inflammation (PGE-2 in rectal dialysis fluid)","No usable data for effect sizes"
"CD015084_pub2_data","2::1::Clinical remission","No usable data for effect sizes"
"CD015084_pub2_data","2::2::Disease improvement: clinical activity scale (Mayo score)","No usable data for effect sizes"
"CD015084_pub2_data","2::3::Number of adverse events","No usable data for effect sizes"
"CD015084_pub2_data","2::4::Withdrawals due to adverse events","No usable data for effect sizes"
"CD015084_pub2_data","3::1::Disease improvement: clinical activity scale (Lichtiger index)","No usable data for effect sizes"
"CD015084_pub2_data","3::2::Disease improvement: biochemical markers of inflammation (serum CRP)","No usable data for effect sizes"
"CD015084_pub2_data","4::1::Clinical relapse","No usable data for effect sizes"
"CD015084_pub2_data","4::2::Disease improvement: clinical activity scale (partial Mayo score)","No usable data for effect sizes"
"CD015084_pub2_data","4::3::Disease improvement: biochemical markers of inflammation (faecal calprotectin)","No usable data for effect sizes"
"CD015084_pub2_data","4::4::Disease improvement: quality of life score (IBDQ)","No usable data for effect sizes"
"CD015084_pub2_data","4::5::Number of adverse events","No usable data for effect sizes"
"CD015084_pub2_data","5::1::Disease improvement: quality of life score (IBDQ)","No usable data for effect sizes"
"CD015084_pub2_data","5::2::Disease improvement: quality of life score (bowel component of IBDQ)","No usable data for effect sizes"
"CD015084_pub2_data","5::3::Disease improvement: quality of life score (systemic component of IBDQ)","No usable data for effect sizes"
"CD015084_pub2_data","5::4::Disease improvement: quality of life score (emotional component of IBDQ)","No usable data for effect sizes"
"CD015084_pub2_data","5::5::Disease improvement: quality of life score (social component of IBDQ)","No usable data for effect sizes"
"CD015084_pub2_data","5::6::Withdrawals due to adverse events","No usable data for effect sizes"
"CD015084_pub2_data","6::1::Disease improvement: quality of life score (IBDQ)","No usable data for effect sizes"
"CD015084_pub2_data","6::2::Disease improvement: quality of life score (bowel component of IBDQ)","No usable data for effect sizes"
"CD015084_pub2_data","6::3::Disease improvement: quality of life score (systemic component of IBDQ)","No usable data for effect sizes"
"CD015084_pub2_data","6::4::Disease improvement: quality of life score (emotional component of IBDQ)","No usable data for effect sizes"
"CD015084_pub2_data","6::5::Disease improvement: quality of life score (social component of IBDQ)","No usable data for effect sizes"
"CD015084_pub2_data","6::6::Withdrawals due to adverse events","No usable data for effect sizes"
"CD015087_pub2_data","1::2::Pain intensity as reported by a third party (0 to 2 hours)","No usable data for effect sizes"
"CD015087_pub2_data","1::3::Pain intensity as reported by a third party (2 to 24 hours)","No usable data for effect sizes"
"CD015087_pub2_data","1::4::Pain intensity as reported by a third party (1 to 7 days)","No usable data for effect sizes"
"CD015087_pub2_data","1::5::Opioid consumption (2 to 24 hours)","No usable data for effect sizes"
"CD015087_pub2_data","1::6::Opioid consumption (1 to 7 days)","No usable data for effect sizes"
"CD015087_pub2_data","2::2::Requiring rescue medication (0 to 2 hours)","No usable data for effect sizes"
"CD015087_pub2_data","2::4::Time to rescue medication reported by a third party","No usable data for effect sizes"
"CD015087_pub2_data","3::4::Serious adverse events","No usable data for effect sizes"
"CD015087_pub2_data","3::5::Pain intensity as reported by a third party (0 to 2 hours)","No usable data for effect sizes"
"CD015087_pub2_data","3::8::Requiring rescue medication (0 to 2 hours)","No usable data for effect sizes"
"CD015087_pub2_data","3::10::Requiring rescue medication (1 to 7 days)","No usable data for effect sizes"
"CD015087_pub2_data","3::12::Opioid consumption (1 to 7 days)","No usable data for effect sizes"
"CD015087_pub2_data","3::14::Return to activities of daily living","No usable data for effect sizes"
"CD015087_pub2_data","4::2::Serious adverse events","No usable data for effect sizes"
"CD015087_pub2_data","4::5::Requiring rescue medication (0 to 2 hours)","No usable data for effect sizes"
"CD015087_pub2_data","4::7::Opioid consumption (2 to 24 hours)","No usable data for effect sizes"
"CD015087_pub2_data","4::10::Any bleeding","No usable data for effect sizes"
"CD015087_pub2_data","5::1::Pain intensity reported by the child (2 to 24 hours)","No usable data for effect sizes"
"CD015087_pub2_data","5::2::Pain intensity reported by the child (1 to 7 days)","No usable data for effect sizes"
"CD015087_pub2_data","5::3::Adverse events","No usable data for effect sizes"
"CD015087_pub2_data","7::1::Pain intensity reported by the child (2 to 24 hours)","No usable data for effect sizes"
"CD015087_pub2_data","7::2::Pain intensity reported by the child (1 to 7 days)","No usable data for effect sizes"
"CD015087_pub2_data","7::3::Adverse events","No usable data for effect sizes"
"CD015087_pub2_data","8::1::Requiring rescue medication (2 to 24 hours)","No usable data for effect sizes"
"CD015087_pub2_data","8::2::Nausea and/or vomiting","No usable data for effect sizes"
"CD015087_pub2_data","8::3::Any bleeding","No usable data for effect sizes"
"CD015087_pub2_data","9::1::Requiring rescue medication (2 to 24 hours)","No usable data for effect sizes"
"CD015087_pub2_data","9::2::Nausea and/or vomiting","No usable data for effect sizes"
"CD015087_pub2_data","9::3::Any bleeding","No usable data for effect sizes"
"CD015087_pub2_data","10::1::Return to activities of daily living","No usable data for effect sizes"
"CD015087_pub2_data","11::1::Requiring rescue medication (0 to 2 hours)","No usable data for effect sizes"
"CD015087_pub2_data","11::2::Nausea and/or vomiting","No usable data for effect sizes"
"CD015101_data","4::1::Quality of life","No usable data for effect sizes"
"CD015112_pub3_data","1::1::Rates of symptomatic PCR-positive SARS‐CoV‐2 infection","No usable data for effect sizes"
"CD015112_pub3_data","1::2::Rates of any positive PCR SARS‐CoV‐2 infection","No usable data for effect sizes"
"CD015112_pub3_data","1::3::Absenteeism","No usable data for effect sizes"
"CD015120_pub2_data","1::1::Smoking cessation","No usable data for effect sizes"
"CD015120_pub2_data","5::1::Smoking cessation","No usable data for effect sizes"
"CD015120_pub2_data","6::1::Smoking cessation","No usable data for effect sizes"
"CD015120_pub2_data","8::1::Smoking cessation","No usable data for effect sizes"
"CD015120_pub2_data","9::1::Smoking cessation","No usable data for effect sizes"
"CD015120_pub2_data","10::1::Smoking cessation","No usable data for effect sizes"
"CD015120_pub2_data","13::1::Smoking cessation","No usable data for effect sizes"
"CD015120_pub2_data","14::1::Smoking cessation","No usable data for effect sizes"
"CD015120_pub2_data","15::1::Smoking cessation","No usable data for effect sizes"
"CD015120_pub2_data","19::1::Smoking cessation","No usable data for effect sizes"
"CD015120_pub2_data","20::1::Smoking cessation","No usable data for effect sizes"
"CD015120_pub2_data","21::1::Smoking cessation","No usable data for effect sizes"
"CD015120_pub2_data","25::1::Smoking cessation","No usable data for effect sizes"
"CD015120_pub2_data","26::1::Smoking cessation","No usable data for effect sizes"
"CD015120_pub2_data","27::1::Smoking cessation","No usable data for effect sizes"
"CD015120_pub2_data","31::1::Smoking cessation","No usable data for effect sizes"
"CD015120_pub2_data","34::1::Smoking cessation","No usable data for effect sizes"
"CD015120_pub2_data","35::1::Smoking cessation","No usable data for effect sizes"
"CD015122_pub2_data","1::8::Unplanned hospitalizations or readmissions","No usable data for effect sizes"
"CD015122_pub2_data","1::10::Blood transfusion (Sensitivity analysis & Risk of bias)","No usable data for effect sizes"
"CD015122_pub2_data","1::11::Stone-free rate (Sensitivity analysis & Risk of bias)","No usable data for effect sizes"
"CD015122_pub2_data","1::12::Thromboembolic events (Sensitivity analysis & Risk of bias)","No usable data for effect sizes"
"CD015122_pub2_data","1::13::Secondary interventions (Sensitivity analysis & Risk of bias)","No usable data for effect sizes"
"CD015122_pub2_data","1::14::Major surgical Complications (Sensitivity analysis & Risk of bias)","No usable data for effect sizes"
"CD015122_pub2_data","1::15::Minor Surgical complications (Sensitivity analysis & Risk of bias)","No usable data for effect sizes"
"CD015122_pub2_data","1::16::Unplanned hospitalizations or readmissions (Sensitivity analysis & Risk of bias)","No usable data for effect sizes"
"CD015122_pub2_data","1::17::Hospital length ofsStay (days) (Sensitivity analysis & Risk of bias)","No usable data for effect sizes"
"CD015122_pub2_data","1::22::Secondary interventions (Sensitivity analysis & definition of stone freedom)","No usable data for effect sizes"
"CD015122_pub2_data","1::25::Unplanned hospitalizations or readmissions (Sensitivity analysis & definition of stone freedom)","No usable data for effect sizes"
"CD015122_pub2_data","2::1::Blood transfusion","No usable data for effect sizes"
"CD015122_pub2_data","2::2::Stone-free rate","No usable data for effect sizes"
"CD015122_pub2_data","2::3::Thromboembolic events","No usable data for effect sizes"
"CD015122_pub2_data","2::4::Adverse event","No usable data for effect sizes"
"CD015122_pub2_data","2::5::Major surgical complications","No usable data for effect sizes"
"CD015122_pub2_data","2::6::Minor surgical complications","No usable data for effect sizes"
"CD015122_pub2_data","2::7::Hospital length of stay (days)","No usable data for effect sizes"
"CD015123_pub2_data","2::1::Number of participants with at least one SAE","No usable data for effect sizes"
"CD015123_pub2_data","2::2::Number of participants with new or enlarging T2-weighted MRI lesions","No usable data for effect sizes"
"CD015123_pub2_data","2::3::Number of participants with new Gd+ T1-weighted MRI lesions","No usable data for effect sizes"
"CD015123_pub2_data","2::4::Number of participants experiencing treatment discontinuation caused by AE","No usable data for effect sizes"
"CD015123_pub2_data","2::5::Number of participants with at least one AE","No usable data for effect sizes"
"CD015123_pub2_data","3::1::Number of participants who experienced at least one relapse","No usable data for effect sizes"
"CD015123_pub2_data","3::2::Number of participants with sustained disability that worsened during the study","No usable data for effect sizes"
"CD015123_pub2_data","3::3::Number of participants with at least one SAE","No usable data for effect sizes"
"CD015123_pub2_data","3::4::Number of participants with at least one SAE (sensitivity analysis: MS relapses excluded) ","No usable data for effect sizes"
"CD015123_pub2_data","3::5::Quality of life: MSIS-29 physical score","No usable data for effect sizes"
"CD015123_pub2_data","3::6::Number of participants experiencing treatment discontinuation caused by AE","No usable data for effect sizes"
"CD015123_pub2_data","3::7::Number of participants with at least one AE","No usable data for effect sizes"
"CD015123_pub2_data","4::1::Number of participants who experienced at least one relapse","No usable data for effect sizes"
"CD015123_pub2_data","4::2::Number of participants with at least one SAE","No usable data for effect sizes"
"CD015123_pub2_data","4::3::Number of participants with at least one AE","No usable data for effect sizes"
"CD015145_pub2_data","1::2::Nausea and vomiting","No usable data for effect sizes"
"CD015145_pub2_data","1::4::Opioid use (MME) 0 to 48 hours after surgery","No usable data for effect sizes"
"CD015145_pub2_data","1::5::Postoperative pain score (VAS) 2 hours","No usable data for effect sizes"
"CD015145_pub2_data","1::9::Time to discharge (hours)","No usable data for effect sizes"
"CD015145_pub2_data","2::2::Postoperative pain score (VAS) during movement 24 hrs","No usable data for effect sizes"
"CD015145_pub2_data","2::5::Postoperative pain score (VAS) 12 hours","No usable data for effect sizes"
"CD015145_pub2_data","2::6::Postoperative pain score (VAS) 48 hours","No usable data for effect sizes"
"CD015145_pub2_data","2::7::Time to first postoperative opioid (minutes)","No usable data for effect sizes"
"CD015145_pub2_data","3::5::Sedation","No usable data for effect sizes"
"CD015145_pub2_data","3::7::Postoperative pain score (VAS) 2 hours","No usable data for effect sizes"
"CD015145_pub2_data","3::12::Time to discharge (hours)","No usable data for effect sizes"
"CD015158_pub2_data","1::1::Forced expiratory volume in 1 second (FEV1) (absolute z score)","No usable data for effect sizes"
"CD015158_pub2_data","1::2::Forced expiratory volume in 1 second (FEV1) (change in z score)","No usable data for effect sizes"
"CD015158_pub2_data","1::3::Forced vital capacity (FVC) (absolute z score)","No usable data for effect sizes"
"CD015158_pub2_data","1::4::Lung Clearance Index (LCI) (absolute change)","No usable data for effect sizes"
"CD015158_pub2_data","1::5::Total CF-CT score (Brody-II)","No usable data for effect sizes"
"CD015158_pub2_data","1::7::Change in proportion of total disease on chest CT scan","No usable data for effect sizes"
"CD015158_pub2_data","1::8::Change in proportion of trapped air on CT scan","No usable data for effect sizes"
"CD015158_pub2_data","1::9::Weight (z score)","No usable data for effect sizes"
"CD015158_pub2_data","1::10::Body mass index (BMI) (z score)","No usable data for effect sizes"
"CD015158_pub2_data","1::11::Change in body mass index (BMI)","No usable data for effect sizes"
"CD015158_pub2_data","1::12::Positive P aeruginosa isolates per participant per year","No usable data for effect sizes"
"CD015158_pub2_data","1::13::Prevalence of P aeruginosa in BAL at 5 years of age","No usable data for effect sizes"
"CD015158_pub2_data","1::14::Sensitivity analysis - prevalence of P aeruginosa in BAL at 5 years of age (40% versus 5%)","No usable data for effect sizes"
"CD015158_pub2_data","1::15::Sensitivity analysis - prevalence of P aeruginosa in BAL at 5 years of age (5% versus 40%)","No usable data for effect sizes"
"CD015158_pub2_data","1::16::Clearance of P aeruginosa after 1 or 2 eradication treatments","No usable data for effect sizes"
"CD015158_pub2_data","1::17::Age at first acquisition of P aeruginosa infection","No usable data for effect sizes"
"CD015158_pub2_data","1::20::Quality of life: Cystic Fibrosis Questionnaire Revised (CFQ-R) score (respiratory symptom score, change from baseline)","No usable data for effect sizes"
"CD015158_pub2_data","1::22::Number of hospital admissions per participant per year","No usable data for effect sizes"
"CD015158_pub2_data","1::23::Number of hospitalisations per person per year due to non-P aeruginosa exacerbations","No usable data for effect sizes"
"CD015158_pub2_data","1::24::Days as a hospital inpatient per participant per year","No usable data for effect sizes"
"CD015158_pub2_data","1::25::Duration of hospital admissions due to non-P aeruginosa exacerbations","No usable data for effect sizes"
"CD015158_pub2_data","1::26::Mean hospital admissions cost per participant (in Australian dollars)","No usable data for effect sizes"
"CD015158_pub2_data","1::27::Total cost of care per participant (in Australian dollars)","No usable data for effect sizes"
"CD015158_pub2_data","1::28::Number of pulmonary exacerbations (requiring oral or intravenous antibiotics) per participant per year","No usable data for effect sizes"
"CD015160_pub2_data","1::3::Surgical site infections (as defined by the included studies) within 90 days of repair","No usable data for effect sizes"
"CD015192_pub2_data","1::3::Re-intervention rate","No usable data for effect sizes"
"CD015192_pub2_data","2::4::Re-intervention rate","No usable data for effect sizes"
"CD015192_pub2_data","2::5::Amputation rate","No usable data for effect sizes"
"CD015192_pub2_data","5::3::All-cause mortality","No usable data for effect sizes"
"CD015192_pub2_data","6::1::Graft infection rate","No usable data for effect sizes"
"CD015192_pub2_data","7::1::Graft infection rate","No usable data for effect sizes"
"CD015192_pub2_data","8::1::Arterial reconstruction failure rate","No usable data for effect sizes"
"CD015192_pub2_data","9::1::Graft infection rate","No usable data for effect sizes"
"CD015192_pub2_data","9::2::Arterial reconstruction failure rate","No usable data for effect sizes"
"CD015192_pub2_data","10::1::Graft infection rate","No usable data for effect sizes"
"CD015192_pub2_data","10::2::Surgical site infection rate","No usable data for effect sizes"
"CD015192_pub2_data","11::1::Surgical site infection rate","No usable data for effect sizes"
"CD015192_pub2_data","11::2::All-cause mortality","No usable data for effect sizes"
"CD015192_pub2_data","11::3::Re-intervention rate","No usable data for effect sizes"
"CD015192_pub2_data","12::1::Surgical site infection rate","No usable data for effect sizes"
"CD015192_pub2_data","13::1::Surgical site infection rate","No usable data for effect sizes"
"CD015192_pub2_data","13::2::All-cause mortality","No usable data for effect sizes"
"CD015192_pub2_data","13::3::Amputation rate","No usable data for effect sizes"
"CD015192_pub2_data","13::4::Adverse events resulting from the interventions for prevention of infection","No usable data for effect sizes"
"CD015192_pub2_data","14::1::Graft infection rate","No usable data for effect sizes"
"CD015192_pub2_data","14::2::Surgical site infection rate","No usable data for effect sizes"
"CD015192_pub2_data","14::3::Amputation rate","No usable data for effect sizes"
"CD015192_pub2_data","15::1::Surgical site infection rate","No usable data for effect sizes"
"CD015192_pub2_data","15::2::Re-intervention rate","No usable data for effect sizes"
"CD015192_pub2_data","15::3::Amputation rate","No usable data for effect sizes"
"CD015192_pub2_data","15::4::Adverse events resulting from the interventions for prevention of infection","No usable data for effect sizes"
"CD015213_pub2_data","2::1::Proportion of wounds healed at 3 months","No usable data for effect sizes"
"CD015213_pub2_data","2::2::Proportion of wounds healed at 12 months","No usable data for effect sizes"
"CD015213_pub2_data","2::11::Time to return to work","No usable data for effect sizes"
"CD015213_pub2_data","2::13::Length of hospital stay","No usable data for effect sizes"
"CD015213_pub2_data","3::3::Proportion of wounds healed","No usable data for effect sizes"
"CD015213_pub2_data","4::1::Recurrence rate","No usable data for effect sizes"
"CD015213_pub2_data","4::2::Wound infection","No usable data for effect sizes"
"CD015213_pub2_data","4::3::Wound dehiscence","No usable data for effect sizes"
"CD015213_pub2_data","5::1::Time to wound healing","No usable data for effect sizes"
"CD015213_pub2_data","5::2::Recurrence rate","No usable data for effect sizes"
"CD015213_pub2_data","5::3::Wound infection","No usable data for effect sizes"
"CD015213_pub2_data","5::4::Wound dehiscence","No usable data for effect sizes"
"CD015213_pub2_data","5::5::Time to return to work","No usable data for effect sizes"
"CD015213_pub2_data","5::6::Operative time","No usable data for effect sizes"
"CD015213_pub2_data","5::7::Length of hospital stay","No usable data for effect sizes"
"CD015213_pub2_data","7::1::Wound infection","No usable data for effect sizes"
"CD015213_pub2_data","7::2::Wound dehiscence","No usable data for effect sizes"
"CD015213_pub2_data","7::3::Operative time","No usable data for effect sizes"
"CD015213_pub2_data","8::1::Recurrence rate","No usable data for effect sizes"
"CD015213_pub2_data","8::2::Wound infection","No usable data for effect sizes"
"CD015213_pub2_data","8::3::Wound dehiscence","No usable data for effect sizes"
"CD015213_pub2_data","8::4::Operative time","No usable data for effect sizes"
"CD015213_pub2_data","9::1::Recurrence rate","No usable data for effect sizes"
"CD015213_pub2_data","9::2::Wound infection","No usable data for effect sizes"
"CD015213_pub2_data","9::3::Wound dehiscence","No usable data for effect sizes"
"CD015213_pub2_data","9::4::Operative time","No usable data for effect sizes"
"CD015213_pub2_data","9::5::Length of hospital stay","No usable data for effect sizes"
"CD015215_pub2_data","1::5::Persistence of OME: randomised by child (very short-term)","No usable data for effect sizes"
"CD015215_pub2_data","1::6::Persistence of OME: randomised by child (medium-term)","No usable data for effect sizes"
"CD015215_pub2_data","1::8::Mean improvement in comprehensive language, randomised by child (medium-term)","No usable data for effect sizes"
"CD015215_pub2_data","1::9::Mean improvement in expressive language, randomised by child (medium-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::1::Return to normal hearing, randomised by child (long-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::2::Mean final hearing threshold, randomised by child (short-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::4::Mean final hearing threshold (air-bone gap), randomised by child, analysed by ear (medium-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::7::Change in hearing threshold from baseline, randomised by child (medium-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::8::Adjusted mean difference in hearing improvement, randomised by child (medium term)","No usable data for effect sizes"
"CD015215_pub2_data","2::9::Adverse event: persistent perforation, randomised by child (medium-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::10::Adverse event: persistent perforation, randomised by child (long-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::11::Presence/persistence of OME, randomised by child, measured by otoscopy (medium-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::12::Presence/persistence of OME, randomised by child, measured by tympanometry (medium-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::13::Presence/persistence of OME, mean percentage of days, randomised by child (medium-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::15::Presence/persistence of OME, adjusted OR, randomised by child (long-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::16::Adverse event: tympanosclerosis (long-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::17::Adverse event: fibrosis (long-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::18::Adverse event: segmental atrophy (long-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::19::Adverse event: retraction pocket with other abnormality (long-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::20::Receptive language development, Reynell test, randomised by child (medium-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::21::Receptive language development, Reynell test, adjusted MD (medium-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::22::Receptive language, Reynell test, randomised by child (long-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::23::Receptive language: Reynell test, long-term, adjusted MD","No usable data for effect sizes"
"CD015215_pub2_data","2::24::Receptive language: WOLD adjusted OR (long-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::25::Receptive language, mean difference (months) in improvement in Reynell test score (equivalent age-real age): medium-term","No usable data for effect sizes"
"CD015215_pub2_data","2::26::Receptive language, adjusted mean difference (months) in improvement in Reynell test score (equivalent age - real age): medium-term","No usable data for effect sizes"
"CD015215_pub2_data","2::27::Expressive language development: Reynell test (medium-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::28::Expressive language development: Reynell test, medium-term, adjusted MD","No usable data for effect sizes"
"CD015215_pub2_data","2::29::Expressive language development: Reynell test (long-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::30::Expressive language development: Reynell test, long-term, adjusted MD","No usable data for effect sizes"
"CD015215_pub2_data","2::31::Expressive language: WOLD adjusted OR (long-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::32::Expressive language, MD (months) in improvement in Schlichting test score (equivalent age-real age): medium-term","No usable data for effect sizes"
"CD015215_pub2_data","2::33::Expressive language, adjusted mean difference (months) in improvement in Schlichting test score (equivalent age-real age): medium-term","No usable data for effect sizes"
"CD015215_pub2_data","2::34::Non-word repetition total score, adjusted OR (long-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::35::Reading , WORD test, adjusted OR (long-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::36::Spelling, ALSPAC test, adjusted OR (long-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::37::Phoneme deletion, adjusted OR (long-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::38::Cognitive development: Griffiths practical reasoning (medium-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::39::Cognitive development: IQ (WISC-III UK short form) adjusted OR (long-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::40::Behaviour, Richman score (medium-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::41::Behaviour, Richman score, dichotomised (medium-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::42::Behaviour, Richman score, adjusted OR (medium-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::43::Behaviour, Richman score (long-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::44::Behaviour, Richman score, dichotomised (long-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::45::Behaviour: SDQ teacher report, total, adjusted OR (long-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::46::Parent-child interaction: Erickson child scale (medium-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::47::Parent-child interaction: Erickson parent scale (medium-term)","No usable data for effect sizes"
"CD015215_pub2_data","2::49::Parental stress, Parental Stress Index, short form (long-term)","No usable data for effect sizes"
"CD015215_pub2_data","3::1::Mean final hearing threshold (short-term)","No usable data for effect sizes"
"CD015215_pub2_data","3::2::Mean final hearing threshold (medium-term)","No usable data for effect sizes"
"CD015215_pub2_data","3::3::Adverse event: myringosclerosis (long-term)","No usable data for effect sizes"
"CD015215_pub2_data","3::4::Number of doctor-diagnosed AOM episodes (medium-term)","No usable data for effect sizes"
"CD015215_pub2_data","3::5::Number of doctor-diagnosed episodes of AOM (long-term)","No usable data for effect sizes"
"CD015215_pub2_data","4::2::Mean final hearing threshold, randomised by child (short-term). Adjusted for non-independence of within-individual measurements; assumed ICC of 0.5","No usable data for effect sizes"
"CD015215_pub2_data","4::3::Mean final hearing threshold, randomised by ear (short-term)","No usable data for effect sizes"
"CD015215_pub2_data","4::5::Adverse event: persistent perforation (medium-term)","No usable data for effect sizes"
"CD015215_pub2_data","4::7::Persistence of OME: VT versus laser myringotomy (short-term)","No usable data for effect sizes"
"CD015215_pub2_data","4::8::Persistence of OME: VT versus thermal myringotomy, randomised by ear (short-term)","No usable data for effect sizes"
"CD015215_pub2_data","4::9::Persistence of OME: VT versus cold-steel myringotomy (medium-term)","No usable data for effect sizes"
"CD015215_pub2_data","4::10::Persistence of OME: VT versus laser myringotomy (medium-term)","No usable data for effect sizes"
"CD015215_pub2_data","4::11::Persistence of OME: VT versus laser myringotomy, randomised by ear (medium-term)","No usable data for effect sizes"
"CD015215_pub2_data","4::17::Adverse event: retraction of TM: VT versus laser myringotomy (medium-term)","No usable data for effect sizes"
"CD015215_pub2_data","4::18::Adverse event: hypertrophic scar of TM: VT versus laser myringotomy (medium-term)","No usable data for effect sizes"
"CD015215_pub2_data","4::19::Adverse event: otorrhoea: VT versus laser myringotomy (medium-term)","No usable data for effect sizes"
"CD015215_pub2_data","5::10::Sensitivity analysis: Persistence of OME: randomised by child (medium-term); ICC = 1.0","No usable data for effect sizes"
"CD015215_pub2_data","5::11::Sensitivity analysis: Persistence of OME: randomised by child (medium-term); ICC = zero","No usable data for effect sizes"
"CD015215_pub2_data","6::1::Sensitivity analysis: Mean final hearing threshold (air-bone gap), randomised by child, analysed by ear (medium-term); ICC = 1.0","No usable data for effect sizes"
"CD015215_pub2_data","6::2::Sensitivity analysis: Mean final hearing threshold (air-bone gap), randomised by child, analysed by ear (medium-term); ICC = zero","No usable data for effect sizes"
"CD015215_pub2_data","6::5::Sensitivity analysis: Persistent perforation, randomised by child (long-term); ICC = 1.0","No usable data for effect sizes"
"CD015215_pub2_data","6::6::Sensitivity analysis: Persistent perforation, randomised by child (long-term); ICC = zero","No usable data for effect sizes"
"CD015215_pub2_data","6::7::Sensitivity analysis: Persistence of OME, randomised by child, measured by otoscopy (medium-term); ICC = 1.0","No usable data for effect sizes"
"CD015215_pub2_data","6::8::Sensitivity analysis: Persistence of OME, randomised by child, measured by otoscopy (medium-term); ICC = zero","No usable data for effect sizes"
"CD015215_pub2_data","6::9::Sensitivity analysis: Tympanosclerosis (long-term); ICC = 1.0","No usable data for effect sizes"
"CD015215_pub2_data","6::10::Sensitivity analysis: Tympanosclerosis (long-term); ICC = zero","No usable data for effect sizes"
"CD015215_pub2_data","6::11::Sensitivity analysis: Adverse event: fibrosis (long-term); ICC = 1.0","No usable data for effect sizes"
"CD015215_pub2_data","6::12::Sensitivity analysis: Adverse event: fibrosis (long-term); ICC = zero","No usable data for effect sizes"
"CD015215_pub2_data","6::13::Sensitivity analysis: Segmental atrophy (long-term); ICC = 1.0","No usable data for effect sizes"
"CD015215_pub2_data","6::14::Sensitivity analysis: Segmental atrophy (long-term); ICC = zero","No usable data for effect sizes"
"CD015215_pub2_data","6::15::Sensitivity analysis: Retraction pocket with other abnormality (long-term); ICC = 1.0","No usable data for effect sizes"
"CD015215_pub2_data","6::16::Sensitivity analysis: Retraction pocket with other abnormality (long-term); ICC = zero","No usable data for effect sizes"
"CD015215_pub2_data","6::17::Sensitivity analysis: Parent-child interaction: Erickson child scale (medium-term); CC = 0.3","No usable data for effect sizes"
"CD015215_pub2_data","6::18::Sensitivity analysis: Parent-child interaction: Erickson child scale (medium-term); CC = 0.7","No usable data for effect sizes"
"CD015215_pub2_data","6::19::Sensitivity analysis: Parent-child interaction: Erickson parent scale (medium-term); CC = 0.3","No usable data for effect sizes"
"CD015215_pub2_data","6::20::Sensitivity analysis: Parent-child interaction: Erickson parent scale (medium-term); CC = 0.7","No usable data for effect sizes"
"CD015215_pub2_data","7::3::Sensitivity analysis: Mean final hearing threshold, randomised by child (short-term); ICC = 1.0","No usable data for effect sizes"
"CD015215_pub2_data","7::4::Sensitivity analysis: Mean final hearing threshold, randomised by child (short-term); ICC = zero","No usable data for effect sizes"
"CD015215_pub2_data","7::5::Sensitivity analysis: Mean final hearing threshold (medium-term); ICC = 1.0","No usable data for effect sizes"
"CD015215_pub2_data","7::6::Sensitivity analysis: Mean final hearing threshold (medium-term); ICC = zero","No usable data for effect sizes"
"CD015215_pub2_data","7::7::Sensitivity analysis: Persistent perforation (medium-term); ICC = 1.0","No usable data for effect sizes"
"CD015215_pub2_data","7::8::Sensitivity analysis: Persistent perforation (medium-term); ICC = zero","No usable data for effect sizes"
"CD015215_pub2_data","7::9::Sensitivity analysis: Persistence of OME: VT versus laser myringotomy (short-term); ICC = 1.0","No usable data for effect sizes"
"CD015215_pub2_data","7::10::Sensitivity analysis: Persistence of OME: VT versus laser myringotomy (short-term); ICC = zero","No usable data for effect sizes"
"CD015215_pub2_data","7::11::Sensitivity analysis: Persistence of OME: VT versus laser myringotomy (medium-term); ICC = 1.0","No usable data for effect sizes"
"CD015215_pub2_data","7::12::Sensitivity analysis: Persistence of OME: VT versus laser myringotomy (medium-term); ICC = zero","No usable data for effect sizes"
"CD015215_pub2_data","7::13::Sensitivity analysis: Persistence of OME: VT versus laser myringotomy, randomised by ear (medium-term); CC = 0.3","No usable data for effect sizes"
"CD015215_pub2_data","7::14::Sensitivity analysis: Persistence of OME: VT versus laser myringotomy, randomised by ear (medium-term); CC = 0.7","No usable data for effect sizes"
"CD015215_pub2_data","7::15::Sensitivity analysis: Retraction of TM: VT versus laser myringotomy (medium-term); ICC = 1.0","No usable data for effect sizes"
"CD015215_pub2_data","7::16::Sensitivity analysis: Retraction of TM: VT versus laser myringotomy (medium-term); ICC = zero","No usable data for effect sizes"
"CD015215_pub2_data","7::17::Sensitivity analysis: Otorrhoea: VT versus laser myringotomy (medium-term); ICC = 1.0","No usable data for effect sizes"
"CD015215_pub2_data","7::18::Sensitivity analysis: Otorrhoea: VT versus laser myringotomy (medium-term); ICC = zero","No usable data for effect sizes"
"CD015219_pub2_data","1::7::Progression to non‐invasive ventilation","No usable data for effect sizes"
"CD015219_pub2_data","4::4::Progression to oxygen therapy","No usable data for effect sizes"
"CD015219_pub2_data","4::6::Duration of hospitalization","No usable data for effect sizes"
"CD015229_pub2_data","2::1::Quality of life at 14 days","No usable data for effect sizes"
"CD015229_pub2_data","2::2::Pain score at 14 days","No usable data for effect sizes"
"CD015229_pub2_data","2::5::Opiate consumption at 14 days","No usable data for effect sizes"
"CD015252_pub2_data","1::2::Serious adverse event: haemorrhage","No usable data for effect sizes"
"CD015252_pub2_data","1::6::Time with effusion","No usable data for effect sizes"
"CD015252_pub2_data","1::7::Number of doctor-diagnosed acute otitis media episodes","No usable data for effect sizes"
"CD015252_pub2_data","2::1::Return to normal hearing","No usable data for effect sizes"
"CD015252_pub2_data","2::5::Time with effusion","No usable data for effect sizes"
"CD015252_pub2_data","2::6::Sensitivity analysis: return to normal hearing ICC 0","No usable data for effect sizes"
"CD015252_pub2_data","2::7::Sensitivity analysis: return to normal hearing ICC 1","No usable data for effect sizes"
"CD015252_pub2_data","3::4::Adverse events: tympanosclerosis","No usable data for effect sizes"
"CD015252_pub2_data","3::5::Adverse events: perforation/retraction","No usable data for effect sizes"
"CD015252_pub2_data","4::2::Presence/persistence of OME","No usable data for effect sizes"
"CD015252_pub2_data","4::3::Time with effusion","No usable data for effect sizes"
"CD015254_pub2_data","1::1::Normal hearing (as complete improvement in air-bone gap in worst ear): short-term","No usable data for effect sizes"
"CD015254_pub2_data","1::5::Hearing threshold: speech awareness threshold (short-term)","No usable data for effect sizes"
"CD015254_pub2_data","1::12::Adverse event: eardrum perforation","No usable data for effect sizes"
"CD015254_pub2_data","1::13::Adverse event: 'gastrointestinal' ","No usable data for effect sizes"
"CD015254_pub2_data","2::1::Hearing returned to normal (very short-term)","No usable data for effect sizes"
"CD015254_pub2_data","2::2::Final hearing threshold (short-term)","No usable data for effect sizes"
"CD015254_pub2_data","2::6::Episodes of acute otitis media (short-term)","No usable data for effect sizes"
"CD015255_pub2_data","1::1::Normal hearing (very short-term - up to 6 weeks)","No usable data for effect sizes"
"CD015255_pub2_data","1::2::Normal hearing (very short-term - up to 6 weeks, adjusted OR)","No usable data for effect sizes"
"CD015255_pub2_data","1::3::Normal hearing defined as complete improvement in air-bone gap (short-term - up to 3 months)","No usable data for effect sizes"
"CD015255_pub2_data","1::4::Normal hearing (medium-term - up to 1 year)","No usable data for effect sizes"
"CD015255_pub2_data","1::5::Hearing threshold (very short-term - up to 6 weeks)","No usable data for effect sizes"
"CD015255_pub2_data","1::6::Hearing threshold (difference in adjusted mean, very short-term - up to 6 weeks)","No usable data for effect sizes"
"CD015255_pub2_data","1::7::Disease-specific quality of life (very short-term - up to 6 weeks)","No usable data for effect sizes"
"CD015255_pub2_data","1::8::Disease-specific quality of life (medium-term - up to 1 year)","No usable data for effect sizes"
"CD015255_pub2_data","1::18::Generic health-related quality of life (PedsQL, very short-term - up to 6 weeks)","No usable data for effect sizes"
"CD015255_pub2_data","1::19::Generic health-related quality of life (PedsQL, medium-term - up to 1 year)","No usable data for effect sizes"
"CD015255_pub2_data","1::20::Generic health-related quality of life (HU13, very short-term - up to 6 weeks)","No usable data for effect sizes"
"CD015255_pub2_data","1::21::Generic health-related quality of life (HU13, medium-term - up to 1 year)","No usable data for effect sizes"
"CD015255_pub2_data","2::1::Persistence of OME (very short-term - up to 6 weeks)","No usable data for effect sizes"
"CD015255_pub2_data","2::2::Persistence of OME (short-term - up to 3 months)","No usable data for effect sizes"
"CD015255_pub2_data","3::1::Change in hearing threshold (short-term - up to 3 months); ICC = 0.5","No usable data for effect sizes"
"CD015255_pub2_data","3::2::Sensitivity analysis: change in hearing threshold (short-term); ICC = 1.0","No usable data for effect sizes"
"CD015255_pub2_data","3::3::Sensitivity analysis: change in hearing threshold (short-term); ICC = zero","No usable data for effect sizes"
"CD015255_pub2_data","3::4::Final hearing threshold (short-term - up to 3 months)","No usable data for effect sizes"
"CD015255_pub2_data","3::5::Disease-specific quality of life (short-term - up to 3 months)","No usable data for effect sizes"
"CD015255_pub2_data","3::6::Disease-specific quality of life (medium-term - up to 1 year)","No usable data for effect sizes"
"CD015255_pub2_data","3::7::Persistence of OME (very short-term - up to 6 weeks); ICC = 0.5","No usable data for effect sizes"
"CD015255_pub2_data","3::8::Sensitivity analysis: persistence of OME (very short-term); ICC = 1.0","No usable data for effect sizes"
"CD015255_pub2_data","3::9::Sensitivity analysis: persistence of OME (very short-term); ICC = zero","No usable data for effect sizes"
"CD015255_pub2_data","3::14::Adverse event: nasal bleeding (medium-term - up to 1 year)","No usable data for effect sizes"
"CD015255_pub2_data","3::15::Generic health-related quality of life (medium-term - up to 1 year)","No usable data for effect sizes"
"CD015255_pub2_data","4::1::Final hearing threshold (very short-term - up to 6 weeks)","No usable data for effect sizes"
"CD015284_pub2_data","1::5::Geriatric Depression Scale (GDS)","No usable data for effect sizes"
"CD015284_pub2_data","1::6::Composite International Diagnostic Interview (CIDI): Depression","No usable data for effect sizes"
"CD015284_pub2_data","1::7::Composite International Diagnostic Interview (CIDI): Dysthymia","No usable data for effect sizes"
"CD015284_pub2_data","1::8::Washington Psychosocial Seizure Inventory (WPSI): Total score","No usable data for effect sizes"
"CD015284_pub2_data","2::3::Change in Liverpool Seizure Severity Scale","No usable data for effect sizes"
"CD015284_pub2_data","2::4::Quality of Life in Epilepsy Inventory Total score (QOLIE-31-P)","No usable data for effect sizes"
"CD015284_pub2_data","2::5::Beck Depression Inventory - II (BDI-II)","No usable data for effect sizes"
"CD015284_pub2_data","2::6::Beck Anxiety Inventory (BAI)","No usable data for effect sizes"
"CD015284_pub2_data","3::6::Change in seizure frequency from baseline","No usable data for effect sizes"
"CD015284_pub2_data","3::7::Seizure frequency: &lt; 1 seizure per month","No usable data for effect sizes"
"CD015284_pub2_data","3::14::Epilepsy and Learning Disabilities Quality of Life Scale: side effects","No usable data for effect sizes"
"CD015284_pub2_data","3::15::EQ-5D-5L index score","No usable data for effect sizes"
"CD015284_pub2_data","3::16::EQ-5D-5L visual analogue scale (VAS)","No usable data for effect sizes"
"CD015284_pub2_data","3::19::Depressive Mood Scale","No usable data for effect sizes"
"CD015284_pub2_data","3::20::Rosenberg Self-Esteem Scale","No usable data for effect sizes"
"CD015284_pub2_data","3::21::Restrictions in daily living","No usable data for effect sizes"
"CD015284_pub2_data","3::22::Mobility and leisure behaviour","No usable data for effect sizes"
"CD015284_pub2_data","3::23::Epilepsy-related fear","No usable data for effect sizes"
"CD015284_pub2_data","3::24::Coping with Epilepsy total score","No usable data for effect sizes"
"CD015284_pub2_data","3::25::Hospital Anxiety and Depression Scale: Depression (HADS-D)","No usable data for effect sizes"
"CD015284_pub2_data","3::26::Hospital Anxiety and Depression Scale: Anxiety (HADS-A)","No usable data for effect sizes"
"CD015284_pub2_data","3::27::Self-mastery and control score","No usable data for effect sizes"
"CD015284_pub2_data","3::32::Morisky Medication Adherence Scale","No usable data for effect sizes"
"CD015284_pub2_data","3::33::AED tolerability score","No usable data for effect sizes"
"CD015284_pub2_data","3::35::Epilepsy Knowledge Scale","No usable data for effect sizes"
"CD015284_pub2_data","4::3::Change in seizure frequency from baseline","No usable data for effect sizes"
"CD015284_pub2_data","4::5::Hospital Anxiety and Depression Scale: Anxiety (HADS-A)","No usable data for effect sizes"
"CD015284_pub2_data","4::6::Hospital Anxiety and Depression Scale: Depression (HADS-D)","No usable data for effect sizes"
"CD015284_pub2_data","4::7::Neurological Disorders Depression Inventory for Epilepsy (NDDIE)","No usable data for effect sizes"
"CD015284_pub2_data","4::8::State-Trait Anxiety Inventory (STAI): State","No usable data for effect sizes"
"CD015284_pub2_data","4::9::State-Trait Anxiety Inventory (STAI): Trait","No usable data for effect sizes"
"CD015284_pub2_data","4::10::Perceived Stress Scale (PSS-10)","No usable data for effect sizes"
"CD015284_pub2_data","4::11::Pittsburgh Sleep Quality Index (PSQI)","No usable data for effect sizes"
"CD015284_pub2_data","4::12::Profile of Mood States (POMS) scale","No usable data for effect sizes"
"CD015284_pub2_data","4::14::Adverse Effects Profile (AEP) scale","No usable data for effect sizes"
"CD015284_pub2_data","5::4::Restrictions in daily life due to epilepsy","No usable data for effect sizes"
"CD015284_pub2_data","5::6::Epilepsy Knowledge Scale","No usable data for effect sizes"
"CD015284_pub2_data","6::2::Seizure frequency: &lt; 1 seizure per month","No usable data for effect sizes"
"CD015284_pub2_data","6::3::≥ 50% reduction in seizure frequency","No usable data for effect sizes"
"CD015284_pub2_data","6::4::Quality of Life in Epilepsy Inventory Total score (QOLIE-31)","No usable data for effect sizes"
"CD015284_pub2_data","6::5::Severe depression (Beck Depression Inventory score &gt; 16)","No usable data for effect sizes"
"CD015284_pub2_data","6::6::Severe anxiety (Beck Anxiety Inventory score ≥ 37)","No usable data for effect sizes"
"CD015313_pub2_data","1::1::Exacerbation rate (per child/year) ","No usable data for effect sizes"
"CD015313_pub2_data","1::2::Improvement in FEV1 % predicted from baseline ","No usable data for effect sizes"
"CD015313_pub2_data","1::3::Improvement in FVC % predicted from baseline ","No usable data for effect sizes"
"CD015326_pub2_data","1::1::BMI (Short-term)","No usable data for effect sizes"
"CD015326_pub2_data","1::3::zBMI (Medium-term)","No usable data for effect sizes"
"CD015326_pub2_data","1::4::BMI percentile (Short-term)","No usable data for effect sizes"
"CD015326_pub2_data","1::6::zBMI (Medium-term) - Sensitivity Analysis: ICC=0.04","No usable data for effect sizes"
"CD015326_pub2_data","2::2::BMI (Medium-term)","No usable data for effect sizes"
"CD015326_pub2_data","2::5::BMI percentile (Short-term)","No usable data for effect sizes"
"CD015326_pub2_data","2::6::BMI percentile (Medium-term)","No usable data for effect sizes"
"CD015326_pub2_data","2::12::BMI (Medium-Term) - Sensitivity Analysis ICC=0.04 ","No usable data for effect sizes"
"CD015326_pub2_data","2::15::BMI percentile (Short-Term) - Sensitivity Analysis ICC=0.04 ","No usable data for effect sizes"
"CD015326_pub2_data","2::16::BMI percentile (Medium Term) - Sensitivity Analysis ICC=0.04 ","No usable data for effect sizes"
"CD015326_pub2_data","4::1::BMI (Short-Term) ","No usable data for effect sizes"
"CD015326_pub2_data","5::1::BMI (Medium-Term)","No usable data for effect sizes"
"CD015326_pub2_data","5::2::zBMI (Short-Term)","No usable data for effect sizes"
"CD015326_pub2_data","5::3::zBMI (Medium Term)","No usable data for effect sizes"
"CD015328_pub2_data","2::7::Percentile short-term","No usable data for effect sizes"
"CD015328_pub2_data","2::8::Percentile medium-term","No usable data for effect sizes"
"CD015328_pub2_data","4::3::Percentile medium-term","No usable data for effect sizes"
"CD015328_pub2_data","4::4::Percentile long-term","No usable data for effect sizes"
"CD015328_pub2_data","5::3::Percentile medium-term","No usable data for effect sizes"
"CD015328_pub2_data","5::4::Percentile long-term","No usable data for effect sizes"
"CD015328_pub2_data","6::3::BMI long-term","No usable data for effect sizes"
"CD015328_pub2_data","6::4::zBMI short-term","No usable data for effect sizes"
"CD015328_pub2_data","6::6::zBMI long-term","No usable data for effect sizes"
"CD015328_pub2_data","6::7::Percentile medium-term","No usable data for effect sizes"
"CD015328_pub2_data","6::8::Percentile long-term","No usable data for effect sizes"
"CD015330_pub2_data","1::3::BMI long term","No usable data for effect sizes"
"CD015330_pub2_data","1::5::zBMI medium term","No usable data for effect sizes"
"CD015330_pub2_data","1::9::Percentile long term","No usable data for effect sizes"
"CD015330_pub2_data","2::3::BMI long term","No usable data for effect sizes"
"CD015330_pub2_data","2::6::zBMI long term","No usable data for effect sizes"
"CD015330_pub2_data","2::7::Percentile medium term","No usable data for effect sizes"
"CD015330_pub2_data","3::7::Percentile short term","No usable data for effect sizes"
"CD015330_pub2_data","3::8::Percentile long term","No usable data for effect sizes"
"CD015330_pub2_data","4::1::BMI short term","No usable data for effect sizes"
"CD015330_pub2_data","4::2::Percentile short term","No usable data for effect sizes"
"CD015331_pub2_data","1::31::Mental state - specific: mean endpoint CESD-R (high = poor)","No usable data for effect sizes"
"CD015331_pub2_data","1::54::Functioning - mean endpoint FAST (high = poor)","No usable data for effect sizes"
"CD015331_pub2_data","1::69::Adverse events - participants with at least one adverse event","No usable data for effect sizes"
"CD015332_pub2_data","1::8::Service use – readmission to hospital ","No usable data for effect sizes"
"CD015332_pub2_data","1::9::Service use – mean number of days in hospital ","No usable data for effect sizes"
"CD015332_pub2_data","1::12::Behaviour – participants with suicide attempts ","No usable data for effect sizes"
"CD015332_pub2_data","1::14::Adverse events – participants with serious adverse events","No usable data for effect sizes"
"CD015332_pub2_data","2::11::Service use – number of days in hospital (separated time points)","No usable data for effect sizes"
"CD015332_pub2_data","2::21::Behaviour – suicide attempts (separated time points)","No usable data for effect sizes"
"CD015332_pub2_data","2::22::Adverse events – participants with at least 1 adverse event","No usable data for effect sizes"
"CD015332_pub2_data","3::21::Service use – number of days in hospital (separated time points)","No usable data for effect sizes"
"CD015332_pub2_data","3::23::Leaving the study early due to adverse effects (separated time points)","No usable data for effect sizes"
"CD015332_pub2_data","3::34::Behaviour – suicide attempts (separated time points)","No usable data for effect sizes"
"CD015332_pub2_data","3::39::Adverse events – lack of improvement (separated time points)","No usable data for effect sizes"
"CD015350_pub2_data","1::2::Size of infiltrate","No usable data for effect sizes"
"CD015350_pub2_data","1::4::Proportion with visual improvement","No usable data for effect sizes"
"CD015350_pub2_data","2::2::Size of infiltrate","No usable data for effect sizes"
"CD015350_pub2_data","2::3::Unaided distance visual acuity","No usable data for effect sizes"
"CD015350_pub2_data","3::1::Days to healing","No usable data for effect sizes"
"CD015350_pub2_data","3::2::Proportion with non-serious or non-severe harms/adverse events","No usable data for effect sizes"
"CD015350_pub2_data","4::1::Subjective signs and symptoms","No usable data for effect sizes"
"CD015350_pub2_data","5::1::Days to healing","No usable data for effect sizes"
"CD015350_pub2_data","5::2::Proportion with non-serious or non-severe harms/adverse events","No usable data for effect sizes"
"CD015350_pub2_data","6::1::Proportion with non-serious or non-severe harms/adverse events","No usable data for effect sizes"
"CD015350_pub2_data","7::1::Proportion with non-serious or non-severe harms/adverse events","No usable data for effect sizes"
"CD015373_pub2_data","1::3::Pain intensity (≥ 50% reduction), immediate-term follow-up","No usable data for effect sizes"
"CD015373_pub2_data","1::7::Pain intensity (≥ 50% reduction), short-term follow-up","No usable data for effect sizes"
"CD015373_pub2_data","1::8::Pain intensity (continuous), medium-term follow-up","No usable data for effect sizes"
"CD015373_pub2_data","1::13::Hallucinations","No usable data for effect sizes"
"CD015373_pub2_data","1::14::Sedation","No usable data for effect sizes"
"CD015373_pub2_data","1::16::Vomiting","No usable data for effect sizes"
"CD015373_pub2_data","1::17::Dizziness","No usable data for effect sizes"
"CD015373_pub2_data","1::19::Serious adverse events","No usable data for effect sizes"
"CD015373_pub2_data","1::20::Disability (Radboud Skills Questionnaire), short-term follow-up","No usable data for effect sizes"
"CD015373_pub2_data","1::21::Health-related quality of life (Fibromyalgia Impact Questionnaire), immediate-term follow-up","No usable data for effect sizes"
"CD015373_pub2_data","1::22::Health-related quality of life (Fibromyalgia Impact Questionnaire), short-term follow-up","No usable data for effect sizes"
"CD015373_pub2_data","2::3::Ketamine versus morphine: adverse events (total)","No usable data for effect sizes"
"CD015373_pub2_data","3::3::Dissociative symptoms","No usable data for effect sizes"
"CD015373_pub2_data","3::4::Sedation","No usable data for effect sizes"
"CD015373_pub2_data","3::5::Nausea","No usable data for effect sizes"
"CD015373_pub2_data","3::6::Dizziness","No usable data for effect sizes"
"CD015373_pub2_data","3::7::Headache","No usable data for effect sizes"
"CD015373_pub2_data","3::8::Serious adverse events","No usable data for effect sizes"
"CD015373_pub2_data","3::9::Tolerability","No usable data for effect sizes"
"CD015373_pub2_data","4::1::Ketamine (oral) versus methadone: pain intensity (continuous), short-term follow-up","No usable data for effect sizes"
"CD015373_pub2_data","4::2::Ketamine (oral) versus methadone: hallucinations","No usable data for effect sizes"
"CD015373_pub2_data","4::3::Ketamine (oral) versus methadone: sedation","No usable data for effect sizes"
"CD015373_pub2_data","4::4::Ketamine (oral) versus methadone: nausea","No usable data for effect sizes"
"CD015373_pub2_data","4::5::Ketamine (oral) versus methadone: vomiting","No usable data for effect sizes"
"CD015373_pub2_data","4::6::Ketamine (oral) versus methadone: dizziness","No usable data for effect sizes"
"CD015373_pub2_data","4::7::Ketamine (oral) versus methadone: headache","No usable data for effect sizes"
"CD015373_pub2_data","4::8::Ketamine (oral) versus methadone: tolerability","No usable data for effect sizes"
"CD015373_pub2_data","5::1::Pain intensity (continuous), immediate-term follow-up","No usable data for effect sizes"
"CD015373_pub2_data","5::3::Pain intensity (≥ 30% reduction), short-term follow-up","No usable data for effect sizes"
"CD015373_pub2_data","5::4::Pain intensity (≥ 50% reduction), short-term follow-up","No usable data for effect sizes"
"CD015373_pub2_data","5::5::Adverse events (total)","No usable data for effect sizes"
"CD015373_pub2_data","5::6::Sedation","No usable data for effect sizes"
"CD015373_pub2_data","5::7::Tolerability","No usable data for effect sizes"
"CD015373_pub2_data","6::1::Ketamine (topical) versus amitriptyline: pain intensity (continuous), immediate-term follow-up","No usable data for effect sizes"
"CD015373_pub2_data","6::2::Ketamine (topical) versus amitriptyline: pain intensity (continuous), short-term follow-up","No usable data for effect sizes"
"CD015373_pub2_data","6::3::Ketamine (topical) versus amitriptyline: pain intensity (≥30% response), short-term follow-up","No usable data for effect sizes"
"CD015373_pub2_data","6::4::Ketamine (topical) versus amitriptyline: pain intensity (≥50% response), short-term follow-up","No usable data for effect sizes"
"CD015373_pub2_data","6::5::Ketamine (topical) versus amitriptyline: adverse events (total)","No usable data for effect sizes"
"CD015373_pub2_data","6::6::Ketamine (topical) versus amitriptyline: sedation","No usable data for effect sizes"
"CD015373_pub2_data","6::7::Ketamine (topical) versus amitriptyline: tolerability","No usable data for effect sizes"
"CD015373_pub2_data","7::1::Pain intensity (continuous), immediate-term follow-up","No usable data for effect sizes"
"CD015373_pub2_data","7::6::Pain intensity (≥ 30% reduction), short-term follow-up","No usable data for effect sizes"
"CD015373_pub2_data","7::9::Pain intensity (≥ 50% reduction), medium-term follow-up","No usable data for effect sizes"
"CD015373_pub2_data","7::17::Other adverse events","No usable data for effect sizes"
"CD015373_pub2_data","7::20::Depressive symptoms (Hospital Anxiety and Depression Scale depression subscale), medium-term follow up","No usable data for effect sizes"
"CD015373_pub2_data","7::22::Health-related quality of life (EQ-5D Visual Analogue Scale), medium-term follow-up","No usable data for effect sizes"
"CD015373_pub2_data","8::1::Pain intensity (continuous), short-term follow up","No usable data for effect sizes"
"CD015373_pub2_data","8::2::Adverse events (total)","No usable data for effect sizes"
"CD015373_pub2_data","8::3::Health-related quality of life (SF-36 General Health subscale), short-term follow up","No usable data for effect sizes"
"CD015373_pub2_data","9::1::Pain intensity (continuous), immediate-term follow-up","No usable data for effect sizes"
"CD015373_pub2_data","9::2::Adverse events (total)","No usable data for effect sizes"
"CD015373_pub2_data","9::3::Nausea","No usable data for effect sizes"
"CD015373_pub2_data","10::1::Pain intensity (continuous), immediate-term follow-up","No usable data for effect sizes"
"CD015373_pub2_data","10::3::Adverse events (total)","No usable data for effect sizes"
"CD015373_pub2_data","11::2::Health-related quality of life (SF-12 Physical Component score), short-term follow up","No usable data for effect sizes"
"CD015373_pub2_data","11::3::Tolerability","No usable data for effect sizes"
"CD015373_pub2_data","12::1::Magnesium (oral) versus aspirin: tolerability","No usable data for effect sizes"
"CD015373_pub2_data","13::1::Tolerability","No usable data for effect sizes"
"CD015383_pub2_data","2::1::Anxiety on STAI-T (scale 20 to 80)","No usable data for effect sizes"
"CD015383_pub2_data","2::2::Anxiety on STAI-S (scale 20 to 80)","No usable data for effect sizes"
"CD015383_pub2_data","2::3::Depression on BDI (scale 0 to 63)","No usable data for effect sizes"
"CD015387_pub2_data","2::2::Good functional outcome at the end of scheduled follow-up: sensitivity analysis of low risk of bias trials only","No usable data for effect sizes"
"CD015387_pub2_data","2::4::All-cause mortality at the end of scheduled follow-up: sensitivity analysis of low risk of bias trials only","No usable data for effect sizes"
"CD015387_pub2_data","2::6::Health-related quality of life at the end of scheduled follow-up","No usable data for effect sizes"
"CD015387_pub2_data","3::9::Health-related quality of life at the end of scheduled follow-up","No usable data for effect sizes"
"CD015387_pub2_data","4::1::Good functional outcome at the end of scheduled follow-up","No usable data for effect sizes"
"CD015387_pub2_data","4::2::All-cause mortality at the end of scheduled follow-up","No usable data for effect sizes"
"CD015387_pub2_data","4::3::Thirty-day case fatality","No usable data for effect sizes"
"CD015387_pub2_data","4::4::Health-related quality of life at the end of scheduled follow-up","No usable data for effect sizes"
"CD015395_pub3_data","1::1::All-cause mortality at day 28","No usable data for effect sizes"
"CD015395_pub3_data","1::2::Worsening of clinical status at day 28: admission to hospital or death","No usable data for effect sizes"
"CD015395_pub3_data","1::5::Serious adverse events during the study period","No usable data for effect sizes"
"CD015395_pub3_data","1::6::Any grade treatment-emergent adverse events during the study period","No usable data for effect sizes"
"CD015395_pub3_data","1::7::Any grade treatment-related adverse events during the study period","No usable data for effect sizes"
"CD015395_pub3_data","1::8::Discontinuation of study drug due to adverse events during the study period","No usable data for effect sizes"
"CD015395_pub3_data","2::1::All-cause mortality at day 28","No usable data for effect sizes"
"CD015395_pub3_data","2::3::Viral clearance at day 7","No usable data for effect sizes"
"CD015395_pub3_data","2::4::Viral clearance at day 14","No usable data for effect sizes"
"CD015432_pub2_data","1::15::Renal dysfunction","No usable data for effect sizes"
"CD015432_pub2_data","2::4::Adverse events","No usable data for effect sizes"
"CD015432_pub2_data","2::7::Pain intensity – as reported by a third party, e.g. parents and caregivers, from 24 hours up to 7 days postintervention","No usable data for effect sizes"
"CD015432_pub2_data","2::11::Opioid consumption, less than 2 hours postintervention","No usable data for effect sizes"
"CD015432_pub2_data","2::12::Time to rescue medication, as reported by a third party, e.g. parents and caregivers","No usable data for effect sizes"
"CD015432_pub2_data","3::1::Adverse events","No usable data for effect sizes"
"CD015432_pub2_data","3::2::Number of children who required rescue medication, from 24 hours up to 7 days","No usable data for effect sizes"
"CD015432_pub2_data","4::1::Adverse events","No usable data for effect sizes"
"CD015432_pub2_data","4::2::Number of children who required rescue medication less than 2 hours postintervention","No usable data for effect sizes"
"CD015432_pub2_data","4::3::Number of children who required rescue medication 2 hours to less than 24 hours postintervention","No usable data for effect sizes"
"CD015432_pub2_data","4::4::Opioid consumption, 2 hours to less than 24 hours postintervention","No usable data for effect sizes"
"CD015432_pub2_data","4::5::Time to rescue medication, as reported by a third party, e.g. parents and caregivers","No usable data for effect sizes"
"CD015432_pub2_data","4::6::Nausea or vomiting ","No usable data for effect sizes"
"CD015432_pub2_data","4::7::Any bleeding, including gastrointestinal bleeding and oral bleeding","No usable data for effect sizes"
"CD015432_pub2_data","5::1::Number of children who required rescue medication 2 hours to less than 24 hours postintervention","No usable data for effect sizes"
"CD015432_pub2_data","5::2::Number of children who required rescue medication from 24 hours to 7 days postintervention","No usable data for effect sizes"
"CD015432_pub2_data","6::1::Number of children who required rescue medication less than 2 hours postintervention","No usable data for effect sizes"
"CD015432_pub2_data","6::2::Nausea or vomiting ","No usable data for effect sizes"
"CD015432_pub2_data","6::3::Any bleeding, including gastrointestinal bleeding and oral bleeding","No usable data for effect sizes"
"CD015432_pub2_data","7::1::Number of children who required rescue medication less than 2 hours postintervention","No usable data for effect sizes"
"CD015443_pub2_data","1::1::Relapse (12 months)","No usable data for effect sizes"
"CD015443_pub2_data","3::3::New gadolinium-enhancing positive T1-weighted MRI lesions (36 months)","No usable data for effect sizes"
"CD015443_pub2_data","3::4::New or enlarging T2-weighted MRI lesions (12 months)","No usable data for effect sizes"
"CD015443_pub2_data","3::6::New or enlarging T2-weighted MRI lesions (36 months)","No usable data for effect sizes"
"CD015443_pub2_data","3::7::QoL total (MSIS-29) ","No usable data for effect sizes"
"CD015443_pub2_data","3::8::QoL Mental (SF-36)","No usable data for effect sizes"
"CD015448_pub2_data","1::2::Mean change from baseline in symptom scores at 6 months","No usable data for effect sizes"
"CD015448_pub2_data","1::5::Mean change from baseline in meibomian gland atrophy at 3 months","No usable data for effect sizes"
"CD015448_pub2_data","1::7::Mean change from baseline in non-invasive tear film breakup time at 4 weeks","No usable data for effect sizes"
"CD015448_pub2_data","2::2::Mean change from baseline in symptom scores at 12 months","No usable data for effect sizes"
"CD015448_pub2_data","2::5::Mean change from baseline in meibomian gland atrophy at 2 months","No usable data for effect sizes"
"CD015448_pub2_data","3::1::Mean change from baseline in symptom scores at 1 week","No usable data for effect sizes"
"CD015448_pub2_data","3::2::Mean change from baseline in symptom scores at 6 months","No usable data for effect sizes"
"CD015448_pub2_data","3::3::Mean change from baseline in meibomian gland expression scores at 1 week","No usable data for effect sizes"
"CD015448_pub2_data","4::1::Mean change from baseline in symptom scores at 42 days","No usable data for effect sizes"
"CD015448_pub2_data","4::2::Mean change from baseline in meibomian gland expression scores at 42 days","No usable data for effect sizes"
"CD015448_pub2_data","4::3::Mean change from baseline in meibum quality scores at 42 days","No usable data for effect sizes"
"CD015448_pub2_data","5::1::Mean change from baseline in symptom scores at 3 months","No usable data for effect sizes"
"CD015448_pub2_data","5::2::Mean change from baseline in meibomian gland expression scores at 3 months","No usable data for effect sizes"
"CD015448_pub2_data","5::3::Mean change from baseline in tear film breakup time at 3 months","No usable data for effect sizes"
"CD015462_pub2_data","1::2::Moderate to severe neurodevelopmental disability at 18 to 26 months - developmental delay more than two SDs below population mean on a standardized test of development: cognitive","No usable data for effect sizes"
"CD015462_pub2_data","1::3::Moderate to severe neurodevelopmental disability at 18 to 26 months - developmental delay more than two SDs below population mean on a standardized test of development: language","No usable data for effect sizes"
"CD015462_pub2_data","1::4::Moderate to severe neurodevelopmental disability at 18 to 26 months - developmental delay more than two SDs below population mean on a standardized test of development: motor","No usable data for effect sizes"
"CD015462_pub2_data","1::6::Side effects (tachycardia, agitation, or feed intolerance) leading to a reduction in dose or withholding of methylxanthines","No usable data for effect sizes"
"CD015462_pub2_data","1::11::Apnea: number of infants with at least one episode (defined as interruption of breathing for more than 20 seconds) after 24 hours of commencing treatment after one week","No usable data for effect sizes"
"CD015462_pub2_data","1::12::Number of days of respiratory support (mechanical ventilation; continuous positive airway pressure [CPAP]; high-flow nasal cannula; non-invasive positive-pressure ventilation [NIPPV])","No usable data for effect sizes"
"CD015462_pub2_data","1::14::Intraventricular hemorrhage on brain ultrasound (any; and severe [Papile grade 3 to 4])","No usable data for effect sizes"
"CD015462_pub2_data","1::15::Periventricular leukomalacia","No usable data for effect sizes"
"CD015495_data","2::1::Treatment-related adverse events ≥ grade 3, in people aged 65 years and older, at any time point","No usable data for effect sizes"
"CD015495_data","2::2::Treatment-related adverse events ≥ grade 3 for people aged 65 to 75 years, inclusive, at any time point","No usable data for effect sizes"
"CD015495_data","4::2::Objective response rate for people aged 65 to 75 years, inclusive, at any time point","No usable data for effect sizes"
"CD015514_pub2_data","1::1::Proportion of eyes with retinal displacement at 6 months","No usable data for effect sizes"
"CD015514_pub2_data","1::6::Quality of life score - NEI-VFQ","No usable data for effect sizes"
"CD015517_data","1::2::CRF at greater than 12 weeks to less than 6 months after the intervention","No usable data for effect sizes"
"CD015517_data","1::5::QoL at greater than 12 weeks to less than 6 months after the intervention","No usable data for effect sizes"
"CD015517_data","1::8::Anxiety ≥ 6 months after the intervention","No usable data for effect sizes"
"CD015517_data","1::10::Depression ≥ 6 months after the intervention","No usable data for effect sizes"
"CD015517_data","8::4::QoL at 6 months or greater after the intervention","No usable data for effect sizes"
"CD015517_data","8::5::Adverse events","No usable data for effect sizes"
"CD015517_data","8::7::Anxiety ≥ 6 months after the intervention","No usable data for effect sizes"
"CD015517_data","8::9::Depression ≥ 6 months after the intervention","No usable data for effect sizes"
"CD015518_data","1::2::Cancer-related fatigue > 12 weeks to < 6 months","No usable data for effect sizes"
"CD015518_data","1::3::Cancer-related fatigue ≥ 6 months","No usable data for effect sizes"
"CD015518_data","1::5::Quality of life > 12 weeks to < 6 months","No usable data for effect sizes"
"CD015518_data","1::6::Quality of life ≥ 6 months","No usable data for effect sizes"
"CD015518_data","1::8::Depression ≥ 6 months","No usable data for effect sizes"
"CD015518_data","1::9::Anxiety ≤ 12 weeks","No usable data for effect sizes"
"CD015518_data","1::10::Anxiety ≥ 6 months","No usable data for effect sizes"
"CD015518_data","7::3::Depression ≤ 12 weeks","No usable data for effect sizes"
"CD015518_data","7::4::Anxiety ≤ 12 weeks","No usable data for effect sizes"
"CD015519_pub2_data","1::2::CRF  ≥ 6 months","No usable data for effect sizes"
"CD015519_pub2_data","1::4::QoL ≥ 6 months","No usable data for effect sizes"
"CD015519_pub2_data","1::6::Depression ≥ 6 months ","No usable data for effect sizes"
"CD015519_pub2_data","1::7::Anxiety ≤ 12 weeks","No usable data for effect sizes"
"CD015519_pub2_data","1::8::Anxiety ≥ 6 months","No usable data for effect sizes"
"CD015519_pub2_data","4::1::Cancer-related fatigue (CRF) ≤ 12 weeks","No usable data for effect sizes"
"CD015519_pub2_data","4::2::Quality of life (QoL) ≤ 12 weeks","No usable data for effect sizes"
"CD015520_data","1::2::CRF > 12 weeks to < 6 months","No usable data for effect sizes"
"CD015520_data","1::7::Depression > 12 weeks to < 6 months ","No usable data for effect sizes"
"CD015520_data","1::8::Depression ≥  6 months","No usable data for effect sizes"
"CD015520_data","1::10::Anxiety > 12 weeks to < 6 months ","No usable data for effect sizes"
"CD015520_data","1::11::Anxiety  ≥ 6 months","No usable data for effect sizes"
"CD015520_data","5::2::CRF > 12 weeks to < 6 months ","No usable data for effect sizes"
"CD015520_data","5::4::QoL > 12 weeks to < 6 months ","No usable data for effect sizes"
"CD015520_data","5::6::Depression > 12 weeks to < 6 months ","No usable data for effect sizes"
"CD015520_data","5::8::Anxiety > 12 weeks to < 6 months ","No usable data for effect sizes"
"CD015524_pub2_data","1::7::Analysis 1.7. Outcome 4: GGT (U/L)","No usable data for effect sizes"
"CD015524_pub2_data","1::25::Analysis 1.25. Outcome 13: Proportion of participants without improvement of LSM","No usable data for effect sizes"
"CD015524_pub2_data","1::34::Analysis 1.34. Outcome 18: FBS (mmol/L)","No usable data for effect sizes"
"CD015524_pub2_data","2::1::Analysis 2.1. Outcome 1: Proportion of participants with serious adverse events","No usable data for effect sizes"
"CD015524_pub2_data","2::6::Analysis 2.6. Outcome 4: GGT (U/L)","No usable data for effect sizes"
"CD015524_pub2_data","2::7::Analysis 2.7. Outcome 5: Proportion of participants with non-serious adverse events","No usable data for effect sizes"
"CD015524_pub2_data","2::12::Analysis 2.12. Outcome 8: HDL cholesterol (mmol/L) ","No usable data for effect sizes"
"CD015524_pub2_data","2::13::Analysis 2.13. Outcome 9: LDL cholesterol (mmol/L) ","No usable data for effect sizes"
"CD015524_pub2_data","3::11::Analysis 3.11. Outcome 6: Proportion of participants without normalisation of ALT","No usable data for effect sizes"
"CD015524_pub2_data","3::12::Analysis 3.12. Outcome 7: Proportion of participants without normalisation of AST","No usable data for effect sizes"
"CD015524_pub2_data","3::13::Analysis 3.13. Outcome 8: Proportion of participants without improvement of the ultrasound","No usable data for effect sizes"
"CD015524_pub2_data","4::4::Analysis 4.4. Outcome 4: GGT (U/L)","No usable data for effect sizes"
"CD015524_pub2_data","4::13::Analysis 4.13. Outcome 10: FBS (mmol/L)","No usable data for effect sizes"
"CD015524_pub2_data","4::14:: Analysis 4.14. Outcome 11: HOMA-IR","No usable data for effect sizes"
"CD015524_pub2_data","4::15::Analysis 4.15. Outcome 12: Insulin (pmol/L)","No usable data for effect sizes"
"CD015524_pub2_data","4::16::Analysis 4.16. Outcome 13: Weight (kg)","No usable data for effect sizes"
"CD015524_pub2_data","4::17::Analysis 4.17. Outcome 14: BMI (kg/m2)","No usable data for effect sizes"
"CD015524_pub2_data","4::18::Analysis 4.18. Outcome 15: WC (cm)","No usable data for effect sizes"
"CD015526_pub2_data","1::1::Dialysis dysequilibrium syndrome","No usable data for effect sizes"
"CD015526_pub2_data","1::2::Severe dialysis dysequilibrium syndrome","No usable data for effect sizes"
"CD015526_pub2_data","1::3::Death","No usable data for effect sizes"
"CD015526_pub2_data","1::4::Adverse events","No usable data for effect sizes"
"CD015526_pub2_data","2::1::Dialysis disequilibrium syndrome","No usable data for effect sizes"
"CD015526_pub2_data","2::2::Severe dialysis dysequilibrium syndrome","No usable data for effect sizes"
"CD015526_pub2_data","2::3::Death","No usable data for effect sizes"
"CD015526_pub2_data","2::4::Adverse events","No usable data for effect sizes"
"CD015530_pub2_data","1::2::All-cause mortality (up to 28 days after final dose)","No usable data for effect sizes"
"CD015530_pub2_data","1::4::Serious adverse events (up to 12 months after final dose)","No usable data for effect sizes"
"CD015530_pub2_data","1::6::Serious adverse events (up to 6 months after final dose)","No usable data for effect sizes"
"CD015530_pub2_data","1::7::Adverse events of special interest - injection site adverse events (up to 28 days after final dose)","No usable data for effect sizes"
"CD015530_pub2_data","1::8::Adverse events of special interest - injection site adverse events (up to 7 days post vaccination)","No usable data for effect sizes"
"CD015530_pub2_data","1::9::Adverse events of special interest - systemic adverse events (up to 28 days after final dose)","No usable data for effect sizes"
"CD015530_pub2_data","1::10::Adverse events of special interest - systemic adverse events (up to 7 days post vaccination)","No usable data for effect sizes"
"CD015530_pub2_data","2::1::Incidence of COVID-19 (up to 6 months after second dose) ","No usable data for effect sizes"
"CD015530_pub2_data","2::2::Adverse events of any grade (up to 6 months after second dose)","No usable data for effect sizes"
"CD015530_pub2_data","2::3::Serious adverse events (up to 6 months after second dose)","No usable data for effect sizes"
"CD015530_pub2_data","3::1::Incidence of COVID-19 (up to median 3.1 months from vaccination)","No usable data for effect sizes"
"CD015530_pub2_data","4::1::Incidence of influenza (within the 2015 to 2016 flu season)","No usable data for effect sizes"
"CD015532_data","1::1::Overall mortality","No usable data for effect sizes"
"CD015532_data","1::2::Duration to liberation from invasive mechanical ventilation","No usable data for effect sizes"
"CD015532_data","1::3::Adverse events","No usable data for effect sizes"
"CD015532_data","1::4::Ventilator-associated pneumonia","No usable data for effect sizes"
"CD015532_data","1::5::Postoperative bleeding","No usable data for effect sizes"
"CD015532_data","1::6::Airway obstruction","No usable data for effect sizes"
"CD015532_data","1::7::ICU length of stay","No usable data for effect sizes"
"CD015532_data","2::2::28-day (± 2) mortality","No usable data for effect sizes"
"CD015532_data","2::3::90-day mortality","No usable data for effect sizes"
"CD015532_data","2::5::Duration to liberation from invasive mechanical ventilation","No usable data for effect sizes"
"CD015532_data","2::6::Duration to decannulation","No usable data for effect sizes"
"CD015532_data","2::7::Postoperative bleeding","No usable data for effect sizes"
"CD015532_data","2::8::Tracheal stenosis","No usable data for effect sizes"
"CD015532_data","2::9::Ventilatory problems","No usable data for effect sizes"
"CD015532_data","3::10::Need for renal replacement therapy","No usable data for effect sizes"
"CD015532_data","3::13::Ventilatory problems","No usable data for effect sizes"
"CD015532_data","3::14::ICU length of stay","No usable data for effect sizes"
"CD015532_data","3::15::Hospital length of stay","No usable data for effect sizes"
"CD015532_data","4::9::Adverse events","No usable data for effect sizes"
"CD015532_data","4::11::Need for renal replacement therapy","No usable data for effect sizes"
"CD015532_data","4::13::Airway obstruction","No usable data for effect sizes"
"CD015532_data","4::18::Hospital length of stay","No usable data for effect sizes"
"CD015536_pub2_data","3::3::Proportion of people with serious adverse events (restricting the analysis to trials at low risk of bias)","No usable data for effect sizes"
"CD015551_pub2_data","1::1::Incidence of herpes zoster (up to 29.4 months after final dose)","No usable data for effect sizes"
"CD015551_pub2_data","2::1::All-cause mortality (up to 15 days post-surgery)","No usable data for effect sizes"
"CD015551_pub2_data","2::2::Any-grade adverse events (up to 15 days post-surgery)","No usable data for effect sizes"
"CD015551_pub2_data","2::3::Serious adverse events (up to 15 days post-surgery)","No usable data for effect sizes"
"CD015551_pub2_data","3::1::Incidence of influenza (within 7 months)","No usable data for effect sizes"
"CD015551_pub2_data","3::2::All-cause mortality (from 180 days to 3 years post-surgery) (hazard ratio)","No usable data for effect sizes"
"CD015551_pub2_data","3::3::Any-grade adverse events (up to 118 days after final dose)","No usable data for effect sizes"
"CD015551_pub2_data","4::1::Incidence of COVID-19 without previous infection (up to 6 months after second dose) ","No usable data for effect sizes"
"CD015551_pub2_data","4::2::Incidence of COVID-19 with and without previous infection (up to 6 months after second dose) ","No usable data for effect sizes"
"CD015551_pub2_data","4::3::Any-grade adverse events (up to 6 months after second dose)","No usable data for effect sizes"
"CD015551_pub2_data","4::4::Serious adverse events (up to 6 months after second dose)","No usable data for effect sizes"
"CD015551_pub2_data","5::1::Incidence of COVID-19 (up to 16.3 months after at least one dose) ","No usable data for effect sizes"
"CD015551_pub2_data","5::2::All-cause mortality (up to 16.3 months after at least one dose) ","No usable data for effect sizes"
"CD015573_data","1::1::Recurrence","No usable data for effect sizes"
"CD015573_data","1::2::Minor complications of treatment","No usable data for effect sizes"
"CD015573_data","2::1::Recurrence","No usable data for effect sizes"
"CD015584_pub2_data","2::3::Need for adjunctive placement measures: analgesia","No usable data for effect sizes"
"CD015588_pub2_data","1::9::Fatal myocardial infarction","No usable data for effect sizes"
"CD015588_pub2_data","1::24::Heart failure","No usable data for effect sizes"
"CD015588_pub2_data","1::30::Creatinine clearance","No usable data for effect sizes"
"CD015588_pub2_data","1::35::Albuminuria progression (Hazard Ratio)","No usable data for effect sizes"
"CD015588_pub2_data","1::36::Moderately increased albuminuria (normo- to microalbuminuria)","No usable data for effect sizes"
"CD015588_pub2_data","1::37::Severely increased albuminuria (micro- to macroalbuminuria)","No usable data for effect sizes"
"CD015588_pub2_data","1::38::Albuminuria regression (Hazard Ratio)","No usable data for effect sizes"
"CD015588_pub2_data","1::39::Micro- to normoalbuminuria","No usable data for effect sizes"
"CD015588_pub2_data","1::40::Macro- to normoalbuminuria","No usable data for effect sizes"
"CD015588_pub2_data","1::41::Macro- to microalbuminuria","No usable data for effect sizes"
"CD015588_pub2_data","2::3::Hospitalisation due to heart failure","No usable data for effect sizes"
"CD015588_pub2_data","2::4::Hypoglycaemia requiring third-party assistance","No usable data for effect sizes"
"CD015588_pub2_data","2::5::Withdrawn due to adverse events","No usable data for effect sizes"
"CD015588_pub2_data","2::6::Amputation","No usable data for effect sizes"
"CD015588_pub2_data","2::7::Genital infection","No usable data for effect sizes"
"CD015588_pub2_data","3::1::All-cause death","No usable data for effect sizes"
"CD015588_pub2_data","3::2::Cardiovascular death","No usable data for effect sizes"
"CD015588_pub2_data","3::3::Hypoglycaemia","No usable data for effect sizes"
"CD015588_pub2_data","3::4::Hypoglycaemia requiring third-party assistance","No usable data for effect sizes"
"CD015588_pub2_data","3::5::HbA1c","No usable data for effect sizes"
"CD015588_pub2_data","3::6::Genital mycotic infection","No usable data for effect sizes"
"CD015588_pub2_data","4::1::All-cause death","No usable data for effect sizes"
"CD015588_pub2_data","4::2::Cardiovascular death","No usable data for effect sizes"
"CD015588_pub2_data","4::3::HbA1c","No usable data for effect sizes"
"CD015588_pub2_data","4::4::Withdrawn due to adverse events","No usable data for effect sizes"
"CD015588_pub2_data","5::1::All-cause death","No usable data for effect sizes"
"CD015588_pub2_data","5::2::Hypoglycaemia requiring third-party assistance","No usable data for effect sizes"
"CD015588_pub2_data","5::3::Withdrawn due to adverse events","No usable data for effect sizes"
"CD015588_pub2_data","5::4::Amputation","No usable data for effect sizes"
"CD015588_pub2_data","5::5::Fracture","No usable data for effect sizes"
"CD015588_pub2_data","5::6::Genital infection","No usable data for effect sizes"
"CD015588_pub2_data","5::7::Diabetic ketoacidosis","No usable data for effect sizes"
"CD015588_pub2_data","6::1::All-cause death","No usable data for effect sizes"
"CD015588_pub2_data","6::2::Cardiovascular death","No usable data for effect sizes"
"CD015588_pub2_data","6::3::eGFR","No usable data for effect sizes"
"CD015592_pub3_data","1::3::Time to perform the lumbar puncture","No usable data for effect sizes"
"CD015592_pub3_data","2::1::Successful lumbar puncture procedure at the first attempt","No usable data for effect sizes"
"CD015594_pub2_data","1::2::Apnea: occurrence of one or more episodes","No usable data for effect sizes"
"CD015636_pub2_data","1::1::All serotypes","No usable data for effect sizes"
"CD015636_pub2_data","3::1::Hospitalizations due to DF or DHF","No usable data for effect sizes"
"CD015673_pub2_data","1::11::Alcohol-related consequences","No usable data for effect sizes"
"CD015673_pub2_data","2::1::Number of participants with continuous abstinence","No usable data for effect sizes"
"CD015673_pub2_data","2::2::Number of heavy-drinking participants","No usable data for effect sizes"
"CD015673_pub2_data","2::4::Number of drinks per drinking day","No usable data for effect sizes"
"CD015673_pub2_data","3::1::Number of heavy-drinking participants","No usable data for effect sizes"
"CD015673_pub2_data","3::2::% Abstinent days","No usable data for effect sizes"
"CD015673_pub2_data","3::4::Dropouts due to adverse events","No usable data for effect sizes"
"CD015698_pub2_data","1::4::Disease-free survival","No usable data for effect sizes"
"CD015698_pub2_data","1::6::Intra-abdominal abscess","No usable data for effect sizes"
"CD015698_pub2_data","2::2::Overall survival (Sensitivity analysis: Excluding studies with overall high risk of bias)","No usable data for effect sizes"
"CD015698_pub2_data","2::3::Serious adverse events","No usable data for effect sizes"
"CD015698_pub2_data","2::4::Grade III-V toxicities","No usable data for effect sizes"
"CD015698_pub2_data","2::6::&nbsp;Anastomotic leakage (Sensitivity analysis: Excluding studies with overall high risk of bias)","No usable data for effect sizes"
"CD015701_pub2_data","1::2::Pregnancy","No usable data for effect sizes"
"CD015701_pub2_data","1::3::Discontinuation of method","No usable data for effect sizes"
"CD015701_pub2_data","1::5::Adverse events","No usable data for effect sizes"
"CD015701_pub2_data","2::1::HIV acquisition","No usable data for effect sizes"
"CD015701_pub2_data","2::2::Pregnancy","No usable data for effect sizes"
"CD015701_pub2_data","2::3::Discontinuation of method","No usable data for effect sizes"
"CD015701_pub2_data","2::5::Adverse events","No usable data for effect sizes"
"CD015701_pub2_data","3::1::HIV acquisition","No usable data for effect sizes"
"CD015701_pub2_data","3::2::Pregnancy","No usable data for effect sizes"
"CD015701_pub2_data","3::3::Discontinuation of method","No usable data for effect sizes"
"CD015701_pub2_data","3::5::Adverse events","No usable data for effect sizes"
"CD015701_pub2_data","4::1::HIV acquisition","No usable data for effect sizes"
"CD015701_pub2_data","4::2::Pregnancy","No usable data for effect sizes"
"CD015711_pub2_data","1::1::Spectacle independence for near vision","No usable data for effect sizes"
"CD015711_pub2_data","1::2::Spectacle independence for intermediate vision","No usable data for effect sizes"
"CD015711_pub2_data","1::3::Proportion of overall patient satisfaction with the procedure and its results","No usable data for effect sizes"
"CD015711_pub2_data","1::4::Frequency of any ocular AE","No usable data for effect sizes"
"CD015711_pub2_data","1::5::Proportion of participants who required further procedures","No usable data for effect sizes"
"CD015711_pub2_data","2::1::Spectacle independence for near vision","No usable data for effect sizes"
"CD015711_pub2_data","2::2::Spectacle independence for intermediate vision","No usable data for effect sizes"
"CD015711_pub2_data","2::3::Proportion of participants achieving 0.0 LogMAR or better for distance vision","No usable data for effect sizes"
"CD015711_pub2_data","2::4::Proportion of participants achieving 0.2 LogMAR or better for near vision","No usable data for effect sizes"
"CD015711_pub2_data","2::5::Proportion of overall patient satisfaction with the procedure and its results","No usable data for effect sizes"
"CD015711_pub2_data","2::6::Frequency of any ocular AE","No usable data for effect sizes"
"CD015711_pub2_data","3::1::Change in quality of life","No usable data for effect sizes"
"CD015746_pub2_data","2::1::Acute typhoid fever","No usable data for effect sizes"
"CD015746_pub2_data","6::1::Serious adverse events sensitivity analysis for risk of bias or trial phase","No usable data for effect sizes"
"CD015746_pub2_data","8::1::Acute typhoid fever 12 months post vaccination","No usable data for effect sizes"
"CD015746_pub2_data","8::3::Acute typhoid fever ≥ two years post vaccination","No usable data for effect sizes"
"CD015749_pub2_data","1::2::Occurrence of adverse events","No usable data for effect sizes"
"CD015749_pub2_data","1::4::Appetite","No usable data for effect sizes"
"CD015749_pub2_data","1::5::Fatigue","No usable data for effect sizes"
"CD015749_pub2_data","1::6::Biochemical markers ","No usable data for effect sizes"
"CD015749_pub2_data","2::6::Fatigue","No usable data for effect sizes"
"CD015749_pub2_data","2::8::Survival","No usable data for effect sizes"
"CD015749_pub2_data","3::6::Fatigue","No usable data for effect sizes"
"CD015779_data","1::2::Progression of rheumatic heart disease (latent RHD) ","No usable data for effect sizes"
"CD015779_data","1::3::Progression of rheumatic heart disease (late-stage RHD)","No usable data for effect sizes"
"CD015779_data","1::4::Cardiac complications","No usable data for effect sizes"
"CD015779_data","1::5::All-cause mortality (latent RHD)","No usable data for effect sizes"
"CD015779_data","1::6::All-cause mortality (late-stage RHD)","No usable data for effect sizes"
"CD015779_data","1::7::Adverse events: anaphylaxis","No usable data for effect sizes"
"CD015779_data","1::8::Adverse events: sciatic nerve injury","No usable data for effect sizes"
"CD015779_data","1::10::Adverse events: local reactions to injection","No usable data for effect sizes"
"CD015779_data","2::3::Progression of rheumatic heart disease ","No usable data for effect sizes"
"CD015779_data","2::4::All-cause mortality","No usable data for effect sizes"
"CD015786_pub2_data","2::1::Overall survival","No usable data for effect sizes"
"CD015786_pub2_data","2::2::Progression (disease)-free survival","No usable data for effect sizes"
"CD015786_pub2_data","2::3::Quality of life (functional) 6 months postsurgery","No usable data for effect sizes"
"CD015786_pub2_data","2::4::Quality of life (functional) 12 months postsurgery","No usable data for effect sizes"
"CD015786_pub2_data","3::2::Late adverse effects","No usable data for effect sizes"
"CD015790_pub2_data","1::13::Reading speed","No usable data for effect sizes"
"CD015802_pub2_data","1::1::Intermittent hypoxemia (IH): number of episodes in the 7 days after treatment discontinued","No usable data for effect sizes"
"CD015802_pub2_data","1::2::All-cause mortality prior to hospital discharge","No usable data for effect sizes"
"CD015802_pub2_data","2::2::IH: number of infants with at least 1 episode in the 7 days after treatment discontinued","No usable data for effect sizes"
"CD015804_pub2_data","1::5::Proportion of participants with a visual acuity Snellen equivalent of 20/40 or better at 24 to 48 weeks","No usable data for effect sizes"
"CD015804_pub2_data","1::12::Mean trough serum concentration after first injection (pg/mL)","No usable data for effect sizes"
"CD015820_pub2_data","1::2::Subjective adherence (3 to 6 months) - subjective physician assessment % adherence","No usable data for effect sizes"
"CD015820_pub2_data","1::3::Subjective adherence (3 to 6 months) - 8‐Item Medication Adherence Scale self-reported questionnaire","No usable data for effect sizes"
"CD015820_pub2_data","1::4::Total hours of adherence (Baseline to 3 months)","No usable data for effect sizes"
"CD015820_pub2_data","1::5::Visual acuity (1 week to 3 months)","No usable data for effect sizes"
"CD015820_pub2_data","1::6::Visual acuity > 4 months - Proportion of participants with significant change","No usable data for effect sizes"
"CD015820_pub2_data","1::7::Stereoacuity (1 week to 3 months)","No usable data for effect sizes"
"CD015820_pub2_data","1::8::Adverse events","No usable data for effect sizes"
"CD015820_pub2_data","2::1::Objective adherence (1 week to 3 months)","No usable data for effect sizes"
"CD015820_pub2_data","2::2::Visual acuity (at 3 months) - percentage of visual deficit corrected","No usable data for effect sizes"
"CD015820_pub2_data","2::3::Adverse events","No usable data for effect sizes"
"CD015820_pub2_data","3::1::Objective adherence (1 week to 3 months)","No usable data for effect sizes"
"CD015820_pub2_data","3::2::Subjective adherence (1 week to 3 months) - 5-point scale","No usable data for effect sizes"
"CD015820_pub2_data","3::4::Stereoacuity (1 week to 10 weeks)","No usable data for effect sizes"
"CD015820_pub2_data","3::5::Stereoacuity (baseline to 3 months)","No usable data for effect sizes"
"CD015820_pub2_data","4::1::Subjective adherence (4 to 6 months)","No usable data for effect sizes"
"CD015820_pub2_data","4::2::Visual acuity (1 week to 3 months)","No usable data for effect sizes"
"CD015820_pub2_data","4::3::Visual acuity (4 to 6 months)","No usable data for effect sizes"
"CD015820_pub2_data","4::4::Adverse events","No usable data for effect sizes"
"CD015824_pub2_data","2::3::Hospitalisation","No usable data for effect sizes"
"CD015824_pub2_data","3::7::Change from baseline in Borg Dyspnea Scale","No usable data for effect sizes"
"CD015849_pub2_data","1::7::4-point MACE","No usable data for effect sizes"
"CD015849_pub2_data","1::10::Kidney failure (Hazard ratio)","No usable data for effect sizes"
"CD015849_pub2_data","1::14::Severe hypoglycaemia (Hazard ratio)","No usable data for effect sizes"
"CD015849_pub2_data","1::15::Nonfatal myocardial infarction","No usable data for effect sizes"
"CD015849_pub2_data","1::17::Fatal myocardial infarction","No usable data for effect sizes"
"CD015849_pub2_data","1::20::All myocardial infarction (Hazard ratio)","No usable data for effect sizes"
"CD015849_pub2_data","1::21::Nonfatal stroke","No usable data for effect sizes"
"CD015849_pub2_data","1::24::Fatal or nonfatal stroke (Hazard ratio)","No usable data for effect sizes"
"CD015849_pub2_data","1::25::Ischaemic stroke","No usable data for effect sizes"
"CD015849_pub2_data","1::26::Haemorrhagic stroke","No usable data for effect sizes"
"CD015849_pub2_data","1::27::Heart failure","No usable data for effect sizes"
"CD015849_pub2_data","1::30::Change in eGFR [%]","No usable data for effect sizes"
"CD015849_pub2_data","1::31::Increased urinary albumin-creatinine ratio","No usable data for effect sizes"
"CD015849_pub2_data","1::32::Body weight [kg]","No usable data for effect sizes"
"CD015849_pub2_data","1::33::Change in body weight [kg]","No usable data for effect sizes"
"CD015849_pub2_data","1::35::BMI [kg/m2]","No usable data for effect sizes"
"CD015849_pub2_data","1::37::Change in BMI [kg/m2]","No usable data for effect sizes"
"CD015849_pub2_data","1::42::Lactic acidosis","No usable data for effect sizes"
"CD015849_pub2_data","1::45::Diabetic ketoacidosis","No usable data for effect sizes"
"CD015849_pub2_data","1::49::Coronary revascularisation","No usable data for effect sizes"
"CD015849_pub2_data","2::3::Urinary albumin-creatinine ratio [mg/g]","No usable data for effect sizes"
"CD015849_pub2_data","2::4::Microalbuminuria [mg/L]","No usable data for effect sizes"
"CD015849_pub2_data","2::6::BMI [kg/m2]","No usable data for effect sizes"
"CD015849_pub2_data","2::7::Serious adverse events","No usable data for effect sizes"
"CD015849_pub2_data","2::8::Withdrawal due to adverse events","No usable data for effect sizes"
"CD015849_pub2_data","2::9::Hypoglycaemia","No usable data for effect sizes"
"CD015849_pub2_data","2::10::Acute kidney injury","No usable data for effect sizes"
"CD015849_pub2_data","2::12::Change in HbA1c [%]","No usable data for effect sizes"
"CD015849_pub2_data","3::1::All-cause death","No usable data for effect sizes"
"CD015849_pub2_data","3::2::Cardiovascular death","No usable data for effect sizes"
"CD015849_pub2_data","3::3::Severe hypoglycaemia","No usable data for effect sizes"
"CD015849_pub2_data","3::4::Fatal stroke","No usable data for effect sizes"
"CD015849_pub2_data","3::5::Serious adverse events","No usable data for effect sizes"
"CD015849_pub2_data","3::6::Withdrawal due to adverse events","No usable data for effect sizes"
"CD015849_pub2_data","3::7::Hypoglycaemia","No usable data for effect sizes"
"CD015849_pub2_data","4::1::All-cause death","No usable data for effect sizes"
"CD015849_pub2_data","4::2::All-cause death (Hazard ratio)","No usable data for effect sizes"
"CD015849_pub2_data","4::3::Cardiovascular death","No usable data for effect sizes"
"CD015849_pub2_data","4::4::Cardiovascular death (Hazard ratio)","No usable data for effect sizes"
"CD015849_pub2_data","4::5::Kidney failure","No usable data for effect sizes"
"CD015849_pub2_data","4::7::Myocardial infarction","No usable data for effect sizes"
"CD015849_pub2_data","4::8::Heart failure","No usable data for effect sizes"
"CD015849_pub2_data","4::10::Change in eGFR [%]","No usable data for effect sizes"
"CD015849_pub2_data","4::11::eGFR loss","No usable data for effect sizes"
"CD015849_pub2_data","4::12::Change in creatinine clearance [mL/min]","No usable data for effect sizes"
"CD015849_pub2_data","4::13::Urinary albumin-creatinine ratio [%]","No usable data for effect sizes"
"CD015849_pub2_data","4::14::Urinary albumin-creatinine ratio [mg/g]","No usable data for effect sizes"
"CD015849_pub2_data","4::15::Urinary albumin excretion rate [%]","No usable data for effect sizes"
"CD015849_pub2_data","4::16::Urinary albumin excretion rate [mg/24 h]","No usable data for effect sizes"
"CD015849_pub2_data","4::18::Change in body weight [kg]","No usable data for effect sizes"
"CD015849_pub2_data","4::19::Body weight increase","No usable data for effect sizes"
"CD015849_pub2_data","4::21::Withdrawal due to adverse events","No usable data for effect sizes"
"CD015849_pub2_data","4::26::Change in HbA1c [mmol/mol]","No usable data for effect sizes"
"CD015849_pub2_data","4::27::Ischaemic stroke","No usable data for effect sizes"
"CD015849_pub2_data","5::1::All-cause death","No usable data for effect sizes"
"CD015849_pub2_data","5::2::Cardiovascular death","No usable data for effect sizes"
"CD015849_pub2_data","5::3::Withdrawal due to adverse events","No usable data for effect sizes"
"CD015849_pub2_data","5::4::HbA1c [%]","No usable data for effect sizes"
"CD015849_pub2_data","5::5::Body weight [kg]","No usable data for effect sizes"
"CD015849_pub2_data","5::6::BMI [kg/m2]","No usable data for effect sizes"
"CD015849_pub2_data","6::1::All-cause death","No usable data for effect sizes"
"CD015849_pub2_data","6::2::Cardiovascular death","No usable data for effect sizes"
"CD015849_pub2_data","6::3::Withdrawal due to adverse events","No usable data for effect sizes"
"CD015849_pub2_data","6::4::Acute kidney injury","No usable data for effect sizes"
"CD015849_pub2_data","9::4::Cardiovascular death (Hazard ratio) ","No usable data for effect sizes"
"CD015849_pub2_data","9::7::4-point MACE (Hazard ratio)","No usable data for effect sizes"
"CD015849_pub2_data","9::9::Composite kidney outcome (Hazard ratio)","No usable data for effect sizes"
"CD015849_pub2_data","9::11::Myocardial infarction","No usable data for effect sizes"
"CD015849_pub2_data","9::12::Fatal or nonfatal stroke","No usable data for effect sizes"
"CD015849_pub2_data","9::13::Hospitalisation due to heart failure","No usable data for effect sizes"
"CD015849_pub2_data","9::15::Withdrawal due to adverse events (Hazard ratio)","No usable data for effect sizes"
"CD015849_pub2_data","9::16::Acute kidney injury (Hazard ratio)","No usable data for effect sizes"
"CD015849_pub2_data","10::4::Cardiovascular death (Hazard ratio) ","No usable data for effect sizes"
"CD015849_pub2_data","10::5::3-point MACE","No usable data for effect sizes"
"CD015849_pub2_data","10::6::3-point MACE (Hazard ratio)","No usable data for effect sizes"
"CD015849_pub2_data","10::9::Myocardial infarction","No usable data for effect sizes"
"CD015849_pub2_data","10::10::Fatal or nonfatal stroke","No usable data for effect sizes"
"CD015849_pub2_data","10::11::Hospitalisation due to heart failure","No usable data for effect sizes"
"CD015849_pub2_data","10::13::Withdrawal due to adverse events (Hazard ratio)","No usable data for effect sizes"
"CD015849_pub2_data","10::14::Acute kidney injury (Hazard ratio)","No usable data for effect sizes"
"CD015849_pub2_data","11::1::HbA1c  [%]","No usable data for effect sizes"
"CD015854_data","1::1::Achievement of definitions of improvement (assessed with IMACS DOI, measured at 8 weeks) ","No usable data for effect sizes"
"CD015854_data","1::2::Withdrawals for either lack of benefit or adverse events","No usable data for effect sizes"
"CD015854_data","2::5::Achievement of definitions of improvement (assessed with moderate or major improvement on Total Improvement Score (TIS))","No usable data for effect sizes"
"CD015854_data","3::1::Improvement of function or disability (assessed with change in Health Assessment Questionnaire) ","No usable data for effect sizes"
"CD015854_data","3::2::Improvement in function or disability (assessed with change in triple Timed Up and Go test; 3TUG) ","No usable data for effect sizes"
"CD015854_data","3::3::Improvement in muscle strength (assessed with change in muscle strength score) ","No usable data for effect sizes"
"CD015854_data","3::4::Achievement of definitions of improvement (assessed with minimal improvement on Total Improvement Score (TIS), measured at 8 weeks)","No usable data for effect sizes"
"CD015854_data","5::2::Serious adverse event","No usable data for effect sizes"
"CD015854_data","5::3::Withdrawals for either lack of benefit or adverse events","No usable data for effect sizes"
"CD015854_data","6::1::Improvement of function or disability (assessed with change in disability according to PROMIS physical function)","No usable data for effect sizes"
"CD015854_data","6::3::Change in skin disease activity (assessed with clinically meaningful improvement in Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) activity scores)","No usable data for effect sizes"
"CD015854_data","7::1::Serious adverse event","No usable data for effect sizes"
"CD015854_data","8::5::Achievement of definitions of improvement (assessed with IMACS DOI)","No usable data for effect sizes"
"CD015854_data","9::1::Achievement of definitions of improvement (assessed with minimal improvement on Total Improvement Score (TIS))","No usable data for effect sizes"
"CD015854_data","9::2::Serious adverse event","No usable data for effect sizes"
"CD015854_data","9::3::Withdrawals for either lack of benefit or adverse events","No usable data for effect sizes"
"CD015854_data","10::1::Improvement of function or disability (assessed with achievement of > 20% improvement on Health Assessment Questionnaire)","No usable data for effect sizes"
"CD015854_data","10::2::Improvement of function or disability (assessed with change in Health Assessment Questionnaire (HAQ))","No usable data for effect sizes"
"CD015854_data","10::4::Improvement of muscle strength (assessed with change in muscle strength (range of scale 0 to 130))","No usable data for effect sizes"
"CD015854_data","10::5::Improvement of muscle strength (assessed with change in MMT8, range 0 to 150) ","No usable data for effect sizes"
"CD015854_data","10::9::Change in skin disease activity (assessed with change in the modified Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI))","No usable data for effect sizes"
"CD015855_data","1::3::Improvement of muscle strength (assessed with achievement of meaningful improvement in muscle strength defined using the modified BMRC index) ","No usable data for effect sizes"
"CD015855_data","1::5::Achievement of definitions of improvement (assessed with minimal improvement on Total Improvement Score (TIS)) ","No usable data for effect sizes"
"CD015855_data","2::1::Improvement of muscle strength (assessed with achievement of  ≥ 15% improvement in muscle strength)","No usable data for effect sizes"
"CD015855_data","2::2::Improvement in muscle strength (assessed with change in muscle strength)","No usable data for effect sizes"
"CD015855_data","2::3::Cumulative corticosteroid dose (mg/kg)","No usable data for effect sizes"
"CD015855_data","3::1::Improvement of function or disability (assessed with change in Functional Rating Scale (FRS))","No usable data for effect sizes"
"CD015855_data","3::2::Improvement in function or disability (assessed with change in 30 metre walking time)","No usable data for effect sizes"
"CD015855_data","3::3::Improvement of muscle strength (assessed with change in Manual Muscle Testing)","No usable data for effect sizes"
"CD015855_data","4::1::Improvement in function or disability (assessed with change in 10 metre walk time)","No usable data for effect sizes"
"CD015855_data","4::2::Improvement of muscle strength (assessed with achievement of > 15% improvement in hand held myometry)","No usable data for effect sizes"
"CD015855_data","4::3::Improvement of muscle strength (assessed with mean change in summed myometry)","No usable data for effect sizes"
"CD015855_data","4::4::Cumulative corticosteroid dose ","No usable data for effect sizes"
"CD015855_data","4::5::Serious adverse event","No usable data for effect sizes"
"CD015855_data","5::1::Improvement of function or disability (assessed with change in the Functional Rating Scale (FRS))","No usable data for effect sizes"
"CD015855_data","5::2::Improvement of function or disability (assessed with change in 30 metre walking time)","No usable data for effect sizes"
"CD015855_data","5::3::Improvement of muscle strength (assessed with change in Manual Muscle Testing)","No usable data for effect sizes"
"CD015855_data","5::5::Serious adverse event","No usable data for effect sizes"
"CD015855_data","6::1::Adverse events ","No usable data for effect sizes"
"CD015855_data","6::2::Withdrawals for either lack of benefit or adverse events","No usable data for effect sizes"
"CD015855_data","7::1::Improvement of function or disability (assessed with change in Functional Rating Scale (FRS))","No usable data for effect sizes"
"CD015855_data","7::2::Improvement of function or disability (assessed with change in 30 metre walking time)","No usable data for effect sizes"
"CD015855_data","7::3::Improvement of muscle strength (assessed with change in Manual Muscle Testing)","No usable data for effect sizes"
"CD015855_data","7::4::Withdrawals for either lack of benefit or adverse events ","No usable data for effect sizes"
"CD015855_data","8::1::Improvement of function or disability (assessed with change in the Functional Rating Scale (FRS))","No usable data for effect sizes"
"CD015855_data","8::2::Improvement of function or disability (assessed with change in 30 metre walking time)","No usable data for effect sizes"
"CD015855_data","8::3::Improvement in muscle strength (assessed with change in Manual Muscle Testing) ","No usable data for effect sizes"
"CD015855_data","8::5::Serious adverse event","No usable data for effect sizes"
"CD015855_data","9::1::Improvement of function or disability (assessed with change in the Functional Rating Scale (FRS))","No usable data for effect sizes"
"CD015855_data","9::2::Improvement of function or disability (assessed with change in 30 metre walking time)","No usable data for effect sizes"
"CD015855_data","9::3::Improvement in muscle strength (assessed with change in Manual Muscle Testing) ","No usable data for effect sizes"
"CD015855_data","9::4::Withdrawals for either lack of benefit or adverse events ","No usable data for effect sizes"
"CD015855_data","10::1::Improvement of function or disability (assessed with change in the Functional Rating Scale (FRS))","No usable data for effect sizes"
"CD015855_data","10::2::Improvement of function or disability (assessed with change in 30 metre walking time)","No usable data for effect sizes"
"CD015855_data","10::3::Improvement of muscle strength (assessed with change in Manual Muscle Testing)","No usable data for effect sizes"
"CD015855_data","10::4::Withdrawals for either lack of benefit or adverse events ","No usable data for effect sizes"
"CD015855_data","11::1::Improvement in function or disability (assessed with achievement of improvement in ADL (combined evaluation of strength and function))","No usable data for effect sizes"
"CD015855_data","11::2::Adverse events","No usable data for effect sizes"
"CD015855_data","12::1::Withdrawals for either lack of benefit or adverse events ","No usable data for effect sizes"
"CD015875_data","1::5::Systolic blood pressure (mmHg) (10 to 19 years) ","No usable data for effect sizes"
"CD015875_data","1::6::Diastolic blood pressure (mmHg) (10 to 19 years) ","No usable data for effect sizes"
"CD015875_data","1::7::Adverse events (10 to 19 years) ","No usable data for effect sizes"
"CD015875_data","1::9::BMI percentile (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","1::10::Hip circumference (cm) (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","1::11::Waist-to-hip ratio (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","1::12::Skinfolds (mm) (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","1::13::Total fat mass (kg) (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","1::14::Total lean mass (kg) (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","1::15::Trunk-fat mass (kg) (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","1::16::Trunk lean mass (kg) (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","1::17::Trunk adiposity (%) (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","1::18::Visceral adipose tissue (L) (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","1::19::Subcutaneous adipose tissue (L) (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","1::20::Liver adiposity (%) (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","1::24::Total cholesterol (mg/dL) (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","1::25::LDL cholesterol (mg/dL) (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","1::26::HDL cholesterol (mg/dL) (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","1::27::Triglycerides (mg/dL) (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","1::28::Free fatty acids (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","1::29::Ghrelin (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","1::30::Leptin (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","1::31::PYY (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","1::32::GLP1 active (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","1::33::GLP1 total (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","2::1::Waist circumference (cm) (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","2::2::Total Body Fat Percentage (%TBF) (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","2::3::Systolic blood pressure (mmHg) (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","2::4::Diastolic blood pressure (mmHg) (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","2::5::Adverse events (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","2::6::BMI Z-score (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","2::7::Total lean mass (kg) (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","2::8::Abnormal glycaemia (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","2::9::Dyslipidaemia (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","2::10::Metabolic syndrome (10 to 19 years) ","No usable data for effect sizes"
"CD015875_data","2::11::Fasting insulin (uIU/mL) (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","2::12::HOMA-IR (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","2::13::Fasting glucose (mg/dL) (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","2::14::HbA1c (%) (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","3::1::Adverse events (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","3::2::Fasting glucose (mg/dL) (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","3::3::HbA1c (%) (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","3::4::Cholesterol (mg/dL) (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","3::5::Triglycerides (mg/dL) (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","3::6::Phospholipids (mg/g) (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","3::7::Long-chain fatty acids (mg/g) (10 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::1::Body Mass Index (kg/m2) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::2::Weight (kg) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::3::Waist circumference (cm) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::4::Total Body Fat Percentage (%TBF) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::5::Systolic blood pressure (mmHg) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::6::Adverse events (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::7::Adverse events: abdominal cramps (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::8::Adverse events: abdominal discomfort (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::9::Adverse events: abdominal distension (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::10::Adverse events: abdominal pain (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::11::Adverse events: constipation (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::12::Adverse events: diarrhoea (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::13::Adverse events: flatulence (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::14::Adverse events: migraine (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::15::Adverse events: vomiting (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::17::Low-intensity physical activity (min/wk) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::18::Moderate-intensity physical activity (min/wk) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::19::Waist-iliac crest circumference (cm) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::20::Waist-umbilicus circumference (cm) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::21::Fat Mass Index (kg/m2) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::22::Fat-Free Mass Index (kg/m2) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::23::Trunk Fat Mass Index (kg/m2) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::24::Visceral fat area (cm2) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::25::Bone mineral density (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::27::HOMA-IR (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::29::HbA1c (%) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::34::Ghrelin (pg/mL) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::35::GIP (pg/mL) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::36::GLP1 (pg/mL) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::37::PYY (pg/mL) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::38::Leptin (ng/mL) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::39::Resistin (ng/mL) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","4::40::Adiponectin (ug/mL) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","5::8::Adverse events: diarrhoea (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","5::9::BMI Z-scores (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","5::10::Mean arterial pressure (MAP) (mmHg) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","5::11::Heart rate (beats/min) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","5::12::Hip circumference (cm) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","5::13::Abdominal fat mass (%) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","5::14::Abdominal fat mass (g) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","5::15::Body fat mass (g) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","5::24::Adiponectin (ug/mL) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","5::25::Leptin (ng/mL) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","5::26::Omentin-1 (ng/mL) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","5::27::Retinol-binding protein 4 (mg/dL) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","6::1::Body Mass Index (kg/m2) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","6::3::Waist circumference (cm) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","6::4::Systolic blood pressure (mmHg) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","6::5::Diastolic blood pressure (mmHg) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","6::7::BMI Z-scores (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","6::8::Physical activity (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","6::9::Waist-to-hip ratio (WHR) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","6::10::HOMA-IR (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","6::11::Fasting glucose (mg/dL) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","6::16::Adiponectin (ug/mL) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","7::1::Waist circumference (cm) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","7::2::Total Body Fat Percentage (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","7::3::Adverse events (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","7::4::Body weight Z-scores (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","7::5::Total lean mass (kg) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","7::6::Fasting glucose (mg/dL) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","7::7::Total cholesterol (mg/dL) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","7::8::LDL cholesterol (mg/dL) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","7::9::HDL cholesterol (mg/dL) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","7::10::Triglycerides (mg/dL) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","8::1::Body Mass Index (kg/m2) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","8::2::Waist circumference (cm) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","8::3::Adverse events: nausea (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","8::4::Adverse events: headache (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","8::5::BMI Z-scores (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","8::6::Fasting insulin (uIU/mL) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","8::7::HOMA-IR (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","8::8::Fasting glucose (mg/dL) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","8::9::Total cholesterol (mg/dL) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","8::10::LDL cholesterol (mg/dL) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","8::11::HDL cholesterol (mg/dL) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","8::12::Triglycerides (mg/dL) (0 to 19 years)","No usable data for effect sizes"
"CD015875_data","8::13::Ghrelin (pg/mL) (0 to 19 years)","No usable data for effect sizes"
"CD015877_data","1::1::BMI reduction, stabilisation and/or maintenance (kg/m2) (0 to 9)","No usable data for effect sizes"
"CD015877_data","1::2::Weight reduction, stabilisation and/or maintenance (kg) (0 to 9)","No usable data for effect sizes"
"CD015877_data","1::3::Adiposity and fat distribution: waist circumference (cm) (0 to 9)","No usable data for effect sizes"
"CD015877_data","2::1::BMI reduction, stabilisation and/or maintenance (kg/m2) (10 to 19)","No usable data for effect sizes"
"CD015877_data","2::2::Weight reduction, stabilisation and/or maintenance (kg) (10 to 19)","No usable data for effect sizes"
"CD015877_data","2::3::Adiposity and fat distribution: waist circumference (cm) (10 to 19)","No usable data for effect sizes"
"CD015877_data","3::1::Resistance to insulin: Homeostasis Model Assessment - Insulin Resistance (HOMA-IR index) (0 to 19)","No usable data for effect sizes"
"CD015894_pub2_data","1::3::Pain assessed with a validated scale for procedural pain in newborns at one to two hours after the procedure","No usable data for effect sizes"
"CD015932_pub2_data","1::1::All-cause mortality","No usable data for effect sizes"
"CD015932_pub2_data","1::2::ICU length of stay","No usable data for effect sizes"
"CD015932_pub2_data","1::3::Rate of pulmonary complications (pneumonia)","No usable data for effect sizes"
"CD015932_pub2_data","2::1::All-cause mortality up to 6 months (time-to-event)","No usable data for effect sizes"
"CD015932_pub2_data","2::2::All-cause mortality","No usable data for effect sizes"
"CD015932_pub2_data","2::3::In-hospital mortality (OR)","No usable data for effect sizes"
"CD015932_pub2_data","2::5::Mortality up to 28 (± 2) days (time-to-event)","No usable data for effect sizes"
"CD015932_pub2_data","2::6::ICU length of stay (time-to-event, measure of association)","No usable data for effect sizes"
"CD015932_pub2_data","2::8::Hospital length of stay (time-to-event, measure of association)","No usable data for effect sizes"
"CD015932_pub2_data","2::10::Rate of pulmonary complications (ventilator-associated pneumonia)","No usable data for effect sizes"
"CD015932_pub2_data","4::6::Number of patients in ICU at day 28 ± 7 (time-to-event)","No usable data for effect sizes"
"CD015932_pub2_data","4::7::Quality of life (GOSE < 5 at 6 months)","No usable data for effect sizes"
"CD015932_pub2_data","4::8::Rate of pulmonary complications – (acute) respiratory failure)","No usable data for effect sizes"
"CD015932_pub2_data","4::9::Rate of pulmonary complications – (acute) respiratory failure (time-to-event)","No usable data for effect sizes"
"CD015932_pub2_data","4::10::Rate of pulmonary complications – ARDS (time-to-event)","No usable data for effect sizes"
"CD015932_pub2_data","4::11::Rate of pulmonary complications – aspiration","No usable data for effect sizes"
"CD015932_pub2_data","4::14::Rate of pulmonary complications – pulmonary embolism (time-to-event)","No usable data for effect sizes"
"CD015932_pub2_data","4::16::Adverse events – granuloma formation in the trachea","No usable data for effect sizes"
"CD015932_pub2_data","4::17::Adverse events – infections of tracheostoma","No usable data for effect sizes"
"CD015932_pub2_data","4::18::Adverse event – surgical site infections","No usable data for effect sizes"
"CD015932_pub2_data","4::19::Adverse event – vocal cord palsy","No usable data for effect sizes"
"CD015968_data","1::1::BMI (z-score) Change","No usable data for effect sizes"
"CD015968_data","1::8::Glycemia fasting - End of study","No usable data for effect sizes"
"CD015968_data","1::9::HDL cholesterol - End of study","No usable data for effect sizes"
"CD015968_data","1::10::LDL cholesterol - End of study","No usable data for effect sizes"
"CD015968_data","1::11::Total cholesterol - End of study","No usable data for effect sizes"
"CD015968_data","1::12::Triglyceride - End of study","No usable data for effect sizes"
"CD015968_data","2::3::BMI (percentile) Change","No usable data for effect sizes"
"CD015968_data","2::5::BMI (Kg/m2) Change","No usable data for effect sizes"
"CD015968_data","2::6::BMI (kg/m2) - End of study","No usable data for effect sizes"
"CD015968_data","2::7::Weight (Kg) Change","No usable data for effect sizes"
"CD015968_data","2::8::Weight (kg) - End of study","No usable data for effect sizes"
"CD015968_data","2::9::Fat mass (%) - End of study","No usable data for effect sizes"
"CD015968_data","2::10::Fat mass (kg) - End of study","No usable data for effect sizes"
"CD015968_data","2::11::Waist circumference (cm) Change","No usable data for effect sizes"
"CD015968_data","2::12::Waist circumference (cm) - End of study","No usable data for effect sizes"
"CD015968_data","2::13::Physical well-being - Change","No usable data for effect sizes"
"CD015968_data","2::14::Mental well-being - Change","No usable data for effect sizes"
"CD015968_data","2::15::Quality of life - Change","No usable data for effect sizes"
"CD015968_data","2::16::Glycemia fasting (mg/dL) - End of study","No usable data for effect sizes"
"CD015968_data","2::17::HDL cholesterol (mg/dL) - End of study","No usable data for effect sizes"
"CD015968_data","2::18::LDL cholesterol (mg/dL) - End of study","No usable data for effect sizes"
"CD015968_data","2::19::Total cholesterol (mg/dL) - End of study","No usable data for effect sizes"
"CD015968_data","2::20::Triglyceride (mg/dL) - End of study","No usable data for effect sizes"
"CD016001_data","1::2::Disability","No usable data for effect sizes"
"CD016001_data","1::3::Secondary events","No usable data for effect sizes"
"CD016001_data","1::4::Falls","No usable data for effect sizes"
"CD016001_data","1::5::Blood pressure (systolic)","No usable data for effect sizes"
"CD016001_data","1::6::Blood pressure (diastolic)","No usable data for effect sizes"
"CD016001_data","1::7::Cardiorespiratory fitness (peak VO<sub>2</sub>)","No usable data for effect sizes"
"CD016001_data","1::18::Health status (overall)","No usable data for effect sizes"
"CD016001_data","1::19::Health status (physical)","No usable data for effect sizes"
"CD016001_data","1::20::Health status (mental)","No usable data for effect sizes"
"CD016001_data","1::22::Mood (anxiety)","No usable data for effect sizes"
"CD016001_data","2::8::Musculoskeletal fitness (strength, LL affected)","No usable data for effect sizes"
"CD016001_data","2::9::Musculoskeletal fitness (strength, LL unaffected)","No usable data for effect sizes"
"CD016001_data","2::10::Musculoskeletal fitness (strength, UL affected)","No usable data for effect sizes"
"CD016001_data","2::13::Walking speed (comfortable)","No usable data for effect sizes"
"CD016001_data","2::16::Balance","No usable data for effect sizes"
"CD016001_data","2::23::Mood (depression)","No usable data for effect sizes"
"CD016002_data","1::12::Walking independence (functional ambulation category)","No usable data for effect sizes"
"CD016002_data","1::20::Health status (mental health)","No usable data for effect sizes"
"CD016002_data","2::9::Musculoskeletal fitness (strength LL, unaffected side)","No usable data for effect sizes"
"CD016002_data","2::12::Walking independence (functional ambulation category)","No usable data for effect sizes"
"CD016031_data","1::1::Comparison 1: Anterior vs posterior, Outcome 1: ADL, early (≤ 4 months, continuous data)","No usable data for effect sizes"
"CD016031_data","1::2::Comparison 1: Anterior vs posterior, Outcome 2: ADL, intermediate ( 4-24 months, continuous data)","No usable data for effect sizes"
"CD016031_data","1::3::Comparison 1: Anterior vs posterior, Outcome 3: HRQoL, intermediate (4-24 months, categorical data)","No usable data for effect sizes"
"CD016031_data","1::4::Comparison 1: Anterior vs posterior, Outcome 4: HRQoL, intermediate (4-24 months, continuous data)","No usable data for effect sizes"
"CD016031_data","1::11::Comparison 1: Anterior vs posterior, Outcome 11: Mortality, late (≥ 24 months, categorical data)","No usable data for effect sizes"
"CD016031_data","1::13::Comparison 1: Anterior vs posterior, Outcome 13: Pain, intermediate (4-24 months, categorical data)","No usable data for effect sizes"
"CD016031_data","1::15::Comparison 1: Anterior vs posterior, Outcome 15: Re-operation rate, early (≤ 4 months, categorical data)","No usable data for effect sizes"
"CD016031_data","1::16::Comparison 1: Anterior vs posterior, Outcome 16: Re-operation rate, intermediate (4-24 months, categorical data)","No usable data for effect sizes"
"CD016031_data","2::2::Comparison 2: Anterior vs lateral, Outcome 2: ADL, intermediate ( 4-24 months, continuous data)","No usable data for effect sizes"
"CD016031_data","2::4::Comparison 2: Anterior vs lateral, Outcome 4: Functional status, early (≤ 4 months, categorical data)","No usable data for effect sizes"
"CD016031_data","2::6::Comparison 2: Anterior vs lateral, Outcome 6: Functional status, intermediate (4-24 months, categorical data)","No usable data for effect sizes"
"CD016031_data","2::7::Comparison 2: Anterior vs lateral, Outcome 7: Mortality, early (≤ 4 months, categorical data)","No usable data for effect sizes"
"CD016031_data","2::10::Comparison 2: Anterior vs lateral, Outcome 10: Pain, intermediate (4-24 months, continuous data)","No usable data for effect sizes"
"CD016031_data","2::12::Comparison 2: Anterior vs lateral, Outcome 12: Re-operation rate, intermediate (4-24 months, categorical data)","No usable data for effect sizes"
"CD016031_data","3::1::Comparison 3: Lateral vs posterior, Outcome 1: ADL, early (≤ 4 months, continuous data)","No usable data for effect sizes"
"CD016031_data","3::2::Comparison 3: Lateral vs posterior, Outcome 2: ADL, intermediate ( 4-24 months, continuous data)","No usable data for effect sizes"
"CD016031_data","3::4::Comparison 3: Lateral vs posterior, Outcome 4: HRQoL, intermediate (4-24 months, continuous data)","No usable data for effect sizes"
"CD016058_pub2_data","1::1::Vaping cessation at 6 months or longer","No usable data for effect sizes"
"CD016058_pub2_data","1::2::Number of participants reporting SAEs","No usable data for effect sizes"
"CD016058_pub2_data","1::4::Number of participants reporting AEs","No usable data for effect sizes"
"CD016058_pub2_data","1::5::Weight (lbs) at longest follow-up","No usable data for effect sizes"
"CD016058_pub2_data","1::6::Systolic blood pressure (mmHg) at longest follow-up","No usable data for effect sizes"
"CD016058_pub2_data","1::7::Heart rate (bpm) at longest follow-up","No usable data for effect sizes"
"CD016058_pub2_data","2::1::Number of  participants reporting SAEs","No usable data for effect sizes"
"CD016058_pub2_data","2::2::Vaping cessation at between 3 & 6 months","No usable data for effect sizes"
"CD016058_pub2_data","2::3::Change in combustible tobacco product use (tobacco cigarette use) at between 3 & 6 months","No usable data for effect sizes"
"CD016058_pub2_data","2::4::Number of participants reporting AEs","No usable data for effect sizes"
"CD016058_pub2_data","2::5::Mean change in systolic blood pressure (mmHg)","No usable data for effect sizes"
"CD016058_pub2_data","2::6::Mean change in diastolic blood pressure (mmHg)","No usable data for effect sizes"
"CD016058_pub2_data","2::7::Mean change in heart rate (bpm)","No usable data for effect sizes"
"CD016058_pub2_data","2::8::Cotinine (ng/ml) at longest follow-up","No usable data for effect sizes"
"CD016058_pub2_data","3::1::Vaping cessation at 6 months or longer","No usable data for effect sizes"
"CD016058_pub2_data","3::5::Weight (lbs) at longest follow-up","No usable data for effect sizes"
"CD016058_pub2_data","3::6::Systolic blood pressure (mmHg) at longest follow-up","No usable data for effect sizes"
"CD016058_pub2_data","3::7::Diastolic blood pressure (mmHg) at longest follow-up","No usable data for effect sizes"
"CD016058_pub2_data","3::8::Heart rate (bpm) at longest follow-up","No usable data for effect sizes"
"CD016058_pub2_data","4::1::Vaping cessation at 6 months or longer","No usable data for effect sizes"
"CD016058_pub2_data","4::2::Vaping cessation at between 3 & 6 months","No usable data for effect sizes"
"CD016058_pub2_data","4::3::Weight (lbs) at longest follow-up","No usable data for effect sizes"
"CD016058_pub2_data","4::4::Systolic blood pressure (mmHg) at longest follow-up","No usable data for effect sizes"
"CD016058_pub2_data","4::5::Heart rate (bpm) at longest follow-up","No usable data for effect sizes"
"CD016058_pub2_data","5::2::Number of participants reporting SAEs","No usable data for effect sizes"
"CD016058_pub2_data","5::3::Vaping cessation at between 3 & 6 months","No usable data for effect sizes"
"CD016058_pub2_data","5::4::Number of participants reporting AEs","No usable data for effect sizes"
"CD016058_pub2_data","6::1::Number of participants reporting SAEs","No usable data for effect sizes"
"CD016058_pub2_data","7::1::Numbers of participants reporting SAEs","No usable data for effect sizes"
"CD016058_pub2_data","7::2::Vaping cessation at between 3 & 6 months","No usable data for effect sizes"
"CD016058_pub2_data","7::3::Number of participants reporting AEs","No usable data for effect sizes"
"CD016058_pub2_data","8::1::Vaping cessation at 6 months or longer","No usable data for effect sizes"
"CD016058_pub2_data","8::2::Vaping cessation at between 3 & 6 months","No usable data for effect sizes"
"CD016058_pub2_data","8::3::Weight (lbs) at longest follow-up","No usable data for effect sizes"
"CD016058_pub2_data","8::4::Systolic blood pressure (mmHg) at longest follow-up","No usable data for effect sizes"
"CD016058_pub2_data","8::5::Heart rate (bpm) at longest follow-up","No usable data for effect sizes"
"CD016058_pub2_data","9::1::Numbers of participants reporting SAEs","No usable data for effect sizes"
"CD016058_pub2_data","9::2::Vaping cessation at between 3 & 6 months","No usable data for effect sizes"
"CD016058_pub2_data","9::3::Number of participants reporting AEs","No usable data for effect sizes"
"CD016064_data","11::3::Risk of fracture","No usable data for effect sizes"
"CD016064_data","16::1::Risk of falling","No usable data for effect sizes"
"CD016064_data","17::1::Rate of falls","No usable data for effect sizes"
"CD016064_data","17::2::Risk of falling","No usable data for effect sizes"
"CD016064_data","19::1::Rate of falls","No usable data for effect sizes"
"CD016064_data","19::3::Risk of falling","No usable data for effect sizes"
"CD016119_data","1::13::Future major surgery","No usable data for effect sizes"
"CD016119_data","1::15::AUS pain score","No usable data for effect sizes"
"CD016119_data","1::16::VNRS-6 pain score","No usable data for effect sizes"
"CD016119_data","1::17::Intraoperative injury","No usable data for effect sizes"
"CD016119_data","1::18::Bladder injury","No usable data for effect sizes"
"CD016120_data","1::6::Sepsis","No usable data for effect sizes"
"CD016120_data","1::9::Change in haemoglobin","No usable data for effect sizes"
"CD016120_data","1::10::Major surgery including hysterectomy","No usable data for effect sizes"
"CD016120_data","1::15::Clotting abnormalities: Activation coagulation time (ACT) at day 1 postpartum","No usable data for effect sizes"
"CD016120_data","1::19::Maternal well-being: Mental fatigue","No usable data for effect sizes"
"CD016120_data","1::20::Maternal well-being: General fatigue","No usable data for effect sizes"
"CD016120_data","1::21::Maternal well-being: Physical fatigue","No usable data for effect sizes"
"CD016120_data","1::22::Maternal well-being: Reduced motivation","No usable data for effect sizes"
"CD016120_data","1::23::Maternal well-being: Reduced activity","No usable data for effect sizes"
"CD016131_data","2::1::RSV-associated lower respiratory tract infection","No usable data for effect sizes"
"CD016131_data","2::2::RSV-associated acute respiratory illness","No usable data for effect sizes"
"CD016131_data","2::3::Mortality from illness caused by RSV","No usable data for effect sizes"
"CD016131_data","2::4::All-cause mortality","No usable data for effect sizes"
"CD016131_data","2::5::Serious adverse events (SAEs) related to vaccination&nbsp;","No usable data for effect sizes"
"CD016131_data","5::1::New RSV infection","No usable data for effect sizes"
"CD016131_data","5::2::Mortality from illness caused by RSV","No usable data for effect sizes"
"CD016131_data","5::3::All-cause mortality&nbsp;","No usable data for effect sizes"
"CD016131_data","5::4::Serious adverse events (SAEs) related to vaccination&nbsp;","No usable data for effect sizes"
"CD016147_data","1::3::Adverse effects (shivering)","No usable data for effect sizes"
"CD016147_data","1::5::Adverse effects (vomiting)","No usable data for effect sizes"
"CD016147_data","1::7::Adverse effects (headache)","No usable data for effect sizes"
"CD016147_data","1::9::Adverse effects (dyspepsia)","No usable data for effect sizes"
"CD016147_data","1::10::Adverse effects (flushes)","No usable data for effect sizes"
"CD016147_data","2::1::Manual removal of the placenta (end of treatment)","No usable data for effect sizes"
"CD016147_data","2::2::Additional uterotonics","No usable data for effect sizes"
"CD016147_data","2::3::Blood transfusion","No usable data for effect sizes"
"CD016147_data","3::1::Manual removal of the placenta (end of treatment)","No usable data for effect sizes"
"CD016147_data","3::2::Additional uterotonics","No usable data for effect sizes"
"CD016147_data","3::3::Blood transfusion","No usable data for effect sizes"
"CD016147_data","4::1::Manual removal of the placenta (end of treatment)","No usable data for effect sizes"
"CD016147_data","4::2::Additional uterotonics","No usable data for effect sizes"
"CD016147_data","4::3::Blood transfusion","No usable data for effect sizes"
"CD016147_data","5::1::Manual removal of the placenta (end of treatment)","No usable data for effect sizes"
"CD016148_data","1::3::3rd degree tears","No usable data for effect sizes"
"CD016148_data","1::4::4th degree tears","No usable data for effect sizes"
"CD016148_data","1::5::PPH ≥ 500mL","No usable data for effect sizes"
"CD016148_data","1::6::Perineal pain","No usable data for effect sizes"
"CD016148_data","1::7::Breastfeeding","No usable data for effect sizes"
"CD016148_data","1::8::Maternal death","No usable data for effect sizes"
"CD016148_data","2::1::2nd degree tears","No usable data for effect sizes"
"CD016148_data","2::2::3rd degree tears","No usable data for effect sizes"
"CD016148_data","2::3::4th degree tears","No usable data for effect sizes"
"CD016148_data","2::4::Maternal satisfaction (dichotomous)","No usable data for effect sizes"
"CD016148_data","2::5::Perineal pain","No usable data for effect sizes"
"CD016148_data","3::5::Perineal pain","No usable data for effect sizes"
"CD016148_data","4::4::Pain","No usable data for effect sizes"
"CD016148_data","5::1::2nd degree tears","No usable data for effect sizes"
"CD016148_data","5::2::3rd degree tears","No usable data for effect sizes"
"CD016148_data","5::3::Maternal satisfaction (continuous)","No usable data for effect sizes"
"CD016148_data","5::4::PPH ≥  500mL","No usable data for effect sizes"
"CD016148_data","6::1::2nd degree tears","No usable data for effect sizes"
"CD016148_data","6::2::3rd or 4th degree tears","No usable data for effect sizes"
"CD016148_data","6::3::PPH ≥ 500mL","No usable data for effect sizes"
"CD016148_data","7::1::3rd degree tears","No usable data for effect sizes"
"CD016148_data","7::2::4th degree tears","No usable data for effect sizes"
"CD016148_data","8::1::3rd or 4th degree tears","No usable data for effect sizes"
"CD016148_data","9::1::2nd degree tears","No usable data for effect sizes"
"CD016148_data","9::2::3rd degree tears","No usable data for effect sizes"
"CD016148_data","10::1::2nd degree tears","No usable data for effect sizes"
"CD016148_data","11::2::2nd degree tears","No usable data for effect sizes"
"CD016148_data","11::4::Side effects","No usable data for effect sizes"
"CD016168_data","1::1::Severe maternal morbidity – composite excluding ICU admission","No usable data for effect sizes"
"CD016168_data","1::2::Severe maternal morbidity – ICU admission","No usable data for effect sizes"
"CD016168_data","1::3::Breastfeeding","No usable data for effect sizes"
"CD016168_data","2::3::Severe maternal morbidity – arterial embolisation","No usable data for effect sizes"
"CD016168_data","2::4::Severe maternal morbidity – hysterectomy (randomised studies)","No usable data for effect sizes"
"CD016168_data","2::5::Severe maternal morbidity – hysterectomy (non-randomised studies)","No usable data for effect sizes"
"CD016168_data","2::7::Adverse effects – dizziness up to 24 hours","No usable data for effect sizes"
"CD016168_data","2::8::Adverse effects – shivering up to 24 hours","No usable data for effect sizes"
"CD016168_data","2::9::Adverse effects – fever up to 24 hours","No usable data for effect sizes"
"CD016168_data","2::10::Adverse effects – abdominal pain up to 24 hours","No usable data for effect sizes"
"CD016168_data","2::11::Adverse effects – headache up to 24 hours","No usable data for effect sizes"
"CD016168_data","2::12::Adverse effects – nausea or vomiting up to 24 hours","No usable data for effect sizes"
"CD016168_data","2::13::Adverse effects – fainting up to 24 hours","No usable data for effect sizes"
"CD016168_data","2::14::Adverse effects – palpitations up to 24 hours","No usable data for effect sizes"
"CD016168_data","2::15::Adverse effects – allergic reaction up to 24 hours","No usable data for effect sizes"
"CD016168_data","2::16::Adverse effects – urticaria up to 24 hours","No usable data for effect sizes"
"CD016168_data","2::17::Adverse effects – itching up to 24 hours","No usable data for effect sizes"
"CD016168_data","2::18::Adverse effects – shortness of breath up to 24 hours","No usable data for effect sizes"
"CD016168_data","2::19::Adverse effects – facial oedema up to 24 hours","No usable data for effect sizes"
"CD016168_data","2::20::Adverse effects – re-admission with the need for re-evacuation of uterine cavity at 6 weeks","No usable data for effect sizes"
"CD016168_data","2::21::Breastfeeding","No usable data for effect sizes"
"CD016168_data","3::1::Maternal death (randomised studies)","No usable data for effect sizes"
"CD016168_data","3::2::Maternal death (non-randomised studies)","No usable data for effect sizes"
"CD016168_data","3::3::Severe maternal morbidity – ICU admission","No usable data for effect sizes"
"CD016168_data","3::4::Severe maternal morbidity – any organ failure","No usable data for effect sizes"
"CD016168_data","3::5::Severe maternal morbidity – laporotomy","No usable data for effect sizes"
"CD016168_data","3::6::Severe maternal morbidity – uterine artery embolisation","No usable data for effect sizes"
"CD016168_data","3::7::Severe maternal morbidity – hysterectomy (randomised studies)","No usable data for effect sizes"
"CD016168_data","3::8::Severe maternal morbidity – hysterectomy (non-randomised studies)","No usable data for effect sizes"
"CD016168_data","3::9::Adverse effects – maternal sepsis","No usable data for effect sizes"
"CD016168_data","3::10::Adverse effects – pulmonary embolism","No usable data for effect sizes"
"CD016168_data","3::11::Adverse effects – other venous/arterial thromboembolic event","No usable data for effect sizes"
"CD016168_data","3::12::Adverse effects – transfusion-related reactions","No usable data for effect sizes"
"CD016168_data","3::13::Other adverse events (as defined by study investigators)","No usable data for effect sizes"
"CD016168_data","3::14::Maternal wellbeing – general fatigue","No usable data for effect sizes"
"CD016168_data","3::15::Maternal wellbeing – physical fatigue","No usable data for effect sizes"
"CD016168_data","3::16::Maternal wellbeing – reduced activity","No usable data for effect sizes"
"CD016168_data","3::17::Maternal wellbeing – reduced motivation","No usable data for effect sizes"
"CD016168_data","3::18::Maternal wellbeing – mental fatigue","No usable data for effect sizes"
"CD016211_data","1::9::Other maternal infections: wound infection (any)","No usable data for effect sizes"
"CD016211_data","1::10::Other maternal infections: wound infection (perineal)","No usable data for effect sizes"
"CD016211_data","1::14::NICU admission","No usable data for effect sizes"
